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“I could recount an endless number of stories about carbon atoms that become colours or 
perfumes in flowers; of others which, from tiny algae to small crustaceans to fish, gradually 
return as carbon dioxide to the waters of the sea… Instead, I will tell just one more story…” 
 
Primo Levi in The Periodic Table, 1975 
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Abstract 
 
Various genetically modified micro-organisms that over-express dioxygenase-type enzymes can 
be used for the whole-cell biotransformation of a wide range of arenes (1) into the 
corresponding cis-1,2-dihydrocatechols (2). These metabolites, which are obtained in 
enantiopure form, can serve as valuable starting materials for the chemical synthesis of a wide-
range of biologically active natural products and related species. 
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This thesis reports on a series of studies, encompassing both natural product synthesis and 
methodological development, that were undertaken with the broad objective of investigating 
new uses and applications of cis-1,2-dihydrocatechols in organic synthesis. In particular, this 
thesis describes a thorough investigation into the value of employing these compounds in 
facially selective Diels-Alder cycloaddition reactions and the utilisation of the resulting adducts 
in the synthesis of the sesquiterpenoid natural products (+)-hirsutic acid, (-)-complicatic acid 
and (-)-platencin. 
 
One limitation of the use of enzymatically derived cis-1,2-dihydrocatechols as starting materials 
in total synthesis is that, in most cases, only one enantiomer of the metabolite is produced 
during the biotransformation. Generally, this limitation means that only one enantiomeric form 
of any target natural product can be accessed. In many instances it has, therefore, only been 
possible to synthesise the non-natural enantiomer of certain natural products. The research 
presented in Chapter Two of this Thesis demonstrates that such constraints can be overcome 
using facially selective Diels-Alder cycloaddition reactions. Specifically, the application of 
cis-1,2-dihydrocatechol 39 in an anti-selective intermolecular Diels-Alder reaction is shown to 
allow for the total syntheses of the natural enantiomeric forms of the linear triquinane-type 
natural products (+)-hirsutic acid [(+)-82] and (-)-complicatic acid [(-)-83]. This work follows 
on from previous studies undertaken in the Banwell group, in which the non-natural 
enantiomeric form of the linear triquinane hirsutene [ent-(-)-84] was synthesised via a 
syn-selective Diels-Alder reaction involving the SAME metabolite (35). 
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Although intermolecular Diels-Alder reactions of cis-1,2-dihydrocatechols have been well 
studied and found extensive use in total syntheses, the corresponding intramolecular process has 
been used to a lesser extent. The work presented in Chapter Three provides a detailed 
characterisation of the intramolecular cycloaddition reactions of cis-1,2-dihydrocatechols, 
demonstrating that the facial selectivity of these reactions can be controlled in an analogous 
manner to the intermolecular variant. These protocols have been utilised, as detailed in Chapter 
Four, in an enantioselective total synthesis of the recently discovered antibacterial natural 
product (-)-platencin [(-)-92]. Specifically, cis-1,2-dihydrocatechol derivative 89 is shown to 
undergo a facially selective intramolecular Diels-Alder reaction to afford cycloadduct 90, which 
is then elaborated to the carbocyclic core structure of this potent antibacterial agent. 
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Glossary 
 
The following abbreviations have been used throughout this thesis: 
 
!   chemical shift (parts per million) 
ºC   degrees Celcius 
"   wavelength (nm) 
"max   wavelength of maximum absorption (nm) 
"transmission  wavelength of transmission (nm) 
µg   microgram(s) 
µL   microlitre(s) 
Ac   acetyl 
AcOH   acetic acid 
AIBN   2,2’-azobis(isobutyronitrile) 
APT   attached proton test (
13
C NMR spectroscopy) 
aq.   aqueous 
Ar   unspecified aryl group 
atm   atmosphere(s) 
BDMA   benzaldehyde dimethylacetal 
BHT   2,6-di-t-butyl-methylphenol 
Bn   benzyl 
BOM   benzyloxymethyl 
br   broad 
Bu   butyl 
n-Bu   normal-butyl 
s-Bu   secondary-butyl 
t-Bu   tertiary-butyl 
c   concentration (g/100 mL) 
ca.   circa (approximately) 
cat.   catalytic/catalyst 
CBS   Corey-Bakashi-Shibata (conditions for an asymmetric reduction ) 
cf.   confer (compare) 
cm   centimetre(s) 
Cod   1,5-cyclooctadiene 
conc.   concentrated 
COSY   
1
H-
1
H correlation spectroscopy 
CSA   (1S)-(+)-10-camphor sulfonic acid 
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d   doublet 
DA   intermolecular Diels-Alder 
DCC   1,3-dicyclohexylcarbodiimide 
DDQ   2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DEAD   diethyl azodicarboxylate 
c-DHC   cis-1,2-dihydrocatechol 
DIBAL-H  diisobutylaluminium hydride 
DMAP   4-(N,N-dimethylamino)pyridine 
DME   1,2-dimethoxyethane 
DMF   N,N-dimethylformamide 
2,2-DMP  2,2-dimethoxypropane 
DMPU   1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
DMS   dimethyl sulfide 
DMSO   dimethyl sulfoxide 
DVK   divinyl ketone 
ee   enantiomeric excess 
e.g.   exempli gratia (for example) 
EI   electron impact (mass spectrometry) 
equiv.   equivalents 
ES   electrospray (mass spectrometry) 
Et   ethyl 
et al.   et alia (and others) 
Et3N   triethylamine 
Et2O   diethyl ether 
EtOAc   ethyl acetate 
EtOH   ethanol 
ETSA   ethyl(trimethylsilyl)acetate 
eV   electron volt(s) 
FGI   functional group interconversion 
g   gram 
GC   gas chromatograpy 
gem   geminal 
gen.   generation 
h   hour(s) 
HATU O-(7-azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium 
hexafluorophosphate 
HMPA   hexamethylphosphoramide 
HRMS   high resolution mass spectrometry 
 Glossary 
 
xv 
h!   light 
Hz   Hertz 
IMDA   intramolecular Diels-Alder 
IBX   2-iodobenzoic acid 
IR   infra red 
J    
1
H-
1
H coupling constant 
kbar   kilobar(s) 
KHMDS  potassium bis(trimethylsilyl)amide 
L   litre(s) 
LDA   lithium diisopropylamide 
LiHMDS  lithium bis(trimethylsilyl)amide 
lit.   literature value 
LiTMP   lithium 2,2,6,6-tetramethylpiperidine  
LRMS   low resolution mass spectrometry 
m   multiplet 
M   molar  
M
+
   molecular ion 
Me   methyl 
MeOH   methanol 
MEM   (2-methoxyethoxy)methoxy 
MHz   mega-Hertz 
min   minute(s) 
mL   millilitre(s) 
mm   millimetre(s) 
mmol   millimole(s) 
mol   mole(s) 
m.p.   melting point (ºC) 
MS   mass spectroscopy 
m/z   mass-to-charge ratio 
NaHMDS  sodium bis(trimethylsilyl)amide 
NBS   N-bromosuccinimide 
nm   nanometer(s) 
NMO   N-methylmorpholine-N-oxide 
NMR   nuclear magnetic resonance 
nOe   nuclear Overhauser enhancement 
ODPM   oxa-di-"-methane 
ORTEP   Oak Ridge Thermal Ellipsoid Plot 
P   unspecified protecting group 
 Glossary 
 
xvi 
p   para 
PCC   pyridinium chlorochromate 
Ph   phenyl 
plc   preparative layer chromatography 
PMB   p-methoxybenzyl 
PMP   p-methoxyphenyl 
ppm   parts per million 
PPTS   pyridinium p-toluenesulfonate 
i-PrMgCl  iso-propyl magnesium chloride 
q   quartet 
qu   quintet 
quant.   quantitative 
ref.   reference 
R   unspecified alkyl group 
Rf   thin layer chromatography retardation factor 
r.t   room temperature 
s   singlet 
SEM   2-(trimethylsilyl)ethoxymethyl 
t   triplet 
t   tertiary 
TASF   tris(dimethylamino)sulfonium difluorotrimethylsilicate 
TBAF   tetra-n-butylammonium fluoride 
TBDPS   t-butyldiphenylsilyl 
TBS   t-butyldimethylsilyl 
TDO   toluene dioxygenase 
TEAD   bis-(2,2,2-trichloroethyl) azodicarboxylate 
temp.   temperature (ºC) 
TEMPO  2,2,6,6-tetramethyl-1-piperidinyloxy free radical 
TES   triethylsilyl 
Tf   trifluoromethanesulfonyl 
TFA   trifluoroacetic acid 
THF   tetrahydrofuran 
THS   t-hexyldimethylsilyl 
TIPS   triisopropylsilyl 
tlc   thin layer chromatography 
TMEDA  N,N,N’,N’-tetramethylenediamine 
TMS   trimethylsilyl 
TPAP   tetrapropylammonium perruthenate 
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TsOH   toluenesulfonic acid 
UV   ultra violet (spectroscopy) 
viz.   videlicit (that is, namely) 
vs.   versus 
v/v   unit volume per unit volume (ratio) 
W   watt(s) 
w/v   unit weight per unit volume (%) 
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CHAPTER ONE 
Introduction: cis-1,2-Dihydrocatechols and their 
use in Diels-Alder Cycloaddition Reactions 
 
1.1 Enzymatic Production of cis-1,2-Dihydrocatechols from Arenes 
 
The ability of microbes to metabolise aromatic hydrocarbons was first demonstrated in 1908 
when Stromer et al. reported the isolation of a bacterial strain, Bacillus hexacarbovorum, able to 
grow using toluene or xylene as a carbon source.1 The risk that aromatic hydrocarbons pose in 
the environment has resulted in much investigation into the microbial degradation of these 
compounds and the various metabolic pathways involved in such processes.2 Gibson et al. 
elucidated one of these pathways in 1968, showing that degradation of several aromatics by the 
soil bacterium Pseudomonas putida proceeds via dihydroxylation of the aromatic ring and 
subsequent dehydrogenation of this primary metabolite to the corresponding catechol.3,4 The 
enzyme responsible for the initial dihydroxylation process was identified as toluene 
dioxygenase (TDO).4,5 In later studies, a chemically mutated strain (39D) of P. putida was 
identified that lacked the dehydrogenase responsible for the conversion of the primary oxidation 
product into the catechol. This mutation resulted in the accumulation of the initial oxidation 
product, which was then characterised as cis-1,2-dihydrocatechol 2 (Scheme 1.1).6 Throughout 
this Thesis the term c-DHC will used as an abbreviation cis-1,2-dihydrocatechols of this type.  
 
 
OH
OH
XX
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Scheme 1.1: Production of various c-DHC derivatives from the corresponding arenes by toluene 
dioxygenase. 
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Since these initial observations, a number of other dioxygenase-type enzymes have been 
identified that utilise polynuclear arenes as substrates. Naphthalene dioxygenase is an example 
of such a species.5 Metabolites produced by the action of dioxygenases on various aromatics are 
highly sought after in organic synthetic chemistry for a number or reasons.7-10 Firstly, the 
dihydroxylation occurs in a completely regio- and enantio-selective manner affording single and 
enantiopure products.11 Secondly, this process is one of only a few known that is able to disrupt 
the highly stable aromatic system. Finally, the array of functional groups generated in the 
products is useful for further transformations. In order to exploit this potential, the genes 
encoding for various dioxygenases have been cloned and recombinantly expressed in host 
organisms such as laboratory strains of Escherichia coli, including the widely used JM109 
(pDTG601) strain.12 These recombinant micro-organisms over-express the cloned 
dioxygenases, but lack the dehydrogenase necessary for the subsequent dehydrogenation of the 
primary dihydocatechol, thereby allowing for highly efficient production of significant amounts 
(up to 35 g per litre of fermentation broth) of enantiopure c-DHCs (>99% ee). The range of 
aromatics that can be converted into c-DHCs by this process is remarkably broad, with more 
than 300 metabolites having been reported to date.5,10,11 A small selection of these metabolites is 
shown in Figure 1.1. 
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Figure 1.1: Examples of c-DHCs that demonstrate the structural diversity of the substrates processed by 
toluene, naphthalene and related dioxygenases. 
 
Nevertheless, there are some limitations to the enzymatic transformations of arenes into 
c-DHCs. Firstly, the efficiency and enantioselectivity of these transformations is dependant on 
the substituents on the aromatic ring.11 While a large variety of c-DHCs have been obtained in 
high enantiomeric excesses, there are also examples where this biotransformation proceeds in a 
less enantioselective manner or, sometimes, not at all. Secondly, in most cases this process only 
 Introduction 3 
allows access to one enantiomeric form of the c-DHC. Although some c-DHC derivatives have 
been chemically manipulated to produce the opposite enantiomer, in a method called 
“enantiomeric switching”,13 the yields are often poor and the additional chemical steps detract 
from the convenience of the one-step microbial generation of the c-DHC. Despite these 
limitations, the metabolites described here have been used successfully as starting materials in 
the development of concise, enantiospecific syntheses of various structurally demanding and 
biologically active natural products.10 
 
1.2 cis-1,2-Dihydrocatechols as 4!-Addends in Diels-Alder 
Cycloaddition Reactions 
 
The endocyclic 1,3-diene moiety of c-DHC derivatives readily participates in Diels-Alder 
cycloaddition reactions with a wide range of electron-deficient dienophiles." This capacity has 
been recognised since the discovery of c-DHCs by Gibson and co-workers, when the 
corresponding Diels-Alder adducts were used to assist in assigning the stereochemistry of the 
first examples of these metabolites (Scheme 1.2).6,14 The bi- or tri-cyclic products obtained from 
this reaction are enantiomerically pure and highly functionalised systems, making them valuable 
compounds for use in enantioselective total synthesis. As a result, there has been much research 
into exploiting the cycloaddition reactions of c-DHCs. Both inter- and intra-molecular 
Diels-Alder reactions of c-DHCs have been reported,7 although the intramolecular variants have 
been studied in much less detail. This Section outlines the work that has been carried out in this 
area to date. However, it is first appropriate to review the stereoselectivities associated with the 
Diels-Alder reaction in general. 
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Scheme 1.2: Reagents and conditions (i) benzene, r.t., 6 days. 
 
 
" The less substituted olefinic bond of c-DHCs has also been observed to function as a dienophile in Diels-Alder 
reactions with various dienes.
10
 These examples will not be covered in this Section, which focuses only on their use 
as the diene component of cycloaddition reactions. 
Chapter One 4 
1.2.1 Selectivity in Diels-Alder cycloaddition reactions 
There are three principal selectivity issues associated with the Diels-Alder cycloaddition 
reaction: diastereoselectivity (endo/exo), regioselectivity (ortho/meta) and facial selectivity 
(syn/anti). All three aspects must be taken into account when considering the possible products 
of any given Diels-Alder cycloaddition reaction involving c-DHCs. 
 
The diastereochemical (endo/exo) outcome of any Diels-Alder cycloaddition reaction reflects 
the orientation of the dienophile with respect to the diene at the transition state.15 endo-Addition 
involves orientation of the dienophile such that the substituent bearing the !-bond is positioned 
towards the diene. In contrast, exo-addition involves orientation of the dienophile such that the 
substituent bearing the !-bond is positioned away from the diene. In the intermolecular 
Diels-Alder reaction the endo-orientation is normally preferred. As a result, the endo-adduct is 
observed in the majority of cases. Accordingly, the Diels-Alder reaction between 
cyclopentadiene and maleic anhydride affords cycloadduct 12 as the exclusive product of the 
reaction (Scheme 1.3).16 This preference for the endo-transition state can be explained in terms 
of maximisation of the secondary orbital overlap and is known as the ‘endo rule’.17,18 However, 
this rule does not reliably predict the diastereochemical outcome of intramolecular Diels-Alder 
cycloaddition reactions. Indeed, mixtures of endo- and exo-adducts are often obtained from 
these reactions.19  
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Scheme 1.3: The Diels-Alder cycloaddition reaction between maleic anhydride (9) and cyclopentadiene 
(11).  
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Two regiochemical (ortho/meta!) outcomes are possible if asymmetrical dienes and/or 
dienophiles are employed in a Diels-Alder reaction. Despite the possibility of mixtures of 
regioisomers being produced, these cycloadditions have been found to be highly regioselective 
in most cases.15 The propensity for ortho- or meta-selectivity varies with the substituents on 
both the diene and the dienophile. However, the ortho-adduct is generally preferred (see 
Scheme 1.4 for examples of this).20,21 This ortho-preference has been attributed to the matching 
of complementary orbital coefficients in combination with secondary orbital interactions22 and 
is known as the ‘ortho effect’. However, in the intermolecular reaction, if the diene and/or the 
dienophile have more than one substituent, problems of regioselectively are often encountered 
and mixtures of products are frequently obtained. In contrast, the regioselectively of the 
intramolecular reaction is largely controlled by the conformational constraints imposed by the 
connecting chain/tether. Specifically, if the tether is short then only one regioisomer is possible 
regardless of the substituents on the diene or the dienophile23 (Scheme 1.4).21 In contrast, the 
regioselectivity of this reaction is less predictable when longer tethers (>10 carbon atoms in the 
chain) are used.15 
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Scheme 1.4: Examples of ortho-outcomes of Diels-Alder reactions for which two regioisomeric products 
are possible.  
 
 
 
! The terms ortho and meta refer to the relative positions of terminal substituents from the diene and the dienophile 
on the newly formed cyclohexene ring of the Diels-Alder adduct. 
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Finally, when there are stereogenic centres associated with either the diene or dienophile the 
facial selectivity (syn/anti) of the reaction must be considered. The components of the reaction 
may approach each other from either the more or less sterically hindered face in processes 
known as syn- and anti-addition, respectively. The facial selectivity of a given Diels-Alder 
reaction is determined through the interplay of steric, orbital and electrostatic factors. The 
outcome of a given reaction is, therefore, difficult to predict and mixtures of compounds are 
often obtained (see Scheme 1.5 for an example).24 Steric interactions are considered to be the 
most influential of these factors. However, when these are minimal, other effects can play a 
decisive role in dictating the facial selectivity of the Diels-Alder reaction. Many interactions 
have been cited to explain the facial selectivities observed for various systems and in 2000 
Mehta and Uma proposed the hierarchy of these effects to be steric > through space interactions 
(electrostatic repulsion/attractive stabilising orbital interactions) > hyperconjugative effects > 
ground-state orbital distortions (generally in substrates devoid of polar substituents).25 
 
 
N
N
OH
OH
N
N OH
OH
PhN
PhN
N
N
PhN
O
O
O
O
O
O
OH
OH
OH
OH
+
N
NPhN
O
O
syn-addition
anti-addition
endo-, syn-adduct
endo-, anti-adduct
21 22
23
24
(75%*)
(25%*)
N
N
PhN
O
O
OH
OH
 
 
Scheme 1.5: The Diels-Alder reaction between 4-phenyl-3H-1,2,4-triazole-3,5(4H)-dione (21) and 
c-DHC 22 (*relative proportions of cycloadducts, not yields). 
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1.2.2 Intermolecular Diels-Alder (DA) reactions of cis-1,2-dihydrocatechols 
The intermolecular Diels-Alder (DA) cycloaddition reactions of c-DHCs have been studied 
extensively. Both acylic and cyclic dienophiles incorporating various combinations of carbon, 
nitrogen and oxygen have been investigated, along with alkynes and nitriles. Furthermore, the 
DA reactions of both free diol and protected derivatives of the c-DHCs have been examined. 
Due to the large number of examples, this Section does not provide a comprehensive account of 
all the reported DA reactions of c-DHCs. For this the reader is directed towards the reviews 
published in the area.7-10 This Section simply provides an introduction to the various 
stereochemical outcomes obtained when c-DHCs participate in DA cycloaddition reactions.  
 
The selectivities associated with the DA reactions of c-DHCs are well established. These 
processes proceed with excellent regio- and diastereo-selectivity to afford, in the majority of 
cases, the ortho-, endo-adducts. The factors that govern these stereochemical outcomes have 
been discussed in the previous Section and the observed selectivities are consistent with the 
ascribed explanations. Conversely, the facial selectivity observed for these reactions is less 
obvious and has therefore been the subject of a number of studies by various groups. Many of 
these investigations demonstrated that the diol protecting group has a major influence on the 
facial selectivity of the reaction. While free c-DHCs tend to undergo cycloaddition to the face 
syn to the diol, protected derivatives often demonstrate a preference for anti-addition. Further to 
this, the dienophile and the solvent have also been observed to influence the facial selectivity of 
the reaction. Burnell et al. have recently published a systematic study demonstrating how each 
of these three aspects can have a dramatic effect on the facial selectivity observed for these 
cycloaddition reactions.24 Some of their results are presented in Figure 1.2.  
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Figure 1.2: The effect of the diol protecting group, solvent and dienophile on the anti-/syn- ratio of 
selected intermolecular Diels-Alder reactions of c-DHCs. 
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The selection of examples in Figure 1.2 were chosen to demonstrate that through the correct 
choice of reaction conditions products from either syn- or anti-addition pathways can be 
prepared quite selectively. Of course, control of the facial selectivity in this manner is extremely 
desirable. However, due to the instability of c-DHCs these reactions are usually carried out at 
room temperature, limiting the basic reaction to examples involving highly reactive 
dienophiles.# Stewart has demonstrated that in cases where less reactive dienophiles such as 
cyclopenten-2-one or 2(5H)-furanone are required, the reaction can be promoted by 
high-pressure techniques.26 The facial selectivity was found to be analogous to that observed 
under conventional conditions. Thus, the use of unprotected c-DHC 35 in a high-pressure 
promoted Diels-Alder reaction with 2(5H)-furanone (36) was found to favour formation of the 
syn-adduct 38 while the acetonide-protected derivative 39 preferentially formed the anti-adduct 
40 (Scheme 1.6). The reaction was also found to be regio- and stereo-selective proceeding via 
an endo-, ortho- transition state. 
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Scheme 1.6: Reagents and conditions (i) 19 kbar, CH2Cl2, 18 ºC, 16 h; (ii) (MeO)2CMe2, p-TsOH•H2O, 
-10 to 18 ºC, 24 h. 
 
 
Stewart reported that dimerisation of the c-DHC was also observed to form compounds of the 
general type 42 (Scheme 1.7).26 This reaction was found to be highly stereoselective. In every 
instance, the only dimer isolated was the result of anti-addition of both the diene and the 
 
# Lewis acids cannot be employed to catalyse such reactions, as c-DHCs are known to undergo rapid dehydration 
and accompanying aromatisation in the presence of acid. 
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dienophilic partners, irrespective of whether the free diol or its hydroxyl-protected derivative 
was used. Dimerisations of derivatives of c-DHC 2 have been reported by a number of groups27-
29 and provide examples of DA reactions of c-DHCs in which the dienophile also possesses 
stereogenic centres. In all cases, these cycloaddition reactions were observed to be highly anti-
selective, with respect to both partners. 
 
 
OH
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X X
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42
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Scheme 1.7: Reagents and conditions (i) 19 kbar, CH2Cl2, 18 ºC, 16 h. 
 
 
1.2.3 Intramolecular Diels-Alder (IMDA) reactions of cis-1,2-dihydrocatechols 
In contrast to the intermolecular (DA) process, the intramolecular Diels-Alder (IMDA) 
cycloadditions of c-DHCs remain largely unexplored, with only a handful of examples reported 
in the literature. The first of these were published by Hudlicky and co-workers and employed 
dienophiles tethered at one of the hydroxy groups of the c-DHC framework via either an ester 
(43) or an ether (45) linkage (Scheme 1.8).30,31 
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Scheme 1.8: Reagents and conditions (i) benzene, 110 ºC (sealed tube), 15 h; (ii) CCl4, 77 ºC, 7 h. 
 
 Introduction 11 
In each of these examples, there are two diene moieties and, as a consequence, two 
regiochemical outcomes are possible. In both cases it was found that the endocyclic diene of the 
c-DHC participates as the 4!-cycloaddend affording a single cycloadduct. In these instances the 
facial selectivity of the IMDA reaction is constrained by the pre-existing stereocentre to which 
the dienophile is attached.  
 
In an extension of this type of work Banwell et al. investigated the IMDA reactions of c-DHC 
derivatives possessing two potentially dienophilic residues, one attached at each hydroxyl group 
of the c-DHC core (Scheme 1.9).32 As in the previous cases, two regiochemical outcomes are 
possible for the cycloaddition reactions of compounds of this type. In the event, it was found 
that, depending on the tetraene precursor (48a to 48d), varying mixtures of cycloadducts 49 and 
50 were obtained (Scheme 1.9). The selectivity of the reaction was observed to be sensitive to 
steric effects with the proportion of cycloadduct 49 (in which the dienophile furtherest from the 
C3 substituent has engaged in the cycloaddition) increasing as the size of X increases. The 
IMDA reactions of mixed diesters, such as 51, were also investigated. These studies revealed 
that the nature of the substituents on the dienophile have a greater effect on the regioselectivity 
of these processes than the substituents on the diene (X), with cycloadduct 52 being the only 
isolable product of the IMDA reaction of tetraene 51.  
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Scheme 1.9: Reagents and conditions (i) toluene, reflux, various times. 
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Mihovilovic et al. have investigated the IMDA reactions of c-DHC derivatives possessing 
various dienophilic tethers attached at C1 of the c-DHC framework (Scheme 1.10).33 In these 
examples, the dienophilic moieties were attached via ester (53a and 53c), amide (53b) or ether 
(53d) linkages and the diol moiety was protected as the corresponding acetonide in order to 
increase the thermal stability of the conjugates.  
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Scheme 1.10: Reagents and conditions (i) microwave, 210 ºC, 500 min (*135 ºC, 200 min). 
 
 
The IMDA reactions of these substrates were found to occur in competition with a dimerisation 
reaction. In particular, significant quantities of dimeric compounds were obtained during the 
reactions of substrates possessing ether or amide linkages. Surprisingly, although the dienophile 
of the allyl ether derivative 53d represents the least activated double bond of all the precursors, 
the IMDA reaction of this substrate was found to be the most efficient, giving an almost 
quantitative yield of the desired product. As this substrate represents the most flexible system 
used in the study, the authors concluded that conformational flexibility plays a significant role 
in reactions of this type.33 
 
Hudlicky and co-workers reported the first examples of IMDA reactions of c-DHC derivatives 
in which the dienophile was not tethered to the diene via a stereogenic centre (Scheme 1.11).34 
This allowed investigation of the diasterio- and facial-selectivities associated with such 
reactions. When trienes 55 and 58 were heated at reflux in benzene, a mixture of two 
cycloadducts was obtained in each case. Following extensive NMR analysis, it was determined 
that, in both instances, the IMDA reaction had occurred with excellent facial selectivity, 
involving exclusive reaction at the face opposite the acetonide moiety (anti-addition). However, 
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as is common for the intramolecular variant of the Diels-Alder reaction, only moderate 
diastereoselectivity was observed with both endo- and exo-isomers being formed."  
 
 
55 5756
i
HN O
CO2Et
1.3 :
O
O
HN
O
CO2Et
O
O
NH
O
1.0
EtO2C
+
O
O
75%
endo-, anti- exo-, anti-
 
58
i
85%
HN O O
O
HN
O
O
O
NH
CO2Et
+
O
O
CO2Et
OCO2Et
6059
2.0 : 1.0
endo-, anti- exo-, anti-
 
 
Scheme 1.11: Reagents and conditions (i) benzene, reflux. 
 
 
1.3 cis-1,2-Dihydrocatechols and  Diels-Alder Cycloaddition 
  Reactions in Natural Product Synthesis 
 
The cycloadducts produced via the Diels-Alder cycloaddition reactions of c-DHC derivatives 
are enantiopure and possess multiple functionalities. As such they can often serve as highly 
valuable intermediates in total synthesis. As a result, this reaction has been exploited in 
enantioselective syntheses of a wide range of natural product frameworks.35-43 The following 
Section provides accounts of two such syntheses: Banwell’s synthesis of (-)-patchoulenone 
[(-)-70],44 which utilises an intermolecular Diels-Alder cycloaddition reaction and Hudlicky’s 
synthesis of (-)-zeylena [(-)-76],30 which employs the intramolecular variant. Both of these 
syntheses rely on a stereoselective Diels-Alder reaction in order to generate the stereochemistry 
required for the target natural products. A particular emphasis is placed on the methods by 
which this stereoselectivity is achieved. 
 
" Endo- and exo-assignments of these cycloadducts are based on the configuration of the amide carbonyl group in 
the transition state leading to the products. 
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Banwell’s synthesis of (-)-patchoulenone (2003) 
The synthesis of the sesquiterpenoid natural product (-)-patchoulenone38 (Scheme 1.12) 
commences with endo-PMB acetal 61 (derived from c-DHC 35), which was reacted with $-
chloroacrylonitrile in a thermally promoted Diels-Alder reaction. The steric bulk imparted by 
the acetal protecting group ensured that the cycloaddition reaction occurred with complete facial 
selectivity, while the regioselectively was governed by the “ortho effect”, to afford, exclusively, 
the anti-, ortho-adducts. This stereochemical outcome ensured the correct stereochemistry was 
established for successful completion of the synthesis of the title natural product. While the 
diastereoselectivity was lower  (a 4:1 mixture of endo- and exo-cycloadducts, 62 and 63 
respectively, was obtained) this was of little consequence as base-promoted hydrolysis of the 
mixture resulted in formation of a single ketone derivative 64.  
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Scheme 1.12: Reagents (i) $-chloroacrylonitrile; (ii) KOH, t-BuOH; (iii) NaHMDS, MeI; (iv) Pt2O, H2; 
(v) Ph3P=CH2; (vi) DIBAL-H; (vii) NaH, BnBr, Bu4NI; (viii) DDQ; (ix) TPAP, NMO; (x) isoproprenyl 
lithium; (xi) NaH, 66 ºC; (xii) PhSH, SmI2; (xiii) 10 % Pd on C, H2; (xiv) SO3/pyridine; (xv) SOCl2, 
pyridine. 
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gem-Dimethylation of ketone 64 followed by hydrogenation of the double bond and Wittig 
olefination to install the exocyclic methylene unit afforded compound 65. Manipulation of the 
PMB acetal moiety within substrate 65 via standard procedures then led, over four steps, to 
ketone 66, which was subsequently reacted with isoprenyl lithium to afford dienol 67 in a 
completely diastereoselective manner.44 1,5-Dienols such as compound 67 participate in anionic 
oxy-Cope rearrangements to afford the corresponding bicyclo[5.3.1]undecanone systems. Thus, 
treatment of compound 67 with sodium hydride in refluxing THF afforded ketone 68, which 
then underwent a reductive cyclisation in the presence of samarium diiodide and thiophenol to 
afford alcohol 69. With the desired tricyclic framework in place, standard functional group 
manipulations allowed for conversion of compound 69 into (-)-patchoulenone [(-)-70].  
 
Hudlicky’s synthesis of (-)-zeylena (1989) 
Hudlicky and co-workers’ total synthesis of (-)-zeylena [(-)-76] (Scheme 1.13) is the only one 
reported to date that exploits the intramolecular Diels-Alder reaction of a c-DHC derivative.30 
This cycloaddition reaction is proposed to mimic the biogenesis of both (-)-zeylena and other 
natural products possessing frameworks of this type. 
 
 
O
OAc
O
Ph
OO
OAc
Ph
(-)-Zeylena
OO
OH
OBz
Ph
OH
OH
OH
OH
N
N
R
R
R = CO2(CH2)2TMS
OAc
O
N
N
R
R
R = CO2(CH2)2TMS
O
Ph
i ii - v
vi
viiviii - xi
71 72 73
7475[(-)-76]
95%
54% 94%
60%
30%
 
 
Scheme 1.13: Reagents (i) bis-(2,2,2-trichloroethyl)azodicarboxylate; (ii) THSCl, imidazole; (iii) Ac2O, 
pyridine; (iv) TBAF; (v) PPh3, DEAD, cinnamic acid; (vi) Zn-Cu couple, AcOH; (vii) benzene, 110 ºC; 
(viii) a) O3; b) DMS; (ix) NaBH4; (x) benzoic acid, isobutyl chloroformate, Et3N; (xi) p-TsOH•H2O.
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Starting with c-DHC 71, which is derived from the microbial oxidation of styrene, the first part 
of the synthesis involved inversion of the C1 alcohol. To this end, the starting material was first 
reacted with the bis-(2,2,2-trichloroethyl) azodicarboxylate (TEAD) to afford cycloadduct 72. 
Protection of the diene moiety in this manner was necessary to avoid aromatisation of the c-
DHC during the subsequent reactions. Compound 72 was then acylated selectively at the C2-
hydroxyl, via a 3-step process, and Mitsunobu inversion of the resulting alcohol then afforded 
cinnamate 73. Thermally-induced cycloreversion of compound 73 afforded tetraene 74, the 
substrate for the key IMDA reaction. As anticipated, tetraene 74 underwent a thermally-induced 
intramolecular Diels–Alder reaction to afford cycloadduct 75 as the exclusive product of the 
reaction. The stereoselectivity of this process can be attributed to the conformational constraints 
imposed at the transition state by the short connecting tether and the pre-existing stereocentre to 
which the dienophile is attached. With the synthesis of the core structure complete, compound 
75 was readily converted into (-)-zeylena [(-)-76] using standard procedures.45 
 
1.4 Enantiodivergent syntheses: Exploiting the Facial Selectivity of  
the Diels-Alder Cycloadditions of cis-1,2-Dihydrocatechols 
 
As described in Section 1.1, one criticism of the use of enzymatically derived c-DHCs as 
enantiopure starting materials in total synthesis is that, in most cases, only one enantiomer can 
be accessed. This would thus seem to limit the user to a single enantiomeric form of any target 
compound, and has often resulted in sole access to the unnatural enantiomeric series of a given 
natural product.46,47 However, it is possible that this limitation could be overcome by using the 
combination of the microbial-oxidation and Diels-Alder cycloaddition reactions described in 
this Chapter. This is because the syn- and anti-adducts produced via the Diels-Alder 
cycloadditions of c-DHC derivatives are pseudo-enantiomeric (Scheme 1.14). As a result, 
synthesis of either enantiomeric form of the Diels-Alder adduct from a single enantiopure 
starting material is possible if the facial selectivity of the Diels-Alder reaction can be controlled.  
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Scheme 1.14: Pseudo-enantiomeric relationship between the syn- and anti-adducts produced during the 
Diels-Alder cycloaddition reactions of c-DHC derivatives. 
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1.5 Overview of the Research Described in this Thesis 
 
The work described in this Thesis was undertaken with the aim of exploring and expanding 
upon the versatility of the enzymatic oxidation and Diels-Alder reaction sequence, described in 
this Chapter, for the purposes of synthesising a structurally diverse range of biologically active 
natural products.  
 
Chapter Two describes the application of an intermolecular Diels-Alder cycloaddition reaction 
in the total synthesis of the linear triquinane type natural products (+)-hirsutic acid [(+)-82] and 
(-)-complicatic acid [(-)-83] (Scheme 1.15). This approach exploits strategies that have been 
developed in the Banwell group, involving a Diels-Alder reaction and subsequent 
photochemical rearrangement as the key steps for the stereoselective generation of cis:anti:cis 
fused linear triquinane frameworks. However, while the previous work utilised a syn-selective 
Diels-Alder cycloaddition reaction for the synthesis of the non-natural enantiomer of the simple 
triquinane ent-(-)-hirsutene,42,43 the syntheses of targets (+)-82 and (-)-83 employ an 
anti-selective Diels-Alder reaction to access the natural enantiomeric series of these more 
complex natural products. Thus, the successful completion of total syntheses of these target 
compounds not only demonstrates an effective application of the enzymatic 
oxidation/Diels-Alder reaction sequence but also supports the proposal that, by controlling the 
facial selectivity of the Diels–Alder reactions involving c-DHC derivatives, either enantiomeric 
form of a target natural product can be accessed. 
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Scheme 1.15: Outline of the work described in Chapter Two. 
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Chapter Three describes the first systematic study of the stereoselectivities associated with the 
intramolecular Diels-Alder reactions of c-DHC derivatives. It also details the syntheses of 
several novel c-DHC derivatives of the general type 85 and their participation in IMDA 
cycloaddition reactions to generate cycloadducts 86 and 87 (Scheme 1.16). The results of 
investigations into the effects of various substitution patterns (varying R1, R3 and R4) and diol 
protecting groups (R2) on the facial selectivity of the reaction are also presented. 
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Scheme 1.16: Outline of the work described in Chapter Three. 
 
 
Chapter Four describes the formal total synthesis of the novel and potent antibacterial agent 
(-)-platencin [(-)-92] (Scheme 1.17). This strategy draws and expands upon the chemistries 
described in Chapter Three. Thus, c-DHC derivative 89 undergoes a stereoselective IMDA 
reaction to afford cycloadduct 90, possessing the correct stereochemistry for the target natural 
product. The elaboration of cycloadduct 90 into enone 91, which has been converted into 
(-)-platencin [(-)-92] by a number of groups,48,49 is then described. 
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Scheme 1.16: Outline of work undertaken in Chapter Four. 
 
 
In summary, this Thesis presents the results of an extended investigation into the value of 
employing c-DHC derivatives in facially selective Diels-Alder reactions. The utility of these 
processes in natural product synthesis is highlighted through the preparations of (+)-hirsutic 
acid, (-)-complicatic acid and (-)-platencin. 

 
 
CHAPTER TWO 
Total Syntheses of (+)-Hirsutic Acid and  
(-)-Complicatic Acid 
 
2.1 Introduction 
2.1.1 Isolation and characterisation of (+)-hirsutic acid and (-)-complicatic acid 
In 1947 Heatley et al. reported the isolation of two linear triquinoid natural products, hirsutic 
acid [(+)-82] and hirsutic acid N, from the basidiomycete Stereum hirsutum.50 Although the 
molecular formula of hirsutic acid was determined at this time its structure and absolute 
configuration were not established until 1967 when an X-ray crystal structure was obtained by 
Comer et al.51-53 Some controversy remains regarding the identity of the basidiomycete from 
which hirsutic acid and hirsutic acid N were isolated. In fact, nobody other than Heatley et al. 
has been able to isolate hirsutic acid from S. hirsutum.53 In 1973, however, Mellows and Mantle 
were able to isolate and characterise (+)-hirsutic acid along with the related sequiterpenoid 
(-)-complicatic acid [(-)-83] from S. complicatum.54 Furthermore, Mellows and Mantle proposed 
that hirsutic acid N was in fact (-)-complicatic acid. 
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Figure 2.1: Target compounds (+)-hirsutic acid and (-)-complicatic acid and their proposed biogenetic 
precursor (+)-hirsutene. 
 
Unlike (+)-hirsutic acid, which is not biologically active,50 (-)-complicatic acid displays activity 
against a range of Gram-positive and Gram-negative bacteria as well as certain fungi.54,55 
(-)-Complicatic acid is also mutagenic, as determined by the Ames test.55 The observed 
antibacterial and mutagenic activity is most likely a consequence of the compound’s ability to 
Chapter Two 22 
conjugate with the amino acid cysteine via the $,%-unsaturated ketone moiety. Indeed, it has 
been proposed that (+)-hirsutic acid is an inactive precursor that is oxidised, at certain stages of 
growth of the producing organism, to biologically active (-)-complicatic acid.50,54 
 
(+)-Hirsutene [(+)-93] (Figure 2.1) is thought to be the biogenetic precursor to the entire linear 
triquinane class of sesquiterpenes, including acids 82 and 83.56 It was first identified as a 
metabolite of the basidiomycete Coriolis consors, and is believed to be generated in vivo, via 
cation-mediated cyclization processes, from the monocyclic and polyunsaturated sesquiterpene 
humulene.57 
 
2.1.2 Previous studies on the synthesis (+)-hirsutic acid and (-)-complicatic acid 
The title natural products have each been the subject of a number of synthetic endeavours. 
Preliminary studies were reported in the early 1970’s by Matsumoto et al.58 and Lansbury et 
al.59,60 These were quickly followed by the first total synthesis of (±)-complicatic acid 
[(±)-83].61 At this time it was also shown that (±)-complicatic acid could be selectively reduced 
to (±)-hirsutic acid using sodium borohydride. Subsequently, six total62-64 or formal total58,65-69 
syntheses of acids (±)-82 and (±)-83, along with two asymmetric syntheses,70,71 have been 
reported.  
 
The following Section provides summaries of these total syntheses. Thus, both of the 
aforementioned enantioselective syntheses are described below, along with two syntheses of 
racemic material that are particularly relevant to the work detailed in this Thesis.  
 
Ikegami’s asymmetric syntheses of (+)-hirsutic acid and (-)-complicatic acid (1982) 
The first enantioselective total syntheses of (-)-complicatic acid and (+)-hirsutic acid were 
reported by Ikegami et al. in 1982 (Scheme 2.1).70,72 These began with the development of an 
asymmetric route to hydroxy ketone 2.7, a key intermediate in the synthesis of (±)-hirsutic acid 
that they had published in 1981.65 So, asymmetric hydroboration of olefin (±)-94 with 
(+)-di-3-pinanylborane afforded, after oxidation with alkaline hydrogen peroxide, an 
inseparable mixture of enantiopure alcohols. PCC-mediated oxidation of this mixture gave 
ketones 95 and 96, both of which were ultimately converted into hydroxy ketone (+)-97.  
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Scheme 2.1: Reagents (i) a) (+)-di-3-pinanylborane; b) H2O2, NaOH; (ii) PCC; (iii) 5% Pd on C, H2; 
(iv) Ph3P=CHOMe; (v) Zn-Cu couple, I2 (cat.); (vi) PCC; (vii) HCl, MeOH; (viii) Jones reagent; (ix) 
CH2N2; (x) MeLi; (xi) K2S2O7; (xii) borane-THF; (xiii) PCC; (xiv) NaH, allyl bromide; (xv) PdCl2, CuCl, 
O2; (xvi) t-BuOK, t-BuOH; (xvii) LDA, MeI; (xviii) LDA, phenylselenyl bromide; (xix) H2O2, AcOH; 
(xx) LiI, DMF; (xxi) H2O2, NaOH; (xxii) NaBH4. 
 
 
Wittig olefination of compound (+)-97 with (methoxymethylene)triphenyl phosphorane, 
followed by a stereoselective Simmons-Smith reaction, yielded cyclopropane 98 incorporating 
the desired stereochemistry at the newly formed quaternary centre. Compound 98 was then 
submitted to a series of functional group manipulations to reveal the methyl ester and methyl 
groups of compound 99 as required at C11 of the natural product.  
 
Ketone 99 was subjected to a series of reactions that ultimately resulted in a 1,2-transposition of 
the carbonyl moiety as well as stereo- and regio-specific installation of the quaternary centre 
alpha to the ketone. This sequence proceeded via an allyl-ketone that was oxidised to 
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1,4-diketone 100 under Wacker oxidation conditions. Intramolecular aldol condensation of 
compound 100 resulted in the formation of the final five-membered ring of triquinane 101, a 
key intermediate of Ikegami’s previously reported synthesis of (±)-hirsutic acid.66 
 
The closing stages of the synthesis involved introduction of the $-methylene functionality via 
the formation and subsequent elimination of a phenyl selenide residue. This was followed by 
cleavage of the methyl ester. Finally, using the protocols of Matsumoto et al.,61 regio- and 
stereo-selective epoxidation of the endocyclic double bond afforded (-)-complicatic acid 
[(-)-83], which was selectively converted into (+)-hirsutic acid [(+)-82] via reduction of the 
former material with sodium borohydride. 
 
Greene’s asymmetric synthesis of (+)-hirsutic acid (1985) 
Greene et al. published their enantioselective synthesis of (+)-hirsutic acid in 1985 (Scheme 
2.2).71 As with the work of Ikegami and co-workers, this synthesis was an extension of a 
synthesis of racemic hirsutic acid that they had published in 1983.63 The key step is an iterative, 
three-carbon annulation protocol that was developed to allow for the construction of complex, 
fused polycyclopentanoid skeleta. Greene and co-workers initially envisioned that an 
asymmetric synthesis could be achieved simply by resolution of keto-acid 102, a key 
intermediate in their synthesis of (±)-hirsutic acid. However, although resolution was examined 
with various chiral amines, the results were disappointing and an alternative route was 
developed involving asymmetric hydroboration of the ester of meso-acid 103. The synthesis of 
compound 103 was readily achieved in three steps from keto-acid 102 and in 82% overall yield.  
 
Acid 103 was protected as the corresponding methyl ester and this was subjected to asymmetric 
hydroboration using (+)-di-iso-pinocampheylborane. Alkaline hydrogen peroxide-mediated 
oxidation to the corresponding alcohol followed by Collins oxidation then afforded 
cyclobutanone (-)-104 in 92% ee. Regioselective ring-expansion was achieved by exposure of 
compound 104 to ethyl diazoacetate and antimony pentachloride. This yielded the desired 
%-keto-ester, which underwent smooth decarboethoxylation on heating to afford diquinane 105. 
A one-pot methylation/dehydrogenation procedure gave cyclopentene 106, the substrate for the 
key three-carbon annulation protocol. So, using previously defined conditions,71 a stereo- and 
regio-selective cycloaddition reaction was performed between olefin 106 and dichloroketene to 
afford the expected cyclobutanone. Subsequent diazomethane-mediated ring expansion then 
gave the required triquinane framework. Finally, zinc-mediated dechlorination afforded the 
cis:anti:cis fused linear triquinoid intermediate 107. 
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Scheme 2.2: Reagents (i) NaBH4; (ii) CH3SO2Cl, Et3N; (iii) Na, NH3; (iv) CH2N2; (v) a) (+)-di-iso-
pinocampheylborane; b) H2O2, NaOH; (vi) Collins reagent; (vii) SbCl5, ethyl diazoacetate; (viii) DME, 
H2O, reflux; (ix) a) CH3MgBr; b) HClO4, H2O; (x) Zn-Cu couple, CCl3COCl, POCl3; (xi) CH2N2; (xii) 
Zn, AcOH; (xiii) PdCl2, Pd(OAc)2; (xiv) tetrahydrothiophene, AlBr3; (xv) LiHMDS, HCO2CH3; (xvi) 
K2CO3, acetone; (xvii) a) H2O2, NaOH; b) NaBH4. 
 
 
Elaboration of triquinane 107 to (+)-hirsutic acid was achieved in six steps. Thus, 
palladium(II)-mediated oxidation of this compound afforded Ikegami’s enone 101,70 the ester 
moiety of which was cleaved, by treatment with aluminium bromide and thiophene, to give the 
corresponding carboxylic acid. The required exocyclic methylene was introduced via the 
corresponding hydroxymethylene derivative and the nucleophilic epoxidation reaction 
proceeded as previously described61 to provide (-)-complicatic acid which could be reduced, in 
situ with sodium borohydride, to (+)-hirsutic acid [(+)-82]. 
 
Schuda’s total syntheses of (±)-complicatic and hirsutic acids (1986) 
Much of Schuda and co-workers 1986 account of their synthesis of complicatic and hirsutic 
acids64 was concerned with stereoselective introduction of the C11 quaternary centre as this was 
noted, by the group, to be a recurring problem encountered in previous syntheses. Their 
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approach employed a rigid tricyclic ring structure to control the assembly of the C11 centre 
after which, cleavage of one of the rings revealed a diquinane intermediate (Scheme 2.3).  
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Scheme 2.3: Reagents (i) LDA, MeI; (ii) KHMDS, NCCO2Me; (iii) NaBH4; (iv) (CF3SO2)2O, pyridine; 
(v) NaI, acetone; (vi) Zn, DME; (vii) RuO2•H2O, NaIO4; (viii) HCl; (ix) LDA, MeI;  (x) a) CH(OMe)3, 
p-TsOH; b) 2-chloro-4-(propylthio)-2-buten-1-ol; c) 165 ºC; (xi) Hg(OAc)2, HCO2H, HCO2NH4; (xii) 
t-BuOK, t-BuOH; (xiii) p-TsOH; (xiv) LiI, DMF; (xv) a) H2O2, NaOH; b) NaBH4; (xvi) H2O2, NaHCO3. 
 
 
Thus, starting from compound 108 (synthesised in five steps from ketal-protected 
cyclopentanone) it was anticipated that alkylation of the C11 enolate would occur from the 
exo-face of the molecule. The desired relative stereochemistry could therefore be installed by 
firstly introducing the methyl group followed by the carboxyl-derived functionality. To this end, 
treatment of compound 108 with lithium diisopropylamide (LDA) followed by the addition of 
methyl iodide gave the predicted exo-methylated ketone (109) as the sole product of the 
reaction. Introduction of the carboxyl functionality proved problematic due to formation of the 
undesired regioisomeric enolate from ketone 109 and O- rather than C-alkylation. Following a 
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series of enolate trapping experiments, it was established that treatment of ketone 109 with 
KHMDS and methyl cyanoformate provided ester 110 in 58% yield. However, concomitant 
formation of the corresponding enol carbonate could not be avoided so this material was 
recycled to methyl ketone 109 by treatment with potassium carbonate in MeOH. 
 
Deoxygenation of compound 110 was achieved via a four-step reaction sequence involving 
reduction of the carbonyl moiety, conversion of the corresponding alcohol into the iodide (via 
the tosylate), and deiodination using zinc in DME/MeOH to yield compound 111 in 57% 
overall yield from %-keto-ester 110. Oxidative cleavage of the norbornene double bond with 
ruthenium tetroxide followed by acid-catalysed hydrolysis of the acetal and concomitant 
bisdecarboxylation then furnished diquinane 112.  
 
The final stages of the synthesis required annulation of the third five-membered ring onto 
diquinane 112. To these ends, alkylation with methyl iodide then 2-chloro-4-(propylthio)-2-
buten-1-ol and  followed by a ketal-Claisen rearrangement allowed stereoselective installation 
of the second quaternary centre yielding compound 113. Hydrolysis-elimination of the side 
chain followed by intramolecular aldol condensation afforded the linear triquinoid intermediate 
115 that was converted, using previously described protocols,61 into (±)-hirsutic acid and 
(±)-complicatic acid. 
 
Singh’s formal total syntheses of (±)-complicatic and hirsutic acids (2004 and 2007) 
The formal total synthesis of (±)-hirsutic acid reported by Singh et al. in 200468 (Scheme 2.4) 
resembles the approach described in this Thesis by virtue of incorporating both a Diels-Alder 
cycloaddition reaction and a photochemical rearrangement process as key steps. So, this 
synthesis commenced with the oxidation of the readily available salicyl alcohol (116) with 
aqueous sodium metaperiodate to give epoxy dimer 117. Pyrolysis of the dimer afforded the 
corresponding diene which then underwent a Diels-Alder reaction with methyl methacrylate to 
afford compound 118.69 Deoxygenation of the oxirane ring using zinc in dioxane furnished 
methyl ketone 119 as a mixture of epimers. Alkylation of this mixture proceeded 
stereoselectively with allyl bromide to give allyl ketone 120 that was readily oxidised, using a 
Wacker protocol, to 1,4-diketone 121. Compounds 120 and 121 were both subjected to triplet 
sensitised, photochemically-induced oxa-di-!-methane rearrangements because this process is 
known to be sensitive to the functional groups appended to the bicyclic system and because 
either of the corresponding products could be elaborated to the natural product. In the event, it 
was found that the reaction proceeded more efficiently when compound 121 (42%) rather than 
congener 120 (30%) was used as the photo-substrate. This was attributed to competitive 
absorption of the light by the olefinic group present in the allylic chain of compound 120. 
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Treatment of diquinane 122 with tri-n-butyltin hydride and 2,2-azobisisobutyronitrile (AIBN) 
selectively cleaved the peripheral cyclopropane bond and a subsequent base-induced 
intramolecular aldol condensation afforded the linear tricyclopentanoid 101. As compound 101 
had already been converted into both complicatic and hirsutic acids its acquisition represented a 
formal total synthesis of the target natural products. 
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Scheme 2.4: Reagents (i) aq. NaIO4; (ii) methyl methacrylate; (iii) Zn, NH4Cl; (iv) NaH, allyl bromide; 
(v) PdCl2, CuCl, O2; (vi) h&, acetone; (vii) tri-n-butyltin hydride, AIBN; (viii) t-BuOK, t-BuOH. 
 
 
In 2007 Singh et al. reported an alternative route to triquinane 101 (Scheme 2.5) in an attempt 
to avoid the problem of the low yielding oxa-di-!-methane rearrangements of bicyclic 
compounds 120 and 121.69 Thus, they proposed that methyl ketone 119 would undergo the 
required photoreaction with better efficiency since it contains only the %,'-enone chromophore 
and that the anticipated photoproduct would be readily elaborated, via a ring-closing metathesis, 
so as to allow installation of the third ring. Accordingly, %,'-enone 119 was irradiated under 
triplet-sensitised conditions to give diquinane 123 in 61% yield. Reductive cleavage of the 
cyclopropane ring was followed by stereoselective installation of two olefinic chains to afford 
124. Ring-closing metathesis of this last compound using Grubb’s second-generation catalyst 
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followed by PCC oxidation furnished intermediate 101, the acquisition of which represents a 
formal synthesis of (±)-complicatic and hirsutic acids. 
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Scheme 2.5: Reagents (i) h&, acetone; (ii) tri-n-butyltin hydride, AIBN; (iii) NaH, allyl bromide; (iv) 
vinylmagnesium bromide, CeCl3 (v) 2
nd Gen. Grubbs’ cat.; (vi) PCC. 
 
 
2.2 Synthetic Strategy  
The continued isolation of novel, highly functionalised and biologically active linear 
triquinane-type sesquiterpenoids has stimulated the ongoing development of new and more 
general strategies for assembly of the cis:anti:cis fused linear triquinane framework associated 
with this class of natural products. This Section describes work undertaken in the Banwell 
group directed towards the development of a general strategy for the enantioselective synthesis 
of a wide variety of linear triquinane type natural products, as well as their non-natural 
enantiomers. 
2.2.1 The Banwell synthesis of ent-(-)-hirsutene 
In 2002 Banwell et al. reported an enantioselective synthesis of the unnatural enantiomer of 
hirsutene [ent-(-)-93](Scheme 2.6).73 To generate the linear triquinane core associated with this 
class of natural products in an enantioselective manner three key reactions were employed: (i) 
the enzymatic generation of optically pure starting material, (ii) a facially selective Diels-Alder 
cycloaddition and (iii) a photochemically-promoted oxa-di-!-methane rearrangement. 
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Scheme 2.6: Reagents (i) 19 kbar; (ii) (MeO)2CMe2, p-TsOH•H2O; (iii) LiHMDS, MeI; (iv) LiAlH4; (v) 
NaH, CS2, MeI; (vi) tri-n-butyltin hydride, AIBN; (vii) AcOH; (viii) 4-acetamido-TEMPO, p-TsOH•H2O; 
(ix) MEMCl, Hunig’s base; (x) h&, acetophenone, acetone; (xi) tri-n-butyltin hydride, AIBN; (xii) 
NaBH4; (xiii) NaH, CS2, MeI; (xiv) tri-n-butyltin hydride, AIBN; (xv) PPTS; (xvi) PCC; (xvii) 
Ph3P=CH2. 
 
 
Using enzymatically derived c-DHC# 35 (see Chapter 1) as the enantiomerically pure starting 
material and drawing on previous work from within the group,26 this diol was engaged in a 
high-pressure promoted Diels-Alder cycloaddition reaction with cyclopenten-2-one (126) to 
afford, as the major product of the reaction, the syn-adduct 127. Protection of the diol moiety 
within this adduct as the corresponding acetonide then allowed for the installation of the gem-
dimethyl group using LiHMDS and methyl iodide. Reduction of the carbonyl moiety and 
removal of the resultant hydroxy group using the Barton-McCombie deoxygenation protocol 
then gave compound 128. The acetonide-protecting group was then cleaved under acid catalysis 
 
# This abbreviation for ‘cis-1,2-dihydrocatechol’ is used throughout this Chapter. 
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and subsequent oxidation of the less hindered of the two hydroxy groups within the resulting 
diol was achieved using 4-acetamido-TEMPO. Owing to the instability of the resulting acyloin, 
the remaining hydroxyl group was protected as the MEM ether to afford compound 129, the 
substrate for the key photochemical rearrangement. 
 
Compound 129 was irradiated under triplet-sensitised conditions to provide, via an 
oxa-di-!-methane rearrangement process, tetracycle 130 in 80% yield. Cleavage of the 
peripheral cyclopropane bond, which was formed during the photochemical rearrangement 
process, was achieved using tri-n-butyltin hydride and AIBN to give linear triquinane 131. 
Removal of the carbonyl function, again using a hydride reduction/Barton-McCombie 
deoxygenation sequence, then furnished compound 132, which was smoothly converted into 
ent-(-)-hirsutene [ent-(-)-93] in three steps using standard procedures. 
 
2.2.2 Proposed synthetic route to (+)-hirsutic acid and (-)-complicatic acid  
With a synthetic route to ent-(-)-hirsutene in hand, it was anticipated that this approach could be 
modified to enable synthesis of more highly functionalised members of the linear triquinane 
class of natural products. Moreover, by virtue of being able to control the facial selectivity of 
the Diels-Alder reaction, as described in Chapter 1, access to both enantiomeric series of these 
compounds should be possible. So, in light of their interesting biological profiles and in order to 
examine the scope of this chemistry that had been developed within the Banwell group, a 
synthetic route to (+)-hirsutic acid and (-)-complicatic acid was proposed (Scheme 2.7). 
 
As in the synthesis of ent-(-)-hirsutene, it was envisaged that c-DHC 35 could be used as the 
enantiopure starting material. However, in order to obtain the correct absolute stereochemistry 
for the natural products, the Diels-Alder cycloaddition reaction must occur with the opposite 
facial selectivity; namely, via anti-addition of the dienophile to the diene. Based on previous 
studies in the group,26 it was anticipated that this could be achieved by engaging the acetonide 
protected derivative of diol 35, viz. compound 39, in a high-pressure promoted Diels-Alder 
reaction with cyclopenten-2-one to afford cycloadduct 81. It was also anticipated that the C6 
quaternary centre (corresponding to C11 in the target molecule) would be able to be installed 
stereoselectively, to afford %-diketone 133, using the protocols of Schuda and co-workers who 
had demonstrated in their syntheses of complicatic and hirsutic acids that alkylation occurs from 
only one face of rigid structures of this type.64 Appropriate functional group interconversions 
should then give the substrate for the key photochemical rearrangement, namely %,'-enone 134. 
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It was envisioned that irradiation of %,'-enone 134 under triplet sensitised conditions should 
result in an oxa-di-!-methane rearrangement to stereoselectively generate tetracycle 135. 
Reductive cleavage of both the peripheral cyclopropane bond and the protected alcohol moiety 
followed by a series of standard functional group interconversions should then deliver dienone 
136, a key intermediate from which both complicatic acid and hirsutic acid have been 
synthesised by a number of groups.61,70,71 The successful implementation of this strategy for the 
total synthesis of (-)-complicatic acid and (+)-hirsutic acid is described in the following 
Sections. 
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Scheme 2.7: Proposed synthetic route to (-)-complicatic acid [(-)-83] and (+)-hirsutic acid [(+)-82]. 
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2.3 Total Syntheses of (+)-Hirsutic acid and (-)-Complicatic acid 
 
2.3.1 The facially selective Diels-Alder cycloaddition reaction 
As described in the previous Section, the establishment of syntheses of (-)-complicatic and 
(+)-hirsutic acids required effective control of the diastereofacial selectivity of the key 
Diels-Alder cycloaddition reaction. Based on studies of related Diels-Alder cycloaddition 
reactions performed by Stewart,26 it was anticipated that the steric bulk imparted by an 
acetonide protecting group on the diol moiety should result in anti-addition of the dienophile to 
the diene to afford the anti-cycloadduct possessing the required stereochemistry. 
 
To this end, toluene-derived c-DHC 35 was converted, under acid catalysis, into acetonide 39, 
which was immediately reacted with cyclopenten-2-one (126) in a high-pressure promoted 
Diels-Alder cycloaddition reaction. This proceeded in a completely endo-selective manner to 
afford a chromatographically separable mixture of three products; the desired anti-adduct 81 
(73%), its previously reported syn-isomer 13742 (13%) and Diels-Alder dimer 138 (10%) 
derived from the starting diene (Scheme 2.8). 
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Scheme 2.8: Reagents and conditions (i) (MeO)2CMe2, p-TsOH•H2O, –10 to 18 °C, 1 h; (ii) 
cyclopenten-2-one (2.0 mole equiv.), CH2Cl2, 19 kbar, 18 °C, 24 h. 
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As is characteristic of Diels-Alder adducts of c-DHCs, the 1H NMR spectrum of compound 81 
(Figure 2.2) features a triplet at ( 6.12 (J = 8.3 Hz) and a doublet at ( 5.77 (J = 8.3 Hz), 
corresponding to C9-H and C10-H respectively, of the newly installed olefin. The multiplet at  
( 2.92 was assigned to the bridgehead methine proton at C8. The analogous multiplet (C8-H) in 
the spectra of the corresponding syn-adduct42 (137) is located at ( 3.09 and represents the key 
difference between the spectra of these isomers. The resonances assigned to the oxymethine 
protons of compound 81 appear at ( 4.25 and 3.81, further upfield than the equivalent signals in 
the starting material (39) and, as expected, a similar upfield shift is observed for the three 
singlets corresponding to the methyl groups. The presence of a molecular ion at m/z 248 in the 
electron impact (EI) mass spectrum, when considered in conjunction with the microanalytical 
data, confirmed the molecular formula as C15H20O3. The stereochemistry of compound 81 was 
unequivocally established through single-crystal X-ray analyses of various derivatives (ie 
Figure 2.3, page 36), which show that cycloadduct 81 is formed through delivery, via an endo-
transition state, of the dienophile to the face of the diene opposite the sterically demanding 
acetonide residue. The adjacent nature of the ketone carbonyl and methyl residues about the 
newly formed cyclohexene ring within adduct 81 derives from the operation of the ortho-rule.22 
 
 
 
Figure 2.2: 300 MHz 1H NMR spectrum of Diels-Alder adduct 81 (recorded in CDCl3). 
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2.3.2 Manipulation of the C ring# 
The next stage of the synthesis required stereoselective formation of a quaternary carbon centre 
at C6 of cycloadduct 81 (which corresponds to C11 of the target compounds). It was anticipated 
that because of the rigid nature of the cyclic framework, alkylation should occur from the 
exo-face of this compound.64 Therefore, the methyl group should be introduced first, and the 
carbomethoxy group second to ensure the desired relative stereochemistry is established. To this 
end, the enolate derived from kinetic deprotonation of ketone 81 using LiHMDS was 
stereoselectively C-alkylated using methyl iodide and so affording a chromatographically 
separable mixture of methyl ketone 139 (82% at 92% conversion) and its gem-dimethylated 
equivalent 140 (15% at 92% conversion) (Scheme 2.9). Single-crystal X-ray analysis of methyl 
ketone 139 (Appendix 1) revealed that, as anticipated, addition had occurred from the exo-face 
and the carbon bearing the newly introduced methyl group possessed the S-configuration. 
Reaction of compound 139 with another aliquot of LiHMDS, and treatment of the ensuing 
enolate with methyl cyanoformate (Mander’s reagent),74 afforded %-keto-ester 133 in 88% yield, 
together with small amounts of enol carbonate 141 (3%). The structure of compound 141 was 
confirmed by single-crystal X-ray analysis (Appendix 2) and must arise via O-acylation of the 
ring-junction enolate derived from precursor 139.  
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Scheme 2.9: Reagents and conditions (i) LiHMDS (1.1 mole equiv.), MeI (1.05 mole equiv.), THF,  
0 to 18 °C, 4 h; (ii) LiHMDS (1.2 mole equiv.), NCCO2Me (2.0 mole equiv.), THF, 0 to 18 °C, 4 h.
 
 
# See Figure 2.1, page 21 for the labelling of the three five-membered rings of the triquinane framework. 
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The most notable feature within the 1H NMR spectrum of compound 133 is the presence of two 
new singlets at ( 3.66 and 1.17, each of which integrates for three protons. They were assigned, 
respectively, to the methoxy moiety of the ester and the methyl group attached to the newly 
formed quaternary centre. The appearance of resonances at ( 173.0 and 51.9 in the 13C NMR 
spectrum of this same material are considered diagnostic for the presence of a methyl ester, 
while the signal at ( 58.4 is characteristic of a %-keto-ester and was determined, by APT 
(attached proton test) 13C NMR spectroscopy, to be due to a quaternary carbon. Carbonyl 
stretching bands were observed in the IR spectrum, at 1753 and 1728 cm-1, as would be 
expected for keto-ester 133. The relative stereochemistry was confirmed by single-crystal X-ray 
analysis (Figure 2.3, Appendix 3). 
 
Figure 2.3: Displacement Ellipsoid Plot (30%!) derived from single-crystal X-ray analysis of 
!-keto-ester 133.! 
 
In addition to the linear triquinoid-type natural products described above, there are a number of 
related compounds, such as (-)-phellodonic acid [(-)-142], that possess the same functionalities 
at C11 although the stereochemistry at this centre now is S rather than R. (Figure 2.4).  
 
HO2C
H
H
O
O
(-)-Complicatic Acid
[(-)-83]
HO2C
H
H
O
O
(-)-Phellodonic Acid
[(-)-142]
H3C(H2C)6OCO
1111
 
Figure 2.4: (-)-Complicatic acid and (-)-phellodonic acid showing the opposite configuration at C11. 
 
" The anisotropic displacement ellipsoids show 30% probability levels. 
! The numbers of the crystal structures within this thesis have been omitted for clarity. Please see appropriate 
appendices for numbered structures and full X-ray structure reports. 
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In light of this, and in order to confirm the rational behind this synthetic method, the C6 epimer 
of compound 133 was synthesised by reversing the order of the methylation and acylation steps 
(Scheme 2.10). Thus, the kinetic enolate of compound 81 was generated as previously described 
and treated with methyl cyanoformate. Because the resultant 1,3-dicarbonyl compound was 
obtained as a mixture of readily interconverting tautomers, full characterisation of this product 
was not possible. Therefore, the C6 configuration was not determined at this stage. 
Nevertheless, when this tautomeric mixture was treated with sodium hydride followed by 
methyl iodide the %-keto-ester 143 was obtained. This possesses a C6 configuration opposite to 
that of the previously prepared %-keto-ester 133.  
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Scheme 2.10: Reagents and conditions (i) LiHMDS (1.5 mole equiv.), NCCO2Me (1.1 mole equiv.), 
THF, -78 to 18 °C, 14 h; (ii) NaH (2.0 mole equiv.), MeI (5.0 mole equiv.), THF, 0 to 18 °C, 2 h. 
 
 
Although the spectral data obtained on compound 143 were very similar to those of congener 
133, comparison of the 13C NMR spectra provided convincing evidence that the opposite 
stereochemistry had been established at C6.) Thus, in the spectrum of keto-ester 133 the signal 
attributed to the endo-oriented C6-methyl group is observed at ( 18.8 while for epimer 143 
(Figure 2.5) the equivalent signal, for the exo-oriented C6-methyl group, is observed downfield, 
at ( 22.3. Similarly, the signal attributed to the carbonyl-carbon of the methyl ester moiety is 
observed further downfield when it is in the exo-position (compound 133, ( 173.0) as compared 
to the when it is in the endo-position (compound 143, ( 172.2). The other sixteen resonances 
appear at very similar chemical shifts in both epimers.  
 
 
 
 
 
) The stereochemistry of %-keto-ester 143 was later confirmed by single-crystal X-ray analysis of a derivative of this 
compound, and shown to be as illustrated.28  
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Figure 2.5: 300 MHz 13C NMR spectrum of !-keto-ester 143 (recorded in CDCl3). 
 
The ketone carbonyl group derived from the dienophile had to this point been an essential 
element in this synthesis owing to the activating and directing effects it exerted in the 
Diels-Alder cycloaddition reaction and because it provided the means by which to install the 
adjacent C6 methyl and carbomethoxy groups. However, at this point in the synthesis it was no 
longer required so methods for its removal were explored. Approaches involving direct 
deoxygenation such as the Wolff-Kishner and Clemmensen protocols require strongly basic or 
acidic conditions and could not, therefore, be used due to the presence of the acetonide and 
%-keto-ester moieties. A modified Clemmensen reduction75 using zinc and gaseous hydrochloric 
acid in THF or Et2O was investigated but without success. Attempts at forming the 
tosylhydrazone or thioketal were similarly unsuccessful. Accordingly, the hydride-
reduction/Barton-McCombie deoxygenation76 sequence used by Harfoot in his synthesis of 
ent-(-)-hirsutene was explored (Scheme 2.11).42 To such ends, the ketone carbonyl of %-keto-
ester 133 was reduced. Initial attempts involved the use of sodium borohydride in MeOH which, 
by itself, yielded an epimeric mixture of alcohols in a disappointing 65% yield. However, when 
cerium trichloride was added to the reaction mixture (Luche conditions)77 the reduction was 
found to proceed in a completely stereoselective manner and to afford alcohol 144 in a much 
improved yield (91%). All the spectral data derived from compound 144 were consistent with 
the formation of the desired product. The IR spectrum proved particularly diagnostic and was 
consequently used to monitor the reaction as the product and starting material were found to co-
migrate under thin layer chromatographic (tlc) conditions. A new IR absorbance at 3541 cm-1, 
together with the disappearance of the stretching band attributable to the ketone carbonyl  
(1753 cm-1) indicated that the desired reduction of the ketone had occurred. The orientation of 
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the newly introduced hydroxy group of alcohol 144 was determined by single-crystal X-ray 
analysis (Appendix 4). This stereochemistry is thought to arise from chelation control of the 
reduction by the added cerium.* 
 
Alcohol 144 was converted into the corresponding S-methyl xanthate ester by using NaHMDS 
to form the corresponding sodium alkoxide and treating this with carbon disulfide and methyl 
iodide. Radical cleavage of the ensuing ester using tri-n-butyltin hydride and AIBN in refluxing 
toluene proceeded smoothly to give the deoxygenated compound 145 in 97% yield (from 
alcohol 144) over the two steps involved (Scheme 2.11). 
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Scheme 2.11: Reagents and conditions (i) CeCl3•7H2O (4.0 mole equiv.), NaBH4 (1.0 mole equiv.), 
MeOH, 0 to 18 °C, 5 h; (ii) NaHMDS (2.0 mole equiv.), CS2 (2.0 mole equiv.), MeI (2.1 mole equiv.), 0 
to 18 °C, 6 h; (iii) tri-n-butyltin hydride (4.0 mole equiv.), AIBN, toluene, ca. 110 °C, 5 h. 
 
 
2.3.3 Deprotection of the acetonide and unexpected formation of a 
hemiorthoester 
With compound 145 in hand, attention turned towards the elaboration of this material into the 
%,'-unsaturated ketone required for the key photochemical rearrangement. Following the 
proposed synthetic strategy, the first step in the relevant sequence involves acetonide 
deprotection. 
 
Cleavage of the acetonide residue within compound 145 proved somewhat problematic. While 
such moieties are normally quite susceptible to acid hydrolysis, this process was difficult to 
accomplish with substrate 145 when conventional conditions were used. This is presumably due 
to the rigid nature of the bicyclo[2.2.2]octene framework to which the acetonide unit is 
 
* When the C6-epimeric keto-ester 143 was subjected to these reduction conditions the epimeric alcohol was 
produced. This indicates that unlike the facial selectivity of the alkylation steps, which is controlled by the rigid 
framework, the facial selectivity of the reduction is controlled by the C6 stereochemistry.
78
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annulated. Attempts to obtain the desired diol involved the use of conditions such as 2 M 
aqueous HCl,79 aqueous HCl in THF80 (various concentrations), acetic acid in water,42 
mercaptoethanol with a Lewis acid (eg boron trifluoride diethyl etherate81) and iodine in MeOH 
(1% w/v)82. Little success was observed under such conditions. 
 
Hydrolysis of the acetonide residue of compound 145 was subsequently attempted with 
trifluoroacetic acid (TFA).83 Although small amounts of the expected diol were obtained, at  
18 ºC, using TFA in the presence of small quantities of water, the hydrolysis was slow and 
inefficient. Unexpectedly, after 72 h the major product was not a diol but a compound that was 
less polar than the starting material. The same type of result was observed when acetonide 81 
was subjected to these reaction conditions (Scheme 2.12). Analysis of the spectroscopic data led 
to the identification of these products as hemiorthoesters 146 and 147. Each of these compounds 
was accompanied by small amounts (<10%) of the corresponding acetonides and diols. 
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Scheme 2.12: Reagents and conditions (i) TFA, H2O, 18 ºC, 3 days. 
 
 
Compounds 146 and 147 were both obtained as single diasteriomers and each was subject to 
various spectroscopic analyses, although the unstable nature of compound 146 made 
characterisation problematic. The EI mass spectrum of hemiorthoester 147 displayed a 
molecular ion at m/z 304 and accurate mass measurement on this species established it 
possessed the molecular formula C14H15F3O4. The infrared spectrum revealed a carbonyl 
stretching band at 1714 cm–1 that is attributed to the ketone moiety. Since trifluoroacetate-type 
carbonyl stretching bands appear at ca. 1780–1790 cm–1, this suggests that compound 147 does 
not exist, to any significant extent, in its open-chain/mono-trifluoroacetate ester form. The 300 
MHz 1H NMR spectrum of hemiorthoester 147 contained oxymethine proton resonances in 
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similar positions to those arising from the equivalent protons in precursor 81. This suggests a 
1,3-dioxolane ring is still present in compound 147. The 75 MHz 13C NMR spectrum displays 
twelve of the expected fourteen resonances, with those resulting from the hemiorthoester and 
CF3-group carbons not being observed. The spectral features just described were also observed 
for congener 146. Single-crystal X-ray analysis (Figure 2.6, Appendix 5) allowed for 
unambiguous assignment of the illustrated structure to compound 147 and revealed the cyclic 
hemiorthoester moiety has the CF3-group in the exo-orientation. 
 
 
Figure 2.6: Displacement Ellipsoid Plot (30%) derived from single-crystal X-ray analysis of 
hemiorthoester 147. 
 
After thorough investigation, the optimal conditions for the generation of diol 149 from 
acetonide 145 proved to involve heating the latter material at 110 °C in MeOH/H2O for 5 days 
in the presence of freshly activated DOWEX-50 resin (Scheme 2.13).84,85 In this manner the 
target diol 149 was obtained in 81% yield.  
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Scheme 2.13: Reagents and conditions (i) DOWEX-50 resin (acidic form), MeOH/H2O (5:1), 110 °C, 5 
days. 
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2.3.4 Formation of the % ,'-unsaturated ketone substrate required for the 
photochemically promoted oxa-di-!-methane rearrangement 
With diol 149 in hand, the next step required oxidation of one of the alcohol moieties to obtain 
the %,'-enone motif necessary for the oxa-di-!-methane rearrangement. Oxidation of the less 
hindered of the two hydroxyl groups was achieved using the sterically demanding 
oxo-ammonium salt derived from p-TsOH•H2O-promoted disproportionation of 
4-acetamido-TEMPO.86 This afforded acyloin 149 in 85% yield (at 92% conversion) (Scheme 
2.14).  
 
In principle, acyloin 149 could have been subjected to the photochemical rearrangement. 
However, it had been observed previously that dimerization of related acyloins occurs readily 
and, as a consequence, the photorearrangement of such compounds can be very inefficient.87 
Such difficulties can be completely avoided by protection of the hydroxyl group. It is important 
that the protecting group chosen is photochemically inert, and not overly bulky because it might 
otherwise inhibit the rearrangement process. It was also envisaged that the O-protected 
hydroxyl group could be removed via a reductive elimination process in an effort to 
simultaneously remove both the cyclopropane and C1-hydroxyl moiety, thereby saving at least 
one step in the reaction sequence. A search of the literature revealed the benzoyl protecting 
group should be suitable for both purposes.88,89 Accordingly, acyloin 149 was converted, under 
standard conditions and in 80% yield, into the corresponding benzoate 150 (Scheme 2.14) and 
this material became the substrate for the photochemical studies outlined in the following 
Section. 
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Scheme 2.14: Reagents and conditions (i) 4-acetamido-TEMPO (2.2 mole equiv.), p-TsOH•H2O (2.2 
mole equiv.), CH2Cl2, 0 to 18 °C, 22 h; (ii) benzoyl chloride (3.5 mole equiv.), DMAP (3.5 mole equiv.), 
Et3N (4.7 mole equiv.), CH2Cl2, 0 to 18 °C, 17 h. 
 
 
The 1H NMR spectrum of benzoate 150 (Figure 2.7) features signals in the aromatic region 
along with a single at ( 5.09 that is assigned to the oxymethine proton of the newly protected 
O-hydroxy moiety. The 13C NMR spectrum (Figure 2.8) features resonances associated with the 
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%,'-unsaturated ketone framework at ( 139.4, 127.0 and 205.3. These are assigned to C5, C6 
and C8, respectively. A signal at ( 74.0 is attributed to the C9 oxymethine carbon. There is a 
complete absence of absorbances attributed to free hydroxyl groups in the IR spectrum, 
indicating protection of this moiety has occurred. Finally, single-crystal X-ray analysis 
(Appendix 6) of compound 150 confirmed that no epimerisation of the hydroxyl group had 
occurred under the reaction conditions used for this conversion.  
 
 
Figure 2.7: 300 MHz 1H NMR spectrum of benzoate 150 (recorded in CDCl3). 
 
 
Figure 2.8: 300 MHz 13C NMR spectrum of benzoate 150 (recorded in CDCl3). 
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2.3.5 The oxa-di-!-methane (ODPM) rearrangement 90,91 
Photochemical rearrangements of %,'-unsaturated ketones incorporated within a rigid 
framework, such as seen in compound 150, can occur via two distinct pathways, resulting in 
either a 1,2- or a 1,3-acyl shift.92 The title rearrangement is a triplet-mediated photochemical 
process resulting in a 1,2-acyl shift, with concurrent formation of a cyclopropyl ketone. Demuth 
and co-workers have described this reaction pathway as involving a series of biradical 
intermediates (Scheme 2.15). Evidence for this stepwise pathway has been obtained in in three 
separate studies.93 
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Scheme 2.15: Pathway for the oxa-di-"-methane rearrangement proposed by Demuth et al.93  
 
 
It was recognised by Singh et al., that as the relative stereochemistry at the ring junctions of the 
rearranged product are governed by the relative stereochemistry of the %,'-unsaturated ketone, 
the desired cis:anti:cis triquinane framework can be accessed if the third ring is annulated onto 
the bicyclic framework in an endo-fashion.94 Furthermore, the ODPM rearrangement is 
expected, on mechanistic grounds, to occur with retention of configuration at all centres. 
Accordingly, tetracycle 154 is the expected product of the oxa-di-!-methane rearrangement of 
compound 150. 
 
In order to bring about the desired rearrangement, compound 150 was irradiated under triplet 
sensitised reaction conditions. To promote triplet excitation, the reaction was conducted in 
acetone with added acetophenone as both these ketones are triplet sensitisers. Additionally, the 
reaction mixture was jacketed by a UV filter solution containing NaBr (750 g/L) and Pb(NO3)2  
Total Syntheses of (+)-Hirsutic Acid and (-)-Complicatic Acid 45 
(8 g/L) to ensure that the wavelength of the transmitted light is greater than 340 nm.95 As 
revealed in Table 2.1, depending upon the precise conditions, including reaction time, substrate 
concentration and the number of equivalents of acetophenone employed, varying proportions 
(and yields) of three photoproducts, compounds 154, 155 and 156, were obtained.  
 
 
Table 2.1: The photochemically promoted rearrangement of compound 150 
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Entry concentration 
acetophenone 
(equiv.) 
time 154 155 156 conversion 
1 0.17 M 0.2 24 h 1 1 2.3 62% 
2 0.17 M 2.5 36 h 1 1 1.9 64% 
3 0.03 M 2.5 36 h 1.7 6.7 1 93% 
4 0.02 M 2.5 80 h 1 9.1 traces 100% 
5 0.01 M 2.5 24 h 1 7.6 1.5 95% 
 
Tetracycles 154 and 155 were identified as products of the desired oxa-di-!-methane 
rearrangement of %,'-enone 150. Accurate mass measurements on the molecular ions observed 
at m/z 368 in the EI mass spectrum of each of these compounds established the molecular 
formula, C22H24O5, indicating that they are isomeric with the starting material, as expected for a 
rearrangement process. The absence of olefinic resonances in the 1H NMR spectra also provided 
evidence that the desired rearrangement had occurred in both instances. Although the 1H NMR 
spectra of photoproducts 154 and 155 (Figure 2.9 and 2.10 respectively) are similar, there is a 
notable difference in the position of the peaks attributed to the C1-oxymethine proton, at ( 4.92 
and 5.34 respectively. On this basis it was proposed that it is at this C1 centre that the two 
compounds differ. Accordingly, assignment of the stereochemistry of each compound was 
carried out using nOe techniques. Thus, a strong nOe correlation was observed between the 
C1-H and C5a-H and a weak correlation between C1-H and C2c-H in compound 154 (Figure 
2.9). In contrast, for compound 155 there was only a weak correlation observed between C1-H 
and the C5b-methyl group. This indicated that while tetracycle 154 was the expected product, in 
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which the rearrangement had occurred with retention of stereochemistry, tetracycle 155 had 
undergone inversion at C1. 
 
 
Figure 2.9: 300 MHz 1H NMR spectrum of photoproduct 154 (recorded in CDCl3). 
 
 
Figure 2.10: 300 MHz 1H NMR spectrum of photoproduct 155 (recorded in CDCl3). 
 
Cyclobutanone 156 (Table 2.1) was presumed to arise from the undesired 1,3-acyl migration 
process, a recognized result of direct singlet irradiation of substrates such as %,'-enone 150.43 
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The mechanism in this case involves initial $-cleavage of the ketone, thereby creating an 
acyl/allyl biradical. Recombination from the alternative allylic position forms the 1,3-acyl shift 
product.90 The presence of a cyclobutanone moiety was established by examination of the IR 
spectrum, which exhibits a prominent ketone carbonyl absorption at 1790 cm-1 (cf. 1740 cm-1 in 
tetracycles 154 and 155). The 13C NMR spectrum features a resonance at ( 200.3, which is in a 
significantly different position to the equivalent resonances for photoproducts 154 and 155 (( 
209.7 and 206.1 respectively). Once again, the EI mass spectrum features a molecular ion at m/z 
368, for which an accurate mass was obtained, thereby indicating that compound 156 is 
isomeric with starting material 150. The 1H NMR spectrum features a pair of signals, at ( 5.75 
and 5.63, arising from the two olefinic protons. Whilst compound 156 was isolated as a single 
diastereomer, the configuration at the benzoyloxy-bearing carbon was not determined. 
 
The various experiments shown in Table 2.1 revealed that the best proportions of the desired 
compounds 154 and 155 were achieved using 2.5 equivalents of acetophenone. Lowering the 
amount of this sensitizer to 0.2 equivalents resulted in a predominance of the undesired 
cyclobutanone 156. The concentration of the substrate was also important, with more dilute 
solutions producing more satisfactory outcomes. Under the optimal conditions, namely 
irradiation of an 0.02 M solution of compound 150 in acetone with 2.5 equivalents of 
acetophenone maintained at 5 to 10 °C for 80 h, full conversion of the substrate could be 
achieved and only small amounts of cyclobutanone 156 were formed (Scheme 2.16).  
 
With conditions in hand that reduced the production of undesired side products attention was 
turned to investigating, in detail, the modes of the formation of the two ODPM products 154 
and 155. The ratio of photoproducts 154 and 155 was found to be highly dependant upon the 
reaction time employed. As shown in Figure 2.11, the former compound is produced first and 
then converted into the latter. 
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Figure 2.11: Graph of percentage composition vs. time (hours) for the oxa-di-"-methane rearrangement 
reaction of !,#- unsaturated ketone 150. 
 
In a control experiment, compound 154 was subjected to the original irradiation conditions and 
was converted, over a period of 36 h and in 97% yield, into epimer 155 (Scheme 2.16). This 
presumably involves a photoenolization process96 and the driving force for this is most probably 
the relief of steric congestion between the abutting angular methyl and benzoyloxy groups in the 
primary photoproduct. As the removal of the C1-benzyloxy group was the planned next step, 
the stereochemistry at this centre is not important, so, and in most cases, the reaction was run 
until the starting material had been consumed, thus generating a mixture of the major two 
photoproducts. 
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Scheme 2.16: Reagents and conditions (i) h& (125 W Philips HPL-N lamp), UV filter [NaBr 759 g/L, 
Pb(NO3)2 8 g/L], acetophenone (2.5 mole equiv.), acetone, 5 to 10 °C, 80 h (ii) as in (i), 36 h. 
 
 
Total Syntheses of (+)-Hirsutic Acid and (-)-Complicatic Acid 49 
2.3.6 Reductive cleavage of the O-benzyloxy group and the cyclopropane ring 
As noted earlier, it was anticipated that compounds 154 and 155 could both be elaborated to the 
target natural products as the next stage involved reductive cleavage of the C1-benzyloxy group. 
Samarium (II) iodide (SmI2) was used for this purpose in the expectation that this reagent 
should effect reductive cleavage of both the C1-benzoyloxy group88 and the carbonyl-
conjugated cyclopropane ring97 and so forming the required linear triquinane framework in a 
single step. To this end, the major photoproduct, 155, was treated with four mole equivalents of 
SmI2 in THF/MeOH between -78 °C and 18 °C for a total of 3 h. However, the desired product 
107 (56%) was accompanied by significant quantities of cyclobutanol 157 (25%) (Scheme 
2.17). In order to understand the formation of this by-product, the two separate transformations, 
cleavage of the O-benzyloxy moiety and cleavage of the cyclopropane, were carried out 
independently (Scheme 2.17).  Thus, it was determined that when tetracycle 155 was treated 
with two equivalents of SmI2 at -78 °C only cleavage of the benzoyloxy moiety occurred, 
producing compound 158 in high yield. When this material was resubjected to reaction with 
SmI2 at -78 °C, no reaction occurred. However, on warming to room temperature formation of 
both tricycle 107 (59%) and cyclobutanol 157 (25%) was observed.  
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Scheme 2.17: Reagents and conditions (i) SmI2 (4.0 mole equiv.), THF/MeOH, +78 to 18 °C, 3 h;  
(ii) SmI2 (2.2 mole equiv.), THF/MeOH, +78 °C, 10 min; (iii) SmI2 (2.2 mole equiv.), THF/MeOH, 
18 °C, 2 h. 
 
 
The formation of compound 157, although unexpected, can be easily explained. It presumably 
involves initial reductive removal of the C1-benzoyloxy group, followed by cyclopropane ring 
cleavage to deliver a compound bearing a radical at C7. Rather than being quenched by an 
external proton source, the C7 radical combines in an intramolecular fashion with the ketyl 
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radical at C5 to afford the observed tertiary alcohol. Hoffmann and co-workers have observed 
similar conversions by employing SmI2 for the pinacolic coupling of 1,4-diketones so forming 
cyclobutene-1,2-diols embedded within polycyclic frameworks.98 The structure of by-product 
157 was confirmed by single-crystal X-ray analysis of the p-nitrobenzoyl derivative (obtained in 
75% yield from 157) (Figure 2.12, Appendix 7). 
 
Figure 2.12: Displacement Ellipsoid Plot (30%) derived from single-crystal X-ray analysis of 
p-nitrobenzoyl derivative of alcohol 157. 
 
After this discovery, an alternate route to compound 107 was sought. Using the protocol 
described above, compound 155 was debenzoylated, in 98% yield, by brief exposure to two 
equivalents of SmI2 at -78 ºC to afford compound 158. Analogous treatment of the C1-epimer, 
154, produced the same outcome, namely generation of the desired product, 158, in 97% yield 
(Scheme 2.18).  
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Scheme 2.18: Reagents and conditions (i) SmI2 (2.2 mole equiv.), THF/MeOH, +78 °C, 10 min;  
(ii) tri-n-butyltin hydride (6.0 mole equiv.), AIBN (trace), benzene, reflux, 1.5 h. 
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Following procedures established by Singh et al.,68 compound 158 was then treated with six 
mole equivalents of tri-n-butyltin hydride and AIBN in refluxing benzene to cleave the 
cyclopropane ring and so form triquinane 107, which was obtained as the sole reaction product 
in 88% yield (at 87% conversion). 
 
Compound 107 is an advanced intermediate associated with the synthesis of (+)-hirsutic acid 
and (-)-complicatic acid reported by Greene et al.71 Accordingly, its acquisition constitutes a 
formal total synthesis of both these natural products. Although the 1H and 13C NMR (Figure 
2.13) spectra of compound 107 could not be directly compared to the spectral data reported in 
the literature (due to the use of different solvents and the fact that Greene et al. reported only 
limited data) these are entirely consistent with the proposed structure and could be fully 
assigned using a variety of NMR connectivity experiments. Furthermore, all other spectral data 
collected were consistent with the equivalent data reported for Greene’s compound. In 
particular, the optical rotation obtained for compound 107 ([$]D = -121) is in full agreement 
with the value reported by Greene and co-workers ([$]D = -125).
71 
 
 
Figure 2.13: 300 MHz 13C NMR spectrum of triquinane 107 (recorded in CDCl3). 
 
2.3.7 Completion of the syntheses of (+)-hirsutic acid and (-)-complicatic acid 
With a successful route to the cis:anti:cis fused linear triquinane framework in hand, 
completion of the total syntheses of (+)-hirsutic acid and (-)-complicatic acid was pursued. The 
first step towards such ends was the oxidation of triquinane 107 to the corresponding enone, the 
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double bond of which would be used in the final stages of the synthesis to install the epoxide 
ring associated with the target natural products. 
 
Initial attempts to introduce the carbonyl-conjugated olefin involved the use of the Saegusa 
oxidation protocol99 (Scheme 2.19). It was anticipated that the angular methyl group would 
provide some control in the regioselective formation of the relevant silyl enol ether. However, a 
study of several bases and silylating agents (Table 2.2) showed only a modest selectivity for the 
desired enol ether 160.  
 
 
Table 2.2: Formation of silyl enol ethers 159 and 160 using various bases and silylating agents. 
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Entry base silylating agent temperature     159 (undesired)* 160 (desired)* 
1 LDA TMSCl -78 ºC 1 1.2 
2 LiHMDS TBSOTf 0 ºC 1 1.2 
3 LiHMDS TBSOTf -78 ºC 1.1 1 
4 LiTMP TMSCl -78 ºC 1 2.5 
5 Lutidine TMSOTf 0 ºC No reaction  
6 Lutidine TMSOTf 0 to 18 ºC 1 3.8 
7 TBAF ETSA -78 to 0 ºC 1 7.0 
8 TBAF ETSA 18 ºC 1 4.0 
* Ratios determined by 1H NMR of the crude reaction mixture 
 
Entries 7 and 8 define conditions reported by Crimmins et al. in their total synthesis of 
silphinene.100 They had encountered, and solved, a similar problem of regioselective silyl enol 
ether formation using ethyl(trimethylsilyl)acetate (ETSA) and catalytic tetra-n-butylammonium 
fluoride (TBAF)101 and thus reporting a 96:4 ratio of products in favour of the desired 
regioisomer. In the context of the present study this set of conditions was found to be the most 
selective. However, it proved difficult to achieve full consumption of the starting material and 
upon prolonged exposure to the reaction conditions the silyl enol ethers were found to hydrolyse 
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back to the starting ketone, presumably due to the catalytic quantities of TBAF present in the 
reaction mixture. The set of reaction conditions that was found to reliably be the most selective 
was 2,6-lutidine and trimethylsilyl triflate (TMSOTf) at 18 ºC (Entry 6), affording a ca. 4:1 
ratio of products favouring the desired regioisomer. Because the undesired enol ether 159 could 
not be oxidised to the corresponding enone it was anticipated that it would be easily recycled to 
the starting ketone via acid hydrolysis. Accordingly, ketone 107 was converted into the 
corresponding a mixture of trimethylsilyl enol ethers which was then treated with Pd(OAc)2 and 
p-benzoquinone in acetonitrile.99 Aqueous work up resulted in hydrolysis of the extraneous 
trimethylsilyl enol ether, providing a chromatographically separable mixture of the starting 
ketone 107 (31% recovery) and the desired enone 101 (85% at 69% conversion). The most 
significant feature of the spectral data collected for enone 101 was the appearance of an olefinic 
signal at ( 5.68 in the 1H NMR spectrum (Figure 2.14), which serves to confirm that installation 
of the double bond conjugated to a carbonyl moiety had taken place. 
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Scheme 2.19: Reagents and conditions (i) TMSOTf (3.0 mole equiv.), 2,6-lutidine (4.0 mole equiv.), 
CH2Cl2, 0 to 18 °C, 1 h; (ii) silica gel; (iii) Pd(OAc)2 (2.0 mole equiv.), p-benzoquinone (1.0 mole 
equiv.), acetonitrile, 18 °C, 18 h; (iii) IBX (3.9 mole equiv.), p-TsOH•H2O (0.3 mole equiv.), 
toluene/DMSO, 85 °C, 72 h. 
 
 
This conversion could also be achieved using 2-iodobenzoic acid102,103 (IBX) (Scheme 2.19). 
This procedure not only proved to be simpler, but to also be more efficient, affording enone 101 
in 89% yield. The various conditions explored during the optimisation of this process revealed 
that four equivalents of IBX were required to achieve complete conversion and the presence of 
an acid source (p-TsOH•H2O) was critical to the success of the reaction. 
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Figure 2.14: 800 MHz 1H NMR spectrum of enone 101 (recorded in CDCl3). 
 
It had been shown in previous syntheses of complicatic and hirsutic acids that the endocyclic 
olefin can be preferentially epoxidised in the presence of an exocyclic equivalent. This dictated 
that the best reaction sequence for completing the total syntheses would involve: (i) introduction 
of the $-methylene functionality, (ii) deprotection of the methyl ester and (iii) nucleophilic 
epoxidation of the endocyclic double bond. In the case of (+)-hirsutic acid these steps would be 
followed by stereoselective reduction of the carbonyl moiety within precursor (-)-83.  
 
Two protocols for installing an exocyclic methylene at C4 of enone 101 were investigated 
(Scheme 2.20). The first of these was reported by Ikegami et al. in their total synthesis of 
(+)-hirsutic acid.72 Thus, enone 101 was treated with LDA and methyl iodide to give a single 
diastereomeric form of $-methyl ketone 161. The stereochemistry of this compound was not 
determined as it was presumed to be of little consequence. The crude product was then treated 
with LDA and phenylselenyl chloride to provide selenide 162 as a 1:2 mixture of diastereomers 
(once again the stereochemistry of the two compounds was not established). Hydrogen peroxide 
and acetic acid in THF were then used to oxidise selenide 162 to $-methylene enone 115 (51% 
over two steps from compound 160). This yield could be improved upon by using sodium 
periodate as the oxidant and thus affording dienone 115 in 72% yield over the two steps. 
Unfortunately, product 115 was often contaminated with significant quantities of its 
chromatographically inseparable precursor 161. 
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Scheme 2.20: Reagents and conditions (i) LDA (2.0 mole equiv.), MeI (10.0 mole equiv.), THF, +78 to 
0 °C, 1.5 h; (ii) LDA (2.0 mole equiv.), PhSeCl (3.0 mole equiv.), THF, +78 to 18 °C, 1.5 h; (iii) NaIO4 
(5.0 mole equiv.), THF/H2O/MeOH, 18 °C, 1 h; (iv) LiHMDS (1.5 mole equiv.), Eschenmoser’s salt (3.0 
mole equiv.), THF, +78 to 18 °C, 17 h; (v) MeI (12.0 mole equiv.), Et2O/CH2Cl2, 18 °C, 16 h; (vi) basic 
alumina, CH2Cl2, 18 °C, 30 min. 
 
 
In order to avoid the problems associated with the previous route, a new method for introducing 
the exocyclic methylene was investigated. Thus, the enolate of enone 101 was generated as 
described previously. However, it was now trapped with Eschenmoser’s salt104 (H2C=NMe2
+ I+) 
to afford the tertiary amine 163 (79%). Quaternization of amine 163 was achieved using methyl 
iodide and thus generating the corresponding methiodide salt 164, which, on stirring with basic 
alumina, underwent a Hofmann-type elimination reaction to afford dienone 115 in 76% yield.105 
 
The 1H NMR spectrum of dienone 115 features two olefinic resonances at ( 5.89 and 5.17. 
Using HSQC experiments, it was determined that the former signal, which integrates for two 
protons, was due to both the proton of the endocyclic olefin and one of the protons of the 
exocyclic methylene. The one-proton singlet at ( 5.17 was assigned to the other proton of the 
terminal methylene. The 13C NMR spectrum exhibited four signals in the olefinic region, 
consistent with the presence of two double bonds in the molecule. The medium strength 
absorption band appearing at 1648 cm-1 in the IR spectrum is characteristic of a carbonyl-
conjugated and exocyclic alkene.  
 
With dieneone 115 in hand, the next step required was the hydrolysis of the methyl ester to the 
carboxylic acid. This was achieved using LiI in refluxing DMF to afford, after acidic work-up, 
crystalline dienone acid 136 in 73% yield (at 78% conversion).  
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Scheme 2.21: Reagents and conditions (i) LiI (15.0 mole equiv.), DMF, reflux, 34 h.
 
 
The spectral data, including optical rotation, obtained for this material matched those reported 
by Greene et al.71 Final confirmation of structure was obtained by single-crystal X-ray analysis 
(Figure 2.15, Appendix 8). 
 
 
Figure 2.15: Displacement Ellipsoid Plot (30%) derived from single-crystal X-ray analysis of dienone 
acid 136. 
 
The synthesis of (-)-complicatic acid [(-)-83] was completed by regio- and stereo-selective 
nucleophilic epoxidation of compound 136 (Scheme 2.22). This was achieved using a three-fold 
excess of alkaline hydrogen peroxide in MeOH at -50 to -36 °C to afford (-)-complicatic acid, 
as an oil, in a modest 35% yield.72 Various attempts to improve upon this outcome were 
unsuccessful. For example, the use of higher reaction temperatures and/or additional quantities 
of alkaline hydrogen peroxide led to complex mixtures of material which appeared to contain 
significant quantities of a bis-epoxide as judged by mass spectral analysis of the crude reaction 
mixture. A slightly better outcome was achieved when the nucleophilic epoxidation process was 
followed by immediate treatment of the crude reaction mixture with sodium borohydride.71 By 
such means (+)-hirsutic acid [(+)-82] could be obtained, after chromatographic purification, in 
46% yield and as a microcrystalline solid (Scheme 2.22).  
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Scheme 2.22: Reagents and conditions (i) H2O2 (3.0 mole equiv.), NaOH (3.0 mole equiv.), 
MeOH/H2O, +50 to -36 °C, 1 h; (ii) a) H2O2 (3.0 mole equiv.), NaOH (3.0 mole equiv.), MeOH/H2O, 
+35 °C, 4 h; b) NaBH4 (19.0 mole equiv.), EtOH, +35 to 0 °C, 30 min. 
 
 
The spectral data obtained on products (+)-82 and (-)-83 are fully consistent with the data 
reported for the natural products. Thus, the 300 MHz 1H NMR spectrum of (-)-complicatic acid 
[(-)-83] (Figure 2.16) features resonances at ( 6.08 and 5.30 that suggest the exocyclic 
methylene is still in place. The appearance of a singlet at ( 3.44 can be attributed to the methine 
proton of the newly installed epoxide. The signal due to the carboxylic acid proton was not 
observed. Unfortunately, and despite purification twice using silica gel column 
chromatography, compound (-)-83 was found to be contaminated with a related compound (ca. 
10%). The resonances associated with this compound in the 1H NMR spectra are consistent with 
those reported for isohirsutic acid60 (165) (Scheme 2.22), which was first reported by Comer et 
al.52 and later synthesised by Lansbury and co-workers.60 Matsumoto et al. also observed the 
O-methylated derivative of isohirsutic acid as a major by-product (20%) of their synthesis of 
complicatic acid.61 The EI mass spectrum of compound (-)-83 displays a molecular ion at m/z 
262, and accurate mass measurement on this species established the molecular formula of the 
compound as C15H18O4. Finally, the specific rotation obtained for compound (-)-83 was [$]D = 
-77 (c 0.3 in CHCl3), which compares favourably with the value of [$]D = -79 (c 1.1 in CHCl3) 
recorded for the originally isolated natural product.54 
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Figure 2.16: 300 MHz 1H NMR spectrum of (-)-complicatic acid [(-)-83] (recorded in CDCl3). 
 
Both the 1H NMR (Figure 2.17) and the 13C NMR spectra (Figure 2.18) of (+)-hirsutic acid 
[(+)-82] display all of the expected features and are in full accord with the data reported for the 
natural product. The EI mass spectrum displays a molecular ion at m/z 264 and a fragment ion at 
m/z 247 resulting from the loss of a hydroxyl group. An accurate mass measurement on the 
molecular ion confirmed its composition as C15H20O4. The specific rotation obtained for 
compound (+)-82 was +113 (c 0.2, CHCl3), which is in good agreement with the value observed 
for the natural product [+116 (c 1.05, CHCl3)]
54 The melting range of 168–171 °C compares 
less favourably with that obtained for the natural product (178.5–180 °C).54 Nevertheless, other 
synthetically-derived samples have melting points closer to this value, for example, Ikegami et 
al. reported a melting point of 170 °C.72 
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Figure 2.17: 600 MHz 1H NMR spectrum of (+)-hirsutic acid [(+)-82] (recorded in CDCl3). 
 
 
 
Figure 2.18: 75 MHz 13C NMR spectrum of (+)-hirsutic acid [(+)-82] (recorded in CDCl3). 
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2.4  Conclusions and Future Work 
In the work described in this Chapter, c-DHC 35, derived from microbial oxidation of toluene, 
has been converted into the natural products (+)-hirsutic acid and (-)-complicatic acid. This 
nineteen-step sequence proceeded in overall yield of ca. 3% and is noteworthy in that seven of 
the fifteen carbons in the title natural products originate from the cheap and abundant toluene 
starting material. When combined with the studies of Harfoot et al.,42,43 these results 
demonstrate that by controlling the facial selectivity of the Diels–Alder reactions involving 
diene 35, either enantiomeric form of the linear triquinane framework can be obtained. 
Furthermore, the reaction sequences described in this Chapter allow for the stereoselective 
introduction of functionality at most positions on the triquinane framework. Such control is 
particularly important given the continued isolation of new and interesting linear triquinoid type 
natural products, many of which display attractive biological profiles.106 Figure 2.19 presents 
some examples of triquinoid natural products that it is anticipated can be synthesised using the 
methodology described here. These compounds all exhibit antibacterial activity against a range 
of Gram-positive and Gram-negative bacteria. However, in addition they show varied and 
interesting biological profiles. For example phelladonic acid, [(-)-142] is highly cytotoxic,107 
desoxyhypnophilin (166) shows significant antimalarial activity,108 while pleurotellol (168) has 
been demonstrated to act as a plant growth inhibitor.109 Creolophin E (169) has been isolated 
recently and shown to inhibit the growth of various cancer cell lines.108  
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Figure 2.19: A selection of linear triquinane natural products with interesting biological properties. 
 
, A total synthesis of phelladonic acid has since been completed in these laboratories utilising the chemistry 
described in this Chapter.
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CHAPTER THREE 
Intramolecular Diels-Alder Cycloaddition 
Reactions of cis-1,2-Dihydrocatechols 
 
3.1  Introduction 
3.1.1 Research objectives 
As described in Chapter 1, both inter- and intra-molecular Diels-Alder cycloaddition reactions 
of c-DHC# derivatives have been reported.7,10 However, while the inter-molecular variant (DA) 
has found extensive use in enantioselective syntheses,37,38,40,73,110-112 the analogous 
intra-molecular (IMDA) process has been used to a lesser extent.30,31 There are a number of 
reasons for this. Firstly, DA cycloaddition reactions can be performed directly on c-DHCs, 
whereas their IMDA counterparts require prior attachment of a dienophilic tether. Due to the 
propensity of c-DHCs to aromatise this can be a challenging task. Secondly, DA cycloaddition 
reactions of c-DHCs are known to be completely endo-selective and by employing either the 
protected or the unprotected derivatives the diastereofacial selectivity can be controlled 
effectively. In contrast, the selectivity profiles of the corresponding IMDA reactions have not 
been well characterised. 
 
The work described in this Chapter was carried out with the aim of better characterising the 
IMDA cycloaddition reactions of c-DHCs and in order to develop new synthetic routes to 
sesquiterpenoid natural products. Thus, the specific objectives were:  
(i) To design precursors in which the dienophilic tether was positioned on the c-DHC 
framework such that a wide range of carbocyclic frameworks could be accessed.  
(ii) To develop coupling methods in order to tether the dienophilic moiety to the c-DHC 
framework in high yields. 
(iii) To characterise the stereoselectivity (endo vs exo) of the IMDA cycloaddition reactions 
of c-DHCs. 
 
# This abbreviation for ‘cis-1,2-dihydrocatechol’ is used throughout this Chapter. 
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(iv) To develop methods for controlling the diastereofacial (syn vs anti) selectivity of the 
IMDA cycloaddition reactions of c-DHCs. 
 
3.2 Intramolecular Diels-Alder (IMDA) Precursors 
3.2.1 Precursor design 
This Section outlines the considerations that influenced the design of the proposed IMDA 
precursors (Figure 3.1). Ultimately, a precursor that included a 5-membered tether with an 
internal ketone-activating group attached at the 3-position of the c-DHC framework was 
identified as the most appropriate substrate for an initial study of the title reactions. 
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Figure 3.1: General structure of IMDA precursors to be investigated. 
 
There are two distinct types of IMDA cycloaddition reaction.19,113,114 These differ in the position 
at which the dienophile is tethered to the diene (Scheme 3.1). In Type I IMDA reactions the 
dienophile is tethered at the terminus of the diene, whereas in the Type II equivalent the 
dienophile is tethered at an internal position of the diene. Because 3-substituted c-DHC 
derivatives are more readily available than the corresponding 4- or 5-substituted derivatives, 
this work focused on Type I IMDA cycloaddition reactions in which the dienophile is tethered 
at the 3-position of the relevant c-DHC framework. 
 
 
TYPE I
TYPE II
170 171
172 173  
Scheme 3.1: The two classes of IMDA cycloaddition reactions. 
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It is worth noting that when the dienophile is tethered through the C-1 or C-2 hydroxyl groups 
within the c-DHC, the facial selectivity of the IMDA cycloaddition reaction is completely 
constrained.31,32 In contrast, with the tether attached at the 3-position, the IMDA cycloaddition 
reaction could potentially occur at either face of the diene such that with the use of different 
alcohol protecting groups (R2), it might be possible to control the diastereofacial (syn/anti) 
selectivity of these processes.  
 
The stereoselectivities of IMDA cycloaddition reactions can be influenced by the position of 
electron-withdrawing group that serves to activate the dienophile in a normal electron-demand 
Diels-Alder reaction.113 It may be positioned internally, within the tether, or at the terminus of 
the dienophile. It was decided that an internal activating group, such as a ketone, would be the 
most versatile as this would allow varied substitution at the terminus of the dienophile (R3/R4) 
as well as enabling further functionalisation of the newly formed ring.  
 
The reason for choosing a five-membered tether in the initial studies derives from the 
expectation that the resulting adducts would provide access to a wide variety of sesquiterpenoid 
natural products. 
 
3.2.2 Retrosynthetic analysis 
Owing to the instability of the c-DHC moiety, microbial oxidation of the aromatic ring should, 
ideally, be the last step in the synthesis of these precursors. However, the substrate range for the 
enzymatic oxidation is limited by the size and nature of the substituents on the benzene ring.11 
The proposed strategy, therefore, relies on a late-stage union of the c-DHC fragment (174) and 
the tether to which the dienophilic residue is already attached (175) (Scheme 3.2). 
 
 
OR2
OR2
O
R3 R4
85
OR2
OR2
X
R2, R2 = H or C(CH3)2
R4
R3O
M
+
X  = I  or Br
R3, R4 = H or CH3
174 175
R1
R1
M  = Zn, Sn or B  
 
Scheme 3.2: Retrosynthetic analysis of IMDA precursors. 
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3.2.3 Previous studies on C-C bond forming reactions of cis-1,2-dihydrocatechols  
Several groups have shown that it is possible to prepare a range of c-DHCs that are substituted 
in the 3-position via metallation of readily available 3-halogenated derivatives.27,115-119 For 
example Boyd et al. have demonstrated that 3-iodo-c-DHC 88 readily participates in palladium-
catalysed Stille cross-coupling reactions with a range of organotin reagents to afford a series of 
3-substituted derivatives in yields from 11-75% (Scheme 3.3).115,116 The modest yields 
sometimes observed are  attributed to the instability of the products to column chromatography. 
However, this procedure has an important advantage, namely the ability to effect direct 
substitution without needing to protect (then deprotect) the diol moiety.  
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Scheme 3.3: Examples of Stille cross-coupling reactions of unprotected 3-iodo-c-DHC (88). 
 
 
Although Boyd et al. found the corresponding bromo-derivative to be less reactive in the Stille 
cross-coupling reactions (substitution was only observed with activated organotin reagents and 
gave lower yields),115 Hudlicky and co-workers demonstrated that 3-bromo-c-DHC readily 
participates in the Sonogashira cross-coupling reaction to give alkynyl-substituted derivatives in 
good yields.117 However, only three examples of such a process have been reported to date 
(Scheme 3.4). 
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Scheme 3.4: Sonogashira coupling reactions of unprotected 3-bromo-c-DHC (180) with various 
terminal acetylenes. 
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Recognising that acetonide-protected derivatives of c-DHCs are significantly more stable and 
thus more likely to produce high yields of coupling products, Ley et al. prepared a variety of 
3-substituted compounds from acetonide 184 (Scheme 3.5).27 
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Scheme 3.5: Examples of Stille couplings and metallations of acetonide-protected 3-bromo-c-DHC 184. 
 
 
Acetonide 184 was found to readily participate in Stille cross-coupling reactions with 
vinylbutyltin and ethynyltributyltin and so afford the corresponding 3-substituted products 
(compounds 185 and 186, respectively) in better yields than those observed for the equivalent 
reactions involving diol 88. It was also found that compound 184 could be metallated with 
tert-butyllithium (t-BuLi) and trapped in situ with trimethyltin chloride or bistributyltin to 
generate the corresponding stannylated compounds 187 and 188 in 27% and 34% yields, 
respectively. Both of these compounds were subsequently used in Stille cross-coupling 
reactions. Finally, the trimethylsilyl derivative 189 was also generated by metallation followed 
by trapping with trimethylsilyl chloride. However, this silylated product was not used in any 
cross-coupling reactions.  
 
In a single example, acetonide-protected 3-iodo-c-DHC 190 has also been metallated using 
tert-butyllithium and the resulting lithiospecies transmetallated using zinc chloride. The 
organozinc species so formed was then subjected to Negishi cross-coupling with a further 
equivalent of iodide 190 to afford dimer 192 in 40% yield (Scheme 3.6).119 
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Scheme 3.6: Negishi coupling of acetonide-protected 3-iodo-cis-1,2-dihydrocatechol 190. 
 
 
Although the work outlined in this Section provides precedent for the union of the c-DHC 
moiety and the dienophilic tether via a cross-coupling reaction, there were certain limitations to 
such processes that needed to be overcome. Firstly, these reactions were generally low-yielding, 
which is mainly due to the instability of the c-DHCs themselves. This problem can be 
minimised, however, by using the corresponding acetonide derivative. Secondly, the successful 
couplings observed to this point generally use highly reactive coupling partners such as vinyl 
and allyl stannanes. In contrast, the coupling partners that would need to be used in the 
synthesis of the desired IMDA precursors, specifically alkyl-based reagents, will be 
considerably less reactive in these cross-coupling reactions. 
 
3.3 Synthesis of IMDA Precursors via Palladium-Catalysed Cross- 
Coupling Reactions 
3.3.1 The Stille cross-coupling approach 
Because Stille cross-coupling reactions have been shown to be successful with both protected 
and unprotected c-DHCs, the first approach to the synthesis of the IMDA precursors utilised 
this reaction. Following the proposed retrosynthetic analysis (Scheme 3.2, page 63), it was 
envisioned that alkylstannane 193 (Figure 3.2) could be engaged in a cross-coupling reaction 
with 3-iodo-c-DHC. However, there is limited literature precedent regarding the use of 
alkylstannanes as coupling partners in Stille cross-coupling reactions. On the other hand, 
allylstannanes readily participate in such cross-coupling reactions, and there are numerous 
examples of such reactions in the literature.120 Accordingly, silyl enol ether 194 was proposed as 
a more appropriate coupling partner than congener 193. 
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Figure 3.2: Proposed organostannaes for use in the Stille cross-coupling reaction. 
 
It was envisioned that the triethylsilyl enol ether moiety would be stable under the reaction 
conditions and that the coupling product could then be hydrolysed to afford the desired vinyl 
ketone functionality. A similar strategy has been used by Krohn and co-workers who coupled 
alkenyl bromide 195 with an allyl stannane possessing a methyl enol ether (196) to obtain 
compound 197. The enol ether moiety within the coupled product was then hydrolysed to afford 
%-keto-ester 198 (Scheme 3.7).121 
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Scheme 3.7: Stille cross-coupling of allyl stannane 196 and subsequent hydrolysis of the methyl enol 
ether to the corresponding ketone. 
 
 
In an effort to implement such ideas, allyl stannane 194 was synthesised using the protocols of 
Fuchs and co-workers (Scheme 3.8).122 Thus, commercially available 1,4-pentadien-3-ol (199) 
was protected as the corresponding triethylsilyl ether 200 and this was treated with 
sec-butyllithium to generate a symmetrical pentadienyl lithium derivative.123 This anion was 
then quenched with tributylstannyl chloride to afford, regioselectively, the '-substituted allyl 
stannane 194. The spectroscopic data derived from this material were fully consistent with those 
reported in the literature.122 Disappointingly, all attempts to engage this material in Stille 
cross-coupling reactions with 3-iodo-c-DHC (88), or the corresponding acetonide 190, only 
resulted in decomposition of the staring materials. 
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Scheme 3.8: Reagents and conditions (i) imidazole (1.2 mole equiv.), TESCl (1.1 mole equiv.), DMF,  
0 to 18 °C, 1 h; (ii) s-BuLi (1.1 mole equiv.), n-Bu3SnCl (1.1 mole equiv.), THF, -78 °C, 1.5 h. 
 
 
3.3.2 The Negishi cross-coupling approach 
Following the abovementioned failure of the Stille reactions, an alternative cross-coupling 
procedure was sought. Pimm and co-workers have shown that an unreactive organostannane can 
be converted into a more active organozinc reagent, which readily participates in a Negishi 
cross-coupling reaction.124 Accordingly, allyl stannane 194 was treated with n-butyllithium (to 
effect a Sn/Li-exchange) then ZnCl2 (to generate the corresponding organozinc compound 201). 
A mixture of acetonide 190 and Pd(PPh3)4 was added to the reaction mixture that was then 
heated at 60 ºC overnight, cooled and subjected to the usual work-up procedures. Although 
significant decomposition of both coupling partners was observed, two products were isolated, 
albeit in small quantities. These were tentatively assigned, through 1H NMR and EI mass 
spectroscopic analysis, as compounds 202 and 203 (Scheme 3.9).  
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Scheme 3.9: Reagents and conditions (i) a) n-BuLi (1.0 mole equiv.), THF, -78 ºC, 15 min; b) ZnCl2 
(1.1 mole equiv.), THF, -78 to 18 °C, 1 h; (ii) 190 (1.1 mole equiv.), Pd(PPh3)4 (13 mol%), THF, 18 ºC, 
16 h. 
 
 
While compound 202 is the desired product of the Negishi cross-coupling reaction, compound 
203 is assumed to arise from Li/Zn transmetallation of unreacted n-butyllithium and subsequent 
cross-coupling of the resultant organozinc species with the c-DHC. Interestingly, although the 
reaction was attempted with a variety of lithium and zinc sources, silyl enol ether 202 was only 
ever obtained in trace amounts. In contrast, it could be shown, in a control experiment, that the 
organozinc reagent derived from n-butyllithium readily participates in the Negishi 
cross-coupling reaction with iodide 190 at room temperature to give significant amounts (not 
quantified) of compound 203.  
 
Unlike the Stille cross-coupling reactions, there are many examples of Negishi cross-coupling 
reactions with alkyl metal species. In fact, alkyl zinc reagents have proven to be superior to any 
other alkyl metal species that have been examined to date.125 In order to test the suitability of an 
alkyl zinc reagent derived from an alkyl halide in this synthetic route, a model reaction was 
conducted using commercially available 1-iodobutane 204. Thus, this material was subjected to 
lithium-for-halogen exchange using tert-butyllithium at -78 ºC and the resulting anion was 
quenched by using a THF solution of anhydrous ZnCl2 to generate, after warming to 18 ºC, the 
desired organozinc species. Subsequent addition of a mixture of iodide 190 and Pd(PPh3)4 
afforded compound 203 in 65% yield (Scheme 3.10). 
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Scheme 3.10: Reagents and conditions (i) a) t-BuLi (2.2 mole equiv.), THF, -78 °C, 20 min; b) ZnCl2 
(1.1 mole equiv.), THF, -78 to 18 °C, 1 h; c) 190 (1.0 mole equiv.), Pd(PPh3)4 (10 mol%), THF, 18 ºC, 2 
h. 
 
 
There are several noteworthy features associated with the 1H NMR spectrum of compound 203 
(Figure 3.3) that proved useful for identifying the presence of coupled products in the 1H NMR 
spectra of crude reaction mixtures arising from related processes. Thus, the signals assigned to 
the protons at C5 (( 5.72) and C3a (( 4.54) in the product are located further up-field than the 
corresponding ones arising from the starting material (( 6.66 and 4.73, respectively). 
Furthermore, a new two-proton multiplet, located at ( 2.23, can be attributed to the allylic 
methylene of the newly introduced butyl-chain. The remainder of the spectrum is in accord with 
the assigned structure. The EI mass spectrum displays a molecular ion at m/z 208 and an 
accurate mass measurement on this species established that it was of the expected molecular 
composition, viz. C13H20O2. A specific rotation of [$]D = +125 (c 1.6, CHCl3) was observed for 
this compound.  
 
 
Figure 3.3: 300 MHz 1H NMR spectrum of coupled product 203 (recorded in CDCl3). 
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With a procedure for the alkylation of acetonide 190 in hand, attention was turned towards the 
design and synthesis of suitable alkyl halides for use in the Negishi cross-coupling reaction in 
order to access substrates required for the proposed IMDA reactions. Such syntheses are 
described in the following Sections. 
 
3.3.3 Halo-dioxin 206 as an %-haloethyl vinyl ketone equivalent 
Any synthesis of the desired IMDA precursors using the abovementioned Negishi cross-
coupling protocol requires the use of %-haloethyl vinyl ketone 205 (Figure 3.4), or an equivalent 
compound, as a precursor to the proposed alkylzinc coupling partner (175, M = Zn) depicted in 
the retrosynthetic analysis (Scheme 3.2, page 63). Although the synthesis of %-chloroethyl vinyl 
ketone has been reported in the literature several times,126 there are no protocols describing the 
preparation of the corresponding bromo- or iodo-derivatives required for the work presented 
here. This is probably due to the inherent instability of these compounds as they would be 
expected to be prone to polymerisation under basic conditions and the %-substituent is also 
likely to be highly susceptible to elimination. Moreover, the lack of selectivity between the two 
electrophilic sites is likely to restrict the types of reactions they could engage in. To circumvent 
these problems, Funk and co-workers introduced dioxin 206 as a %-haloethyl vinyl ketone 
equivalent (Scheme 3.11).127 In that work, it was demonstrated that dioxin 206 could be 
alkylated on the halogen-bearing centre then, via a cycloreversion process involving the 
1,3-dioxin, the enone moiety could be revealed for further reaction. 
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Scheme 3.11: Dioxin 206 as a !-haloethyl vinyl ketone (205) synthon. 
 
 
There are several features of dioxin 206 that made it an attractive coupling partner for use in the 
present work. These are: 
 
(i)  Protection of the carbonyl moiety in the suggested manner should allow for the use of 
tert-butyllithium to affect the lithium-for-halogen exchange (this is required prior to 
formation of the organozinc species).  
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(ii)  It was envisioned the cycloreversion process would be followed, in situ, by the 
intramolecular Diels-Alder reaction.- This would remove the need to isolate and handle 
the potentially unstable enone intermediate. 
(iii)  It is possible that substituents could be introduced at C4 of dioxin 206. This would 
allow investigation of the influence of dienophilic substituents on the IMDA reaction.  
 
Accordingly, attention was turned to the preparation of iodo-dioxin 207 and its 
C4-gem-dimethyl derivative 208. 
 
207
O
O
I
208
O
O
I
4
4
 
Figure 3.4: Iodoethyl-dioxins sought for Negishi cross-coupling with c-DHC 190. 
 
3.3.4 Synthesis of dioxins 207 and 208  
3.3.4.1 Unsubstituted iodoethyl-dioxin 207 
Iodo-dioxin 207 was prepared via the synthetic sequence reported by Funk and co-workers.127 It 
was found that some of the reported procedures had to be modified in order to attain the 
reported yields. These modifications are now discussed, albeit briefly. The synthesis began with 
the preparation of keto-alcohol 213, which was achieved via two distinct routes (Scheme 3.12). 
Thus, the procedure of Taylor and LaMattina129 (Route 1) involves formation of the dianion of 
ethyl acetoacetate (209) and subsequent alkylation with benzyloxymethyl chloride (BOM-Cl) to 
afford compound 210 in 46% yield. Route 2 followed the protocols of Heathcock et al.,130 and 
utilised commercially available 3-(benzyloxy)-1-propanol (211) as the starting material. This 
was oxidised, under Swern-Moffit conditions, to the corresponding aldehyde 212. Treatment of 
the crude samples of aldehyde 212 with ethyl diazoacetate in the presence of tin (II) chloride 
furnished %-keto-ester 210 in 55% yield over the two steps. Although there was little difference 
observed in the overall yield of compound 210 (ca. 50%) via either route, Route 2 afforded a 
cleaner reaction that allowed for more ready purification of the product. Accordingly, this 
second route was preferred. Hydrogenolysis of the benzyl moiety within compound 210 
(obtained by either route) was achieved using catalytic Pd(OH)2 to afford keto-alcohol 213 in 
 
- Funk and co-workers have carried out a similar ‘one-pot’ cycloreversion process followed in situ by a 
cycloaddition reaction on a substrate possessing an amidodioxin moiety.
128
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95% yield. All spectral data collected on this compound were consistent with those reported in 
the literature.129  
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Scheme 3.12: Reagents and conditions (i) a) NaH (1.1 mole equiv.), n-BuLi (1.05 mole equiv.), THF, 
-5 °C, 20 min; b) BOM-Cl (1.5 mole equiv.), THF, 0 ºC, 2 h; (ii) oxalyl chloride (1.5 mole equiv.), 
DMSO (2.0 mole equiv.), CH2Cl2, -78 °C, 45 min; (iii) SnCl2 (0.2 mole equiv.), ethyl diazoacetate (1.05 
mole equiv.), CH2Cl2, 18 °C, 16 h; (iv) Pd(OH)2 on C, H2 (1 atm), EtOH, 18 ºC, 22 h. 
 
 
The next stage of the synthesis involved formation of the 1,3-dioxin moiety via acid-catalysed 
protection of alcohol 213 with 2-methoxypropene (Scheme 3.13). Funk and co-workers127 
reported that they observed initial, rapid, formation (1-2 h) of conjugated acetonide 214, which, 
after 16 h, had converted, almost exclusively, into the desired endocyclic isomer 215. In our 
hands, however, extended reaction times (3 days) were required in order to obtain a satisfactory 
ratio of compounds 214 and 215 (1:11 as juged by 1H NMR analysis of the crude reaction 
mixture). The peaks assigned to the major isomer in 1H NMR spectrum are consistent with 
those reported in the literature for compound 215.127 
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Scheme 3.13: Reagents and conditions (i) 2-methoxypropene (3.0 mole equiv.), PPTS (0.3 mole 
equiv.), THF, 0 to 18 °C, 3 days. 
 
 
Unfortunately, these isomers were not able to be separated by standard chromatographic 
methods. As a result, the mixture was treated with lithium aluminium hydride (LiAlH4) to 
afford the corresponding mixture of alcohols, 216 and 217 (Scheme 3.14). The isomeric 
alcohols, so formed, could then be separated by column chromatography. 
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Scheme 3.14: Reagents and conditions (i) LiAlH4 (1.5 mole equiv.), Et2O, 0 °C, 30 min. 
 
 
The final step in the synthesis of iodo-dioxin 207 involved conversion of alcohol 217 into the 
corresponding iodide (Scheme 3.15). Following the protocols of Funk and co-workers (PPh3, I2, 
imidazole) the reaction proceeded smoothly to yield (before purification) a mixture of iodide 
207 and PPh3/PPh3O. Unfortunately, in our hands, iodide 207 proved unstable to column 
chromatography so it could not be obtained in a pure form. This problem was overcome by 
employing polymer-bound PPh3, which allowed pure samples of iodo-dioxin 207 to be obtained 
in 73% yield.  
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Scheme 3.15: Reagents and conditions (i) imidazole (2.3 mole equiv.), polymer-bound PPh3 (2.0 mole 
equiv.), I2 (2 mole equiv.), THF, 0 to 18 °C, 1 h. 
 
 
Although iodoethyl-dioxin 207 is relatively stable in solution, neat samples were found to 
rapidly decompose with accompanying loss of molecular iodine. Thus, this compound was 
stored as its alcohol precursor (217) and only converted into the iodide (following the procedure 
outline above) immediately prior to use.  
 
3.3.4.2 C4-gem-dimethyl iodo-dioxin 208 
With a successful synthesis of iodo-dioxin 207 in hand, attention was turned to the preparation 
of the C4-gem-dimethyl derivative. To this end, disubstituted %-keto-ester 219 was prepared 
from commercially available 4-hydroxy-4-methyl-2-pentanone (218) (Scheme 3.16). %-Hydroxy 
ketones such as 218 can be doubly deprotonated with two equivalents of an amide base to 
generate either the proximal or the distal dianions. The enolization and trapping of such systems 
have been studied by Albizati et al.131 In this work, conditions for regioselective generation of 
either the proximal or the distal dianion were identified. Accordingly, %-hydroxy ketone 218 
was treated with two equivalents of LDA at -78 ºC, then allowed to warm to 18 ºC and stirred 
for 15 min at this temperature in order to generate the desired distal dianion. Mander’s reagent 
then was added to the resulting solution (at -78 ºC) to afford the desired %-keto-ester 219 in 50% 
yield. This product was accompanied by traces of compound 220, formed via acylation of the 
proximal enolate. All spectral data collected on compound 219 were consistent with those 
reported in the literature.132 
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Scheme 3.16: Reagents and conditions (i) a) LDA (2.3 mole equiv.), THF, -78 to 18 °C, 30 min; b) 
NCCO2Me (1.05 mole equiv.), THF, -78 °C, 15 min.  
 
 
Following the modified procedures described in the previous Section (3.3.4.1), %-keto-ester 219 
was successfully converted into iodide 208 (Scheme 3.17). Thus, treatment of compound 219 
with 2-methoxypropene and pyridinium tosylate (PPTS) afforded, after 3 days, a 1:2 mixture of 
acetonides 221 and 222. Various attempts to improve on this ratio proved fruitless. Reduction of 
the mixture was achieved using LiAlH4 to afford, after chromatographic separation, alcohols 
223 and 224. Finally, alcohol 224 was converted, by standard means, into iodide 208, which 
was obtained in 83% yield. 
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Scheme 3.17: Reagents and conditions (i) 2-methoxypropene (3.15 mole equiv.), PPTS (0.3 mole 
equiv.), THF, 0 to 18 °C, 3 days; (ii) LiAlH4 (1.3 mole equiv.), Et2O, 0 °C, 30 min; (iii) imidazole (2.5 
mole equiv.), polymer-bound PPh3 (2.0 mole equiv.), I2 (2.0 mole equiv.), THF, 0 to 18 °C, 1 h. 
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The 1H NMR spectrum obtained on iodide 208 was fully consistent with the assigned structure. 
It features a one-proton singlet in the olefinic region along with two two-proton triplets at ( 3.26 
and 2.55, which were assigned to the C1 and C2 methylene units, respectively. Two singlets 
integrating for six protons each confirmed the presence of the two non-equivalent gem-dimethyl 
units. The 13C NMR spectrum provided evidence that the desired iodide substitution had 
occurred at C1, by virtue of a new signal appearing at ( 2.48, which was attributed to the 
iodomethylene carbon. Iodide 208 was found to be equally as unstable as its unsubstituted 
counterpart 207. Thus, alcohol 224 was also only converted into the iodide 208 immediately 
prior to use. 
 
3.3.5 Negishi cross-couplings of cis-1,2-dihydrocatechols and iodo-dioxins 207 
and 208 
With the relevant coupling partners in hand, their suitability as participants in Negishi 
cross-coupling reactions was investigated. To this end, iodide 207 was treated with 
tert-butyllithium at -78 ºC to effect lithium-for-halogen exchange. The resultant anion was then 
treated with a THF solution of anhydrous ZnCl2 to generate, after warming to 18 ºC, the desired 
organozinc species. Subsequent addition of a mixture of iodide 190 and catalytic quantities of 
Pd(PPh3)4 afforded compound 225, albeit it in only 10% yield (Scheme 3.18).  
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Scheme 3.18: Reagents and conditions (i) a) t-BuLi (3.0 mole equiv.), THF, -78 °C, 15 min; b) ZnCl2 
(1.1 mole equiv.), THF, -78 to 18 °C, 30 min; c) 190 (1 mole equiv.), Pd(PPh3)4 (10 mol%), THF, 18 ºC, 
2 h. 
 
 
The 1H NMR spectrum of triene 225 features signals associated with both the c-DHC and the 
ethyl-dioxin moieties, and was fully consistent with the notion that there had been a successful 
union of the two coupling partners. The doublets observed at ( 5.73 and 4.55, which can be 
assigned to C5 and C3a respectively, are characteristic of a coupled product (as described in 
Section 3.3.2), as are the multiplets at ( 2.41 and 2.26, which can be attributed to the allylic 
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methylene units of the newly introduced ethyl-dixoin moiety. The 13C NMR spectrum (Figure 
3.5) displays the expected seventeen carbon resonances and is fully consistent with the assigned 
structure. The EI mass spectrum displays a molecular ion at m/z 292 and an accurate mass 
measurement on this species established that it was of the expected molecular composition, viz. 
C17H24O4.  
 
 
Figure 3.5: 75 MHz 13C NMR spectrum of coupled product 225 (recorded in CDCl3). 
 
Having successfully coupled compounds 207 and 190, attention was turned to optimising this 
process. Unfortunately, and despite extensive efforts, the yield could not be improved beyond 
ca. 30% (which was obtained using 1.5 equivalents of the organozinc coupling partner that had 
been made using a freshly prepared THF solution of anhydrous zinc chloride).# This reaction 
was also carried out using unprotected c-DHC 88 and the C4-gem-dimethyl dioxin 208 (Scheme 
3.19) to afford compounds 226 (24%) and 227 (43%), respectively. Thus, three different IMDA 
precursors were able to be synthesised using this type of reaction, albeit only in modest yield. 
 
 
# The reader will observe, in Chapter Four that, for related system significant improvements in yield were observed 
by replacing ZnCl2 with ZnI2. However, due to time restraints the reaction described here was not attempted using 
these improved reaction conditions. 
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Scheme 3.19: Reagents and conditions (i) a) iodo-dioxin partner (1.5 mole equiv.) t-BuLi (3.3 mole 
equiv.), THF, -78 °C, 15 min; b) ZnCl2 (1.65 mole equiv.), THF, -78 to 18 °C, 30 min; c) cis-
dihydrocatechol partner (1.0 mole equiv.), Pd(PPh3)4 (10 mol%), THF, 18 ºC, 2 h. 
 
 
Although none of the desired materials could be obtained in high yield, sufficient quantities of 
compounds 225, 226 and 227 were available to permit a preliminary assessment of the capacity 
of these c-DHC derivatives to participate in IMDA cycloaddition reactions. The results of such 
investigations are discussed in the following Section. 
 
3.4 Stereochemical Outcomes of IMDA Cycloaddition Reactions of 
cis-1,2-Dihydrocatechol-Dioxin Conjugates 
 
While intermolecular Diels-Alder reactions have a strong preference for an endo-transition 
state, this effect does not dominate the intramolecular variant to the same extent.19 For this 
reason, there were four possible cycloadducts that could be produced during the reactions under 
investigation; namely, the i) endo-, anti- ii) endo-, syn- iii) exo-, anti- and/or iv) exo-, syn-
adducts. The aim of the work outlined in the present Section was to investigate the 
stereochemical outcomes of the intramolecular Diels-Alder reactions of c-DHC derivatives. 
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3.4.1 IMDA cycloaddition reaction of precursor 225 
Following the procedure of Funk and co-workers,128 dioxin 225 was heated in refluxing toluene 
for 16 h in the presence of butylated hydroxytoluene (BHT) (to prevent decomposition via 
autooxidation) and a mild acid scavenger (N,N-diethylaniline). Under such conditions, 
retrocycloaddition of the dioxin moiety was followed by an in situ intramolecular Diels-Alder 
cycloaddition reaction to afford a ca. 1:1 mixture of just two (of the possible four) cycloadducts. 
These were obtained in 81% combined yield and readily separated by column chromatography. 
Using X-ray crystallography, these compounds were assigned as the endo-, anti-adduct 225. 
and the endo-, syn-adduct 226# (Scheme 3.20 and Figure 3.8).  
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Scheme 3.20: Reagents and conditions (i) BHT (0.5 mole equiv.), N,N-diethylaniline (14.3 mole 
equiv.), toluene, reflux, 16 h.  
 
 
 
Figure 3.8: Displacement Ellipsoid Plots (30%) derived from single-crystal X-ray analysis of IMDA 
adducts 229 and 230 (Appendices 9 and 10 respectively). 
 
 
 
. Addition of the dienophile to the face of the diene opposite the acetonide residue. 
# Addition of the dienophile to the face of the diene bearing the C-O bonds of the acetonide ring.  
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Figure 3.6: 300 MHz 1H NMR spectrum of Diels-Alder adduct 229 (recorded in CDCl3). 
 
 
 
 
Figure 3.7: 300 MHz 1H NMR spectrum of Diels-Alder adduct 230 (recorded in CDCl3). 
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Unsurprisingly, the spectroscopic data obtained on the two adducts were very similar and fully 
consistent with the assigned structures. Each isomer gives rise to a peak at ca. ( 2.8 in the 1H 
NMR spectrum (Figures 3.6 and 3.7) and this is attributed to a single allylic proton (C4-H). The 
resonances observed in the olefinic region also display coupling patterns that are characteristic 
of Diels-Alder adducts of c-DHCs,. Each isomer exhibited a carbonyl stretching band at ca. 
1740 cm-1 in the IR spectrum as is characteristic of a five-membered ring ketone. The molecular 
formula of each adduct (C14H18O3) was readily established using a combination of mass 
spectrometry and elemental analysis. Conversely, the melting points of the two isomers were 
found to be significantly different; melting was observed in the range of 93 - 96 ºC for the syn-
adduct (230) and 131 - 135 ºC for the anti-adduct (229). 
 
The stereochemical outcome observed for this reaction was unexpected for several reasons. 
While the endo/exo selectivity of the cycloaddition reaction could not have been predicted, it 
was anticipated that the syn/anti selectivity would follow from the outcomes observed in the 
analogous intermolecular cycloaddition reactions26 and thus give the anti-adduct as the major 
product of the reaction. However, it was observed that the cycloaddition occurred 
stereoselectively, via an endo-transition state, but with essentially no facial selectivity, affording 
the syn- and anti- adducts in a 1:1.1 ratio, respectively. As discussed in Chapter 1, it is widely 
recognised that both steric and electronic factors contribute significantly to the facial selectivity 
of Diels-Alder reactions of c-DHCs. It has been shown that, in the absence of any pronounced 
steric effects, stereoelectronic control of the reaction results in preferential formation of the syn-
adduct. However, by protection of the diol moiety, and the associated increase in bulk, steric 
interactions become the governing factor, thereby affording the anti-adduct as the major 
product. In the intermolecular variant, the acetonide-protecting group was found to provide 
sufficient steric bulk to override the underlying electronic factors and so leading to the anti-
adduct as the major product of the reaction. In the intramolecular reaction, however, the 
acetonide-protecting group is clearly not large enough to control the facial selectivity, resulting 
in a ca. 1:1 mixture of syn- and anti-adducts. Of course, it is possible that the use of a bulkier 
protecting group could improve the anti-selectivity of this reaction.24 
 
 
, See Chapter Two, Section 2.3.1 for a description of characteristic resonances observed in the 1H NMR spectra of 
Diels-Alder adducts of cis-1,2-dihydrocatechols. 
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3.4.2 IMDA cycloaddition reaction of precursor 226 
On heating under the same conditions as described in the preceding Section (3.3.6.1), diol 226 
underwent a retrocycloaddition then an IMDA cycloaddition reaction to afford a 3:1 mixture of 
two cycloadducts in 78% combined yield. There were several indications that the 
stereochemical outcome of this cycloaddition reaction was different to that observed for the 
previous one. For example, the olefinic resonances in the 1H NMR spectrum were notably 
different for the two isomers, a feature not usually observed for mixtures of syn- and anti- 
adducts. It was, therefore, proposed that this reaction had occurred with excellent facial 
selectivity, most probably delivering the syn-adduct preferentially, but with only moderate 
stereoselectivity to give a mixture of the syn-, endo- (231) and syn-, exo- (232) cycloadducts 
(Scheme 3.21). 
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Scheme 3.21: Reagents and conditions (i) BHT (0.1 mole equiv.), N,N-diethylaniline (8.0 mole equiv.), 
toluene, reflux, 16 h.  
 
 
Owing to the small scale of the reaction and the difficulties associated with chromatographic 
separation of these isomers, it was not possible to confirm this tentative assignment by X-ray 
crystallography. Thus, it was necessary to confirm the stereochemistry of the two cycloadducts 
by other means, namely by NMR and chemical correlation techniques. The 1H NMR spectrum 
of the mixture (Figure 3.10) clearly exhibits two quite distinct sets of olefinic resonances in a 
3:1 ratio. The major product gives rise to peaks in the olefinic region at ( 6.32 (dd, J = 8.2 and 
6.6 Hz) and 5.83 (d, J = 8.2 Hz) and an essentially reversed pattern is displayed by the minor 
component with resonances observed at ( 6.23 (d, J = 8.2 Hz) and 6.13 (dd, J = 8.2 and 6.3 Hz). 
Krantz and co-workers have reported a remarkably similar pattern of reciprocity between the 
olefinic resonances of a related set of endo- and exo-isomers.133 In their example, triene 233 
undergoes an IMDA cycloaddition reaction to yield isomeric tricyclic ketones 234 and 235 in 
79% and 21% yields, respectively (Scheme 3.22). The NMR spectra of these two cycloadducts 
are shown in Figure 3.9. Notably, the shifts for the two vinyl hydrogens are larger for the 
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endo-isomer than the exo-isomer and the coupling pattern is reversed. This compares favourably 
with the pattern observed in the 1H NMR spectrum of the mixture of cycloadducts 234 and 235, 
thereby lending support to the proposition that a mixture of endo- and exo-adducts was obtained 
in which the former isomer was the major one. 
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Scheme 3.22: Intramolecular Diels-Alder reaction of triene 233 to afford a mixture of endo- (230) and 
exo- (231) cycloadducts.133 
 
 
 
 
Figure 3.9: 300 MHz 1H NMR spectra of Diels-Alder adducts 234 and 235 (recorded in CDCl3 by 
Krantz and co-workers).
133
 Reprinted with permission from J. Am. Chem. Soc., 95, 5662. Copyright 
(1973) American Chemical Society. 
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Figure 3.10: 300 MHz 1H NMR spectrum of the products of the IMDA cycloaddition reaction of triene 
226 (recorded in CDCl3). 
 
With assignment of one aspect of the stereochemistry achieved, the facial selectivity of the 
reaction required investigation, particularly because it was evident from the IMDA 
cycloaddition reaction with precursor 225 that the facial selectivity cannot be predicted based 
on the corresponding intermolecular DA cycloaddition reactions. Since the acetonide 
derivatives of the endo-, anti- (229) and the endo-, syn-cycloadducts (230) had already been 
prepared, and their structures confirmed by X-ray crystallography (Figure 3.6), the diols were 
converted into the corresponding acetonides to enable assignment of the facial selectivity 
(Scheme 3.23).  
 
 
+
232
HO
HO
O
231
O
HO
HO
O
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O
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i
71%
 
 
Scheme 3.23: Reagents and conditions (i) (MeO)2CMe2, (15.0 mole equiv.), p-TsOH•H2O (0.4 mole 
equiv.), CH2Cl2, 18 °C, 16 h.  
 
 
On subjecting the mixture of diols to protection, using standard protocols, as the corresponding 
acetonide, it was surprising to find that only one product was observed in the 1H NMR spectrum 
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of the crude reaction mixture. Upon comparing this spectrum with that of cycloadducts 229 and 
230 it became evident that the compound that had been obtained was the syn-, endo-isomer 
(230), thereby establishing that the IMDA cycloaddition reaction was syn-selective. The 
disappearance of the corresponding syn-, exo-isomer was unexpected and may be due to acid-
induced epimerisation. Ouellett and co-workers have previously conducted base-induced 
epimerisation studies with a number of substituted bicylo[2.2.2]octenes, demonstrating that 
under equilibration conditions there is a preference for the endo-substituted congener.134 This 
was proposed, by the authors, to be a consequence of unfavourable steric interactions in the 
exo-adducts. Studies to determine if cycloadducts 231 and 232 demonstrate similar behaviour 
are now underway. 
 
In summary, it has been established that the IMDA cycloaddition reaction of the unprotected c-
DHC derivative 226 occurred with excellent facial selectivity, affording only the syn-adduct. 
However, unlike previous examples of DA cycloaddition reactions, only moderate 
diastereoselectivity was obtained, affording a mixture of endo- and exo-isomers in a 3:1 ratio, 
respectively. 
 
3.4.3 IMDA cycloaddition reaction of precursor 227 
The IMDA cycloaddition reaction of the bis-gem-dimethylated system 227 was the last to be 
studied. Under the same reaction conditions as described previously (toluene, ca. 110 ºC, 16 h), 
no reaction was observed. However, on changing the solvent from toluene to mesitylene and 
heating the reaction mixture at 165 ºC for 4 days, two reaction products were observed. 
Unfortunately, there was also a substantial amount of dioxin 227 remaining (~25% after 4 
days), which could not be induced to undergo further reaction by simply increasing the duration 
of the reaction. 1H NMR analysis of the crude reaction mixture revealed that one products was, 
as determined by the presence of characteristic olefinic resonances, indeed an IMDA 
cycloadduct. However, the presence of three distinct olefinic signals associated with the second 
product was indicative of a dimeric species resulting from a DA reaction between two c-DHC 
moieties. Owing to the small scale of the reaction, the dimer could not be isolated and 
characterised. However, its presence was confirmed by EI-inducted mass spectroscopy of the 
crude reaction mixture. The IMDA cycloadduct was eventually isolated in 32% yield (Scheme 
3.24) and its structure confirmed by single-crystal X-ray analysis (Figure 3.12, Appendix 12) as 
the endo-, anti-isomer 237. 
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Scheme 3.24: Reagents and conditions (i) BHT (0.1 mole equiv.), N,N-diethylaniline (14.1 mole 
equiv.), mesitylene, reflux, 4 days. 
 
 
 
Figure 3.12: Displacement Ellipsoid Plot (30%) derived from single-crystal X-ray analysis of IMDA 
adduct 237. 
 
The presence of the gem-dimethyl group at C4 of the dioxin moiety appears to have 
significantly affected both stages of this reaction. Firstly, the observation that significant 
amounts of the starting dioxin 227 could be re-isolated while none of the corresponding enone 
233 was observed suggests that the methyl groups hinder the cycloreversion process. Thus, 
higher temperatures (165 ºC cf. 110 ºC) and longer reaction times are required to overcome the 
greater activation energy. Secondly, the steric influence of the methyl groups also affected the 
stereochemistry of the IMDA cycloaddition reaction, with addition of the dienophile occurring 
solely at the face of the diene opposite to the acetonide residue, and thus affording only the anti-
adduct. In contrast, the IMDA cycloaddition reaction involving the unsubstituted derivative 225 
yielded a ca. 1:1 mixture of syn- and anti-adducts.  
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3.4.4 Conclusion 
This work was initiated with the aim of investigating IMDA cycloaddition reactions of c-DHCs. 
The data presented here show that these reactions are syn-selective for the unprotected c-DHC, 
while protection of the diol moiety with an acetonide results in a mixture of syn- and anti-
adducts. The alteration of the facial selectivity through the use of protecting groups is promising 
and it is hoped that bulkier protecting groups will further improve the anti-selectivity of the 
process. Additionally, while substitution at C4 of the dioxin improves the anti-selectivity of the 
IMDA reaction it appears to adversely affect the efficiency of the retrocycloaddition reaction of 
the dioxin moiety. Thus, the development of synthetic routes to substrates for the IMDA 
reaction that posesses unprotected dienophilic moieties would greatly enhance the versatility of 
this methodology.  
 
3.5 Synthesis of IMDA Precursors via a Conjugate Addition  
Reaction 
3.5.1 Introduction 
Owing to the abovementioned problems associated with the previous strategy, the development 
of an alternative procedure for the synthesis of the IMDA precursors was necessary. A survey of 
the literature suggested divinyl ketone (DVK) 239 might be a suitable reagent for the 
introduction of the desired dienophilic moiety.135,136 While DVK is capable of undergoing a 
double Michael addition, Spitzner et al. found that, under aprotic conditions, it reacts with 
anions such as 238 to afford the product of a single Michael addition, compound 240, as the 
exclusive product of the reaction. (Scheme 3.25).135 Hagiwara et al. subsequently reported 
improved yields of such products (41 - 49%) via addition of HMPA and quenching at low 
temperature.136 
 
 
239
i
238 240
OLi
O
OO
+
18%
 
 
Scheme 3.25: Reagents and conditions (i) THF, -70 ºC, 15 mins. 
 
 
Thus, it was envisioned that conjugate addition of an anion derived from c-DHC to DVK would 
allow the rapid synthesis of the desired IMDA precursors without the need to protect the 
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$,%-unsaturated ketone moiety. Furthermore, if substituted derivatives of DVK are used in this 
reaction it was expected that the conjugate addition process would occur at the less sterically 
hindered end, yielding IMDA precursors incorporating substituted dienophilic residues. The 
following Section details the synthesis of DVK (239) and its !,!-dimethylated derivative 242.  
 
3.5.2 Synthesis of divinyl ketones 
Despite the many reported uses of DVK in the literature,137 acquiring sufficient quantities of this 
reagent proved to be surprisingly difficult. Specifically, its volatility, propensity to polymerise 
and lachrymatory properties made the isolation of DVK and its derivatives highly challenging. 
After several protocols were evaluated, the preparations reported below were found to be the 
most reliable ones for obtaining useful quantities of DVK and its !,!-dimethylated derivative. 
 
The !,!-dimethylated DVK 242 was found to be most easily prepared via the method of 
Mironov and co-workers.138 This involved a Mannich reaction between diacetone alcohol 218, 
formaldehyde and diethylamine hydrochloride and subsequent decomposition of the ensuing 
Mannich base 241 at 150-210 ºC, to afford compound 242139 in 35% yield (Scheme 3.26). 
Although this yield is low, the reagents are inexpensive and the reaction can be readily scaled-
up in order to obtain multi-gram quantities of the desired product.  
 
 
218
i
O OH O
N
Et
Et
HCl .
ii
O
241 242
35% over two 
steps
 
 
Scheme 3.26: Reagents and conditions (i) Et2NH•HCl (1.0 mole equiv.), CH2O (1.0 mole equiv.), 
hydroquinone (0.02 mole equiv.), HCl (trace), 100 ºC, 2h; (ii) 150 – 200 ºC. 
 
 
While Mironov and co-workers reported that acetone works equally well in this reaction, and 
thus gives the parent DVK 239, this process proved difficult to reproduce. Accordingly, an 
alternative route, involving oxidation of divinyl carbinol 199 to the corresponding ketone 239, 
was used./ After screening various oxidants, DDQ was found to be the most effective, affording 
 
/ This reaction was modified from the work of Reed and co-workers who oxidised carbinol 199 to DVK 239 in 
yields of between 5–50% using manganese dioxide.
140
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DVK (239)141 in 72% yield.) It should be noted that the !,!-dimethylated DVK 242  can also be 
made via this route (Scheme 3.27); however, the method shown in Scheme 3.26 was routinely 
used, as it was the less expensive option. 
 
 
199  R = H     
243  R = Me
i
OH OR
R
R
R
239  R = H    (72%)
242  R = Me  (41%)  
 
Scheme 3.27: Reagents and conditions (i) DDQ (1.1 mole equiv.), Et2O, 18 ºC, 24 h. 
 
 
Since the reaction conditions used are rather mild it is anticipated that this method will be able 
to be applied in the preparation of more highly functionalised divinyl ketone derivatives for the 
synthesis of more complex IMDA precursors in future studies.  
 
3.5.3 The conjugate addition reaction 
With the desired Michael acceptors now in hand, the pivotal conjugate addition reaction could 
be examined. To this end, the acetonide protected c-DHC 190 was treated with i-PrMgCl in 
order to generate the corresponding Grignard reagent 244. It is recognised that the magnesium-
for-halogen exchange of alkenyl iodides is slow and often requires the use of highly reactive 
magnesium reagents and/or warming to room temperature in order to obtain synthetically useful 
results.142-144 Alkenyl iodide 190 proved to be no exception in this regard with the exchange 
reaction requiring 1-2 h0 at 0 ºC to achieve full conversion to the magnesium derivative (as 
determined by 1H NMR of a sample of the reaction mixture). Intermediate 244 was 
subsequently treated with CuBr•SMe2 and HMPA, followed by the addition of a mixture of 
DVK (239) and TMSCl.145,146 Under these conditions, the expected 1,4-addition process took 
place to afford, following workup,1 the desired product 228 in 65% yield (Scheme 3.28).  
 
 
) The product is obtained as a solution in Et2O and pentane. Most of the solvent can be removed under reduced 
pressure although a small amount of product is lost during this process. To minimise loss of product the solution is 
reduced until it is ca. 60% solution in Et2O/pentane. 
0 The progress of this conversion was routinely checked by 1H NMR as the times required for the exchange reaction 
to go to completion were found to vary and it could not be monitored by tlc. 
1 The initial product of the reaction is the trimethylsilyl enol ether derivative of compound 228, which is 
subsequently hydrolysed on workup to afford the product shown. There were instances in which the silyl enol ether 
was not fully hydrolysed and in these cases the crude product was stirred, for a brief period, with TBAF to complete 
the conversion.  
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Scheme 3.28: Reagents and conditions (i) i-PrMgCl (1.2 mole equiv.), THF, -30 to 0 ºC, 2h; (ii) 
CuBr•SMe2 (0.1 mole equiv.), HMPA (3.0 mole equiv.), TMSCl (3.0 mole equiv.), 239 (2.1 mole equiv), 
THF, -78 to 18 ºC, 16 h. 
 
 
As expected, the 1H NMR spectrum of $,%-unsaturated ketone 228 (Figure 3.13) features six 
signals in the olefinic region. The resonances attributed to the alkene of the $,%-unsaturated 
ketone moiety are distinct from those due to the c-DHC subunit and the magnitude of the 
couplings allowed full assignment of this region of the spectrum (see Figure 3.13 for 
assignments). Signals corresponding to the oxymethine protons C3a-H and C7a-H were 
observed at ( 4.66 and 4.53, respectively, while the peaks at ( 2.56 and 2.83 were assigned to 
the C8 and C9 methylene units. The APT 13C NMR spectrum (Figure 3.14) exhibits the 
expected fourteen carbon resonances while the EI mass spectrum shows a molecular ion at m/z 
234. An accurate mass measurement on this species established that it was of the expected 
elemental composition, viz. C14H18O3. 
Chapter Three 92 
 
 
Figure 3.13: 300 MHz 1H NMR spectrum of compound 228 (recorded in CDCl3). 
 
 
 
 
Figure 3.14: 75 MHz APT 13C NMR spectrum of compound 228 (recorded in CDCl3). 
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Having identified suitable conditions for the conjugate addition reaction, it remained to 
synthesise a range of IMDA precursors to allow further investigation into the cycloaddition 
reactions of these types of c-DHC derivatives (Table 3.1). Firstly, and in order to investigate the 
influence of a bulkier protecting group on the facial selectivity of the IMDA cycloaddition 
reaction, the endo-benzylidene acetal derivative 245 of iodo-diol 88 was prepared using 
standard procedures.147 Compound 245 was subsequently engaged in a conjugate addition 
reaction with DVK (239) to afford the desired product, 246, in 63% yield (Entry 2).  
 
Attention was next directed towards the synthesis of IMDA substrates carrying substituents on 
the dienophile and/or the diene. Accordingly, acetonides 190 (Entry 2) and 247 (which is 
substituted at C7 of the diene, Entry 4) were added to gem-dimethyl DVK 242. As anticipated, 
the conjugate additions occurred exclusively at the less substituted end of the potentially 
“double” Michael acceptor to afford compounds 236 and 248, respectively.  
 
Finally, an IMDA precursor with free hydroxy groups was sought. Initial efforts involved 
cleavage of the acetonide residue of compound 228 or the benzylidene acetal of 246 to reveal 
the diol moiety. However, despite screening a number of reaction conditions, the desired diol 
was never obtained. Rather, phenolic by-products were often observed, indicating the major 
reaction pathway was via aromatisation of the c-DHC moiety. Consequently, iodo-diol 88 was 
protected as the bis-(t-butyldimethylsilyl) (TBS) ether 249 in the belief that these protecting 
groups would be able to be removed under milder and non-acidic conditions. Although 
preparation of the magnesium derivative of bis-TBS ether 249 was unsuccessful, it was found 
that it could, instead, be converted into the corresponding stoichiometric copper reagent using a 
procedure described by Noyori et al.148,149 Thus, bis-ether 249 was metallated using 
tert-butyllithium and the resulting lithiospecies was treated with copper (I) iodide (1 mole 
equivalent) and tributylphosphine (3 mole equivalents) to generate the mixed cuprate. 
Conjugate addition of this species to DVK 242 and subsequent deprotection of the silyl groups 
using TBAF afforded diol 250 in 33% yield. An equivalent reaction was also attempted between 
bis-ether 249 and unsubtituted DVK (239) but with no success. Although tlc analysis of the 
crude reaction suggested that the conjugate addition reaction been successful the Michael 
product was unstable to the basic deprotection conditions (TBAF) used and rapidly 
decomposed, possibly via polymerisation processes. Due to time restraints these reactions were 
not pursed any further by the author but studies directed towards optimising this protocol are 
being continued by other members of the group. 
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Table 3.1: Conjugate additions of c-DHC derivatives to divinyl ketones 239 and 242. 
 
Entry 
cis-dihydrocatechol 
derivative 
Michael 
acceptor 
product yield (%) 
1! 
O
O
I
190  
O
239  O
O
O
228  
65 
2! 
O
O
I
245
Ph
 
O
239  O
O
O
246
Ph
 
63 
3! 
O
O
I
190  
O
242  
O
O
O
236  
74 
4! O
O
I
247  
O
242  O
O
O
248  
60 
5$ 
OTBS
OTBS
I
249  
O
242  O
OH
OH
250  
33 
 
!Reagents and conditions: (i) i-PrMgCl (1.2 mole equiv.), THF, -30 to 0 ºC, 2h; (ii) CuBr•SMe2 (0.1 
mole equiv.), HMPA (3.0 mole equiv.), TMSCl (3.0 mole equiv.), 239/242 (2.1 mole equiv), THF, -78 to 
18 ºC, 16 h. 
$Reagents and conditions: (i) t-BuLi (2.0 mole equiv.), Et2O, -78 ºC, 3h; (ii) CuI (1.0 mole equiv.), 
n-Bu3P (2.5 mole equiv.), THF, -78 ºC, 15 min; (iii) HMPA (3.0 mole equiv.), TMSCl (3.0 mole equiv.), 
242 (2.1 mole equiv), THF, -78 to 18 ºC, 16 h; (iv) TBAF, THF, 0 to 18 ºC, 2 h. 
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The most significant features observed in the 1H NMR spectrum of diol 250 are the resonances 
associated with the diol moiety (Figure 3.15). The broad doublets at ( 2.45 and 2.93 correspond 
to the hydroxyl groups and the signals at ( 4.07 and 4.27 are consistent with the presence of 
oxymethine protons at C3a and C7a respectively. The infrared spectrum of this compound also 
supports the presence of free hydroxyl groups as judged by the appearance of an OH stretching 
band at 3372 cm-1. 
 
 
Figure 3.15: 300 MHz 1H NMR spectrum of compound 250 (recorded in CDCl3). 
 
3.6 Stereochemical Outcomes of IMDA Cycloaddition Reactions of  
cis-1,2-Dihydrocatechol-Enone Conjugates  
 
With five c-DHC-based IMDA substrates, 228, 246, 236, 248, and 250, in hand (see Table 3.1), 
the stereochemical outcomes of their IMDA cycloaddition reactions were investigated. The 
cycloaddition reactions were performed using dilute solutions of the substrates in refluxing 
toluene (ca. 110 ºC) or mesitylene (ca. 165 ºC). Catalytic amounts of BHT were added to the 
reaction mixtures and the product ratios were determined by 1H NMR spectroscopic analysis of 
the crude reaction mixtures. These ratios were found to be essentially the same as those 
obtained for the isolated and purified products. The results of the IMDA cycloaddition reactions 
are summarised in Table 3.2. 
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Table 3.2: IMDA cycloaddition reactions of c-DHC derivatives. 
 
Entry 
IMDA 
substrate 
reaction 
conditions 
anti-adduct 
yield 
(%) 
syn-adduct  
yield 
(%) 
1 
O
O
O
228  
toluene, 
BHT, reflux, 
16 h O
O
O
229  
44 
O
O
O
230  
39 
2 
O
O
O
246
Ph
 
toluene, 
BHT, reflux, 
16 h 
251
O
O H
O
 
59 
O
O
O
H
252  
21 
3 
O
O
O
236  
mesitylene, 
BHT, reflux, 
4 days O
O
O
237  
45 Not observed  
4 
O
O
O
248  
mesitylene, 
BHT, reflux, 
4 days 
Observed by 
1H NMR but 
not isolated 
<10
% 
Not observed  
 
The IMDA cycloaddition reaction of the acetonide derivative 228 (Entry 1) was found to afford 
the same ratio of adducts 229 and 230 (1:1.1 respectively) as the cycloaddition reaction of the 
corresponding dioxin precursor 225 (Section 3.4.1) and these products were obtained in 
comparable yields. The use of a bulkier protecting group, as demonstrated by the 
endo-benzylidene acetal derivative 246 (Entry 2), was found to increase the selectivity for the 
anti-adduct affording a ca. 3:1 mixture of adducts 251 and 252, respectively. Once again, higher 
temperatures and longer reaction times were required to ensure complete consumption of 
precursor 236 which possesses a substituted dienophile (Entry 3). No reaction of this substrate 
was observed when toluene was used as the solvent. There are two explanations for the lower 
yield of this reaction than the ones involving precursors 228 and 246. Firstly, despite extended 
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reaction times (up to 7 days), the cycloaddition process never proceeded to completion. 
Secondly, despite using very dilute solutions (0.005 M), dimerisation, via intermolecular 
cycloaddition of the DHC moiety, was observed. These difficulties were even more pronounced 
for precursor 248 (Entry 4), which is substituted on both the diene and dienophile. 1H NMR 
analysis of the crude reaction mixture revealed it was composed primarily of precursor 248 and 
its Diels-Alder dimer, with only small amounts of IMDA product present (<10%). Finally, the 
IMDA cycloaddition reaction of diol 250 (not featured in Table 3.2) was unsuccessful. No 
reaction was observed on heating this substrate refluxing in toluene, due to the substitution on 
the dienophile, while temperatures higher than ca. 110 ºC were found to cause aromatisation of 
the c-DHC moiety. Although this result was disappointing, it was not unexpected since the 
parent diol is known to be much more susceptible to aromatisation than the corresponding 
acetonide-protected derivative.  
 
An examination of the literature suggested that that the efficiency of the IMDA cycloaddition 
reactions of the type described above could be improved by increasing the flexibility of the 
tethers. Mihovilovic et al. have also reported examples of IMDA cycloaddition reactions of 
c-DHC derivatives where the IMDA cycloaddition reaction is competing against a dimerisation 
reaction of the precursors.33 In this work, it was observed that the flexibility of the tether was 
more important for the success of the reaction than activation of the dienophile. For example, 
when compound 53c was refluxed in toluene, no IMDA product was obtained and only 
polymerisation and dimerisation products were observed. In contrast, precursor 53d, despite 
possessing a less activated dienophile, gave almost quantitative yields of the cycloadduct 54d 
(Scheme 3.29). This outcome is attributed to the increased flexibility of the side chain in 
compound 53d as compared with that in congener 53c. 
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Scheme 3.29: Reagents and conditions (i) toluene, reflux, 3 to 7 days. 
 
Chapter Three 98 
To this end, compounds 236 and 248 were treated with sodium borohydride to effect reduction 
of the side-chain carbonyl moieties. The corresponding alcohols, 253 and 254 respectively, 
were obtained in good yields and as a ca. 1:1 mixture of diasteriomers (as determined by 
GCMS) (Scheme 3.30). 
 
 
i
O
O
O
236   R = H
248   R = Me
HO
O
O
(ca. 1:1)
R R
253   R = H    (84%)
254   R = Me  (83%)  
Scheme 3.30: Reagents and conditions (i) NaBH4 (2.0 mole equiv.), MeOH, 0 to 18 ºC, 2 h. 
 
 
With the desired alcohols in hand, the IMDA cycloaddition reactions of these compounds were 
attempted. Each substrate was heated in refluxing mesitylene in the presence of a catalytic 
amount of BHT and, in both cases, after 4 days the starting materials had been consumed and a 
single Diels-Alder adduct had formed (Scheme 3.31). Disappointingly, the yield obtained for 
the IMDA cycloaddition reaction of alcohol 253 (44%) was less that arising from the 
corresponding carbonyl compound, 236 (52%). However, a pronounced improvement was 
observed for the IMDA precursor that possesses substitution on both the diene and dienophile. 
Thus, while compound 248 (possessing the carbonyl moiety) would not undergo the desired 
cycloaddition reaction (Entry 4, Table 3.2), the corresponding alcohol 254 afforded cycloadduct 
256 in 46% yield. 
 
 
i
253   R = H
254   R = Me
HO
O
O
(ca. 1:1)
R
255   R = H    (44%)
256   R = Me  (46%)
O
O
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(single diastereomer)
 
Scheme 3.31: Reagents and conditions (i) BHT (0.1 mole equiv.), mesitylene, reflux, 4 days. 
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It was surprising to find that, despite IMDA 
precursors 253 and 254 being mixtures of 
diasteriomers, a single diasteriomer of the 
IMDA product was obtained in each case. 
Given that the yield is less than 50% in both 
instances, one possible explanation is that 
only one diastereomer is participating in the 
Diels-Alder reaction and the other is 
decomposing. However, this has not yet 
been confirmed and studies directed 
towards understanding this result are 
continuing. 
 
In order to unambiguously determine the 
stereochemistry at C6 in alcohol 256, the 
compound was converted into the 
corresponding 3,5-dinitrobenzoate 
derivative and its structure was determined 
by single-crystal X-ray analysis (Figure 
3.16, Appendix 12). In this manner, it was established that the hydroxy group of compound 256 
is in the exo-position. Since an X-ray crystal structure of alcohol 255 (or a suitable derivative) 
could not be obtained, the assignment of the C6 stereochemistry was made by analysis of the 1H 
NMR spectrum. Comparison of 1H NMR spectra of alcohols 256 (Figure 3.17) and 255 (Figure 
3.18) revealed that the signals relevant to assignment of the C6 stereochemistry, namely those 
arising from C5a-H and C6-H, are very similar for the two compounds. The signals due to the 
oxymethine proton (C6-H) appear at the same position, ca. ( 3.85, in the spectra of both 
alcohols. Furthermore, in both spectra the doublets assigned to the C5a proton are in similar 
positions and have similar coupling constants, ( 1.23 (J = 9.3 Hz) and ( 1.23 (J = 8.1 Hz), for 
alcohol 255 and 256, respectively. Both of these coupling constants are consistent with the C5a 
and C6 protons possessing a trans relationship as determined by the Karplus curve.150 In this 
manner, it was determined that both alcohols possess the same (C6) stereochemistry.  
 
Figure 3.16: Displacement Ellipsoid Plot 
(30%) derived from single-crystal X-ray 
analysis of the 3,5-dinitrobenzoyl derivative of 
alcohol 256.  
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Figure 3.17: 300 MHz 1H NMR spectrum of alcohol 256 (recorded in CDCl3). 
 
 
 
 
Figure 3.18: 300 MHz 1H NMR spectrum of alcohol 255 (recorded in CDCl3). 
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3.7 Conclusions  
 
This Chapter details the synthesis of several novel c-DHC derivatives and their participation in 
IMDA cycloaddition reactions. These studies have given an insight into the stereoselectivities 
associated with the IMDA cycloaddition reactions of c-DHCs and the types of frameworks 
accessible via this process. The following observations should be reiterated: 
 
- The union of the c-DHC moiety and the dienophilic tether can be achieved via two distinct 
protocols; namely a palladium-catalysed Negishi cross-coupling or a conjugate addition 
reaction. These procedures should allow the preparation of a range of substituted c-DHC 
derivatives that cannot currently be accessed, either by microbial transformation or by the 
coupling methods that have been reported to date. 
 
-IMDA reactions of unprotected c-DHC derivatives were found to proceed with excellent facial 
selectivity, via syn- addition, but with essentially no diastereoselectivity, affording a mixture of 
endo- and exo- adducts. 
 
-IMDA reactions of acetonide protected c-DHC derivatives occurred diastereoselectively, via an 
endo-transition state, but with essentially no facial selectivity, affording both syn- and anti- 
adducts. 
 
-The anti-selectivity of the IMDA reactions could be improved by increasing the steric demands 
on the system. This could be achieved either by using a bulky protecting group on the c-DHC, 
or by introducing substitution on the diene and/or the dienophile. 
 
-Dimerisation of the IMDA precursors was found to be a competing process when the systems 
were highly substituted. In these instances, the efficiency of the IMDA reaction could be 
improved by increasing the flexibility of the tether. In this manner, cycloadducts possessing two 
contiguous quaternary centres were prepared. 
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3.8 Future Work 
Future aspects of this project will be directed towards exploiting the IMDA cycloaddition 
reaction of c-DHC derivatives for the total syntheses of a range of biologically relevant natural 
products. The following Sections present possible targets and strategies for obtaining them. 
 
3.8.1 Proposed access to terpenoid natural products by elaboration of IMDA 
cycloadducts 
Tricyclic systems possessing annulated bicyclo[2.2.2]octane frameworks are present in a 
number of natural product families, such as the khusianes,151,152 ermolactones,153,154 lacinanes155 
and dupreziananes.156 The cycloadducts described in this Chapter embody the core structures of 
these natural products, as well as possessing the correct substitution patterns in a number of 
cases. Scheme 3.32 highlights examples of natural products that it is envisioned could be readily 
accessed by elaboration of the relevant IMDA cycloadducts. 
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Scheme 3.32: Proposed access to various terpene natural products from Diels-Alder adducts 256, 230 
and 237. 
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One particularly compelling target is the neurotrophic factor (-)-O-11-debenzoyltashironin 
[(-)-260] (Figure 3.19).157,158 Both the interesting biological activity and the complex molecular 
architecture of this compound makes developing a synthesis of compound 260 an ideal means 
of highlighting of the versatility of the protocols detailed earlier in this Chapter. 
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Figure 3.19: The core structure of (-)-11-O-debenzoyltashironin [(-)-260] as possessed by compound 
256. 
 
 
3.8.2 Proposed access to sesquiterpenoid natural products via a combination of 
IMDA cycloadditions reactions and photochemical rearrangements 
The versatility of the cycloadducts prepared by the protocols described in this Chapter is further 
highlighted when their potential to act as substrates in photochemical rearrangements (such as 
that used in Chapter Two) is considered. This Section presents a selection of sesquiterpene 
natural products that might be accessed utilising a combination of the chemistries presented in 
Chapters Two and Three. 
 
Diels-Alder adducts 229 and 230, produced during the IMDA reaction of enone 228, are 
pseudo-enantiomeric, meaning that, following the appropriate manipulations, both enantiomeric 
series of a target molecule can, in principle, be accessed. This feature of the IMDA 
cycloaddition reactions of c-DHC derivatives is particularly useful in the synthesis of natural 
products, especially where the absolute stereochemistry of the target compound has not yet been 
established, or when synthesising compounds from a class of natural products that possess 
members in both enantiomeric series. A pertinent example of such a class is the angular 
triquinane family. It is envisioned that Diels-Alder adducts 229 and 230 could be converted, via 
a series of standard functional group interconversions, into %,'-unsaturated ketones 261 and 
262, respectively (Scheme 3.33). Triplet sensitised irradiation of both of these compounds 
should then effect formation of the oxa-di-!-methane rearrangement products 263 and 265. At 
this stage the enantiomeric relationship between these compounds is clearly apparent. Reductive 
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cleavage of the peripheral cyclopropane bond of each compound should then generate the 
corresponding tricyclic systems, which encompass the core structures of the triquinane natural 
products ventricos-7(13)-ene (264)159 and subergorgic acid (266).160,161 
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Scheme 3.33: Proposed access to angular triquinane-type natural products of either enantiomeric 
series. 
 
 
A similar strategy could be applied to the synthesis of the novel sesquiterpenoids viridianol 
[(+)-270]162 and tamariscene [(-)-272] (Scheme 3.34).163 In this case endo-, anti-adduct 251 
possesses the desired stereochemistry for the synthesis of both natural products. Elaboration of 
the cycloadduct 251 to the %,'-unsaturated ketone 268, and subsequent irradiation, (this time 
under direct irradiative photochemical reaction conditions) should afford cyclobutanone 269 
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and/or the cyclopropane 271 (via spontaneous decarboxylation). Each of these photoproducts 
closely resembles the tricyclic frameworks assigned to the target natural products. 
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Scheme 3.34: Proposed access to (-)-tamariscene and (+)-viridianol. 
 
 
The broad range of targets that is likely to be accessible by exploiting the IMDA cycloaddition 
of c-DHC derivatives serves to highlight the importance of the protocols presented in this 
Chapter. A pertinent example of this is presented in the following Chapter wherein a formal 
total synthesis of the potent antibacterial agent platencin,164 which utilizes this IMDA 
cycloaddition reaction as the key step, will be discussed. 

 
 
CHAPTER FOUR 
Formal Total Synthesis of (-)-Platencin 
 
4.1 Introduction 
4.1.1 Isolation and structure of (-)-platencin 
In 2007 Singh and co-workers, based at the Merck Research Laboratories in New Jersey, 
described the isolation of (-)-platencin [(-)-92] from a strain Steptomyces platensis MA7339 
found in a soil sample collected in Spain.164 This discovery was made via high-throughput 
screening of natural product extracts using a target-based, whole-cell approach that was 
developed by these researchers in their quest for new antibiotic agents with novel modes of 
action.165 The use of this assay had, a year earlier, led to the identification of (-)-platensimycin 
[(-)-273],166 a related natural product that attracted considerable attention due to its potent 
activity against many antibiotic-resistant bacteria.167-171 
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Figure 4.1: Target compound (-)-platencin and the related compound (-)-platensimycin. 
 
(-)-Platensimycin and (-)-platencin are structurally and biologically related. Both compounds 
are comprised of two structurally distinct subunits, namely a 3-amino-2,4-dihydroxybenzoic 
acid moiety, which is common to both, and this is linked, via an amide bond, to a lipophilic 
domain that is unique to each compound. While the core of platensimycin consists of a 
tetracyclic motif incorporating a cyclic ether, (-)-platencin possesses a tricyclic core devoid of 
ring oxygens.172,173  
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Although (-)-platensimycin and (-)-platencin were initially isolated from different strains of S. 
platensis, they have since been co-isolated.174 This observation suggests that they share a 
common biosynthetic pathway. Following feeding studies, Singh and co-workers have proposed 
that a non-mevalonate terpeniod pathway is involved in the synthesis of the core structure of 
both compounds, while an intermediate from the citric acid cycle and phosphoenolpyruvate 
(PEP) are utilized in the biogenesis of the aromatic unit.174,175  
 
4.1.2 Biological properties of (-)-platencin 
The increasingly significant problem of antibacterial resistance has prompted a world-wide 
search for new types of antibiotics that function via novel modes of action. As a consequence, 
the discovery of (-)-platensimycin and (-)-platencin, which act via a mechanism unexploited by 
established antibiotics, has generated much interest. The mode of action of these compounds is 
via inhibition of %-keto-acyl-(acyl-carrier-protein) synthase (KAS) enzymes that are involved in 
bacterial fatty acid biosynthesis. This is an essential metabolic process that bacteria require for 
the assembly of their cell membranes.176 While (-)-platensimycin is a selective inhibitor of the 
enzyme FabF (KAS II),164 (-)-platencin exhibits dual activity, inhibiting both FabF (KAS II) and 
FabH (KAS III).166 As these enzymes are highly conserved among pathogens, both compounds 
exhibit broad-spectrum antibacterial properties. Furthermore, since this mode of action is 
unique and not, therefore, targeted by any existing antibiotics, these compounds show no 
cross-resistance and are active against all key drug-resistant bacterial strains. Specifically, both 
compounds exhibit activity against key Gram-positive pathogens such as MRSA (methicillin-
resistant Staphylococcus aureus) and VRE (vancomycin-resistant Enterococci) as well as 
linezolid-resistant and macrolide–resistant pathogens. However, (-)-platencin shows the greater 
antibacterial activity against vancomycin-resistant Enterococcus faecium and efflux-negative 
Escherichia coli.164 
 
The ability of (-)-platencin to inhibit two enzymes on the same pathway not only makes it more 
active than (-)-platensimycin but should also result in a lower resistance potential. Thus, it 
would seem that it is the more attractive lead compound for the development of new antibiotics. 
Unfortunately, like (-)-platensimycin, (-)-platencin has poor in vivo activity unless administered 
by continuous infusion. This situation is attributed to its poor pharmacokinetic properties.164 
These properties could potentially be improved by chemical modification. However, the first 
step in the production of more active (-)-platencin analogues is to develop a strategy for the 
synthesis of the parent molecule. As such, this Chapter presents the development of a new and 
enantioselective route to (-)-platencin that should allow for the synthesis of novel antibacterial 
analogues. 
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4.2 Previous Studies on the Synthesis of (-)-Platencin 
4.2.1 Overview 
Owing to the novel structure and remarkable biological properties of (-)-platencin, it has 
attracted significant attention from the synthetic community. The first total synthesis of 
(-)-platencin was reported by Nicolaou and co-workers in early 2008.48 This was promptly 
followed by reports from a number of other groups, such that seven total48,49 or formal total177-181 
syntheses of platencin have been published this year.2 Four of these syntheses, which are 
particularly outstanding and/or relevant to the work detailed in this Thesis, are described 
below.# 
 
4.2.2 Total and formal total syntheses 
Nicolaou’s asymmetric synthesis of (-)-platencin (2008) 
Nicolaou and co-workers48 reported the first synthesis of (-)-platencin just eight months after the 
paper detailing its isolation and structure was published. Their approach employed an 
asymmetric intermolecular Diels-Alder reaction, a gold-catalysed cyclisation process and a 
homoallyl radical cyclisation as the key steps in the construction of the core structure 91 
(Scheme 4.1). The installation of the propionamide-linked anilide unit was achieved using 
protocols analogous to those employed in the synthesis of (-)-platensimycin.182,183  
 
The synthesis of the key structure, 91, commenced with a Rawal-type asymmetric Diels-Alder 
reaction184 between the known 1-amino-3-siloxy-diene 274 and acetylenic aldehyde 275 
(synthesised in one pot from 4-pentyn-1-ol in 53% yield), which afforded cyclohexene 276 in 
92% yield and ca. 93% ee. Reduction of the aldehyde moiety, followed by exposure of the 
ensuing alcohol to aqueous HCl, generated the corresponding hydroxy-enone that was then 
protected as the SEM ether. Exposure of this last compound to triisopropylsilyl triflate 
(TIPSOTf) generated silyl enol ether 277, the substrate for the key gold-catalysed cyclisation 
reaction. Thus, exposure of acetylenic diene 277 to the gold catalyst derived from [AuCl(PPh3)] 
and AgBF4 brought about the desired cyclisation, affording bicyclic enone 278 in excellent 
yield (94%). Conjugate addition of the cuprate derived from allylmagnesium chloride to the 
enone moiety was followed by reduction of the residual ketone and thereby generating a 2:1 
mixture of diastereomeric alcohols. These were then converted into the corresponding xanthate 
esters 279 (2:1 mixture of diastereomers). The pivotal homoallylic radical rearrangment 
 
2 Reference 181 refers to the publication of the synthesis detailed in this Chapter. 
# These syntheses were all published during the course of this research. 
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proceeded smoothly on exposure of the mixture of xanthate esters (279) to AIBN and 
tri-n-butyltin hydride to afford bicyclo[2.2.2]diene 280. Wacker oxidation of diene 280 
followed by deprotection of the SEM protected primary alcohol afforded the corresponding 
hydroxy-ketone that was found to exist, preferentially, as hemiacetal 281. Finally, oxidation of 
compound 281 and subsequent aldol condensation of the ensuing keto-aldehyde generated 
enone 91, the key precursor to the target molecule. 
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Scheme 4.1: Reagents (i) Cr(III)-salen complex catalyst; (ii) a) LiAlH4; b) HCl;  (iii) SEMCl, Et3N, 
DMAP; (iv) TIPSOTf, Et3N; (v) [AuCl(PPh3)], AgBF4; (vi) allylmagnesium chloride, CuBr•Me2S;  
(vii) NaBH4; (viii) CS2, KHMDS, MeI; (ix) n-Bu3SnH, AIBN; (x) PdCl2, CuCl, O2; (xi) TASF, DMPU; 
(xii) TPAP, NMO; (xiii) NaOH; (xiv) KHMDS, MeI; (xv) KHMDS, allyl iodide; (xvi) Hoveyda-Grubbs 
II cat., benzoquinone; (xvii) Me3NO; (xviii) NaClO2, NaH2PO4, 2-methyl-2-butene; (xix) HATU, Et3N; 
(xx) TASF. 
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The conversion of enone 91 into (-)-platencin began with the diastereoselective installation of 
the methyl and propionic acid groups. To this end, compound 91 was sequentially alkylated 
with methyl iodide then allyl bromide. Due to the rigid structure of the molecule alkylation 
occurred selectively at the exo-face to generate the desired stereochemistry at C4. The resulting 
triene underwent regioselective cross-metathesis at the newly installed allyl olefin, in the 
presence of Hoveyda-Grubbs’ catalyst and benzoquinone, with vinyl-pinacol boronate ester to 
afford boronate 282, as a ca. 3:1 mixture of E/Z isomers. This mixture of boronates was 
oxidised, via the corresponding aldehyde, to carboxylic acid 283 thereby completing installation 
of the propionic acid unit. Amide coupling of compound 283 with aniline 284 was achieved 
using HATU as the coupling reagent and deprotection of the ensuing TMSE ether derivative 
afforded (-)-platencin. 
 
Rawal’s total synthesis of (±)-platencin (2008) 
The synthetic route to platencin published by Rawal et al.49 (Scheme 4.2) made use of this 
group’s cycloaddition methodology by employing a 1-amino-3-siloxy-diene derivative as a 
highly reactive diene in a challenging Diels-Alder reaction. These reagents had previously been 
developed as effective substitutes for electron-rich dienes and shown to readily participate in 
Diels-Alder reactions without the need for Lewis-acid activation or high temperatures.3 Thus, 
an uncatalysed Diels-Alder reaction between diene 285 and cyclohexanone 286 (prepared from 
O-anisic acid in 37% yield over 2 steps) and subsequent selenoxide formation and elimination 
afforded the racemic modification of bisenone 287. Regio- and stereo-selective reduction of the 
less hindered carbonyl group delivered alcohol 288, which served as the substrate for the second 
key process in this synthetic sequence, namely a Ni-promoted reductive cyclisation reaction. 
Treatment of compound 288 with [Ni(cod)2] promoted a 5-exo-trig cyclisation of the alkenyl 
bromide onto the enone moiety, thus generating compound 289 which embodies the desired 
methylenebicyclo[2.2.2]octane framework. Removal of the ketone, via the corresponding 
tosyhydrazone, and oxidation of the allylic alcohol afforded enone 91, embodying the core 
structure of platencin. 
 
Rawal and co-workers next focused on the development of a concise route to the natural 
product from this key intermediate. Alkylation of enone 91 with methyl iodide, followed by 
allylation with (E)-1-tribenzyl-silyl-3-iodo-prop-1-ene, gave compound 290 in a completely 
diastereoselecive manner. Oxidation of the vinyl silane (using a modification of the 
Fleming-Tamao protocol) afforded the corresponding aldehyde that was readily converted, 
using a Lindgren-Kraus oxidation, into carboxylic acid 283. This sequence proved to be both 
 
3 Rawal et al. also pioneered the asymmetric variant of this reaction,184 which was used by Nicolaou in the 
synthesis described above. 
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shorter and higher yielding (4-steps vs 5-steps, 57% vs 23%) than that reported by Nicolaou et 
al.48 Direct amide coupling of the fully unprotected anilide fragment 291 using DCC and 
DMAP then completed the reaction sequence and delivered (±)-platencin in 62% yield.  
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Scheme 4.2: Reagents (i) 40 ºC; (ii) aq. HF; (iii) H2O2, pyridine; (iv) DIBAL-H; (v) [Ni(cod)2], cod; (vi) 
p-TsOH, TsNHNH2; (vii) NaBH3CN, ZnCl2; (viii) MnO2; (ix) KHMDS, MeI; (x) KHMDS, 
(E)-1-tribenzylsilyl-3-iodo-prop-1-ene; (xi) TBAF, iodosobenzene, H2O2, KHCO3; (xii) NaClO2, 
NaH2PO4, 2,3-dimethylbutene; (xiii) DCC, DMAP, Et3N. 
 
 
Mulzer’s formal total synthesis of (-)-platencin (2008) 
Remarkable brevity is the signature feature of the five-step, protecting-group-free synthesis of 
the core of (-)-platencin reported recently by Mulzer et al. (Scheme 4.3).178 This route utilised a 
Diels-Alder cycloaddition reaction between the Rawal diene 285 and commercially available 
(-)-perillaldehyde (292, >92% ee) to afford, after acid hydrolysis, bicylic enone 293 possessing 
all three stereocentres associated with the platencin core. The third ring was then formed via 
ring closing metathesis of triene 294 (prepared from cycloadduct 293 by Wittig methylenation) 
in the presence of Grubbs’ second-generation catalyst to produce the desired 
bicyclo[2.2.2]octane framework of compound 295. Finally, isomerization of the endocyclic 
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double bond to the exocyclic position was achieved by a two step procedure involving allylic 
bromination and chromium (III)-mediated reduction to afford the core of (-)-platencin, thereby 
completing the most concise route to compound 91 reported to date. 
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Scheme 4.3: Reagents (i) a) 110 ºC; b) aq. HCl; (ii) Ph3P=CH2; (iii) 2
nd Gen. Grubbs’ cat.; (iv) NBS; (v) 
CrCl3, LiAlH4. 
 
 
Chen and Nicolaou’s formal total synthesis of (-)-platencin (2008) 
The formal total synthesis of (-)-platencin reported by Chen and Nicolaou180 (Scheme 4.4) 
utilised an IMDA reaction to generate the tricyclic core structure of the target molecule in a 
single step. The first stage of the synthesis was concerned with the preparation of an 
enantiopure substrate for the key IMDA reaction. To this end, protection of guaiacol (297) as 
the TBS ether allowed for ortho-lithiation and subsequent reaction with Weinreb amide 298 to 
afford ketone 299. Asymmetric reduction of the latter compound under Corey-Bakashi-Shibata 
(CBS) conditions, followed by desilylation, delivered benzyl alcohol 300 in 90% ee. Generation 
of the desired substrate was then achieved by oxidation of benzyl alcohol 300 with PhI(OAc)2 to 
afford o-benzoquinone 301. This immediately underwent a stereoselective IMDA reaction to 
give cycloadduct 302 as the major product. The high level of selectivity observed for this 
reaction is quite remarkable considering that it was controlled by a single stereocentre. With the 
construction of the bicylo[2.2.2]octane framework complete, standard functional group 
manipulations were used to convert compound 302 into the platencin core (91). 
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Scheme 4.4: Reagents (i) TBDPSCl, imidazole, DMAP; (ii) s-BuLi, TMEDA, 298; (iii) (S)-(-)-2-
methyl-CBS-oxazaborolidine, catechol borane; (iv) TBAF; (v) a) PhI(OAc)2, KHCO3; b) 110 ºC; (vi) Pd 
on C, H2; (vii) PCC; (viii) PhNTf2, KHMDS; (ix) Pd(PPh3)2Cl2, n-Bu3N, HCO2H; (x) SmI2, MeOH; (xi) 
MeMgBr; (xii) Mn(OAc)3, t-BuOOH, O2; (xiii) Martin’s sulfurane. 
 
 
4.3 Retrosynthetic Analysis and Strategy 
 
It was envisioned that by exploiting the methodologies described in the previous Chapter, 
namely the IMDA reaction of a c-DHC derivative, the basic framework of (-)-platencin could 
be synthesised in a particularly efficient manner. The appropriate retrosynthetic analysis of 
target (-)-92 is shown in Scheme 4.5 and involved initial detachment of the two side-chain 
residues of the molecule from the tricyclic core structure giving enone 91; a known precursor to 
(-)-platencin.48,49 It was anticipated that this key structure could, in turn, be derived from Diels-
Alder adduct 90 using standard procedures. Compound 90 is the expected product of a 
stereoselective IMDA reaction of precursor 89, wherein the acetonide protecting group on the 
diol moiety should ensure the cycloaddition occurs with anti-selectivity. This outcome is crucial 
to ensuring the cycloadduct possesses the correct absolute stereochemistry required for the 
natural product. It was anticipated that compound 89 could, in turn, be obtained by a coupling 
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reaction between the acetonide-protected derivative of c-DHC 88 and an appropriate 6-carbon 
partner possessing a dienophilic moiety. 
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Scheme 4.5: Retrosynthetic analysis of (-)-platencin [(-)-92] 
 
 
The successful implementation of this strategy as part of establishing a formal total synthesis of 
(-)-platencin (through the aquisition of compound 91) is discussed in the following Sections and 
serves to highlight the synthetic utility of the protocols described in the previous Chapter, 
namely the IMDA reaction of c-DHCs, for the synthesis of natural products. 
 
4.4  Formal Total Synthesis of (-)-Platencin 
4.4.1 Synthesis of IMDA precursor 89 
4.4.1.1  Michael addition approach 
The previous Chapter detailed how c-DHC 190 could be engaged in a conjugate addition 
reaction with various enones to deliver a number of derivatives. As such, it was anticipated that 
a similar approach could be used for the synthesis of the desired substrate for the IMDA 
reaction, namely c-DHC 89. To this end, and following the protocols defined in Chapter Three, 
the acetonide-protected c-DHC 190 was treated with i-PrMgCl (to generate the corresponding 
Grignard reagent) then CuBr•SMe2 and HMPA (Scheme 4.6). A mixture of acrolein 305 and 
TMSCl145,146 was then added dropwise to the ensuing reaction mixture. While tlc analysis of the 
reaction mixture suggested that the expected 1,4-addition process had taken place to generate 
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silyl enol ether 306, when the reaction mixture was worked up using standard protocols (quench 
with a saturated aqueous solution of NH4Cl, followed by drying of the separated organic 
fractions with Na2SO4 or MgSO4) the desired aldehydic product 307 was not generated. Instead, 
a mixture of decomposition products was obtained as judged by 1H NMR analysis of the crude 
reaction mixture. Following extensive investigations it was established that the 1,4-addition 
reaction proceeds smoothly, generating silyl enol ether 306 as the sole product. However, on 
hydrolytic workup of the reaction mixture, the ensuing aldehyde (307) rapidly decomposes. In 
contrast, silyl enol ether 306 was found to be stable enough to isolate (using Et3N and water to 
quench the reaction mixture) and could subsequently be treated with a fluoride source (HF 
buffered with pyridine) at -78 ºC to generate aldehyde 307, which was found to be stable at low 
temperature. Aldehyde 307 was then treated, in situ, with allyl magnesium bromide to generate 
the desired IMDA precursor, 308, as a ca. 1:1 mixture of diastereomers, in 13% yield. Despite 
efforts to improve this reaction sequence, a higher yield was never obtained. 
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Scheme 4.6: Reagents and conditions (i) a) 190, (1.0 mole equiv.), i-PrMgCl (1.5 mole equiv.), THF,  
-30 to 0 ºC, 2 h; b) CuBr•SMe2 (0.1 mole equiv.), HMPA (3.0 mole equiv.), TMSCl (3.0 mole equiv.), 
305 (2.1 mole equiv), THF, -78 to 18 ºC, 16 h; (ii) HF-pyridine/pyridine (2.9 mole equiv.), THF, -78 ºC, 
2 h; (iii) allyl magnesium bromide (5.0 mole equiv.), -78 to 0 ºC, 1.25 h. 
 
 
Although significant quantities of compound 308 could not be obtained, a small amount was 
used to evaluate whether this substrate would undergo the pivotal IMDA cycloaddition reaction. 
In the event, heating compound 308 in refluxing toluene for 16 h lead to a reaction mixture that 
appeared to contain the anticipated Diels-Alder adducts, as judged by 1H NMR analysis. While 
these cycloadducts were not isolated or characterised, the feasibility of this approach had been 
confirmed and attention was now turned to the development an alternative, and higher yielding, 
synthetic route to the desired IMDA precursor. 
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4.4.1.1  Negishi cross-coupling approach 
Despite the limited success of the Negishi cross-coupling reaction as described in the previous 
Chapter, the model study of this reaction had appeared extremely promising. It seemed 
probable, therefore, that the difficulties encountered earlier were a consequence of the 
instability of the alkyl iodide (dioxin) coupling partners. Thus, it was decided that the title 
reaction would be revisited as part of a new approach to the requisite IMDA precursor. 
 
The synthesis of the desired coupling partner, viz. compound 313, began with commercially 
available dienol 309, which was converted, under standard conditions, into the corresponding 
and previously reported tert-butyldimethylsilyl (TBS) ether 310 (Scheme 4.7). The next stage 
involved conversion of this diene into alcohol 311 by selective ozonolysis.185,186 One difficulty 
associated with a partial ozonolyses of this type is that the end point cannot readily be 
determined by classical methods, i.e. the appearance of blue colouration indicating excess 
ozone. Although dyes have been developed for the monitoring of selective reactions,186 these 
rely on a significant difference in reactivity between the two (or more) olefinic bonds present in 
the molecule, an unlikely prospect in the case of diene 310. In this instance, the yield of alcohol 
311 was maximised by careful control of the reaction parameters (ozone flow rate, ozone 
content of the flow, reaction temperature, concentration) and optimization of the reaction time 
under these conditions. Using these conditions, a solution of 1 g of diene 310 in 
CH2Cl2/MeOH/2,6-lutidine
4 was cooled to -78 ºC and treated with ozone for 10 mins. The 
ensuing mixture of ozonides was warmed to 0 ºC and granular NaBH4 was added portionwise 
over 2 h. This procedure reliably afforded a chromatographically separable mixture of the 
staring material 310 (11% recovery), the unwanted diol 312 (46% at 89% conversion) and the 
required mono-ol 311 as a ca. 1:1 mixture of diastereomers (48% at 89% conversion).  
 
 
4 The presence of pyridine or 2,6-lutidine is known to slow the ozonolysis rate by slow oxidation to the 
corresponding N-oxide.
187
 This can allow for small electronic differences in the olefins to impact the 
chemoselectivity of the reaction.
188
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OHHO
OTBS
+
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(48%)*
(46%)*  
 
Scheme 4.7: Reagents and conditions (i) 2,6-lutidine (1.75 mole equiv.), TBSOTf (1.5 mole equiv.), 
CH2Cl2, 0 to 18 ºC, 2.5 h; (ii) a) O3, 2,6-lutidine (1.4 mole equiv.), CH2Cl2/MeOH, -78 ºC, 1 h; b) NaBH4, 
MeOH, 0 to 18 ºC, 3 h. *Yields are over two steps and are based on recovered starting material. 
 
 
Alcohol 311 was readily converted into the corresponding iodide by treatment with molecular 
iodine in the presence of triphenylphosphine and imidazole (Scheme 4.8) to afford compound 
313 in 75% yield. 
 
 
313311
OH
OTBS
I
OTBS
i
75%
 
 
Scheme 4.8: Reagents and conditions (i) PPh3 (1.6 mole equiv.), imidazole (1.6 mole equiv.), I2 (1.6 
mole equiv.), benzene/Et2O, 18 ºC, 2 h.  
 
 
With the desired coupling partner in hand, initial attempts at the Negishi cross-coupling reaction 
were made using the protocol defined in Chapter Three. Specifically, a THF solution of iodide 
313 was cooled to -78 ºC, then treated sequentially with tert-butyllithium (t-BuLi) and 
anhydrous zinc chloride (1.0 M solution in THF). The ensuing mixture was allowed warm to 18 
ºC and acetonide 190 and Pd(PPh3) were then added. Unfortunately, these conditions delivered 
a mixture of products. While one of these compounds was recognised as the desired coupled 
product, the others were identified as compounds 315, 316 and 19226 (Scheme 4.9). As 
demonstrated in Scheme 4.9 these products all derive from organolithium 314, indicating that 
the desired lithium-zinc transmetallation reaction was not occurring efficiently. Further 
investigation revealed that when zinc chloride was used as the source of inorganic zinc then 
complete transmetallation required the use of ambient temperatures and extended reaction 
times. However, when zinc iodide was used, the corresponding organozinc reagent was formed 
at -78 ºC in less that 10 min. In addition, the formation of compound 316, via a retro-Brook 
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rearrangement189 of organolithium 314, could be minimised by using Et2O instead of THF as the 
reaction solvent. It has previously been shown that silyl group migrations of this type are highly 
solvent dependant. So, while these processes occur readily in THF and HMPA, they are 
suppressed in Et2O.
189 
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Scheme 4.9: Alternative reaction pathways of organolithium 314. 
 
 
Successful formation of the required organozinc reagent (involving treatment of a Et2O solution 
of iodide 313 with t-BuLi then anhydrous zinc iodide) was followed by a Negishi cross-
coupling of this species with acetonide 190, in the presence of Pd(Ph3P)4, to afford compound 
318 in 75% yield and as a ca. 1:1 mixture of diastereoisomers (Scheme 4.10).  
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75%
 
Scheme 4.10: Reagents and conditions (i) a) 313 (1.0 mole equiv.), t-BuLi (2.2 mole equiv.), ZnI2 (1.1 
mole equiv.), Et2O, -78 to 0 ºC, 1.25 h; b) 190 (1.0 mole equiv.), Pd(PPh3)4 (10 mol%), THF, 18 ºC, 3 h. 
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Figure 4.2: 300 MHz 1H NMR spectrum of triene 318 (ca. 1:1 mixture of diastereomers) (recorded in 
CDCl3). 
 
 
Figure 4.3: 75 MHz APT 13C NMR spectrum of triene 318 (ca. 1:1 mixture of diastereomers) (recorded 
in CDCl3). 
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The spectral data obtained on triene 318 were indicative of a successful union of the two 
coupling partners. Thus, for example, the 300 MHz 1H NMR spectrum (Figure 4.2) features six 
olefinic signals with three being attributable to the c-DHC moiety and three to the terminal 
alkene. Signals corresponding to the oxymethine protons were observed at ( 4.65 and 4.50, 
while the multiplets at ( 2.27 and 1.64 were assigned to the three methylene units. Although the 
1H NMR spectrum gave little indication that compound 318 was, in fact, a diastereomeric 
mixture, this is clearly evident by both GC mass spectrometry and analysis of the APT  
13C NMR spectrum (Figure 4.3). So, as expected, the APT 13C NMR spectrum exhibits twenty-
one distinct carbon resonances. However, on closer inspection many of these consist of two 
peaks, as demonstrated in the expanded region of Figure 4.3. The EI mass spectrum displays a 
molecular ion at m/z 364 and an accurate mass measurement on this species established that it 
was of the expected composition, viz. C21H36O3Si.  
 
4.4.2 The IMDA reaction and characterisation of cycloadducts 319 – 322 
With the desired precursor now in hand, the pivotal IMDA reaction could be examined. The 
lack of activation of the dienophilic portion of substrate 318 meant that there was concern 
regarding whether or not an endo-selective cycloaddition reaction would be observed and 
whether the activation energy required to initiate such a process might be prohibitively high. In 
the event it was established that, by heating compound 318 in refluxing toluene for 16 h, a 
smooth cycloaddition reaction takes place generating a mixture of four cycloadducts, 
compounds 319 – 322 (Scheme 4.11), in a ratio of ca. 10:10:1:1, respectively, as determined by 
1H NMR analysis of the crude reaction mixture (Figure 4.4). 
 
 
i
319  R = H, R' = OTBS    (10)
320  R = OTBS, R' = H
O
O
TBSO
O
O
O
O
+
321  R = H, R' = OTBS    (1)
322  R = OTBS, R' = H
R
R
R'
R'
318
97%
(1)(10)
 
 
Scheme 4.11: Reagents and conditions (i) BHT (cat.), toluene, reflux, 16 h. 
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Figure 4.4: 300 MHz 1H NMR spectrum of the crude reaction mixture of the IMDA reaction of triene 
318 (recorded in CDCl3). 
 
While column chromatography allowed for the isolation of clean samples of cycloadducts 319 
and 322, compounds 320 and 321 were obtained as an inseparable mixture. This mixture was 
thus subjected to TBAF-promoted deprotection of the silyl groups to afford the corresponding 
alcohols, 323 and 324, which could now be readily separated from one another using 
conventional chromatographic techniques. 
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Scheme 4.12: Reagents and conditions (i) TBAF (2.3 mole equiv.), THF, 18 ºC, 72 h. 
 
 
With all four cycloadducts separated, the assigned structures could be confirmed by single-
crystal X-ray analysis. The X-ray structures clearly demonstrated that the major pair of 
cycloadducts, compounds 319 and 320 (Figure 4.5, Appendices 13 and 14), were formed via an 
endo-transition state and involved addition of the dienophile to the less hindered face of the 
diene, namely via an anti-addition pathway. These endo-, anti-adducts were obtained in 90% 
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combined yield and embody the required enantiomeric form of the tricyclic framework for the 
synthesis of (-)-platencin.  
 
 
Figure 4.5: Displacement Ellipsoid Plot (30%) derived from single-crystal X-ray analysis of 
cycloadducts 319 and 323 (free-alcohol derivative of cycloadduct 320). 
 
The minor pair of cycloadducts 321 and 322 (see Figure 4.6 for single-crystal X-ray structures 
of the corresponding free-alcohol derivatives 324 and 325, respectively), were also formed via 
an endo-transition state. However, in these cases, addition of the dienophile had occurred at the 
sterically more crowded face of the diene to afford the corresponding syn-adducts. This pair of 
cycloadducts embody the opposite enantiomeric form of the tricyclic framework (see Section 
1.4 “Enantiodivergent Syntheses”) and so they could, in principle, be employed for the 
synthesis of ent-(+)-platencin. This may be a worthwhile endeavour since the non-natural 
enantiomer could also possess interesting biological properties. Accordingly, efforts to 
synthesise greater quantities of these compounds, via a syn-selective IMDA reaction, are 
described in the future work Section of this Chapter. 
 
 
Figure 4.6: Displacement Ellipsoid Plot (30%) derived from single-crystal X-ray analysis of alcohols 
324  and 325 (free-alcohol derivatives of cycloadducts 321 and 322, respectively). 
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The improved facial selectivity of this IMDA reaction, which involves a substrate possessing a 
six-carbon tether (10:1, anti : syn), when compared to the analogous five-membered example 
presented in Chapter Three (ca. 1:1, anti : syn) is noteworthy. This is most likely a consequence 
of the increased flexibility imparted to the system via lengthening the tether by one carbon.  
 
4.4.3 Elaboration of the IMDA products to the core structure of (-)-platencin 
Having established the basic tricyclic framework of the target molecule through the acquisition 
of compounds 319 and 320, attention now turned towards the elaboration of these materials into 
the core structure of (-)-platencin. As oxidation of the C7-hydroxyl group within these 
compounds was required to complete the synthesis of enone 91, the stereochemistry at this 
centre was not important. Thus, it was decided that cycloadducts 319 and 320 would be 
combined and carried though the final parts of the reaction sequence as a mixture. While 
cycloadduct 319 was isolated as the TBS-ether derivate, cycloadduct 320 had been deprotected 
to the corresponding free-alcohol (323) in order to separate it from syn-adduct 321 (Scheme 
4.12). Thus, TBS-ether 319 was treated with TBAF to afford the corresponding alcohol, before 
the product alcohols 323 and 326 were subject to hydrogenation, either independently, or as a 
mixture, at 1 atmosphere in the presence of 10% palladium on carbon. In this manner, the 
corresponding saturated systems 328 (99%, m.p. 131–132 °C) and 327 (98%, m.p. 120–121 °C) 
were obtained. Alternatively, it was found that if TBS-ether 319 was hydrogenated directly, the 
conditions employed for this reaction also resulted in deprotection of the TBS group to afford 
the corresponding saturated alcohol 327 in a single step. 
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Scheme 4.13: Reagents and conditions (i) TBAF (4.0 mole equiv.), THF, 18 ºC, 16 h; (ii) 10% Pd on C, 
H2, EtOH, 18 ºC, 16 h. 
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Prior to hydrolysis of the acetonide residue, alcohols 327 and 328 were subjected (as a mixture) 
to O-benzoylation under standard conditions to provide ester 329 in 95% yield (Scheme 4.14). 
This protecting group was chosen on the basis that it would be able to withstand the acidic 
conditions required for removal of the acetonide group and could later be removed under 
sufficiently mild conditions to ensure the survival of sensitive functionalities associated with the 
target framework, particularly the exocyclic methylene unit.5  
 
 
327
95%
O
O
H
HO
O
O
HO
H
O
O
BzO
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+
328 329
(ca. 1:1 7S/R-mixture)
7 7 7
(7R-epimer)(7S-epimer)  
 
Scheme 4.14: Reagents and conditions (i) Et3N (4.0 mole equiv.), DMAP (4.0 mole equiv.), BzCl (2.9 
mole equiv.), CH2Cl2, 0 ºC, 1 h. 
 
 
The 1H NMR spectrum of benzoate 329 (Figure 4.4) is consistent with the presence of a ca. 1:1 
mixture of the C7 epimeric forms of this compound. While the aromatic and aliphatic proton 
resonances associated with each diastereomer overlap, creating complex mutiplets in these 
regions, the resonances associated with three oxymethine protons proved to be distinct to each 
isomer. In particular, the C7 proton appears as a singlet at ( 5.27 for 7R-329 and as a triplet of 
triplets at ( 4.85 for 7S-329. Likewise, the doublet attributed to C9b-H is situated further 
downfield for 7R-329 than 7S-329. The 13C NMR spectrum displays the expected doubling of 
signals and is fully consistent with the assigned structure. Although the molecular ion was not 
observed in the EI mass spectrum, a strong peak at m/z 341 was attributed to a fragment ion 
resulting from loss of a methyl radical. An accurate mass measurement on this species 
confirmed the molecular formula of compound 329 as being C22H28O4. 
 
 
 
5 A benzoate group could not have been used from the beginning of this synthesis, as it was incompatible with both 
the ozonolysis and the Negishi cross-coupling reactions. 
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Figure 4.7: 300 MHz 1H NMR spectrum of benzoate 329 (recorded in CDCl3). 
 
The next stage of the synthesis focused on installation of the exocyclic methylene via 
manipulation of the diol moiety associated with compound 329 (Scheme 4.15). It was 
anticipated that this could be achieved by employing a similar series of functional group 
manipulations to that described in Chapter Two. Specifically, selective oxidation of the less 
hindered of the two hydroxyl moieties should afford the corresponding hydroxy-ketone 
possessing the carbonyl group in correct position to allow for introduction of the desired 
methylene unit via a Wittig methylenation reaction.  
 
To this end, the acetonide residue of compound 329 was hydrolysed using previously defined 
conditions (acid-activated DOWEX-50 resin in aqueous MeOH at 110 °C for 48 h) to afford 
diol 330 (Scheme 4.15). Unfortunately, even under such forcing conditions complete conversion 
could not be achieved (63% conversion after 72 h). Initial attempts at selective oxidation of diol 
330 using 4-acetamido-TEMPO (4-NHAc-TEMPO) and p-toluenesulfonic acid (p-TsOH•H2O) 
afforded only low yields of hydroxy-ketone 331, which was accompanied by an undesired by-
product. However, it was found that side-reactions could be avoided by forming the active 
oxidising agent prior to addition to the reaction mixture, via premixing of p-TsOH•H2O and 4-
NHAc-TEMPO to form the corresponding oxoammonium salt, and by keeping the reaction at 
low temperature (0 ºC c.f 18 ºC). In this manner, acyloin 331 was obtained in 94% yield. The 
presence of prominent absorption bands at both 1714 and 3464 cm-1 in the IR spectrum of 
compound 331 confirmed the presence of both carbonyl and hydroxyl moieties in the molecule. 
The EI mass spectrum featured a molecular ion at m/z 314, consistent with a decrease of two 
mass units and the oxidative nature of the reaction. An accurate mass measurement on this ion 
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confirmed that it was of the anticipated composition, viz. C19H22O4. Finally, the use of various 
connectivity and proximity experiments allowed full assignment of the 1H and 13C NMR spectra 
and it was thus established that the oxidation had occurred at the less hindered of the two 
hydroxy groups.  
 
With acyloin 331 in hand, the free hydroxyl group was converted, using standard protocols, into 
the corresponding benzoate (332) (82%) in order to facilitate its removal via reductive cleavage. 
Thus, treatment of bis-benzoate 332 with SmI2 in THF/MeOH at –78 °C resulted in a smooth 
reduction to the corresponding ketone 333 (quantitative yield), Wittig methylenation of which 
generated the corresponding olefin 334 in 84% yield (Scheme 4.15). 
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Scheme 4.15: Reagents and conditions (i) DOWEX-50 resin (acidic form), MeOH/H2O (5:1), 110 °C, 
72 h; (ii) 4-acetamido-TEMPO (2.2 mole equiv.), p-TsOH•H2O (2.1 mole equiv.), CH2Cl2, 0 °C, 4 h; (iii) 
DMAP (4.0 mole equiv.), BzCl (3.0 mole equiv.), CH2Cl2, 0 ºC, 2 h; (iv) SmI2 (2.2 mole equiv.), 
THF/MeOH (2:1), +78 °C, 15 min; (v) KHMDS (1.7 mole equiv.), Ph3PCH3Br (1.8 mole equiv.), THF,  
-78 to 18 ºC, 3.5 h. 
 
 
With the exocyclic methylene in place all that remained to complete the synthesis of the core 
structure of (-)-platencin was to install the associated enone moiety. To this end, the ester group 
within compound 334 was saponified, using potassium carbonate in MeOH, to give alcohol 335, 
which was then subjected to oxidation with IBX. At this point in the synthesis the two 
diastereomers converged to furnish a single, crystalline ketone, 336 (m.p. 57–59 °C), in 95% 
yield over the two steps (Scheme 4.16). 
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Scheme 4.16: Reagents and conditions (i) K2CO3 (2.1 mole equiv.), MeOH, 18 ºC, 72 h; (ii) IBX (1.5 
mole equiv.), DMSO, 18 ºC, 16 h. 
 
 
The 1H NMR spectrum of compound 336 features a complex aliphatic region and two signals in 
the olefinic region that were attributed to the protons of the terminal methylene unit. The  
13C NMR spectrum displays thirteen resonances, with the signal corresponding to the newly 
formed ketone carbon appearing at ( 211.7, and the peaks corresponding to two olefinic carbons 
visible at ( 150.8 and ( 105.5. The presence of a strong carbonyl absorption at 1713 cm-1 in the 
IR spectrum provided further evidence that the expected oxidation had taken place. A single-
crystal X-ray structure was obtained (Figure 4.8, Appendix 17). This provided final 
confirmation of the assigned structure. 
 
 
Figure 4.8: Displacement Ellipsoid Plot (30%) derived from single-crystal X-ray analysis of ketone 336. 
 
Completion of the synthesis of the target compound 91 required oxidation of precursor 336 to 
the corresponding enone. Initial attempts to introduce the carbonyl-conjugated olefin directly 
using IBX were unsuccessful. Thus, alternative protocols, which employed the corresponding 
silyl enol ether as an intermediate, were investigated. While it was hoped that deprotonation at 
C8 would be favoured under kinetic conditions, this was found not to be the case. Rather, a 
study of several bases and silylating agents (Table 4.2) showed little selectivity for the desired 
enol ether (337). As a result, it has, thus far, been impossible to avoid co-production of isomer 
339. 
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Table 4.1: Formation of silyl enol ethers 337 and 338 using various bases and silylating agents. 
 
+
O
336
R3Si
337
R3Si
338
R = TMS or TES
8
6
see table
 
 
Entry Reagents Temperature 337* (desired) 338* (undesired) 
1 LiHMDS, TESCl -100 ºC and -78ºC 1 2 
2 KHMDS, TESCl -78 ºC 2 1 
3 LiTMP, TESCl -78 ºC 1 4 
4 2,6-Lutidene, TMSOTf 0 to 18 ºC 1 1.4 
5 Et3N, TMSOTf 18 ºC 1 1.5 
6 Me3N, TMSOTf 0 ºC 4 1 
*Ratios of 337 : 338 determined by GCMS or 1H NMR analysis of the crude reaction mixture. 
 
Under the optimal conditions identified to date (Table 4.1, Entry 6), which involved a protocol 
defined by Lalic and Corey in their synthesis of the core of platensimycin,190 a solution of 
ketone 336 in CH2Cl2 was cooled to 0 °C then treated with trimethylamine and trimethylsilyl 
triflate (TMSOTf). A DMSO solution of the resulting mixture of silyl enol ethers was treated, at 
18 °C, with IBX and 4-methoxypyridine-N-oxide (MPO). In this way a chromatographically 
separable mixture of compounds 91 (64%) and 339 (21%) was obtained.  
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O
339(64%) (21%)  
 
Scheme 4.17: Reagents and conditions (i) a) Me3N, TMSOTf, CH2Cl2, 0 to 18 ºC, 2 h; b) IBX, MPO, 
DMSO, 18 ºC, 16 h. 
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Figure 4.9: 300 MHz 1H NMR spectrum of enone 91 (recorded in CDCl3). 
 
 
 
Figure 4.10: 300 MHz 13C NMR spectrum of enone 91 (recorded in CDCl3). 
 
The spectral data derived from each of these compounds were in full accord with the assigned 
structures. Furthermore, the 1H NMR (Figure 4.9) and the 13C NMR (Figure 4.10) spectra 
obtained on enone 91 completely matched the data reported by Nicolaou et al. Additionally, the 
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specific rotation obtained for compound 91 of +27 (c 0.9, CHCl3), which is somewhat higher 
than the value reported by Nicolaou et al. [+6.3 (c 0.46, CHCl3)], is in good agreement with the 
value of +27.5 (c 0.83, CHCl3) recorded by Multzer et al. for the same compound. 
 
The acquisition of enone 91 by the means described here constitutes a formal total synthesis of 
platencin owing to the recent reports from the Nicoloau and Rawal groups describing the 
conversion of compound 91 into the target 92, as discussed in Section 4.2.  
 
4.5  Future Research 
The approach to (-)-platencin detailed in this Chapter represents a viable route to novel 
platencin analogues and future aspects of this project will be directed towards such ends. 
However, this research will be undertaken in collaboration with commercial partners and is 
therefore beyond the scope of this Thesis. Other future work will include establishing a 
synthesis of ent-(+)-platencin. The following Section discusses some preliminary results and 
proposes future strategies for achieving such ends. 
 
4.6.1 Preliminary results  
It was anticipated, at the outset of this work, that the unprotected c-DHC derivative 340, would 
undergo a syn-selective IMDA cycloaddition reaction to afford the corresponding endo-, syn-
cycloadducts as the major products. As discussed in Section 4.4.2 (page 123), such compounds 
(324 and 325, Figure 4.6) embody the non-natural enantiomeric form of the tricyclic 
framework. Accordingly, it was anticipated that they could be employed in a synthesis of 
ent-(+)-platencin. To this end, bis-ether 249 was subjected to a Negishi cross-coupling reaction 
with the organozinc reagent derived from alkyl iodide 313, in the presence of Pd(Ph3P)4, to 
afford compound 340 in ca. 65% yield# and as a ca. 1:1 mixture of diastereoisomers (Scheme 
4.18). Tris-silyl ether 340 was then deprotected using TBAF to afford triol 341, the desired 
substrate for the IMDA reaction. 
 
 
# This compound was contaminated with the dimer derived from alkyl iodide 313 so an accurate yield could not be 
obtained. 
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Scheme 4.18: Reagents and conditions conditions (i) a) 313 (1.0 mole equiv.), t-BuLi (2.2 mole equiv.), 
ZnI2 (1.1 mole equiv.), Et2O, -78 to 0 ºC, 1.25 h; b) 249 (1.0 mole equiv.), Pd(PPh3)4 (10 mol%), THF,  
18 ºC, 3 h; (ii) TBAF, THF, 0 to 18 ºC, 2 h. 
 
 
Unfortunately, despite several attempts, the IMDA cycloaddition reaction of triol 340 was 
unsuccessful. While no reaction was observed in refluxing toluene, temperatures higher than ca. 
110 ºC were found to cause aromatisation of the c-DHC moiety. This result was not entirely 
unexpected as the parent diol is known to be a less reactive diene in Diels-Alder reactions191 and 
much more susceptible to aromatisation than the corresponding acetonide-protected derivative.  
 
4.6.2 Revised strategy 
Based on the results presented above, it appears that the dienophile requires activation in order 
for the desired IMDA reaction to occur. Scheme 4.19 presents a revised approach to 
ent-(+)-platencin in which the IMDA substrate possesses a carbonyl group at C4 to increase the 
reactivity of the dienophile. In addition, it is envisioned that this carbonyl group could be used 
to install the C4 methyl group, the presence of which may also improve the selectivity of the 
final oxidation step, a matter that proved problematic in the initial synthesis. 
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Scheme 4.19: Proposed approach to ent-(+)-platencin. 
 
 
Thus, it is anticipated that triene 342 will engage in an IMDA cycloaddition reaction to afford 
the endo-, syn-adduct 343 as the major product. Wittig methylenation, followed by reduction of 
both the newly installed exocyclic double bond and the internal olefin should afford compound 
344. It is envisioned that this compound could be elaborated, using procedures essentially 
identical to those detailed in this Chapter, to enone 345 and the propionamide-aniline unit then 
installed using protocols analogous to those employed in the Rawal49 and Nicolaou48 syntheses 
of (-)-platencin. 
 
4.7 Conclusions  
 
In the work described in this Chapter, c-DHC 88 has been converted, over 16 steps and in 9% 
overall yield, into the core structure of (-)-platencin. This synthesis, although longer than others, 
such as that of Mulzer et al,178 has several desirable attributes:  
 
(i) By virtue of the highly enantioselective enzymatic process used to produce the c-DHC 
starting material, this synthesis produces a product of higher enantiomeric purity (>99% ee) 
than other syntheses. The enantiomeric excesses associated with the other synthetic routes are 
limited either by the starting material (the commercially available (-)-perillaldehyde 292 used 
by Mulzer et al.,178 Rutjes et al.,179 and Lee et al.177 is available in ca. >92% ee), or the 
asymmetric catalytic techniques used (Nicolau et al.48 and Chen et al.180 achieved 93% and 90% 
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ee, respectively). These days, an enantiomeric excess of 98% is generally considered the 
minimum acceptable level for chiral pharmaceutical reagents.192 
(ii) Despite the promising antibacterial activity displayed by (-)-platencin, its use as a 
pharmaceutical agent is limited by its poor activity in vivo. Thus, synthesis of novel 
(-)-platencin analogues will be necessary in order to improve the pharmacokinetic properties. 
Therefore, rapid access to the core framework, which is likely to be a necessary part of all 
analogues, is desirable. While many of the published synthetic routes to (-)-platencin involve 
synthesis of the core via a bicyclic intermediate, the approach described in this Chapter employs 
a highly efficient and stereoselective IMDA cycloaddition reaction to synthesise the entire 
tricyclic framework in a single step. As such, it is anticipated that the present route may be well 
suited to the synthesis of platencin analogues. 
(iii) The IMDA cycloaddition reaction employed in this synthesis not only produces the 
anti-addition products, which are of the correct enantiomeric form to allow the synthesis of 
(-)-platencin, but also affords the corresponding syn-adducts. These syn-cycloadducts embody 
the opposite enantiomeric form of the tricyclic framework and so, in principle, could be 
elaborated, using protocols essentially identical to those detailed in this Chapter, to 
ent-(+)-platencin. The synthesis and biological testing of this unnatural enantiomer could further 
aid the development of new antibacterial agents based on platencin. 
 
Table 4.2: Comparison of number of steps, overall yield and enantiomeric excesses (ee) of the various 
published routes to the core structure of platencin (compound 91). 
 
Date Published Group No. of steps Yield (%) ee (%) Reference 
07/01/08 Nicoloau et al. 15 6 93 48 
02/05/08 Rawal et al. 10 5 (±) 49 
11/06/08 Lee et al. 15 10 >92 177 
04/07/08 Mulzer et al. 5 26 >92 178 
29/07/08 Rutjes et al. 9 16 >92 179 
30/07/08 Chen et al. 13 9 90% 180 
18/09/08 Banwell et al. 16 9 >99 181 
 
% Further enantiomeric enrichement can be achieved via a kinetic resolution followed by recrystallisation to afford 
essentially enantiomerically pure material (as determined by the observed optical rotation).
180
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In summary, the work presented in this Chapter provides a clear demonstration of the utility of 
the methodology developed and described in Chapter Three. By performing an IMDA 
cycloaddition reaction on an enantiopure c-DHC derivative, a formal total synthesis of the 
medicinally important antibacterial agent (-)-platencin has been achieved and in a manner that 
could provide an efficient synthetic route to the (-)-platencin analogues pertinent to the 
development of a medicinally useful compound. 
 

 
 
CHAPTER FIVE 
Experimental Procedures Associated with Work 
Described in Chapters Two to Four 
 
5.1 General Procedures 
 
Starting materials and reagents were generally available from the Sigma-Aldrich, Merck, TCI, 
Strem or Lancaster Chemical Companies and were used as supplied or, occasionally, 
recrystallised or distilled. Inorganic salts were purchased from Sigma Aldrich, AJAX, BDH or 
Unilab Chemical companies. The cis-1,2-dihydrocatechols used as starting materials were 
purchased from Professor Derek Boyd of The Queen’s University of Belfast (Belfast, UK). 
 
Tetrahydrofuran (THF), diethyl ether (Et2O) and benzene were distilled, under nitrogen, from 
sodium benzophenone ketyl. Toluene was distilled, through a Vigreux column, from molten 
sodium metal. Methanol (MeOH) and ethanol (EtOH) were distilled from their respective 
magnesium alkoxide salts. Dichloromethane (CH2Cl2) and acetonitrile (MeCN) were distilled 
under nitrogen, through Vigreux columns, from calcium hydride. N,N-Dimethylformamide 
(DMF), pyridine, triethylamine and diisopropylamine were stored over anhydrous 4Å molecular 
sieves that had previously been dried using a conventional microwave oven, then cooled under 
high vacuum and stored under anhydrous nitrogen or argon. 
 
Glassware was soaked in a base bath (Pyroneg® in water) before being rinsed with water then 
acetone and oven-dried at 120 ºC. Assembled apparatus was evacuated (<0.1 mm Hg) and 
flushed three times with dry nitrogen, prior to use. All reaction mixtures were manipulated 
under nitrogen using standard Schlenk techniques and, unless otherwise specified, stirred 
magnetically. Deoxygenated solutions were obtained by bubbling nitrogen through the relevant 
solution for at least 15 min. 
 
Ambient temperature was assumed to be ca. 18 ºC. Temperatures higher than ambient were 
attained using thermostated oil baths. To attain temperatures lower than ambient, a cooled, 
water circulating bath (0 to 10 ºC) or relevant cryostats (ice/water, 0 ºC; dry-ice/acetone, -78 ºC; 
liquid nitrogen/MeOH, -100 ºC) were used. 
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Organic solutions (extracts) obtained from the work-up of reaction mixtures were dried with 
sodium sulfate (Na2SO4) or magnesium sulfate (MgSO4) before filtration and concentration 
under reduced pressure on a rotary evaporator with the water bath temperature generally not 
exceeding 40 °C unless otherwise specified. 
 
High pressure-promoted reactions were performed using a PISKA Pressure Systems Ltd. 20 
kbar High Pressure Reactor. Reaction mixures were prepared (as solutions in CH2Cl2) in a 
compressible reaction vessel manufactured from Teflon® which was immersed in a castor 
oil/methanol mixture (85:15) contained in a cavity within the reactor and subjected to 19 kbar 
pressure at ambient temperature.  
 
Ozonolyses were performed using a Model 500 Fischer portable ozone-generator with the 
luteinizing power and flow rate adjusted to 80 V and 50 L/h, respectively. 
 
Flash column chromatography was performed using analytical grade solvents and silica gel 60 
(230 – 400 mesh, 0.040 – 0.0063 mm) as supplied by Merck. 
 
Analytical thin layer chromatography (tlc) was performed on self-indicating aluminium backed 
0.2 mm thick silica gel 60 GF254 plates as supplied by Merck. Similarly, preparative layer 
chromatography (plc) was performed on self-indicating glass-backed 1.0 mm thick silica gel 60 
GF254 plates, as supplied by Merck. Eluted plates were visualised using a 254 nm UV lamp 
and/or by treatment with a suitable dip followed by heating. These dips included: a) 
phosphomolybdic acid : cerium sulfate : sulfuric acid (conc.) : water (15 g : 2.5g : 15 mL : 485 
mL); b) potassium permanganate : potassium carbonate : 5% sodium hydroxide aqueous 
solution : water (3 g : 20 g : 5 mL : 300 mL); c) anisaldehyde : sulfuric acid (conc.) : ethanol 
(3ml : 4.5 mL : 200 mL); d) vanillin : ethanol : sulfuric acid (conc.) : water (18 g : 285 mL : 3 
mL : 15 mL). 
 
Melting points were measured on a Stanford Research Systems Optimelt – Automated Melting 
Point System or on a Reichert hot-stage microscope apparatus and are uncorrected. 
 
Unless otherwise specified, proton (1H) and carbon (13C) NMR spectra were recorded at 20 °C 
in base-filtered deuterochloroform (CDCl3) on a Varian Mercury 300 or Varian Inova 300 NMR 
spectrometer operating at 300 MHz for proton and 75 MHz for carbon nuclei. In certain cases a 
Varian 500 spectrometer operating at 500 MHz for proton nuclei and 125 MHz for carbon 
nuclei and a Bruker 800 spectrometer operating at 800 MHz for proton nuclei were used.  
Signals arising from the residual protio-forms of the solvent were used as the internal standard. 
Chemical shifts are recorded as ( values in parts per million (ppm). 1H NMR data are recorded 
as follows: chemical shift (() [multiplicity, coupling constant(s) J (Hz), relative integral] where 
multiplicity is defined as: s = singlet; d = doublet; t = triplet; q = quartet; qu = quintet, p = 
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pentet; m=multiplet or combinations of the above. The central peak (( 77.0) of the CDCl3 triplet 
was used as the reference for proton-decoupled 13C NMR spectra. For 13C NMR spectra, the 
data are given as: chemical shift ((), (protonicity), where protonicity is defined as:  
C = quaternary; CH = methine; CH2 = methylene; CH3 = methyl. The assignment of signals 
observed in proton and carbon NMR spectra was assisted by conducting complementary 
connectivity and/or proximity experiments. Connectivity experiments used included the 
attached proton test (APT), homonuclear (1H/1H) correlation spectroscopy (COSY) and/or 
heteronuclear (1H/13C) correlation spectroscopy [heteronuclear multiple quantum coherence 
(HMQC) and/or heteronuclear multiple-bond correlation (HMQC)]. Proximity experiments 
included one or two-dimensional nuclear Overhauser effect and exchange spectroscopy 
(NOESY) experiments. 
 
Infrared spectra (%max)  were recorded on a Perkin-Elmer 1800 Series FTIR Spectrometer. 
Samples were analysed as KBr discs (for solids) or as thin films on KBr plates (for liquids/oils). 
 
Mass spectrometry was performed by the Australian National University’s Mass Spectrometric 
Services Unit located in the Research School of Chemistry, Canberra, Australia. Low and high 
resolution electron impact (EI) spectra were obtained on a VG Fisions AutoSpec M series 
three-sector (E/B/E) double-focussing mass spectrometer (located at the Australian National 
University). Low and high resolution electrospray (ES) mass spectra were recorded on a 
Micromass-Waters LC-ZMD single quadrupole liquid chromatograph-MS or a VG Quattro II 
triple quadrupole MS instrument (both located at The Australian National University) operating 
in positive and/or negative ionisation mode. Gas chromatographic analysis and mass 
spectrometry (GCMS) were performed using, respectively, Varian 3400 Gas Chromatograph or 
an Agilent/HP 6890-5973 instrument (both located at The Australian National University) fitted 
with a capillary column. Peaks were detected using a flame ionisation detector operating at  
300 ºC and helium was employed as the carrier gas (flow rate ca. 35 cm.s-1) with an isothermal 
temperature programme of 50 ºC. 
 
Optical rotations were measured between 17 to 20 °C with a Perkin-Elmer 241 polarimeter at 
the sodium-D line (6 = 589 nm) and the concentrations (c) (g/100 mL) indicated using 
spectroscopic grade chloroform (CHCl3) as solvent. The measurements were carried out in a 
cell with a path length (l) of 1 dm. Specific rotations [$]D were calculated using the equation 
[$]D = 100.$/(c.l) and are given in 10
-1.deg.cm2.g-1. 
 
Elemental analyses were performed by the Australian National University’s Microanalytical 
Services Unit based at the Research School of Chemistry, Canberra, Australia, using a Carbo 
Erba EA 1106 CHN-O automatic elemental analyser. 
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5.2 Experimental Procedures for Chapter Two 
 
(3aR,7aS)-2,2,4-Trimethyl-3a,7a-dihydro-1,3-benzodioxole (39) 
 
35 39
O
O
OH
OH
18 oC, 1h
2,2-DMP, p-TsOH•H2O,
 
 
Following a procedure established by Banwell et al.193 a solution of (1S,2R)-3-
methylcyclohexa-3,5-diene-1,2-diol (35) (905 mg, 7.18 mmol) in 2,2-dimethoxypropane (150 
mL) was treated with p-TsOH•H2O (a few crystals) at 18 ºC and stirred at this temperature for 1 
h. After this time, a further amount of p-TsOH•H2O (14 mg, 0.072 mmol) was added and the 
ensuing mixture was stirred for 10 min then quenched by addition of NaHCO3 (50 mL of a 
saturated aqueous solution) and diluted with CH2Cl2 (150 mL). The separated aqueous phase 
was extracted with CH2Cl2 (2 x 50 mL) and the combined organic phases were washed with 
NaOH (50 mL of a 2 M solution) and brine (50 mL) then dried (Na2SO4), filtered and 
concentrated under reduced pressure (temp. = 30 ºC) to give title acetonide 39 (1.01 mg, 85%) 
as a pale brown oil (Rf = 0.6, 3:7 v/v EtOAc/hexane). This material was sufficiently pure to be 
used in the next step of the reaction sequence without further purification. 
 
1
H NMR (300 MHz) ( 5.95 (dd, J = 9.6 and 5.6 Hz, 1H), 5.79 (dd, J = 9.6 and 4.0 Hz, 1H), 
5.70 (m, 1H), 4.64 (dd, J = 8.7 and 4.0 Hz, 1H), 4.48 (d, J = 8.7 Hz, 1H), 1.87 (br s, 3H), 1.40 
(s, 3H), 1.38 (s, 3H). 
 
The data presented above as well as all the other data acquired on this compound matched those 
reported in the literature.193 
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(3aR,4S,4aS,7aS,8R,8aS)-2,2,4-Trimethyloctahydro-5H-4,8-ethenoindeno[5,6-d][1,3]- 
dioxol-5-one (81), (3aR,4R,4aR,7aR,8S,8aS)-2,2,4-trimethyloctahydro-5H-4,8-
ethenoindeno[5,6-d][1,3]dioxol-5-one (137) and (3aR,5aR,6R,6aR,9aS,10S,10aS,10bS)- 
2,2,4,6,8,8-hexamethyl-3a,5a,6,6a,9a10,10a,10b-octahydro-6,10-ethenonaphtho[1,2-d:6,7-
d']bis[1,3]dioxole (138)  
 
39
CH2Cl2, 19 kbar, 
18 ºC, 24 h
O
O
O
O
O
O
O
OO
+ +
O
O
O
13781 138
+
O
126
 
  
A solution of acetonide 39 (505 mg, 3.04 mmol) and cyclopentenone (126) (500 mL, 6.18 
mmol) in CH2Cl2 (12 mL) was pressurized to 19 kbar in a PSIKA high-pressure reactor. After 
24 h at ca. 18 °C the reaction mixture was removed from the reactor and concentrated under 
reduced pressure. The resulting dark-yellow oil was subjected to flash column chromatography 
(silica, 5:95 ! 1:4 v/v EtOAc/hexane gradient elution) and thus affording two fractions, A and 
B. 
 
Concentration of fraction A (Rf = 0.2, 3:7 v/v EtOAc/hexane) gave a white solid, 
recrystallization (iso-propanol) of which afforded the anti-isomer 81 (549 mg, 73%) as white 
needles, m.p. = 79–80 °C. 
 
1
H NMR (300 MHz) ( 6.12 (br t, J = 8.3 Hz, 1H), 5.77 (d, J = 8.3 Hz, 1H), 4.25 (ddd, J = 7.2, 
3.3 and 0.9 Hz, 1H), 3.81 (dd, J = 7.2 and 1.3 Hz, 1H), 2.92 (m, 1H), 2.46 (m, 1H), 2.15–1.97 
(complex m, 3H), 1.91 (d, J = 9.5 Hz, 1H), 1.68 (m, 1H), 1.44 (s, 3H), 1.30 (s, 3H), 1.27 (s, 
3H). 
13
C NMR (75 MHz) ( 219.7(C), 135.5 (CH), 129.8 (CH), 108.9 (C), 82.7 (CH), 78.9 (CH), 52.3 
(CH), 41.9 (C), 40.7 (CH), 39.5 (CH2), 36.3 (CH), 25.5 (CH3), 25.1 (CH2), 25.0 (CH3), 18.7 
(CH3). 
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IR &max 2939, 2886, 1732, 1458, 1372, 1264, 1167, 1073, 1053, 889, 728 cm
+1. 
Mass spectrum (EI, 70 eV) m/z 248 (M+•, 13%), 233 (69), 190 (89), 161 (82), 134 (85), 119 
(81), 105 (89), 100 (87), 91 (83), 85 (86), 77 (59), 43 (100). 
HREIMS Found: M+•, 248.1405. Calculated for C15H20O3 requires M
+•, 248.1412. 
Elemental Analysis Found: C, 72.25; H, 8.21. C15H20O3 requires C, 72.55; H, 8.12%.  
Optical Rotation [$]D = +172 (c 1.0, CHCl3). 
 
Concentration of fraction B (Rf = 0.4, 3:7 v/v EtOAc/hexane) afforded a yellow oil that was 
subjected to further flash column chromatography (silica, 0:1 ! 1:9 v/v EtOAc/hexane gradient 
elution) and thus affording two fractions, C and D. 
 
Concentration of fraction C [Rf = 0.4(1), 3:7 v/v EtOAc/hexane] afforded the syn-isomer 137 
(99.5 mg, 13%) as a clear, colourless oil.  
 
1
H NMR (300 MHz) ( 6.17 (dd, J = 8.1 and 6.6 Hz, 1H), 5.84 (dd, J = 8.1 Hz, 1H), 4.07 (dd, J 
= 8.4 and 3.9 Hz, 1H), 3.69 (d, J = 8.1 Hz, 1H), 3.09 (m, 1H), 2.86 (m, 1H), 2.54 (d, J = 9.3 Hz, 
1H), 2.15 -1.95 (m, 3H), 1.53 (m, 1H), 1.47 (s, 3H), 1.45 (s, 3H), 1.32 (s, 3H). 
 
The data presented above as well as all the other data acquired on this compound matched those 
reported by Banwell et al.42 
 
Concentration of fraction D [Rf = 0.3(9), 3:7 v/v EtOAc/hexane] afforded dimer 138 (102 mg, 
10%) as clear, colourless oil.  
 
1
H NMR (300 MHz) ( 5.90 (br t, J = 6.3 Hz, 1H), 5.65 (d, J = 8.1 Hz, 1H), 5.45 (m, 1H), 4.32 
(ddd, J = 8.1, 5.4 and 0.9 Hz, 1H), 4.12 (dd, J = 5.1 and 1.5 Hz, 1H), 4.06 (br d, J = 5.1 Hz, 
1H), 3.87 (dd, J = 7.2 and 2.2 Hz, 1H), 2.83 (m, 1H), 2.25 (br d, J = 9.0 Hz, 1H), 2.04 (m, 1H), 
1.74 (s, 3H), 1.34 (s, 3H), 1.33 (s, 3H), 1.30 (s, 3H), 1.29 (s, 3H), 1.28 (s, 3H). 
13
C NMR (75 MHz) ( 137.1 (CH), 133.0 (C), 127.9 (CH), 122.4 (CH), 108.5 (C), 107.5 (C), 
82.8 (CH), 79.2 (CH), 78.4 (CH), 73.6 (CH), 43.5 (C), 40.4 (CH), 39.0 (CH), 35.5 (CH), 27.9 
(CH3), 26.8 (CH3), 25.5 (CH3), 25.1 (CH3), 19.6 (CH3), 19.4 (CH3). 
IR &max 2981, 2935, 2874, 1454, 1370, 1240, 1209, 1161, 1062, 1025, 882, 725 cm
+1. 
Mass spectrum (EI, 70 eV) m/z 332 (M+•, 2%), 317 (10), 274 (14), 216 (52), 109 (81), 108 
(100), 80 (53). 
HREIMS Found: M+•, 332.1973. C20H28O4 requires M
+•, 332.1988. 
Optical Rotation [$]D = +57 (c 0.3, CHCl3). 
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(3aR,4R,4aR,7aR,8S,8aS)-2,2,4,6,6-Pentamethyloctahydro-5H-4,8-ethenoindeno[5,6-d]- 
[1,3]dioxol-5-one (140) and (3aR,4R,4aR,6S,7aR,8S,8aS)-2,2,4,6-tetramethyloctahydro-5H-
4,8-ethenoindeno[5,6-d][1,3]dioxol-5-one (139) 
 
14081 139
+
LiHMDS, MeI, THF,
O
O
O
O
O
O
0  to 18 oC, 4 h
O
O
O
 
  
A solution of ketone 81 (2.00 g, 8.05 mmol) in THF (80 mL) was cooled to 0 °C then treated, 
dropwise, with LiHMDS (8.8 mL of a 1.0 M solution in THF, 8.80 mmol). The resulting 
mixture was maintained at 0 °C for 45 min then warmed to 18 °C over a period of 1.25 h. The 
reaction mixture was then re-cooled to 0 °C and treated, dropwise, with iodomethane (526 mL, 
8.45 mmol). The ensuing mixture was stirred at 0 °C for 45 min then warmed to 18 °C over 
1.25 h, quenched with NH4Cl (20 mL of a saturated aqueous solution) then diluted with CH2Cl2 
(80 mL). The separated aqueous phase was extracted with CH2Cl2 (2 " 20 mL) and the 
combined organic phases then dried (Na2SO4), filtered and concentrated under reduced pressure. 
The ensuing orange semi-solid was subjected to flash column chromatography (silica, 5:95 ! 
15:85 v/v EtOAc/hexane gradient elution) and thus affording three fractions, A, B and C. 
 
Concentration of fraction A (Rf = 0.4, 3:7 v/v EtOAc/hexane) afforded the gem-dimethylated 
derivative 140 (310 mg, 15% at 92% conversion) as white crystalline solid, m.p. = 101–105 °C. 
 
1
H NMR (300 MHz) ( 5.95 (m, 1H), 5.82 (br d, J = 8.4 Hz, 1H), 5.27 (ddd, J = 7.2, 3.3 and 0.9 
Hz, 1H), 3.81 (dd, J = 7.2 and 1.2 Hz, 1H), 2.86 (m, 1H), 2.48 (m, 1H), 2.14 (d, J = 1.5 Hz, 1H), 
1.87 (dd, J = 12.9 and 8.9 Hz, 1H), 1.56 (s, 3H), 1.34 (m, 1H), 1.30 (s, 3H), 1.27 (s, 3H), 0.97 
(s, 3H), 0.92 (s, 3H). 
13
C NMR (75 MHz) ( 221.3 (C), 135.9 (CH), 129.8 (CH), 109.0 (C), 83.2 (CH), 78.9 (CH), 
49.6 (CH), 47.0 (C), 40.7 (C), 40.4 (CH2), 39.4 (CH) 33.4 (CH), 26.4 (CH3), 25.5 (CH3), 25.0 
(CH3), 22.1 (CH3), 18.7 (CH3). 
IR &max 2963, 2933, 2871, 1731, 1455, 1373, 1324, 1269, 1254, 1208, 1166, 1054, 1073, 891, 
875, 820, 732 cm+1. 
Mass spectrum (EI, 70 eV) m/z 276 (M+•, 13%), 261 (38), 218 (90), 176 (78), 134 (80), 105 
(100). 
HREIMS Found: M+•, 276.1727. C17H24O3 requires M
+•, 276.1725. 
Optical Rotation [$]D = +88 (c 1.0, CHCl3). 
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Concentration of fraction B (Rf = 0.3, 3:7 v/v EtOAc/hexane) afforded the title compound 139 
(1.58 g, 82% at 92% conversion) as a white crystalline solid, m.p. = 67–69 °C. 
 
1
H NMR (300 MHz) ( 6.16 (br t, J = 8.3 Hz, 1H), 5.71 (d, J = 8.3 Hz, 1H), 4.26 (ddd, J = 7.8, 
3.5 and 0.7 Hz, 1H), 3.83 (dd, J = 7.2 and 1.2 Hz, 1H), 2.93 (m, 1H), 2.31 (br t, J = 9.4 Hz, 1H), 
2.13 (m, 1H), 1.95 (d, J = 9.3 Hz, 2H), 1.63 (m, 1H), 1.40 (s, 3H), 1.30 (s, 3H), 1.27 (s, 3H), 
0.93 (d, J = 6.8 Hz, 3H). 
13
C NMR (75 MHz) ( 219.5 (C), 134.9 (CH), 129.7 (CH), 108.2 (C), 82.2 (CH), 78.6 (CH), 
52.4 (CH), 43.7 (CH), 41.8 (C), 40.4 (CH), 34.4 (CH), 33.2 (CH2), 25.0 (CH3), 24.6 (CH3), 18.4 
(CH3), 13.8 (CH3). 
IR &max 2974, 2932, 2874, 1732, 1455, 1373, 1266, 1207, 1164, 1078, 1055, 886, 732 cm
+1. 
Mass spectrum (EI, 70 eV) m/z 262 (M+•, 10%), 247 (43), 204 (86), 175 (57), 162 (72), 134 
(100), 105 (96), 100 (82), 92 (60), 91 (63), 43 (69). 
HREIMS Found: M+•, 262.1568. C16H22O3 requires M
+•, 262.1569. 
Optical Rotation [$]D = +172 (c 0.5, CHCl3). 
 
Concentration of fraction C [Rf = 0.2(5), 3:7 v/v EtOAc/hexane] afforded the starting ketone 81 
(169 mg, 8% recovery) as a white crystalline solid. This material was identical, in all respects, 
with authentic material. 
 
Methyl (3aR,4R,6S,7aR,8S,8aS)-2,2,4,6-tetramethyl-3a,6,7,7a,8,8a-hexahydro-4H-4,8-
ethenoindeno[5,6-d][1,3]dioxol-5-yl carbonate (141) and methyl 
(3aR,4R,4aR,6S,7aR,8S,8aS)-2,2,4,6-tetramethyl-5-oxooctahydro-3aH-4,8-ethenoindeno-
[5,6-d][1,3]dioxole-6-carboxylate (133) 
 
LiHMDS, NCCO2Me, THF,
O
O
O
O
O
O
0 to 18 oC, 4 h
OO
O
O
OO
O
+
139 141 133  
 
A solution of compound 139 (1.94 g, 7.41 mmol) in THF (75 mL) was cooled to 0 °C then 
treated, dropwise, with LiHMDS (8.9 mL of a 1.0 M solution in THF, 8.90 mmol). The 
resulting mixture was maintained at 0 °C for 45 min, warmed to 18 °C over 1.25 h then 
re-cooled to 0 °C and treated dropwise with Mander’s reagent (1.18 mL, 14.9 mmol). Stirring 
was continued at 0 °C for 45 min then the reaction mixture was warmed to 18 °C over 1.25 h, 
quenched with NH4Cl (20 mL of a saturated aqueous solution) and diluted with CH2Cl2 (80 
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mL). The separated aqueous phase was extracted with CH2Cl2 (3 " 20 mL) and the combined 
organic phases then washed with water (2 " 10 mL) before being dried (Na2SO4), filtered and 
concentrated under reduced pressure. The ensuing pale-yellow oil was subjected to flash 
column chromatography (silica, 5:95 ! 15:85 v/v EtOAc/hexane gradient elution) and thus 
affording two fractions, A and B. 
 
Concentration of fraction A (Rf = 0.5, 3:7 v/v EtOAc/hexane) afforded the title enol carbonate 
141 (71 mg, 3%) as a white needles, m.p. = 100–104 °C. 
 
1
H NMR (300 MHz) ( 5.97 (d, J = 8.1 Hz, 1H), 5.81 (dd, J = 8.1 and 6.8 Hz, 1H), 4.36 (dd, J = 
7.2 and 3.6 Hz, 1H), 4.02 (br d, J = 6.8 Hz, 1H), 3.82 (s, 3H), 2.85 (m, 1H), 2.70 (m, 2H), 1.80–
1.55 (complex m, 2H), 1.40 (s, 3H), 1.32 (s, 3H), 1.28 (s, 3H), 1.10 (d, J = 6.8 Hz, 3H). 
13
C NMR (75 MHz) ( 153.8 (C), 145.5 (C), 138.0 (CH), 130.9 (C), 127.2 (CH), 109.5 (C), 80.6 
(CH), 80.3 (CH), 55.2 (CH3), 42.6 (C), 41.7 (CH), 40.1 (CH), 39.3 (CH), 37.7 (CH2), 25.5 
(CH3), 25.0 (CH3), 16.3(5) (CH3), 16.3(2) (CH3). 
IR &max 2958, 2939, 2881, 1764, 1693, 1456, 1441, 1371, 1272, 1245, 1207, 1182, 1072, 1045, 
1010, 950, 896, 871, 818, 783, 729 cm+1. 
Mass spectrum (EI, 70 eV) m/z 320 (M+•, 5%), 305 (4), 247 (51), 203 (100), 187 (69), 186 
(95), 161 (60), 144 (92), 101 (77). 
HREIMS Found: M+•, 320.1631. C18H24O5 requires M
+•, 320.1624. 
Optical Rotation [$]D = +50 (c 0.9, CHCl3). 
 
Concentration of fraction B (Rf = 0.2, 3:7 v/v EtOAc/hexane) afforded a solid that was 
recrystallized (EtOAc) to give title keto-ester 133 (2.09 g, 88%) as white needles, m.p. = 91– 
94 °C. 
 
1
H NMR (300 MHz) ( 5.97 (br t, J = ca. 5.0 Hz, 1H), 5.84 (d, J = 5.0 Hz, 1H), 4.28 (dd, J = 4.2 
and 2.1 Hz, 1H), 3.82 (d, J = 4.2 Hz, 1H), 3.66 (s, 3H), 2.88 (m, 1H), 2.57 (m, 2H), 2.26 (d, J = 
6.0 Hz, 1H), 1.57 (s, 3H), 1.34 (m, 1H), 1.30 (s, 3H), 1.27 (s, 3H), 1.17 (s, 3H). 
13
C NMR (75 MHz) ( 213.2 (C), 173.0 (C), 136.5 (CH), 130.0 (CH), 109.6 (C), 83.3 (CH), 
79.1 (CH), 58.4 (C), 52.9 (CH3), 51.8 (CH), 41.3 (C), 39.7 (CH), 38.2 (CH2), 34.8 (CH), 25.8 
(CH3), 25.3 (CH3), 18.9 (CH3), 18.8 (CH3). 
IR &max 2976, 2935, 2878, 1753, 1728, 1456, 1375, 1267, 1208, 1151, 1069, 889, 736 cm
+1. 
Mass spectrum (EI, 70 eV) m/z 320 (M+•, 18%), 305 (60), 262 (89), 247 (74), 202 (78), 173 
(55), 157 (59), 134 (78), 105 (84), 100 (100), 92 (62), 91 (66), 85 (59), 69 (52), 43 (71), 41 (58). 
HREIMS Found: M+•, 320.1621. C18H24O5 requires M
+•, 320.1624. 
Optical Rotation [$]D = +105 (c 1.0, CHCl3). 
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Methyl (3aR,4R,4aR,7aR,8S,8aS)-2,2,4-trimethyl-5-oxooctahydro-3aH-4,8-
ethenoindeno[5,6-d][1,3]dioxole-6-carboxylate (143a) methyl (3aR,4R,4aR,6R,7aR,8S,8aS)-
2,2,4,6-tetramethyl-5-oxooctahydro-3aH-4,8-ethenoindeno[5,6-d][1,3]dioxole-6-
carboxylate (143) 
 
81 81a 143
LiHMDS, NCCO2Me,
O
O
O
O
O
O
OO
NaH, MeI, THF,
O
O
O
O
O
THF, 0  to 18 oC, 14 h 0 to 18 ºC, 1.75 h
 
 
Step i: A solution of ketone 81 (202 mg, 0.82 mmol) in THF (2.5 mL) was cooled to #78 °C 
then treated, dropwise over 30 min, with LiHMDS (1.22 mL of 1.0 M solution in THF, 1.22 
mmol). The ensuing mixture was stirred at #78 °C for 1.5 h then treated with Mander’s reagent 
(71 mL, 0.90 mmol) before being allowed to warm to 18 °C over 14 h. The reaction mixture 
was then treated with water (5 mL) and CH2Cl2 (5 mL) and the separated aqueous phase was 
extracted with CH2Cl2 (2 " 5 mL). The combined organic fractions were washed with NaHCO3 
(2 mL of a saturated aqueous solution) and brine (2 mL) then dried (Na2SO4), filtered and 
concentrated under reduced pressure to give a pale-yellow oil. Subjection of this material to 
flash column chromatography (silica, 1:9 ! 1:3 v/v EtOAc/hexane gradient elution) and 
concentration of the relevant fractions gave a light-yellow oil tentatively identified as a mixture 
of title compound 81a (stereochemistry not determined) and its various tautomers (191 mg, 
78%) (Rf = 0.3, 3:7 v/v EtOAc/hexane). This material was subjected, without full 
characterization, to step ii of the reaction sequence as detailed immediately below. 
 
Step ii: A suspension of NaH (15 mg, 0.63 mmol) in THF (5 mL) was cooled to 0 °C then 
treated with a sample of compound 81a obtained in step i (94 mg, 0.31 mmol) dissolved in THF 
(1.5 mL). The ensuing mixture was warmed to 18 °C then allowed to stir at this temperature for 
45 min before being treated with iodomethane (96 mL, 1.54 mmol). After a further 1 h, the 
reaction mixture was treated with NH4Cl (5 mL of a saturated aqueous solution) and CH2Cl2 (5 
mL). The separated aqueous phase was extracted with CH2Cl2 (2 " 5 mL) and the combined 
organic extracts were washed with water (5 mL) and brine (5 mL) then dried (Na2SO4), filtered 
and concentrated under reduced pressure. The white solid so obtained was subjected to flash 
column chromatography (silica, 1:9 ! 3:7 v/v EtOAc/hexane gradient elution) and 
concentration of the appropriate fractions (Rf = 0.2, 3:7 v/v EtOAc/hexane) afforded the title 
keto-ester 143 (90 g, 91%) as white needles, m.p. = 92–96 °C. 
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1
H NMR (300 MHz) ( 6.01 (m, 1H), 5.76 (br d, J = 8.4 Hz, 1H), 4.27 (br dd, J = 7.5 and 4.8 
Hz, 1H), 3.81 (dd, J = 7.5 and 1.2 Hz, 1H), 3.68 (s, 3H), 2.95 (m, 1H), 2.48 (m, 1H), 2.36 (dd, J 
= 13.5 and 7.2 Hz, 1H), 2.13 (d, J = 9.9 Hz, 1H), 1.92 (dd, J = 13.8 and 9.2 Hz, 1H), 1.57 (s, 
3H), 1.31 (s, 3H), 1.29 (s, 3H), 1.27 (s, 3H). 
13
C NMR (75 MHz) ( 214.2 (C), 172.2 (C), 135.1 (CH), 129.8 (CH), 109.2 (C), 82.9 (CH), 
78.8 (CH), 58.2 (C), 52.5 (CH3), 50.7 (CH), 41.2 (C), 39.5 (CH), 36.9 (CH), 33.6 (CH2), 25.5 
(CH3), 25.0 (CH3), 22.3 (CH3), 18.6 (CH3). 
IR &max 2936, 2876, 1748, 1728, 1458, 1375, 1268, 1209, 1165, 1065, 999, 883, 728 cm
+1. 
Mass spectrum (EI, 70 eV) m/z 320 (M+•, 8%), 305 (55), 262 (87), 220 (60), 202 (55), 173 
(61), 157 (73), 134 (96), 105 (100). 
HREIMS Found: M+•, 320.1637. C18H24O5 requires M
+•, 320.1624. 
Optical Rotation [$]D = +11 (c 0.2, CHCl3). 
 
Methyl (3aR,4R,4aR,5S,6S,7aR,8S,8aS)-5-hydroxy-2,2,4,6-tetramethyloctahydro-3aH-4,8-
ethenoindeno[5,6-d][1,3]dioxole-6-carboxylate (144) 
 
 
CeCl3•7H2O, NaBH4, MeOH,
O
O
O
0  to 18 oC, 5 h
OO
O
O
HO
OO
133 144  
 
A solution of CeCl3•7H2O (16.01 g, 43.0 mmol) and ketone 133 (6.88 g, 21.5 mmol) in MeOH 
(107 mL) was cooled to 0 °C then treated in portions, over 30 min, with NaBH4 (1.63 g, 43.0 
mmol). The resulting mixture was allowed to warm to 18 °C, stirred at this temperature for 2 h 
then re-cooled to 0 °C and treated with an additional aliquot of NaBH4 (1.68 g, 44.5 mmol). The 
reaction mixture was then re-warmed to 18 °C, stirred at this temperature for an additional 2 h 
then diluted (SLOWLY) with water (20 mL). After hydrogen evolution had ceased the reaction 
mixture was concentrated under reduced pressure and the residue extracted with CH2Cl2 (4 " 
150 mL). The combined organic extracts were washed with water (50 mL) then dried (Na2SO4), 
filtered and concentrated under reduced pressure to give the title hydroxy-ester 144 (6.30 g, 
91%) as a low-melting solid, (Rf = 0.2, 3:7 v/v EtOAc/hexane). 
 
1
H NMR (300 MHz) ( 6.10 (m, 2H), 4.28 (dd, J = 11.5 and 5.9 Hz, 1H), 4.20 (dd, J = 7.0 and 
3.3 Hz, 1H), 3.82 (d, J = 7.0 Hz, 1H), 3.67 (s, 3H), 2.81 (m, 1H), 2.24–2.08 (complex m, 2H), 
1.93 (dd, J = 10.5 and 5.9 Hz, 1H), 1.56 (d, J = 6.6 Hz, 1H), 1.42 (s, 3H), 1.30 (s, 3H), 1.25 (s, 
3H), 1.20 (s, 3H), 1.08 (br t, J = 11.5 Hz, 1H). 
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13
C NMR (75 MHz) ( 176.9 (C), 137.7 (CH), 130.7 (CH), 109.0 (C), 83.3 (CH), 79.9 (CH), 
77.6 (CH), 56.6 (CH3), 52.0 (C), 50.7 (CH), 40.6 (two signals overlapping, CH and C), 37.9 
(CH), 37.4 (CH2), 25.4 (CH3), 24.8 (CH3), 19.6 (CH3), 18.3 (CH3). 
IR &max 3541, 2974, 2934, 2877, 1728, 1457, 1377, 1277, 1256, 1207, 1163, 1080, 1054, 1038, 
980, 895, 877, 825, 728 cm+1. 
Mass spectrum (EI, 70 eV) m/z 322 (M+•, 2%), 307 (62), 264 (99), 222 (100), 187 (87), 186 
(99), 144 (87), 117 (60), 106 (81), 91 (68), 85 (60), 43 (89). 
HREIMS Found: M+•, 322.1780. C18H26O5 requires M
+•, 322.1780. 
Optical Rotation [$]D = -20 (c 1.0, CHCl3). 
 
Methyl (3aR,4R,4aR,5S,6S,7aR,8S,8aS)-2,2,4,6-tetramethyl-5-{[(methylthio)carbono-
thioyl]oxy}octahydro-3aH-4,8-ethenoindeno[5,6-d][1,3]dioxole-6-carboxylate (144a)  
 
144 144a
NaHMDS, Me2S, MeI, THF,
0  to 18 oC, 6 h
O
O
O
O
O
O
O
HO
OO
S
S
 
  
A solution of alcohol 144 (1.91 g, 5.91 mmol) in THF (60 mL) was cooled to 0 °C then treated 
with NaHMDS (11.8 mL of a 1.0 M solution in THF, 11.8 mmol). The ensuing mixture was 
stirred at 0 °C for 1.5 h, warmed to 18 °C over 30 min then re-cooled to 0 °C and treated with 
carbon disulfide (711 mL, 11.8 mmol). After stirring at 0 °C for 1.5 h the reaction mixture was 
warmed to 18 °C over 30 min then immediately re-cooled to 0 °C and treated with iodomethane 
(773 mL, 12.4 mmol). Stirring was continued at 0 °C for 1.5 then the reaction mixture was 
warmed to 18 °C, stirred at this temperature for 30 min then diluted with Et2O (60 mL) and 
washed with water (100 mL), HCl (100 mL of a 1.0 M aqueous solution) and brine (50 mL) 
before being dried (MgSO4), filtered and concentrated under reduced pressure to give an orange 
oil. The bulk of this material was subjected, as obtained, to the next step of the reaction 
sequence as detailed in the following Section. For the purposes of characterization, a sample of 
this material was subjected to flash column chromatography (silica, 1:9 ! 3:7 v/v 
EtOAc/hexane gradient elution). Concentration of the relevant fractions (Rf = 0.3, 3:7 v/v 
EtOAc/hexane) afforded the title xanthate ester 144a as a light-yellow oil. 
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1
H NMR (300 MHz) ( 6.64 (d, J = 5.1 Hz, 1H), 5.91 (m, 2H), 4.20 (dd, J = 7.2 and 3.0 Hz, 
1H), 3.79 (d, J = 7.2 Hz, 1H), 3.72 (s, 3H), 2.80 (m, 1H), 2.60 (s, 3H), 2.24–2.05 (complex m, 
3H), 1.42 (t, J = 10.3 Hz, 1H), 1.32 (s, 3H), 1.26 (s, 3H), 1.17 (s, 3H), 1.12 (s, 3H). 
13
C NMR (75 MHz) ( 216.1 (C), 175.6 (C), 137.2 (CH), 125.9 (CH), 109.1 (C), 86.2 (CH), 
83.6 (CH), 79.6 (CH), 57.0 (C), 52.4 (CH3), 50.0 (CH), 40.3 (CH), 40.0 (C), 39.4 (CH2), 37.5 
(CH), 25.5 (CH3), 25.0 (CH3), 19.6 (CH3), 19.2 (CH3), 18.3 (CH3). 
IR &max 2975, 2932, 1730, 1457, 1377, 1286, 1245, 1207, 1057, 877, 729 cm
+1. 
Mass spectrum (EI, 70 eV) m/z 412 (M+•, 43%), 379 (44), 246 (51), 187 (85), 186 (75), 159 
(48), 145 (82), 144 (83), 91 (100), 43 (46). 
HREIMS Found: M+•, 412.1387. C20H28O5S requires M
+•, 412.1378. 
Optical Rotation [$]D = +64 (c 0.5, CHCl3). 
 
Methyl (3aR,4R,4aR,6S,7aS,8S,8aS)-2,2,4,6-tetramethyloctahydro-3aH-4,8-ethenoindeno-
[5,6-d][1,3]dioxole-6-carboxylate (145) 
 
 144a 145
n-Bu3SnH, AIBN, toluene,
reflux, 5 h
O
O
O
O
O
O
O
O
O
S
S
 
  
A solution of xanthate ester 144a (ca. 5.91 mmol, obtained as described immediately above) in 
toluene (100 mL) was treated with AIBN (20 mg, 0.122 mmol) and tri-n-butyltin hydride (3.2 
mL, 11.9 mmol) and the ensuing mixture heated under reflux for 1.5 h then cooled to 18 °C and 
treated with additional aliquots of AIBN (20 mg, 0.122 mmol) and tri-n-butyltin hydride (3.2 
mL, 11.9 mmol). The resulting mixture was again heated under reflux, this time for 3.5 h. The 
cooled reaction mixture was then concentrated under reduced pressure and the residue so 
obtained subjected to flash column chromatography (silica, hexane then 1:4 v/v EtOAc/hexane 
elution) to give, after concentration of the appropriate fractions (Rf = 0.4, 3:7 v/v 
EtOAc/hexane), the title compound 145 (1.76 g, 97% from alcohol 144) as a white crystalline 
solid, m.p. =  63–64 °C 
 
1
H NMR (300 MHz) ( 6.00 (br t, J = 8.0 Hz, 1H), 5.74 (dd, J = 8.0 and 1.0 Hz, 1H), 4.18 (ddd, 
J = 8.1, 3.6 and 3.2 Hz, 1H), 3.79 (dd, J = 8.1 and 0.9 Hz, 1H), 3.64 (s, 3H), 2.72 (m, 1H), 2.23–
2.07 (complex m, 3H), 1.79 (m, 1H), 1.31 (s, 3H), 1.25 (s, 3H), 1.19 (s, 3H), 1.17 (s, 3H), 1.01 
(m, 2H). 
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13
C NMR (75 MHz) ( 178.5 (C), 135.6 (CH), 130.3 (CH), 108.8 (C), 83.4 (CH), 79.7 (CH), 
51.9 (CH3), 50.8 (C), 45.2 (CH), 41.8 (CH2), 41.5 (C), 40.5 (CH), 40.4 (CH2), 38.7 (CH), 25.6 
(CH3), 24.9 (CH3), 23.8 (CH3), 19.7 (CH3). 
IR &max 2960, 2932, 2873, 1731, 1456, 1377, 1254, 1206, 1168, 1101, 1065, 1031, 879 cm
+1. 
Mass spectrum (EI, 70 eV) m/z 291 [(M – CH3•)
+, 73%], 248 (77), 206 (95), 189 (83), 188 
(92), 173 (73), 159 (100), 146 (92), 145 (91), 144 (92), 131 (90), 109 (64), 105 (70), 100 (77), 
91 (82), 43 (67). 
HREIMS Found: (M – CH3•)
+, 291.1589. C18H26O4 requires (M – CH3•)
+, 291.1589. 
Elemental Analysis Found: C, 70.16; H, 8.07. C18H26O4 requires C, 70.56; H, 8.55%. 
Optical Rotation [$]D = ca. 0 (c 1.2, CHCl3). 
 
Methyl (2S,3aR,4R,4aR,6S,7aS,8S,8aS)-2-hydroxy-4,6-dimethyl-2-(trifluoromethyl)-
octahydro-3aH-4,8-ethenoindeno[5,6-d][1,3]dioxole-6-carboxylate (146) and methyl 
(2S,3aR,4R,7S,7aS,8S,9R)-8,9-dihydroxy-2,4-dimethyl-2,3,3a,4,7,7a-hexahydro-1H-4,7-
ethanoindene-2-carboxylate (148) 
 
145 146
TFA/H2O,
18 oC, 3 days
O
O CF3
OH
O
O
O
O
O
O
148
OH
OH
O
O
+
 
 
A solution of acetonide 145 (122 mg, 0.39 mmol) in TFA (2 mL) and water (5 drops) was 
stirred at 18 ºC for 3 days then concentrated under reduced pressure and any residual TFA 
removed azeotropically using toluene. Subjection of the resulting solid to flash column 
chromatography (silica, 1:9 ! 1:1 v/v EtOAc/hexane gradient elution), afforded three fractions, 
A, B and C.  
 
Concentration of fraction A (Rf = 0.5, 3:7 v/v EtOAc/hexane) gave the starting acetonide 145 
(9.5 mg, 8% recovery) as a white crystalline solid. This material was identical, in all respects, 
with authentic material.  
 
Concentration of fraction B (Rf = 0.3 in 3:7 v/v EtOAc/hexane) afforded hemiorthoester 146 (98 
mg, 74% at 92% conversion) as clear, colourless oil.  
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1
H NMR (300 MHz) $ 6.21 (m, 1H), 5.95 (dm, J = 8.4 Hz, 1H), 4.43 (ddd, J = 7.5, 3.3 and 0.9 
Hz, 1H), 4.04 (dd, J = 7.5 and 1.2 Hz, 1H), 3.65 (s, 3H), 2.89 (m, 1H), 2.29–2.08 (complex m, 
3H), 1.83 (m, 1H), 1.25 (s, 1H), 1.23 (s, 3H), 1.20 (s, 3H), 1.07–0.92 (m, 2H). 
13
C NMR (75 MHz) $ 178.1 (C), 136.7 (CH), 131.6 (CH), 85.4 (CH), 81.7 (CH), 52.0 (CH3), 
50.7 (C), 44.6 (CH), 41.9 (C), 41.7 (CH2), 40.3 (CH2), 39.8 (CH), 38.8 (CH), 23.7 (CH3), 19.3 
(CH3) (signals due to CF3 and hemiorthoester carbons not observed). 
IR !max 3401, 2962, 2932, 1728, 1712, 1463, 1378, 1332, 1298, 1181, 1104, 1075, 1018, 978, 
827, 731, 648 cm#1. 
Mass spectrum (EI, 70 eV) m/z 362 (M+•, 3%), 303 (23), 206 (95), 174 (78), 159 (68), 146 
(100), 131 (85), 105 (63), 101 (69), 91 (69). 
HREIMS Found: M+•, 362.1332. C17H21F3O5 requires M
+•, 362.1341. 
 
Concentration of fraction C (Rf = 0.1, 3:7 v/v EtOAc/hexane) gave diol 148 (8 mg, 7% at 92% 
conversion) as a white, crystalline solid. This material was identical, in all respects, with 
authentic material that was prepared at a later stage.  
 
(2S,3aR,4R,4aR,7aR,8S,8aS)-2-Hydroxy-4-methyl-2-(trifluoromethyl)octahydro-5H-4,8-
ethenoindeno[5,6-d][1,3]dioxol-5-one (147) and (3aR,4S,7R,7aR,8R,9S)-8,9-dihydroxy-7-
methyl-2,3,3a,4,7,7a-hexahydro-1H-4,7-ethanoinden-1-one (147a) 
 
81 147
TFA/H2O,
18 oC, 3 days
O
O CF3
OH
O
O
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A solution of acetonide 81 (102 mg, 0.41 mmol) in TFA (2 mL) and water (5 drops) was stirred 
at 18 ºC for 3 days then concentrated under reduced pressure and any residual TFA removed 
azeotropically using toluene. Subjection of the resulting solid to flash column chromatography 
(silica, 2:8 ! 1:1 v/v EtOAc/hexane gradient elution), afforded three fractions, A, B and C.  
 
Concentration of fraction A (Rf  = 0.25, 3:7 v/v EtOAc/hexane) gave the starting acetonide 81 
(4.5 mg, 4% recovery) as a white crystalline solid. This material was identical, in all respects, 
with authentic material.  
 
Concentration of fraction B (Rf = 0.1, 3:7 v/v EtOAc/hexane) afforded a white solid that upon 
recrystallization (MeOH) gave hemiorthoester 147 (104 mg, 87% at 96% conversion) as a 
white, crystalline solid, m.p. = 180–181 °C.  
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1
H NMR (300 MHz) $ 6.32 (m, 1H), 5.98 (dm, J = 8.4 Hz, 1H), 4.51 (ddd, J = 7.5, 3.3 and 0.9 
Hz, 1H), 4.07 (dd, J = 7.5 and 1.2 Hz, 1H), 3.26 (s, 1H), 3.09 (m, 1H), 2.49 (m, 1H), 2.20–2.00 
(complex m, 3H), 1.95 (d, J = 9.6 Hz, 1H), 1.70 (m, 1H), 1.52 (s, 3H). 
13
C NMR (75 MHz) $ 218.2 (C), 136.5 (CH), 131.1 (CH), 84.6 (CH), 80.8 (CH), 51.3 (CH), 
42.1 (C), 40.6 (CH), 39.2 (CH2), 35.7 (CH), 24.9 (CH2), 18.4 (CH3) (signals due to CF3 and 
hemiorthoester carbons not observed).  
IR !max 3118, 2938, 1714, 1262, 1238, 1174, 1077, 1056, 987, 819, 741, 729, 651 cm
#1. 
Mass spectrum (EI, 70 eV) m/z 304 (M+•, 4%), 149 (38), 148 (100), 120 (55), 106 (90), 105 
(73), 92 (85), 91 (65), 56 (70). 
HREIMS Found: M+•, 304.0932. C14H15F3O4 requires M
+•, 304.0922. 
 
Concentration of fraction C (Rf << 0.1 in 3:7 v/v EtOAc/hexane) gave diol 147a (3 mg, 6% at 
96% conversion) as a white, crystalline solid. The spectral data acquired on this compound 
matched those reported by Stewart.26 
 
Methyl (2S,3aR,4R,7S,7aS,8S,9R)-8,9-dihydroxy-2,4-dimethyl-2,3,3a,4,7,7a-hexahydro-1H-
4,7-ethanoindene-2-carboxylate (148) 
 
 145 148
DOWEX-50, MeOH/H2O,
OH
OH
O
O
O
O
O
O
110 oC, 3 to 5 days
 
 
A solution of acetonide 145 (507 mg, 1.65 mmol) in MeOH/water (12 mL of a 5:1 v/v mixture) 
was treated with DOWEX-50 resin [500 mg that had been washed, successively, with NaHCO3 
(saturated aqueous solution), water (distilled), HCl (1.0 M aqueous solution) and water 
(distilled)]. The ensuing mixture was heated at 110 °C until tlc analysis revealed that the staring 
material had been consumed (normally 3–5 days). The cooled reaction mixture was filtered and 
the resin thus retained washed with MeOH (3 " 10 mL). The combined filtrates were 
concentrated under reduced pressure then the residue diluted with NaCl (20 mL of a ca. 1.5 M 
aqueous solution) and the resulting mixture extracted with CH2Cl2 (5 " 20 mL). The combined 
organic fractions were dried (Na2SO4), filtered and concentrated under reduced pressure to give 
the title diol 148 (357 mg, 81%) as a clear, colourless oil (Rf = 0.2, 1:1 v/v EtOAc/hexane). 
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1
H NMR (300 MHz) $ 6.14 (dd, J = 8.3 and 6.5 Hz, 1H), 5.85 (dd, J = 8.3 and 1.1 Hz, 1H), 
3.82 (dd, J = 7.4 and 2.3 Hz, 1H), 3.63 (s, 3H), 3.39 (d, J = 7.4 Hz, 1H), 2.86 (br s, 1H), 2.73 (br 
s, 1H), 2.68 (m, 1H), 2.22–2.13 (complex m, 3H), 1.82 (m, 1H), 1.16(8) (s, 3H), 1.16(6) (s, 3H), 
0.93 (m, 2H). 
13
C NMR (75 MHz) $ 178.5 (C), 136.5 (CH), 131.6 (CH), 74.7 (CH), 71.3 (CH), 51.9 (CH3), 
50.1 (C), 45.9 (CH), 42.8 (C), 41.9 (CH2), 41.5 (CH), 40.9 (two signals overlapping, CH and 
CH2), 23.7 (CH3), 19.4 (CH3). 
IR !max 3400, 2933, 1729, 1457, 1404, 1375, 1170, 1099, 1058, 1021, 995, 833, 791, 728 cm
#1. 
Mass spectrum (EI, 70 eV) m/z 267 [(M + H)+, 1%], 206 (94), 174 (56), 146 (100), 131 (90), 
101 (45), 91 (35). 
HREIMS Found: (M + H)+, 267.1595. C15H22O4 requires (M + H)
+, 267.1596. 
Optical Rotation [%]D = -5.5 (c 1.2, CHCl3). 
 
Methyl (2S,3aR,4R,7S,7aS,9R)-9-hydroxy-2,4-dimethyl-8-oxo-2,3,3a,4,7,7a-hexahydro-1H-
4,7-ethanoindene-2-carboxylate (149) 
 
148
4-AcNH-TEMPO,  p-TsOH•H2O,
OH
OH
O
O
CH2Cl2, 0 to 18 
oC, 18 h
149
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A solution of diol 148 (1.13 g, 4.25 mmol) in CH2Cl2 (100 mL) was cooled to 0 °C then treated 
with p-TsOH•H2O (1.76 g, 9.25 mmol). 4-Acetamido-TEMPO (1.97 g, 9.25 mmol) was then 
added, in portions over 2.5 h, to the reaction mixture which was then stirred at 0 °C for 2 h. 
After this time it was warmed to 18 °C, stirred at this temperature for 16 h then treated with 
NaHCO3 (50 mL of a saturated aqueous solution) and the separated aqueous phase was 
extracted with CH2Cl2 (4 " 50 mL). The combined organic phases were then dried (Na2SO4), 
filtered and concentrated under reduced pressure to give an orange-coloured semi-solid. 
Subjection of this material to flash column chromatography (silica 1:9 !1:4 v/v EtOAc/hexane 
gradient elution) afforded two fractions, A and B. 
 
Concentration of fraction A afforded the starting diol 148 (93 mg, 8% recovery) as a white 
crystalline solid (Rf = 0.2, 1:1 v/v EtOAc/hexane). This material was identical, in all respects, 
with authentic material. 
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Concentration of fraction B (Rf = 0.4, 1:1 v/v EtOAc/hexane) afforded the title acyloin 149 (882 
mg, 85% at 92% conversion) as a clear, colourless oil. 
 
1
H NMR (300 MHz) $ 6.04 (m, 2H), 3.30 (s, 3H), 3.62 (s, 1H), 3.08 (dm, J = 9.9 Hz, 1H), 2.98 
(br s, 1H), 2.55 (m, 1H), 2.32–2.14 (complex m, 3H), 1.21 (s, 3H), 1.20 (s, 3H), 1.05 (m, 2H).  
13
C NMR (75 MHz) $ 211.4 (C), 177.9 (C), 140.1 (CH), 126.2 (CH), 74.4 (CH), 52.0 (CH3), 
50.8 (CH), 50.1 (C), 47.3 (CH), 44.7 (C), 41.4 (CH2), 40.7 (CH2), 38.7 (CH), 23.6 (CH3), 18.1 
(CH3).  
IR !max 3462, 2962, 2931, 2872, 1729, 1463, 1450, 1374, 1325, 1286, 1199, 1171, 1080, 1037, 
881, 818, 763, 721, 661 cm#1. 
Mass spectrum (EI, 70 eV) m/z 264 (M+•,7%), 233 (10), 199 (40), 140 (100), 43 (50). 
HREIMS Found: M+•, 264.1361. C15H20O4 requires M
+•, 264.1362. 
Optical Rotation [%]D = +148 (c 0.1, CHCl3). 
 
Methyl (2S,3aR,4R,7S,7aS,9R)-9-(benzoyloxy)-2,4-dimethyl-8-oxo-2,3,3a,4,7,7a-
hexahydro-1H-4,7-ethanoindene-2-carboxylate (150) 
 
 149
BzCl, Et3N, DMAP, CH2Cl2,
0 to 18 oC, 16 h
150
OBz
O
O
O
OH
O
O
O
 
 
A solution of the acyloin 149 (880 mg, 3.33 mmol) and 4-(N,N-dimethylamino)pyridine (1.43 g, 
11.7 mmol) in CH2Cl2 (30 mL) was cooled to 0 °C then treated with triethylamine (2.2 mL, 15.7 
mmol) and benzoyl chloride (1.35 mL, 11.7 mmol). The ensuing mixture was warmed to 18 °C 
then stirred at this temperature for 16 h before being quenched with water (20 mL) then diluted 
with CH2Cl2 (50 mL). The separated organic phase was washed with NaHCO3 (2 " 20 mL of a 
saturated aqueous solution) and brine (20 mL) then dried (Na2SO4), filtered and concentrated 
under reduced pressure. The ensuing light-yellow oil was subjected to flash column 
chromatography (silica, 1:9 v/v EtOAc/hexane elution) and so affording, after concentration of 
the appropriate fractions (Rf = 0.4, 3:7 v/v EtOAc/hexane), a white solid, recrystallization 
(iso-propanol) of which gave the title benzoate 150 (984 mg, 80%) as white needles, m.p. = 
121–123 °C. 
 
1
H NMR (300 MHz) $ 8.00 (dm, J = 7.8 Hz, 2H), 7.55 (m, 1H), 7.41 (tm, J = 7.8 Hz, 2H), 6.23 
(br t, J = 7.5 Hz, 1H), 6.14 (dd, J = 7.5 and 0.6 Hz, 1H), 5.10 (s, 1H), 3.69 (s, 3H), 3.20 (ddd, J 
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= 6.5, 2.5 and 1.1 Hz, 1H), 2.73 (m, 1H), 2.49–2.29 (complex m, 3H), 1.30 (s, 3H), 1.16 (s, 3H), 
1.13 (partially obscured m, 2H).  
13
C NMR (75 MHz) $ 205.3 (C), 177.7 (C), 166.1 (C), 139.4 (CH), 133.2 (CH), 129.9 (CH), 
129.4 (C), 128.3 (CH), 127.0 (CH), 74.0 (CH), 52.1 (CH3), 51.6 (CH), 50.2 (C), 47.0 (CH), 43.8 
(C), 41.6 (CH2), 40.9 (CH2), 39.2 (CH), 23.7 (CH3), 18.3 (CH3).  
IR !max 2965, 2932, 1740, 1725, 1450, 1325, 1268, 1197, 1172, 1110, 1070, 1028, 985 cm
#1. 
Mass spectrum (EI, 70 eV) m/z 368 (M+•, 1%), 309 (12), 246 (51), 218 (51), 206 (25), 186 
(18), 174 (26), 159 (37), 158 (75), 146 (55), 131 (20), 106 (45), 105 (100), 91 (20), 77 (70). 
HREIMS Found: M+•, 368.1625. C22H24O5 requires M
+•, 368.1624.  
Elemental Analysis Found: C, 71.24; H, 6.54. C22H24O5 requires C, 71.72; H, 6.57%. 
Optical Rotation [%]D = +179 (c 1.0, CHCl3). 
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Methyl (1R,2aR,2bR,2cR,4S,5aR,5bS,5cS)-1-(benzoyloxy)-4,5b-dimethyl-2-oxodecahydro-
1H-cyclopenta[a]cyclopropa[cd]pentalene-4-carboxylate (154), methyl 
(1S,2aR,2bR,2cR,4S,5aR,5bS,5cS)-1-(benzoyloxy)-4,5b-dimethyl-2-oxodecahydro-1H-
cyclopenta[a]cyclopropa[cd]pentalene-4-carboxylate (155) and methyl 
(1S/R,2aR,4aR,6S,7aR,7bS)-1-(benzoyloxy)-6,7b-dimethyl-2-oxo-2,2a,4a,5,6,7,7a,7b-
octahydro-1H-cyclobuta[e]indene-6-carboxylate (156) 
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O
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150
154 155 156
11
h!, acetone, acetophenone,
5 to 10 ºC, 80 h
  
 
A deoxygenated solution of compound 150 (217 mg, 0.59 mmol) and acetophenone (172 mL, 
1.47 mmol) in acetone (120 mL) contained in a Pyrex™ vessel jacketed by a water-cooled (5–
10 °C) solution of sodium bromide (750 g) and lead(II) nitrate (8 g) in water (1000 mL) was 
subjected to irradiation with a Philips 125 W HPL-N lamp for 80 h. The reaction mixture was 
then concentrated under reduced pressure and the ensuing pale-yellow oil subjected to flash 
column chromatography (silica, 5:95 ! 3:7 v/v EtOAc/hexane gradient elution) and thus 
affording three fractions, A, B and C. 
 
Concentration of fraction A [Rf = 0.3(5), 3:7 v/v EtOAc/hexane] afforded the title  
1(R)-tetracycle 154 (19.2 mg, 9%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) $ 8.05 (m, 2H), 7.57 (tt, J = 7.5 and 1.5 Hz, 1H), 7.43 (tm, J = 7.5 Hz, 
2H), 4.92 (br s, 1H), 3.68 (s, 3H), 2.82 (ddd, J = 13.8, 9.3 and 2.1 Hz, 1H), 2.65 (m, 1H), 2.53 
(t, J = 6.0 Hz, 1H), 2.39 (m, 1H), 2.23 (m, 2H), 1.79 (dd, J = 10.2 and 6.0 Hz, 1H), 1.57 (m, 
1H), 1.36 (s, 3H), 1.30 (m, 1H), 1.19 (s, 3H). 
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C NMR (75 MHz) $ 209.7 (C), 177.7 (C), 165.6 (C), 133.3 (CH), 129.9 (CH), 129.4 (C), 
128.4 (CH), 84.3 (CH), 60.1 (CH), 52.2 (CH3), 51.6 (C), 50.9 (C), 44.6 (CH2), 43.4 (CH), 40.8 
(CH), 40.6 (CH2), 39.5 (CH), 39.0 (CH), 25.0 (CH3), 15.4 (CH3). 
IR !max 2919, 1726, 1451, 1315, 1266, 1197, 1175, 1106, 1069, 1026, 711 cm
#1. 
Mass spectrum (EI, 70 eV) m/z 368 (M+•, 5%), 309 (12), 263 (38), 246 (68), 218 (47), 206 
(52), 203 (56), 159 (63), 158 (93), 146 (75), 145 (55), 106 (81), 105 (95), 77 (100). 
HREIMS Found: M+•, 368.1623. C22H24O5 requires M
+•, 368.1624. 
Optical Rotation [%]D = +35 (c 0.6, CHCl3). 
 
Concentration of fraction B [Rf = 0.3(0), 3:7 v/v EtOAc/hexane] afforded the title  
1(S)-tetracycle 155 (178 mg, 82%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) $ 8.02 (dm, J = 7.8 Hz, 2H), 7.57 (tt, J = 7.8 and 1.5 Hz, 1H), 7.44 (t, J = 
7.8 Hz, 2H), 5.34 (d, J = 1.5 Hz, 1H), 3.65 (s, 3H), 2.77 (ddd, J =13.8, 9.3 and 2.4 Hz, 1H), 
2.67–2.49 (complex m, 2H), 2.29 (t, J = 5.4 Hz, 1H), 2.14–2.04 (complex m, 2H), 1.79 (dd, J = 
10.2 and 5.4 Hz, 1H), 1.55 (t, J = 12.0 Hz, 1H), 1.36 (s, 3H), 1.33 (m, 1H), 1.25 (s, 3H). 
13
C NMR (75 MHz) $ 206.1 (C), 177.8 (C), 165.4 (C), 133.4 (CH), 129.9 (CH), 129.3 (C), 
128.4 (CH), 83.1 (CH), 54.2 (CH), 52.0 (CH3), 51.5 (C), 49.7 (C), 44.5 (CH2), 43.0 (CH), 40.4 
(CH2), 36.0 (CH), 33.6 (CH), 32.5 (CH), 24.8 (CH3), 20.6 (CH3). 
IR !max 2928, 1740, 1725, 1451, 1314, 1269, 1176, 1112, 1071, 999, 711 cm
#1. 
Mass spectrum (EI, 70 eV) m/z 368 (M+•, 66%), 309 (16), 263 (61), 246 (25), 203 (35), 106 
(50), 105 (100), 77 (78). 
HREIMS Found: M+•, 368.1622. C22H24O5 requires M
+•, 368.1624. 
Optical Rotation [%]D = -75 (c 0.4, CHCl3). 
 
Concentration of fraction C (Rf = 0.5, 3:7 v/v EtOAc/hexane) afforded the title cyclobutanone 
156 (traces) as a clear, colourless oil. This material is unstable and decomposes on standing at 
18 °C in air for short periods of time. 
 
1
H NMR (300 MHz) $ 8.07 (dm, J = 7.2 Hz, 2H), 7.60 (tt, J = 7.2 and 1.5 Hz, 1H), 7.45 (tm, J 
= 7.2 Hz, 2H), 5.94 (d, J = 3.0 Hz, 1H), 5.74 (dm, J = 10.0 Hz, 1H), 5.63 (ddd, J = 10.0, 4.8 and 
2.7 Hz, 1H), 3.68 (s, 3H), 3.18 (m, 1H), 3.02 (m, 1H), 2.74–2.60 (complex m, 2H), 2.35 (dd, J = 
13.0 and 7.2 Hz, 1H), 1.67 (dd, J = 13.0 and 1.5 Hz, 1H), 1.29 (s, 3H), 1.19 (s, 3H), 1.18 
(partially obscured m, 1H). 
13
C NMR (75 MHz) $ 200.3 (C), 178.8 (C), 165.0 (C), 133.6 (CH), 133.3 (CH), 130.0 (CH), 
128.7 (C), 128.5 (CH), 118.5 (CH), 82.9 (CH), 57.7 (CH), 52.1 (CH3), 48.4 (C), 43.6 (CH2), 
42.2 (CH), 40.4 (CH2), 38.2 (CH), 37.1 (C), 27.7 (CH3), 19.2 (CH3). 
IR !max 2954, 2873, 1790, 1727, 1451, 1267, 1217, 1165, 1107, 1025, 990, 710 cm
#1. 
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Mass spectrum (EI, 70 eV) m/z 325 [(M – CO – CH3•)
+, < 1%], 246 (28), 206 (37), 159 (50), 
158 (99), 146 (72), 145 (59), 106 (53), 105 (67), 77 (100). 
HREIMS Found: (M – CO – CH3•)
+, 325.1436. C22H24O5 requires (M – CO – CH3•)
+, 325.1440. 
 
Methyl (1S,2aR,2bR,2cR,4S,5aR,5bS,5cS)-1-(benzoyloxy)-4,5b-dimethyl-2-oxodecahydro-
1H-cyclopenta[a]cyclopropa[cd]pentalene-4-carboxylate (154) 
 
MeO2C
H
H
O
H
OBz
MeO2C
H
H
O
H
OBz
154 155
h!, acetone, acetophenone,
5 to 10 ºC, 36 h
 
 
A sample of compound 154 (50.4 mg, 0.14 mmol) was subjected to the irradiation for 36 h 
under the conditions defined immediately above. Work-up followed by chromatographic 
purification afforded isomer 155 (48.9 mg, 97%). This material proved identical, in all respects, 
with authentic material. 
 
Methyl (2S,3aR,3bR,6aS,7aS)-2,3b-dimethyl-5-oxodecahydro-1H-cyclopenta[a]pentalene-
2-carboxylate (107) and methyl (2S,2aR,2bS,4S,5aR,6S,6aR)-2-hydroxy-4,6-
dimethyldecahydro-2,6-methanocyclobuta[a]pentalene-4-carboxylate (157) 
 
Method 1: 
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155 107 157
SmI2, THF/MeOH,
-78 to 18 ºC, 3 h
 
 
A solution of cyclopropane 155 (67 mg, 0.18 mmol) in THF/MeOH (1.5 mL of a 2:1 v/v 
mixture) was cooled to #78 °C then treated with samarium(II) iodide (7.28 mL of a 0.1 M 
solution in THF, 0.73 mmol). The ensuing mixture was stirred at #78 °C for 1 h then warmed to 
18 °C and stirred at the latter temperature for a further 2 h and after which time the initial blue 
colour of the reaction mixture had been discharged. The reaction mixture so obtained was 
treated with K2CO3 (5 mL of a saturated aqueous solution) and the separated aqueous phase was 
extracted with Et2O (3 " 10 mL). The combined organic fractions were washed with water (5 
mL) and brine (5 mL) before being dried (Na2SO4), filtered and concentrated under reduced 
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pressure. The ensuing pale-yellow oil was subjected to flash column chromatography (silica, 1:9 
v/v Et2O/hexane elution) to yield two fractions, A and B.  
 
Concentration of fraction A (Rf = 0.3, 3:7 v/v EtOAc/hexane) afforded the title triquinane 107 
(25.5 mg, 56%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) $ 3.66 (s, 3H), 2.70 (m, 1H), 2.60–2.34 (complex m, 4H), 2.24–2.06 
(complex m, 3H), 2.03 (d, J = 7.2 Hz, 2H), 1.70 (m, 1H), 1.58–1.44 (complex m, 1H), 1.30 (s, 
3H), 1.06 (m, 1H), 1.04 (s, 3H). 
13
C NMR (75 MHz) $ 220.2 (C), 178.0 (C), 52.9 (CH), 52.0 (C), 51.9 (CH3), 51.2 (CH2), 49.1 
(C), 46.0 (CH2), 44.5 (CH), 42.9 (CH2), 41.4 (CH), 40.6 (CH2), 39.6 (CH2), 24.4 (CH3), 22.1 
(CH3). 
IR !max 2950, 1740, 1460, 1406, 1377, 1306, 1251, 1196, 1168, 1080, 846 cm
#1. 
Mass spectrum (EI, 70 eV) m/z 250 (M+•, 3%), 248 (2), 192 (100), 133 (75), 105 (61). 
HREIMS Found: M+•, 250.1570. C15H22O3 requires M
+•, 250.1569. 
Optical Rotation [%]D = #121 (c 0.2, CHCl3) [lit.
71 [$]D = #125 (c 1.2, CHCl3)]. 
 
The data presented above matched the equivalent spectral information reported in the 
literature.71 
 
Concentration of fraction B (Rf = 0.2, 3:7 v/v EtOAc/hexane) afforded the title cyclobutanol 157 
(11.4 mg, 25%) as a white crystalline solid, m.p. = 79–82 °C. 
 
1
H NMR (300 MHz) $ 3.62 (s, 3H), 2.52–2.24 (complex m, 3H), 2.14 (br s, 1H), 2.04 (ddd, J = 
12.6, 7.2 and 2.7 Hz, 1H), 1.91 (t, J = 3.0 Hz, 1H), 1.89 (dd, J = 3.6 and 1.5 Hz, 1H), 1.64 (s, 
1H), 1.57 (m, 1H), 1.38 (dd, J = 9.6 and 1.5 Hz, 1H), 1.24 (s, 3H), 1.06 (m, 1H), 1.01 (s, 3H), 
0.93 (m, 1H), 0.87 (m, 1H).  
13
C NMR (75 MHz) $ 178.4 (C), 77.9 (C), 63.3 (CH), 58.5 (CH), 51.9 (CH3), 51.8 (C), 48.0 
(C), 44.9 (CH2), 42.9 (CH2), 39.5 (CH), 39.4 (CH2), 39.2 (CH2), 36.9 (CH), 24.3 (CH3), 18.2 
(CH3).  
IR !max 3424, 2951, 2870, 1730, 1463, 1450, 1375, 1331, 1312, 1287, 1247, 1222, 1195, 1168, 
1106, 1091, 875, 774, 763, 701 cm#1. 
Mass spectrum (EI, 70 eV) m/z 250 (M+•, 2%), 235 (3), 207 (13), 193 (76), 147 (50), 133 
(100). 
HREIMS Found: M+•, 250.1576. C15H22O3 requires M
+•, 250.1569. 
Optical Rotation [%]D = +6 (c 0.9, CHCl3). 
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Method 2:  
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158 107 157
SmI2, THF/MeOH,
-78 to 18 ºC, 3 h
 
 
A solution of cyclopropane 158 (293 mg, 1.18 mmol, obtained as described on page 162) in 
THF/MeOH (15 mL of a 2:1 v/v mixture) was cooled to #78 °C then treated with samarium(II) 
iodide (24 mL of a 0.1 M solution in THF, 2.4 mmol). The ensuing mixture was treated in the 
same manner as detailed immediately above in Method 1 and thus affording a pale-yellow oil 
upon work-up. Subjection of this material to flash column chromatography (silica, 1:9 v/v 
Et2O/hexane elution) yielded two fractions, A and B.  
 
Concentration of fraction A (Rf = 0.4, 3:7 v/v EtOAc/hexane) afforded triquinane 107 (173 mg, 
59%) as a clear, colourless oil. This material was identical, in all respects, with that obtained via 
Method 1. 
 
Concentration of fraction B (Rf = 0.2, 3:7 v/v EtOAc/hexane) afforded cyclobutanol 157 (74 mg, 
25%) as a white crystalline solid. This material was identical, in all respects, with that obtained 
via Method 1. 
 
Methyl (2S,2aR,2bS,4S,5aR,6S,6aR)-4,6-dimethyl-2-[(4-nitrobenzoyl)oxy]decahydro-2,6-
methanocyclobuta[a]pentalene-4-carboxylate (157a) 
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CH2Cl2, 18 ºC, 3 h
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A solution of alcohol 157 (20 mg, 0.08 mmol) and 4-(N,N-dimethylamino)pyridine (34 g, 0.28 
mmol) in CH2Cl2 (2 mL) was treated with triethylamine (30 mL, 0.22 mmol) and freshly 
prepared p-nitrobenzoyl chloride (52 mg, 0.28 mmol). The ensuing mixture was stirred at 18 °C 
for 3 h before being quenched with water (2 mL) then diluted with CH2Cl2 (10 mL). The 
separated organic phase was washed with NaHCO3 (2 mL of a saturated aqueous solution) and 
brine (2 mL) then dried (Na2SO4), filtered and concentrated under reduced pressure. The 
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ensuing solid was recrystallized (hexane) to give the title ester 157a (24 mg, 75%) as a white 
crystalline solid (Rf  = 0.5, 3:7 v/v EtOAc/hexane), m.p. = 89–95 °C (with decomposition). 
 
1
H NMR (300 MHz) $ 8.27 (d, J = 9.0 Hz, 2H), 8.16 (d, J = 9.0 Hz, 2H), 3.67 (s, 3H), 2.67 (q, J 
= 6.1 Hz, 1H), 2.56–2.34 (complex m, 3H), 2.20–1.98 (complex m, 3H), 1.78 (dd, J = 9.3 and 
1.5 Hz, 1H), 1.56 (br s, 1H), 1.41 (br dd, J = 9.3 and 1.8 Hz, 1H), 1.27 (s, 3H), 1.10 (s, 3H), 
1.00 (dd, J = 12.3 and 11.1 Hz, 1H), 0.90 (dd, J = 12.3 and 8.4 Hz, 1H). 
13
C NMR (75 MHz) $ 178.2 (C), 163.7 (C), 150.4 (C), 136.0 (C), 130.7 (CH), 123.5 (CH), 81.6 
(C), 61.3 (CH), 58.2 (CH), 51.9 (CH3), 51.7 (C), 47.5 (C), 42.8 (CH2), 42.0 (CH2), 40.1 (CH), 
39.1 (CH2), 37.8 (CH), 37.7 (CH2), 24.2 (CH3), 18.1 (CH3). 
IR !max 2954, 2920, 2862, 1727, 1528, 1349, 1284, 1270, 1224, 1169, 1147, 1118, 872, 831, 
718 cm#1. 
Mass spectrum (EI, 70 eV) m/z 399 (M+•, 2%), 340 (10), 339 (5), 249 (15), 232 (22), 193 (67), 
150 (100), 120 (85). 
HREIMS Found: M+•, 399.1684. C22H25NO6 requires M
+•, 399.1682. 
Optical Rotation [%]D = #19 (c 0.5, CHCl3). 
 
Methyl (2aR,2bR,2cR,4S,5aR,5bS,5cS)-4,5b-dimethyl-2-oxodecahydro-1H-cyclopenta[a]-
cyclopropa[cd]pentalene-4-carboxylate (158) 
 
Method 1: 
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SmI2, THF/MeOH,
18 ºC, ca. 10 min
 
 
A solution of compound 154 (185 mg, 0.50 mmol) in THF/MeOH (7.5 mL of a 2:1 v/v mixture) 
was cooled to #78 °C then treated, dropwise, with samarium(II) iodide (11 mL of 0.1 M 
solution in THF, 1.1 mmol) until a blue colour persisted (ca. 10 min). The reaction mixture was 
then poured into K2CO3 (10 mL of saturated aqueous solution) and the separated aqueous phase 
extracted with Et2O (3 " 20 mL). The combined organic fractions were washed with water (10 
mL) and brine (10 mL) then dried (Na2SO4), filtered and concentrated under reduced pressure to 
give the title compound 158 (122 mg, 98%) as a clear, colourless oil (Rf = 0.2, 3:7 v/v 
EtOAc/hexane). 
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1
H NMR (300 MHz) $ 3.64 (s, 3H), 2.76 (ddd, J = 13.8, 9.3 and 2.1 Hz, 1H), 2.56 (m, 1H), 
2.37 (t, J = 5.4 Hz, 1H), 2.30 (dd, J = 18.0 and 1.2 Hz, 1H), 2.20–2.08 (complex m, 2H), 2.05–
1.94 (complex m, 2H), 1.63 (dd, J = 10.2 and 6.3 Hz, 1H), 1.48 (t, J = 13.8 Hz, 1H), 1.34 (s, 
3H), 1.29 (s, 3H), 1.24 (br s, 1H). 
13
C NMR (75 MHz) $ 214.5 (C), 178.1 (C), 63.0 (CH2), 56.5 (CH), 52.0 (CH3), 51.5 (C), 47.1 
(C), 44.6 (CH2), 43.1 (CH), 40.6 (CH2), 40.0 (CH), 39.2 (CH), 38.6 (CH), 25.2 (CH3), 22.1 
(CH3). 
IR !max 2959, 2928, 2872, 1727, 1461, 1378, 1289, 1196, 1160, 1124, 1086, 958, 874, 808 cm
#1. 
Mass spectrum (EI, 70 eV) m/z 248 (M+•, 16%), 206 (90), 174 (72), 146 (100), 131 (82). 
HREIMS Found: M+•, 248.1414. C15H20O3 requires M
+•, 248.1412. 
Optical Rotation [%]D = #36 (c 1.3, CHCl3). 
 
Method 2:  
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18 ºC, ca. 10 min
 
 
A sample of compound 155 (720 mg, 1.96 mmol) was subjected reaction with samarium(II) 
iodide at #78 °C under the conditions defined immediately above. Work-up provided the title 
compound 158 (470 mg, 97%) as a clear, colourless oil. This material was identical, in all 
respects, with the material generated by Method 1. 
 
Methyl (2S,3aR,3bR,6aS,7aS)-2,3b-dimethyl-5-oxodecahydro-1H-cyclopenta[a]pentalene-
2-carboxylate (107) 
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reflux, 4.5 h
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A solution of cyclopropane 158 (756 mg, 3.04 mmol) and AIBN (10 mg, 0.06 mmol) in 
benzene (95 mL) was treated, at 18 °C, with tri-n-butyltin hydride (1.64 mL, 6.09 mmol). The 
ensuing mixture was heated at reflux for 1.5 h then cooled to 18 °C and treated with further 
aliquots of AIBN (10 mg, 0.06 mmol) and tri-n-butyltin hydride (1.64 mL, 6.09 mmol) and 
refluxing of the reaction mixture continued for a further 1.5 h. This process was repeated once 
more and such that a total of six equivalents of tri-n-butyltin hydride were added to the original 
Chapter Five 164 
reaction mixture and a total reflux time of 4.5 h had been applied. The cooled reaction mixture 
was then concentrated under reduced pressure and the light-yellow oil so obtained subject to 
flash column chromatography (silica, 0:1 !& 1:4 v/v EtOAc/hexane gradient elution) and thus 
providing two fractions, A and B. 
 
Concentration of fraction A (Rf = 0.3, 3:7 v/v EtOAc/hexane) afforded compound 107 (580 mg, 
88% at 87% conversion) as a clear, colourless oil. This material was identical, in all respects, 
with that obtained via the previous method. 
 
Concentration of fraction B (Rf = 0.2, 3:7 v/v EtOAc/hexane) afforded the starting cyclopropane 
158 (101 mg, 13% recovery) as a clear, colourless oil. This material was identical, in all 
respects, with authentic material. 
 
Methyl (2S,3aR,3bS,7aS)-2,3b-dimethyl-5-oxo-2,3,3a,3b,4,5,7,7a-octahydro-1H-
cyclopenta[a]pentalene-2-carboxylate (101) 
 
Method 1: 
 
1.  TMSOTf, 2,6-lutidine,
     CH2Cl2, 0 to 18 ºC, 1 h
107
MeO2C
H
H
O
H
MeO2C
H
H
O
101
2.  Pd(OAc)2, p-benzoquinone,
     MeCN, 18 ºC, 18 h
  
 
A solution of ketone 107 (51.5 mg, 0.21 mmol) and 2,6-lutidine (96 mL, 0.82 mmol) in CH2Cl2 
(2 mL) was cooled to 0 °C then treated, dropwise, with TMSOTf (112 mL, 0.62 mmol). The 
ensuing mixture was warmed to 18 °C, stirred for 1 h at this temperature then treated with water 
(2 mL) and CH2Cl2 (10 mL). The separated aqueous phase was extracted with CH2Cl2 (3 " 5 
mL) and the combined organic fractions then dried (Na2SO4), filtered and concentrated under 
reduced pressure to give a 4:1 mixture, as judged by 1H NMR spectroscopic analysis, of silyl 
enol ethers as a light-yellow oil. A solution of these ethers in MeCN (1.5 mL) was added to a 
slurry of palladium (II) acetate (92 mg, 0.41 mmol) and p-benzoquinone (23 mg, 0.21 mmol) in 
MeCN (0.5 mmol). The ensuing mixture was stirred at 18 °C for 18 h then diluted with Et2O (15 
mL) and filtered through a pad of Celite™ contained in a sintered glass funnel. The solids thus 
retained were washed with additional Et2O (3 " 5 mL) and the combined filtrates concentrated 
under reduced pressure to give a light-yellow oil. Subjection of this material to flash column 
chromatography (silica, 1:4 v/v EtOAc/hexane elution) afforded two fractions, A and B.  
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Concentration of the fraction A (Rf = 0.4, 3:7 v/v EtOAc/hexane) afforded the starting ketone 
107 (16 mg, 31% recovery) as a clear, colourless oil. This material was identical, in all respects, 
with authentic material. 
 
Concentration of the fraction B (Rf = 0.4, 1:1 v/v EtOAc/hexane) afforded the title enone 101 
(35 mg, 85% at 69% conversion) as a clear, colourless oil. 
 
1
H NMR (300 MHz) $ 5.68 (m, 1H), 3.66 (s, 3H), 2.84–2.63 (complex m, 2H), 2.52 (ddd, J = 
12.3, 7.5 and 1.5 Hz, 1H), 2.44–2.21 (complex m, 3H), 2.27 (s, 2H), 1.53–1.39 (complex m, 
1H), 1.35 (s, 3H), 1.24 (m, 1H), 1.10 (s, 3H). 
13
C NMR (75 MHz) $ 210.5 (C), 195.0 (C), 178.0 (C), 122.5 (CH), 54.7 (C), 52.5 (CH2), 52.0 
(CH3), 50.6 (CH), 49.2 (C), 46.3 (CH2), 44.4 (CH), 37.1 (CH2), 32.5 (CH2), 24.5 (CH3), 24.4 
(CH3). 
IR !max 2960, 1728, 1709, 1635, 1467, 1202, 1169, 1093, 876 cm
#1. 
Mass spectrum (EI, 70 eV) m/z 248 (M+•, 100%), 233 (32), 189 (75), 188 (70), 173 (63), 120 
(70), 108 (92), 91 (55), 81 (68), 80 (82), 79 (68). 
HREIMS Found: M+•, 248.1416. C15H20O3 requires M
+•, 248.1412. 
Optical Rotation [%]D = +56 (c 0.6, CHCl3) [lit.
71 [%]D = +57 (c 0.7, CHCl3)]. 
 
The data presented above matched the equivalent spectral information reported in the 
literature.71 
 
Method 2:  
 
IBX, p-TsOH•H2O,
toluene/DMSO,
107
MeO2C
H
H
O
H
MeO2C
H
H
O
101
85 ºC, 72 h
 
 
A solution of ketone 107 (462 mg, 1.88 mmol) in toluene/DMSO (7.5 mL of a 2:1 v/v mixture) 
was treated with p-TsOH•H2O (105 mg, 0.55 mmol) and IBX (2.07 g, 7.38 mmol) and the 
resulting solution heated at 85 °C for 72 h then cooled and diluted with Et2O (100 mL). The 
separated organic phase was washed with NaHCO3 (2 " 5 mL of a 5% w/v aqueous solution), 
water (2 " 50 mL) and brine (50 mL) then dried (Na2SO4), filtered and concentrated under 
reduced pressure to give a light-yellow oil. Subjection of this material to flash column 
chromatography (silica, 1:4 v/v EtOAc/hexane elution) afforded, after concentration of the 
appropriate fractions (Rf = 0.4, 1:1 v/v EtOAc/hexane), the title enone 101 (408 mg, 89%) as a 
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clear, colourless oil. This material was identical, in all respects, with that generated via Method 
1. 
 
Methyl (2S,3aR,3bS,7aS)-2,3b-dimethyl-4-methylene-5-oxo-2,3,3a,3b,4,5,7,7a-octahydro-
1H-cyclopenta[a]pentalene-2-carboxylate (115) 
 
Method 1: [via methyl (2S,3aR,3bR,7aS)-2,3b,4-trimethyl-5-oxo-2,3,3a,3b,4,5,7,7a-
octahydro-1H-c yclopenta[a]pentalene-2-carboxylate (161) and methyl (2S,3aR,3bS,7aS)-
2,3b,4-trimethyl-5-oxo-4-(phenylseleno)-2,3,3a,3b,4,5,7, 7a-octahydro-1H-
cyclopenta[a]pentalene-2-carboxylate (162)] 
 
LDA, PhSeCl, 
THF,-78 to 18 ºC, 
1.25 h
101
MeO2C
H
H
O
NaIO4, THF/H2O/
MeOH,18 ºC, 1h
LDA, MeI, THF,
-78 to 0 ºC, 1h
MeO2C
H
H O
115
MeO2C
H
H O
161
MeO2C
H
H O
162
4
4
SePh
 
 
Step i: Following a procedure established by Ikegami et al.,72 a solution of enone 101 (27 mg, 
0.11 mmol) in THF (1 mL) was cooled to #78 °C then treated with freshly prepared LDA (513 
mL of a 0.43 M solution in THF, 0.22 mmol). The ensuing mixture was stirred at #78 °C for 10 
min then treated with iodomethane (68 mL, 1.09 mmol) after which it was allowed to warm to 0 
°C over 1 h then quenched with NH4Cl (2 mL of a saturated aqueous solution) and extracted 
with Et2O (3 " 5 mL). The combined organic fractions were washed with brine (5 mL) then 
dried (MgSO4), filtered and concentrated under reduced pressure to give methyl enone 161
72 as 
a clear, colourless oil and as a single diastereoisomer of undetermined configuration at C4. This 
material was used directly in Step ii. 
 
Step ii: A solution of compound 161 (obtained as described in Step i, assumed 0.11 mmol) in 
THF (1.5 mL) was cooled to #78 °C then treated with freshly prepared LDA (513 mL of a 0.43 
M solution, 0.22 mmol). Stirring was continued at #78 °C for 30 min then the reaction mixture 
was treated with a solution of phenylselenyl chloride (68.3 mL, of a 0.48 M solution in THF, 
0.33 mmol). Stirring was continued for 15 min then the reaction mixture was warmed to 18 °C 
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over 30 min and quenched with NH4Cl (2 mL of a saturated aqueous solution). The ensuing 
mixture was extracted with Et2O (3 " 5 mL) and the combined organic fractions washed with 
brine (5 mL), dried (MgSO4), filtered and concentrated under reduced pressure to give a ca. 3:1 
mixture of the two diasteroisomeric forms of selenide 16272 as a clear, colourless oil. This 
material was used directly in Step iii. 
 
Step iii: A solution of selenide 162 (obtained as described in Step ii, assumed 0.11 mmol) in 
THF/water/MeOH (4 mL of a 1:1:2 v/v/v mixture) was treated with NaIO4 (121 mg, 0.54 mmol) 
and the ensuing mixture stirred at 18 °C for 1 h then diluted with CH2Cl2 (10 mL) and Na2S2O3 
(5 mL of a saturated aqueous solution). The separated aqueous phase was extracted with CH2Cl2 
(3 " 10 mL) and the combined organic fractions were then dried (MgSO4), filtered and 
concentrated under reduced pressure to give a pale-yellow oil. Subjection of this material to 
flash column chromatography (silica, 3:7 v/v EtOAc/hexane elution) afforded, after 
concentration of the appropriate fractions (Rf = 0.5, 1:1 v/v EtOAc/hexane), the title dienone 
115 (17.4 mg, 61% from compound 101) as a clear, colourless oil. This material was often 
contaminated with varying amounts of the chromatographically inseparable precursor 161. As a 
result, full characterization of compound 115 was carried out using samples prepared by 
Method 2 detailed immediately below. 
 
Method 2: [via methyl (2S,3aR,3bR,7aS)-4-[(dimethylamino)methyl]-2,3b-dimethyl-5-oxo-
2,3,3a,3b,4,5,7,7a-octahydro-1H-cyclopenta[a]pentalene-2-carboxylate (163)] 
 
MeO2C
H
H
O
MeO2C
H
H
O
NMe2163
LiHMDS, C3H8NI, THF,
-78 to 18 ºC, 16 h
101
4
 
 
Step i: A solution of enone 101 (94 mg, 0.38 mmol) in THF (5 mL) maintained at #78 °C under 
a nitrogen atmosphere was treated, dropwise, with LiHMDS (566 mL of a 1.0 M solution in 
THF, 0.57 mmol) and the resulting mixture stirred at this temperature for 1 h. After this time 
Eschenmoser’s salt (227 mg, 1.13 mmol) was added, in one portion, to the reaction mixture and 
this was then allowed to warm to 18 °C and stirred at this temperature for 16 h. The ensuing 
mixture was then quenched with HCl (20 ml of a 3.0 M aqueous solution) and after stirring for 
5 min the aqueous phase was separated and extracted with Et2O (3 " 20 mL). The combined 
organic phases were washed with NaHCO3 (20 mL of saturated aqueous solution) and brine (10 
mL) then dried (Na2SO4), filtered and concentrated under reduced pressure to afford the starting 
enone 101 (5 mg, 5% recovery) as a clear, colourless oil, which was identical, in all respects, 
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with authentic material. The aqueous layers obtained as described above were combined and 
basified to pH 14 using NaOH (4.0 M aqueous solution) and then extracted with CH2Cl2 (3 " 50 
mL). The combined organic fractions were then dried (Na2SO4), filtered and concentrated under 
reduced pressure to give amine 163 (91 mg, 79% at 95% conversion) as a clear, colourless oil 
and as a single diastereoisomer of undetermined configuration at C4. 
 
1
H NMR (300 MHz) $ 5.63 (d, J = 1.5 Hz, 1H), 3.65 (s, 3H), 2.75 (dd, J = 15.0 and 8.0 Hz, 
1H), 2.68–2.44 (complex m, 3H), 2.40–2.24 (complex m, 5H), 2.20 (s, 6H), 1.47 (dd, J = 13.8 
and 8.0 Hz, 1H), 1.34 (s, 3H), 1.27 (dd, J = 12.0 and 1.5 Hz, 1H), 1.13 (s, 3H). 
IR !max 2957, 2923, 2851, 1729, 1700, 1635, 1465, 1373, 1198, 1165, 1093 cm
#1. 
Mass spectrum (EI, 70 eV) m/z 305 (M+•, 20%), 260 (12), 201 (16), 200 (15), 170 (18), 141 
(16), 77 (27), 58 (100). 
HREIMS Found: M+•, 305.1992. C18H27NO3 requires M
+•, 305.1991. 
 
MeO2C
H
H
O
MeO2C
H
H
O
NMe2
163
1. MeI, Et2O/CH2Cl2,
    18 ºC, 16 h
2.  Basic alumina,
     CH2Cl2, 18 ºC, 30 min
115  
 
Step ii: A solution of amine 163 (275 mg, 0.90 mmol) in Et2O/CH2Cl2 (40 mL of a v/v 3:1 
mixture) was treated with iodomethane (678 mL, 10.9 mmol), the resulting solution stirred at 18 
°C for 16 h and then concentrated under reduced pressure. The ensuing white residue was 
dissolved in CH2Cl2 (5 mL) and the resulting solution treated with basic alumina (ca. 250 mg of 
0.063–0.200 mesh and grade 1 activity material). The suspension thus formed was stirred at 18 
°C for 30 min then concentrated under reduced pressure and the solid mass so obtained was 
dried under reduced pressure (ca. 6 mm Hg). The resulting solid was loaded onto the top of a 
flash chromatography column comprised of alumina and this was subsequently eluted with 
CH2Cl2. Concentration of the relevant fractions (Rf = 0.5, 1:1 v/v EtOAc/hexane) then afforded 
the title dienone 115 (179 mg, 76%) as a clear, colourless oil. 
 
1
H NMR (600 MHz) $ 5.89 (s, 2H), 5.17 (s, 1H), 3.65 (s, 3H), 2.80 (dd, J = 7.5 and 3.9 Hz, 
1H), 2.70 (m, 1H), 2.55 (dd, J = 6.3 and 4.2 Hz, 1H), 2.46–2.36 (complex m, 2H), 2.29 (ddd, J 
= 7.5, 3.6 and 0.6 Hz, 1H), 1.68–1.56 (complex m, 1H), 1.38 (s, 3H), 1.30 (t, J = 6.0 Hz, 1H), 
1.17 (s, 3H). 
13
C NMR (125 MHz) $ 197.6 (C), 189.3 (C), 177.9 (C), 153.6 (C), 123.5 (CH), 113.3 (CH2), 
54.9 (C), 52.1 (CH3), 51.7 (C), 48.1 (CH), 46.4 (CH2), 44.9 (CH), 37.0 (CH2), 32.3 (CH2), 24.5 
(CH3), 23.4 (CH3). 
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IR !max 2962, 2925, 1727, 1701, 1622, 1466, 1374, 1307, 1256, 1196, 1165, 1094, 860 cm
#1. 
Mass spectrum (EI, 70 eV) m/z 260 (M+•, 65%), 247 (21), 232 (27), 202 (100), 201 (90), 200 
(93), 132 (68), 121 (65), 91 (67). 
HREIMS Found: M+•, 260.1417. C16H20O3 requires M
+•, 260.1412. 
Optical Rotation [%]D = +91 (c 0.3, CHCl3) [lit.
72 [%]D = +76.9 (c 0.4, CHCl3) for 80% ee 
material].  
 
The data presented above matched the equivalent spectral information reported in the 
literature.72 
 
(2S,3aR,3bS,7aS)-2,3b-Dimethyl-4-methylene-5-oxo-2,3,3a,3b,4,5,7,7a-octahydro-1H-
cyclopenta[a]pentalene-2-carboxylic acid (136) 
 
LiI, DMF,
reflux, 34 h
MeO2C
H
H
O
115
HO2C
H
H
O
136  
 
A solution of ester 115 (101 mg, 0.39 mmol) and anhydrous lithium iodide (780 mg, 5.83 
mmol) in DMF (15 mL) was heated at reflux for 34 h then cooled and diluted with water (15 
mL). The ensuing mixture was acidified with HCl (10% w/w aqueous solution) to pH 1–2 and 
then extracted with Et2O (5 " 30 mL). The combined organic fractions were washed with water 
(10 mL) then dried (MgSO4), filtered and concentrated under reduced pressure. The resulting 
light-yellow oil was subject to flash column chromatography (silica, 1:1 v/v EtOAc/hexane 
elution) to afford two fractions, A and B. 
 
Concentration of fraction A (Rf = 0.5, 1:1 v/v EtOAc/hexane) afforded the starting ester 115 (23 
mg, 22% recovery) as a clear, colourless oil. This material was identical, in all respects, with 
authentic material. 
 
Concentration of fraction B (Rf = 0.2, 1:1 v/v EtOAc/hexane) afforded the title acid 136 (69 mg, 
73% at 78% conversion) as white needles, m.p. = 137–143 ºC (with decomposition) (lit.64 m.p. 
= 113–115 °C). 
 
1
H NMR (500 MHz) $ 5.90 (d, J = 0.9 Hz, 1H), 5.89 (s, 1H), 5.16 (s, 1H), 2.86–2.72 (complex 
m, 2H), 2.55 (ddd, J = 7.5, 4.2 and 0.9 Hz, 1H), 2.50–2.36 (complex m, 2H), 2.30 (m, 1H), 1.61 
(dd, J = 7.5 and 4.8 Hz, 1H), 1.41 (s, 3H), 1.33 (t, J = 6.9 Hz, 1H), 1.17 (s, 3H) (signal due to 
carboxylic acid proton not observed). 
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13
C NMR (125 MHz) $ 197.7 (C), 189.3 (C), 183.7 (C), 153.5 (C), 123.5 (CH), 113.5 (CH2), 
54.7 (C), 51.7 (C), 48.1 (CH), 46.2 (CH2), 44.8 (CH), 36.8 (CH2), 32.3 (CH2), 24.3 (CH3), 23.4 
(CH3). 
IR !max 2965, 1698, 1646, 1614, 1468, 1404, 1307, 1257, 1197, 1156, 941, 861 cm
#1. 
Mass spectrum (EI, 70 eV) m/z 246 (M+•, 100%), 218 (31), 201 (62), 200 (43), 132 (40), 91 
(57). 
HREIMS Found: M+•, 246.1256. C15H18O3 requires M
+•, 246.1256. 
Optical Rotation [%]D = +77 (c 0.7, CHCl3) [lit.
71 [%]D = +74 (c 0.4, CHCl3)]. 
 
The data presented above matched the equivalent spectral information reported in the 
literature.64,71,72 
 
(1aS,3aR,3bR,5S,6aR,7aS)-3a,5-Dimethyl-3-methylene-2-oxodecahydrocyclopenta-
[4,5]pentaleno[1,6a-b]oxirene-5-carboxylic acid {(–)-complicatic acid [(-)-83]} 
 
H
H
HO2C
O
136
H
H
HO2C
O
O
(-)-83
H2O2, NaOH, H2O/MeOH,
-50 to -30 ºC, 45 min
 
 
Following a procedure established by Ikegami et al.,72 a solution of acid 136 (27 mg, 0.11 
mmol) in MeOH (1.5 mL) was cooled to #50 °C and treated with hydrogen peroxide (110 µL of 
a 30% w/v aqueous solution, 0.33 mmol) then NaOH (330 µL of a 1.0 M aqueous solution, 0.33 
mmol). The ensuing mixture was warmed to #36 °C over a period of 45 min, poured into NH4Cl 
(5 mL of a saturated aqueous solution) and extracted with Et2O (3 " 5 mL). The combined 
organic fractions were washed with brine (2 mL) then dried (MgSO4), filtered and concentrated 
under reduced pressure to give a pale-yellow oil. Subjection of this material to flash column 
chromatography (silica, 1:1 v/v EtOAc/hexane elution) and concentration of the relevant 
fractions (Rf = 0.3, 1:1 v/v EtOAc/hexane) gave (–)-complicatic acid [(-)-83] (10 mg, 35%) as a 
clear, colourless oil. 
 
1
H NMR (300 MHz) $ 6.08 (s, 1H), 5.30 (s, 1H), 3.44 (s, 1H), 2.74 (m, 1H), 2.56 (ddd, J = 7.8, 
4.5 and 3.9 Hz, 1H), 2.44 (m, 1H), 2.10–1.96 (complex m, 3H), 1.59 (dd, J = 7.8 and 5.4 Hz, 
1H), 1.42 (s, 3H), 1.29 (t, J = 14.7 Hz, 1H), 1.19 (s, 3H) (signal due to carboxylic acid proton 
not observed). 
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13
C NMR (75 MHz) $ 197.7 (C), 183.7 (C), 152.6 (C), 120.5 (CH2), 76.4 (C), 60.9 (CH), 53.2 
(C), 49.6 (CH), 46.4 (C), 46.0 (CH2), 39.2 (CH), 36.8 (CH2), 29.7 (CH2), 24.1 (CH3), 17.4 
(CH3). 
IR !max 2966, 1729, 1697, 1637, 1469, 1407, 1312, 1227, 1159, 1098, 944, 794, 750 cm
#1. 
Mass spectrum (EI, 70 eV) m/z 262 (M+•, 4%), 205 (70), 159 (42), 105 (100), 77 (41). 
HREIMS Found: M+•, 262.1215. C15H18O4 requires M
+•, 262.1205. 
Optical Rotation [%]D = #77 (c 0.3, CHCl3) [lit.
54 [%]D = #79 (c 1.1, CHCl3)]. 
 
The data presented above matched the equivalent spectral information reported in the 
literature.72 
 
(1aR,2R,3aR,3bR,5S,6aR,7aS)-2-Hydroxy-3a,5-dimethyl-3-methylenedecahydro-
cyclopenta[4,5]pentaleno[1,6a-b]oxirene-5-carboxylic acid [(+)-hirsutic acid (82)] 
 
H
H
HO2C
O
136
H
H
HO2C
OH
O
(+)-82
1.  H2O2, NaOH, H2O/ 
     EtOH, -35 ºC, 4 h
2.  NaBH4, EtOH,
     -35 to 0 ºC, ca. 1 h
 
 
Following a procedure established by Greene et al.,71 a solution of acid 136 (25 mg, 0.10 mmol) 
in EtOH (1.5 mL) was cooled to -35 °C and treated with hydrogen peroxide (100 µL of a 30% 
w/v aqueous solution, 0.30 mmol) then NaOH (300 µL of a 1.0 M aqueous solution, 0.30 
mmol). The reaction mixture was stirred at -35 °C for 4 h then EtOH (1.5 mL) and sodium 
borohydride (72 mg, 1.90 mmol) were added to the reaction mixture which was gradually 
warmed to 0 °C and then diluted with water (5 mL) followed by CH2Cl2 (5 mL). The ensuing 
mixture was then acidified with HCl (2% w/v aqueous solution). The separated aqueous phase 
was extracted with CH2Cl2 (3 " 10 mL) and the combined organic phases were then dried 
(MgSO4), filtered and concentrated under reduced pressure to give a pale-yellow oil. Subjection 
of this material to flash column chromatography (silica, 8:2:1 v/v/v hexane/EtOAc/acetic acid 
elution) afforded a white solid (Rf = 0.1, 1:1 v/v EtOAc/hexane). Recrystallization 
(CH2Cl2/cyclohexene) of this material afforded (+)-hirsutic acid (82) (12 mg, 46%) as white 
needles, m.p. = 168–171 ºC (lit.72 m.p. = 170 ºC). 
 
1
H NMR (600 MHz) $ 5.27 (s, 1H), 5.00 (s, 1H), 4.60 (s, 1H), 3.47 (s, 1H), 2.65 (m, 1H), 2.49 
(dd, J = 6.0 and 3.9 Hz, 1H), 2.34 (m, 1H), 2.27 (m, 1H), 1.88 (m, 2H), 1.49 (dd, J = 6.6 and 4.5 
Hz, 1H), 1.38 (s, 3H), 1.21 (m, 1H), 1.04 (s, 3H) (signals due to carboxylic acid and hydroxyl 
protons not observed). 
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13
C NMR (75 MHz) $ 183.4 (C), 158.4 (C), 111.9 (CH2), 75.3 (C), 74.0 (CH), 63.6 (CH), 53.1 
(C), 48.5 (C), 48.4 (CH), 46.3 (CH2), 39.2 (CH), 36.5 (CH2), 29.9 (CH2), 24.1 (CH3), 17.0 
(CH3). 
IR !max 3397 (broad), 2965, 2071, 1698, 1468, 1438, 1405, 1378, 1310, 1260, 1217, 1168, 
1099, 1066, 1029, 1000, 916, 888, 684 cm#1. 
Mass spectrum (EI, 70 eV) m/z 264 (M+•, 20%), 189 (100), 138 (90), 105 (67), 81 (60), 43 
(63). 
HREIMS Found: M+•, 264.1367. C15H20O4 requires M
+•, 264.1362. 
Optical Rotation [%]D = +113 (c 0.2, CHCl3) [lit.
54 [%]D = +116 (c 1.05, CHCl3)]. 
 
The data presented above matched the equivalent spectral information reported in the 
literature.64,71,72 
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5.3 Experimental Procedures for Chapter Three 
 
Triethyl[(1-vinylprop-2-en-1-yl)oxy]silane (200) 
 
imidazole, TESCl,
DMF, 0 to 18 ºC, 1 h OTESOH
199 200  
 
Following a procedure established by Oppolzer et al.,123 a solution of 1,4-pentadiene-3-ol (199) 
(2.30 mL, 23.7 mmol) and imidazole (1.94 g, 28.5 mmol) in DMF (2 mL) was cooled to 0 ºC 
then chlorotriethylsilane (4.40 mL, 26.2 mmol) was added dropwise. The ensuing mixture was 
warmed to 18 ºC and stirred at this temperature for 1 h then poured into water (10 mL). The 
mixture was extracted with pentane (3 x 50 mL) and combined organic fractions were washed 
with water (2 x 20 mL) and brine (20 mL) then dried (Na2SO4), filtered and carefully 
concentrated under reduced pressure to give title silyl ether 200 (4.51 g, 96%) as a clear, 
colourless oil (Rf = 0.8, 1:1 v/v EtOAc/hexane). This material was sufficiently pure to be used in 
the next step of the reaction sequence without further purification. 
 
1
H NMR (300 MHz) ( 5.83 (ddd, J = 17.2, 10.2 and 5.5 Hz, 2H), 5.22 (dt, J = 17.2 and 1.5 Hz, 
2H), 5.07 (dt, J = 10.3 and 1.4 Hz, 2H), 4.60 (m, 2H), 0.96 (m, 9H), 0.62 (m, 6H). 
 
The data presented above as well as all the other data acquired on this compound matched those 
reported in the literature.123 
 
Triethyl({1-[2-(tributylstannyl)ethyl]prop-2-en-1-yl}oxy)silane (194) 
 
200 194
s-BuLi, n-Bu3SnCl,
THF, -78 ºC, 1.5 hOTES
Bu3Sn
OTES
 
 
Following a procedure established by Fuchs et al.,122 a solution of s-BuLi (13.7 mL of a 1.4 M 
solution in cyclohexane, 19.2 mmol) was added dropwise to a solution of silyl ether 200 (3.46 g, 
17.4 mmol) in THF (11.5 mL) that had been cooled to -78 ºC. After the reaction mixture had 
been stirred at this temperature for 30 min tri-n-butyltin chloride (5.0 mL, 18.4 mmol) was 
added slowly. The reaction was allowed to stir for 1 h at -78 ºC then poured into NH4Cl (20 mL 
of a saturated aqueous solution). The mixture was then extracted with CH2Cl2 (3 x 50 mL) and 
the combined organic fractions were washed with brine (20 mL), dried (Na2SO4), filtered and 
concentrated under reduced pressure to give a colourless oil. Purification of this material by 
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flash column chromatography (silica, hexane elution) and concentration of the appropriate 
fractions (Rf = 0.5, hexane) gave the title silyl enol ether 194 (6.87 g, 81%) as a clear, colourless 
oil. 
 
1
H NMR (300 MHz) ( 6.11 (dd, J = 17.0 and 10.7 Hz, 1H), 5.09 (d, J = 16.9 Hz, 1H), 4.94 (t, J 
= 9.3 Hz, 1H), 4.76 (d, J = 10.6 Hz, 1H), 1.75 (d, J = 9.2 Hz, 1H), 1.46 (m, 6H), 1.28 (m, 6H), 
1.00 (m, 9H), 0.87 (m, 15H), 0.71 (m, 6H). 
 
The data presented above as well as all the other data acquired on this compound matched those 
reported in the literature.122 
 
(3aS,7aS)-4-Iodo-2,2-dimethyl-3a,7a-dihydro-1,3-benzodioxole (190) 
 
88 190
I
O
O
I
OH
OH
18 oC, 1h
2,2-DMP, p-TsOH•H2O,
 
 
A solution of (1S,2S)-3-iodocyclohexa-3,5-diene-1,2-diol (88) (1.00 g, 4.20 mmol) in 
2,2-dimethoxypropane (20 mL) was treated with p-TsOH•H2O (ca. 30 mg, 0.16 mmol) then 
stirred at 18 ºC for 1 h before being quenched with triethylamine (0.5 mL) and concentrated 
under reduced pressure. The resultant brown residue was partitioned between water (20 mL) 
and Et2O (50 mL) and the separated aqueous phase was extracted with Et2O (2 x 100 mL). The 
combined organic phases were washed with NaOH (50 mL of a 2.0 M solution) and brine (50 
mL) then dried (Na2SO4), filtered and concentrated under reduced pressure (temp. = 30 ºC) to 
give title acetonide 190 (1.06 g, 91%) as a pale yellow oil (Rf = 0.6, 3:7 v/v EtOAc/hexane). 
This material was sufficiently pure to be used in the next step of the reaction sequence without 
further purification. 
 
1
H NMR (300 MHz) ( 6.63 (d, J = 6.0 Hz, 1H), 6.03 (dd, J = 9.6 and 4.1 Hz, 1H), 5.76 (dd, J = 
9.6 and 6.0 Hz, 1H), 4.74 (d, J = 8.5 Hz, 1H), 4.63 (dd, J = 8.5 and 4.1 Hz, 1H), 1.45 (s, 3H), 
1.43 (s, 3H). 
 
The data presented above as well as all the other data acquired on this compound matched those 
reported in the literature.194 
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(3aR,7aS)-4-Butyl-2,2-dimethyl-3a,7a-dihydro-1,3-benzodioxole (203) 
 
190 203
1. t-BuLi, ZnCl2, THF,
    -78 to 18 oC, 1 h
2. Pd(PPh3)4,THF,
    18 oC, 2 h
O
O
I
I
O
O
+
204  
 
A solution of iodobutane (204) (80 µL, 0.70 mmol) in THF (3.5 mL) was cooled to -78 ºC then 
treated dropwise with t-BuLi (0.91 mL of a 1.7 M solution in pentane, 1.55 mmol). After 
stirring for 20 min, the reaction mixture was treated with ZnCl2 (1.0 M solution of freshly fused 
ZnCl2 in THF, 0.77 mL, 0.77 mmol) then warmed to 18 ºC and stirred at this temperature for  
1 h to give a cloudy white solution. A solution of acetonide 190 (195 mg, 0.70 mmol) and 
Pd(PPh3)4 (81 mg, 0.07 mmol) in THF (3.5 mL) was added to the reaction mixture which was 
then stirred at 18 ºC for a further 2 h before being quenched by addition of water (15 mL) and 
Et2O (30 mL). The separated aqueous phase was extracted with Et2O (2 x 30 mL) and combined 
organic fractions were washed with water (20 mL), and brine (20 mL) then dried (Na2SO4), 
filtered and concentrated under reduced pressure. Purification by flash column chromatography 
(silica, 1:9 v/v EtOAc/hexane gradient elution) and concentration of the appropriate fractions  
(Rf = 0.4, 1:9 v/v EtOAc/hexane) gave title compound 203 (94.7 mg, 65%) as a clear, colourless 
oil.  
 
1
H NMR (300 MHz) ( 5.97 (dd, J = 9.8 and 5.7 Hz, 1H), 5.77 (dd, J = 9.8 and 3.9 Hz, 1H), 
5.71 (d, J = 5.7 Hz, 1H), 4.65 (dd, J = 8.5 and 3.9 Hz, 1H), 4.53 (d, J = 8.5 Hz, 1H), 2.22 (m, 
2H), 1.56–1.22 (complex m, 4H), 1.41 (s, 3H), 1.38 (s, 3H), 0.92 (t, J = 7.3 Hz, 3H). 
13
C NMR (75 MHz) ( 138.8 (C), 124.8 (CH), 122.4 (CH), 118.1 (CH), 105.2 (C), 73.5 (CH), 
71.3 (CH), 33.3 (CH2), 29.4 (CH2), 26.9 (CH3), 25.1 (CH3), 22.5 (CH2), 13.9 (CH3). 
IR &max 3046, 2958, 2931, 2872, 1466, 1378, 1368, 1236, 1217, 1159, 1051, 870 cm
-1. 
Mass spectrum (EI, 70 eV) 208 (M+•, 3%), 205 (6), 193 [(M – CH3•)
+, 11%], 150 (60), 121 
(22), 107 (100), 94 (75), 77 (40), 57 (38), 43 (47). 
HREIMS Found: M+•, 208.1468. C13H20O2 requires M
+•, 208.1463; 
Found: [(M – CH3•)
+, 193.1228. C13H20O2 requires [(M – CH3•)
+, 193.1229. 
Optical Rotation [$]D = +125 (c 1.6, CHCl3). 
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Ethyl 5-(benzyloxy)-3-oxopentanoate (210) 
 
Method 1: 
 
1. NaH, then n-BuLi,
    THF, -5 ºC, 20 min
2. BOMCl, THF,
    0 ºC, 2 h
209
O
OEt
O
BnO
210
OEt
O
O
 
 
Following a procedure established by Taylor et al.,129 a suspension of sodium hydride (1.10 g, 
27.5 mmol) in THF (20 mL) maintained at -5 ºC was treated with ethyl acetoacetate (209) (3.20 
mL, 25.1 mmol) in a dropwise manner. The reaction mixture was then stirred for 10 min at -5 
ºC before being treated with n-BuLi (16.8 mL of a 1.6 M solution in THF, 26 mmol) and stirred 
at -5 ºC for a further 10 min. A solution of benzyl chloromethyl ether (ca. 60%, 8.74 mL, 37.7 
mmol) in THF (10 mL) was then added and the mixture was stirred at 0 ºC for 2 h before being 
poured into NaCl (50 mL of a saturated aqueous solution). The mixture was acidified by 
addition of HCl (15 mL of a 10% aqueous solution) then extracted with Et2O (3 x 25 mL). The 
combined organic fractions were dried (Na2SO4), filtered and concentrated under reduced 
pressure to give the crude product as a yellow oil. Purification of tis material by flash column 
chromatography (silica, 1:9 7 3:7 v/v EtOAc/hexane gradient elution) and concentration of the 
appropriate fractions (Rf = 0.3, 3:7 v/v EtOAc/hexane) gave the title compound 210 (2.89 g, 
46%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( 7.32 (m, 5H), 4.51 (s, 2H), 4.18 (q, J = 7.1 Hz, 2H), 3.75 (t, J = 6.2 Hz, 
2H), 3.48 (s, 2H), 2.83 (t, J = 6.2 Hz, 2H), 1.27 (t, J = 7.1 Hz, 3H). 
 
The data presented above as well as all the other data acquired on this compound matched those 
reported in the literature.130 
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Method 2: 
 
BnO BnO
212211
OHO
oxalyl chloride, 
DMSO, CH2Cl2,
 -78 ºC, 45 min
ethyl diazoacetate, 
SnCl2, CH2Cl2,
18 ºC, 16 h O
OEt
O
BnO
210  
 
Following a procedure established by Heathcock et al.,130 a solution of oxalyl chloride (3.10 
mL, 35.5 mmol) in CH2Cl2 (50 mL) was cooled to -78 ºC and dimethyl sulfoxide (3.30 mL, 46.6 
mmol) was added over 15 min. After stirring for a further 15 min a solution of 3-(benzyloxy)-1-
propanol (211) (3.90 mL, 24.5 mmol) in CH2Cl2 (5 mL) maintained at -78 ºC was added via 
cannula. After 45 min triethylamine (13.0 mL, 93.3 mmol) was added and the ensuing mixture 
was warmed to 18 ºC and stirred at this temperature for 1 h. The reaction mixture was then 
poured into water (100 mL) and the separated aqueous phase was extracted with Et2O (150 mL). 
The combined organic fractions were washed with water (2 x 50 mL) and brine (50 mL) then 
dried (Na2SO4), filtered and concentrated under reduced pressure to give aldehyde 212 (4.12 g). 
This material was sufficiently pure to be used in the next step of the reaction sequence without 
further purification. 
 
1
H NMR (300 MHz) ( 9.80 (t, J = 1.8 Hz, 1H), 7.34 (m, 5H), 4.54 (s, 2H), 3.82 (t, J = 6.1 Hz, 
2H), 2.70 (td, J = 6.1 and 1.8 Hz, 2H). 
 
The data presented above as well as all the other data acquired on this compound matched those 
reported in the literature.195 
 
The crude aldehyde 212 (assumed 24.5 mmol), obtained as described immediately above, was 
dissolved in CH2Cl2 (60 mL) and the resuling solution was treated with SnCl2 (884 mg, 4.66 
mmol) then ethyl diazoacetate (2.7 mL, 25.7 mmol) over 25 min. The resulting exotherm was 
controlled by using a water bath maintained at 18 ºC. After 16 h the reaction mixture was 
poured into HCl (100 mL of a 1.0 M aqueous solution) and extracted with Et2O (150 mL). The 
separated organic phase was washed with HCl (50 mL of a 1.0 M aqueous solution) and brine 
(50 mL) then dried (Na2SO4), filtered and concentrated under reduced pressure to give an 
orange oil. Purification by flash column chromatography (silica, 1:9 7 3:7 v/v EtOAc/hexane 
gradient elution) and concentration of the appropriate fractions (Rf = 0.3, 3:7 v/v EtOAc/hexane) 
gave title compound 210 (3.37 g, 55% over two steps). This material was identical, in all 
respects, with material obtained via method 1.  
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Ethyl 5-hydroxy-3-oxopentanoate (213) 
 
O
OEt
O
HO
213
O
OEt
O
BnO
210
Pd(OH)2/C, H2, EtOH,
18 ºC, 22 h
 
 
A solution of benzyl ether 210 (2.89 g, 11.5 mmol) in EtOH (50 mL) was treated with 20% 
palladium hydroxide on carbon (480 mg) and the resulting suspension was stirred at 18 °C 
under a hydrogen atmosphere (1 atm) for 22 h. The reaction mixture was filtered through a pad 
of CeliteTM (approx 5 cm thick) and the retained solids were washed with EtOH (2 x 20 mL) and 
EtOAc (2 x 20 mL). The combined filtrates were concentrated under reduced pressure to give 
the title alcohol 213 (1.76 g, 95%) as a clear, colourless oil (Rf = 0.2, 1:1 v/v EtOAc/hexane).  
 
1
H NMR (300 MHz) ( 4.19 (q, J = 7.2 Hz, 2H), 3.86 (dt, J = 6.2 and 5.5 Hz, 2H), 3.48 (s, 2H), 
2.80 (t, J = 5.5 Hz, 2H), 2.45 (br t, J = 6.2 Hz, 1H), 1.27 (t, J = 7.2 Hz, 3H). 
 
The data presented above matched the equivalent spectral information reported in the 
literature.129 In addition, the following data were acquired on this compound, particularly 
because such spectral information is not available in the literature.  
 
13
C NMR (75 MHz) ( 203.4 (C), 166.9 (C), 61.5 (CH2), 57.5 (CH2), 49.6 (CH2), 44.9 (CH2), 
14.0 (CH3). 
IR &max 3418, 2982, 2939, 2904, 1740, 1713, 1467, 1446, 1410, 1369, 1316, 1265, 1198, 1148, 
1095, 1031, 921, 850, 648, 588 cm-1. 
Mass spectrum (EI, 70 eV) m/z 160 (M+•, 2%), 115 (24), 88 (19), 73 (66), 69 (14), 60 (18), 55 
(51), 43 (100). 
HREIMS Found: M+•, 160.0738. C7H12O4 requires M
+•, 160.0736. 
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Ethyl 2-(2,2-dimethyl-1,3-dioxan-4-ylidene)acetate (214) and ethyl (2,2-dimethyl-4H-1,3-
dioxin-6-yl)acetate (215) 
 
+
O
OEt
O
HO O
O
OEt
O
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O
OEt
O
213 215214
1 11:
THF, 0 to 18 oC, 3 days
2-methoxypropene, PPTS,
 
 
A procedure established by Funk et al.,127 was adapted such that a solution of alcohol 213 (2.67 
g, 16.7 mmol) in THF (55 mL) was cooled to 0 ºC then treated with 2-methoxypropene (97%, 
5.0 mL, 50.6 mmol) and pyridinium p-toluenesulfonate (1.26 g, 5.01 mmol). The ensuing 
mixture was allowed to warm to 18 ºC and stirred at this temperature for 3 days after which 
time solid Na2CO3 (5 g) was added. The resulting mixture was stirred at 18 ºC for 1 h then 
filtered and the retained solids were washed with dry Et2O (3 x 20 mL). The combined filtrates 
were concentrated under reduced pressure and the crude product was subjected to flash column 
chromatography (silica, 1:4 v/v EtOAc/hexane elution). Concentration of the appropriate 
fractions (Rf = 0.6, 3:7 v/v EtOAc/hexane) gave an inseparable mixture (1:11) of the title 
compounds 214 and 215 (2.48 g, 74%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( (215, major isomer) 4.79 (t, J = 2.7 Hz, 1H), 4.21 (m, 2H), 4.15 (q, J = 
7.2 Hz, 2H), 3.04 (m, 2H), 1.46 (s, 6H), 1.25 (t, J = 7.2 Hz, 3H); (214, minor isomer) 5.32 (t, J 
= 1.2 Hz, 1H), 4.11 (q, J = 7.2 Hz, 2H), 3.96 (t, J = 6.3 Hz, 2H), 3.07 (dd, J = 6.3 and 1.5 Hz, 
2H), 1.48 (s, 6H), 1.26 (t, J = 7.2 Hz, 3H). 
 
The 1H NMR spectral data derived from compound 215 were in agreement with those reported 
in the literature.127 
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2-(2,2-Dimethyl-1,3-dioxan-4-ylidene)ethanol (216) and 2-(2,2-dimethyl-4H-1,3-dioxin-6-
yl)ethanol (217) 
 
LiAlH4, Et2O,
0 oC, 30 min
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Following a procedure established by Funk et al.,127 a suspension of LiAlH4 (708 mg, 18.6 
mmol) in Et2O (115 mL) was cooled to 0 ºC and a solution of esters 214 and 215 (2.48 g, 12.4 
mmol) in Et2O (10 mL) was then added dropwise over 10 min. The ensuing mixture was stirred 
at 0 ºC for 30 min then quenched, successively, with water (1 mL), NaOH (1.1 mL of a 10% w/v 
aqueous solution) and water (2.2 mL). The resulting suspension was filtered, the retained solids 
washed with Et2O (3 x 50 mL) and then the combined filtrates were concentrated under reduced 
pressure. Purification of the ensuing yellow oil by flash column chromatography (silica, 2:3 v/v 
EtOAc/hexane elution) and concentration of the appropriate fractions (Rf = 0.3, 1:1 v/v 
EtOAc/hexane) gave the title alcohol 217 (1.76 g, 90%) as a clear, colourless oil. Alcohol 216 
was never isolated in significant quantities.  
 
1
H NMR (300 MHz) ( 4.71 (t, J = 2.6 Hz, 1H), 4.19 (m, 2H), 3.74 (q, J = 5.9 Hz, 2H), 2.29 (t, J 
= 6.0 Hz, 2H), 1.83 (t, J = 5.9 Hz, 1H), 1.45 (s, 6H) (OH proton resonances not observed). 
 
The data presented above as well as all the other data acquired on this compound matched those 
reported in the literature.127 
 
6-(2-Iodoethyl)-2,2-dimethyl-4H-1,3-dioxine (207) 
 
217 207
O
O
OH
O
O
I
imidazole, polymer-PPh3,
I2, THF, 0 to 18 
oC, 1 h
 
 
A procedure established by Funk et al.,127 was adapted such that a solution of alcohol 217 (208 
mg, 1.31 mmol) in THF (12.5 mL) was cooled to 0 ºC and treated with imidazole (202 mg, 2.96 
mmol), polymer bound triphenylphosphine (3 mmol/g, 878 mg, 2.63 mmol) and molecular 
iodine (669 mg, 2.63 mmol). The ensuing mixture was allowed to warm to 18 ºC and stirred at 
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this temperature for a further 1 h then poured into Na2S2O3 (10 mL of a 10% w/v aqueous 
solution). The resulting mixture was extracted with Et2O (3 x 30 mL) and the combined organic 
fractions were washed with brine (10 mL) then dried (Na2SO4), filtered and concentrated under 
reduced pressure (water bath kept at 5–10 ºC, protect from light) to afford iodo-dioxin 207 (255 
mg, 73%) as an unstable colourless oil (Rf = 0.7, 1:1 v/v EtOAc/hexane). This material was used 
immediatly in the next step of the reaction sequence. 
 
1
H NMR (300 MHz) ( 4.71 (t, J = 2.6 Hz, 1H), 4.18 (m, 2H), 3.26 (t, J = 7.1 Hz, 2H), 2.58 (t, J 
= 7.1 Hz, 2H), 1.46 (s, 6H). 
 
The data presented above as well as all the other data acquired on this compound matched those 
reported in the literature.127 
 
Methyl 5-hydroxy-5-methyl-3-oxohexanoate (219) 
 
218
O
HO
O
O
OMe
HO
219
1. LDA, THF, -78 
    to 18 oC, 30 min
2. NCCO2Me, THF,
    -78 oC, 15 min
 
 
A solution of diisopropylamine (3.0 mL, 21.4 mmol) in THF (20 mL) was cooled to -78 ºC then 
treated with n-BuLi (12.5 mL of a 1.6 M solution in hexanes, 20.0 mmol) in a dropwise manner. 
After 15 min 4-hydroxy-4-methyl-2-pentanone (218) (1.1 mL, 8.82 mmol) was added dropwise 
and the ensuing reaction mixture was stirred at -78 ºC for 10 min then warmed to 18 ºC and 
stirred for a further 15 min at this temperature. The resultant solution was re-cooled to -78 ºC 
then treated with methyl cyanoformate (720 µL, 9.07 mmol) in THF (20 mL) and stirred for 15 
min before being diluted with HCl to a pH of <1 (3.0 M aqueous solution, ca. 10 mL). The 
ensuing mixture was extracted with Et2O (3 x 30 mL) and the combined organic extracts were 
washed with water (20 mL) and brine (20 mL) before being dried (Na2SO4), filtered and 
concentrated under reduced pressure to give a yellow liquid. Purification of this material by 
flash column chromatography (silica, 3:7 v/v EtOAc/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.2, 1:1 v/v EtOAc/hexane) gave the title keto-alcohol 219 (789 mg, 
50%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( 3.74 (s, 3H), 3.48 (s, 2H), 2.73 (s, 2H), 1.27 (s, 6H) (OH proton 
resonances not observed). 
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13
C NMR (75 MHz) ( 204.3 (C), 167.3 (C), 69.7 (C), 53.6 (CH2), 52.5 (CH3), 50.3 (CH2), 29.3 
(CH3). 
IR &max 3511, 2974, 1746, 1708, 1653, 1631, 1438, 1378, 1325, 1258, 1171, 1073, 1018 cm
-1
. 
Mass spectrum (EI, 70 eV) m/z 159 [(M – CH3•)
+, 10%], 127 (16), 116 (16), 101 (16), 83 (25), 
59 (58), 55 (25), 43 (100). 
HREIMS Found: (M – CH3•)
+, 159.0660. C8H14O4 requires (M – CH3•)
+, 159.0657. 
 
Methyl 2-(2,2,6,6-tetramethyl-1,3-dioxan-4-ylidene)acetate (221) and methyl (2,2,4,4-
tetramethyl-4H-1,3-dioxin-6-yl)acetate (222)  
 
O
O
OMe
HO
219
THF, 0 to 18 oC, 3 days
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A solution of alcohol 219 (2.37 g, 13.6 mmol) in THF (45 mL) was cooled to 0 ºC and treated 
with 2-methoxypropene (97%, 4.5 mL, 42.9 mmol) and pyridinium p-toluenesulfonate (1.03 g, 
4.09 mmol). The ensuing mixture was allowed to warm to 18 ºC and stirred at this temperature 
for 3 days after which time solid Na2CO3 (5 g) was added. The resulting mixture was stirred at 
18 ºC for 1 h then filtered and the retained solids washed with dry Et2O (3 x 20 mL). The 
combined filtrates were concentrated under reduced pressure and the crude product was 
subjected to flash column chromatography (silica, 1:9 v/v EtOAc/hexane elution). Concentration 
of the appropriate fractions (Rf = 0.5, 3:7 v/v EtOAc/hexane) gave an inseparable mixture (1:2) 
of the title compounds 221 and 222 (2.02 g, 69%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( (222, major isomer) 4.85 (s, 1H), 3.70 (s, 3H), 3.05 (s, 2H), 1.48 (s, 6H), 
1.31 (s, 6H); (221, minor isomer) 5.37 (s, 1H), 3.66 (s, 3H), 3.23 (s, 2H), 1.49 (s, 6H), 1.31 (s, 
6H). 
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2-(2,2,4,4-Tetramethyl-4H-1,3-dioxin-6-yl)ethanol (224) and 2-(2,2,6,6-tetramethyl-1,3-
dioxan-4-ylidene)ethanol (223) 
 
+
O
O
OMe
O
O
O
OMe
O
O
O
OH
O
O
OH
+
222 221 224 223
LiAlH4, Et2O,
0 oC, 30 min
2 : 1:1 2  
 
A suspension of LiAlH4 (461 mg, 12.1 mmol) in Et2O (90 mL) was cooled to 0 ºC and a 
solution of esters 221 and 222 (2.00 g, 9.34 mmol) in Et2O (5 mL) was added dropwise over 10 
min. The ensuing reaction mixture was stirred at 0 ºC for 30 min then quenched, successively, 
with water (475 µL), NaOH (735 µL of a 10% w/v aqueous solution) and water (1.4 mL). The 
resulting suspension was filtered, the retained solids washed with Et2O (3 x 50 mL) then the 
combined filtrates were concentrated under reduced pressure. The ensuing yellow oil was 
subjected to flash column chromatography (silica, 3:7 7 1:1 v/v EtOAc/hexane gradient 
elution) to afford two fractions, A and B. 
 
Concentration of fraction A (Rf = 0.2, 3:7 v/v EtOAc/hexane) afforded title alcohol 224 (1.15 g, 
66%) as a clear, colourless oil.  
 
1
H NMR (300 MHz) ( 4.77 (m, 1H), 3.74 (q, J = 5.9 Hz, 2H), 2.28 (t, J = 4.6 Hz, 2H), 1.75 (t, J 
= 5.9 Hz, 1H), 1.48 (s, 6H), 1.29 (s, 6H) (OH proton resonances not observed). 
13
C NMR (75 MHz) ( 146.4 (C), 106.6 (CH), 99.2 (C), 71.0 (C), 60.4 (CH2), 37.1 (CH2), 30.4 
(CH3), 26.8 (CH3). 
IR &max 3411, 2974, 2917, 2849, 1693, 1379, 1368, 1344, 1243, 1215, 1201, 1152, 1105, 1044, 
1018, 976, 910, 872, 733 cm-1. 
Mass spectrum (EI, 70 eV) m/z 187 [(M + H)+, 5%], 169 (5), 128 (6), 111 (18), 95 (9), 83 (84), 
73 (25), 59 (32), 55 (42), 43 (100). 
HREIMS Found: (M + H)+, 187.1337. C10H18O3 requires (M + H)
+, 187.1334. 
 
Concentration of fraction B [Rf = 0.1(5), 3:7 v/v EtOAc/hexane] gave the title alcohol 223 (527 
mg, 30%) as a clear, colourless oil.  
 
1
H NMR (300 MHz) ( 5.21 (tt, J = 7.9 and 1.5 Hz, 1H), 4.09 (d, J = 7.9 Hz, 2H), 2.52 (s, 2H), 
1.75 (br s, 1H), 1.45 (s, 6H), 1.29 (s, 6H). 
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13
C NMR (75 MHz) ( 151.2 (C), 105.6 (CH), 101.0 (C), 71.5 (C), 57.6 (CH2), 34.6 (CH2), 30.0 
(CH3), 29.5 (CH3). 
IR &max 3409, 2976, 2936, 2876, 1678, 1380, 1369, 1306, 1241, 1202, 1150, 1097, 1018, 987, 
929, 875 cm-1. 
HREIMS (ES, +ve mode) Found: (M + Na)+, 209.1152. C10H18O3 requires (M + Na)
+, 
209.1154. 
 
6-(2-Iodoethyl)-2,2,4,4-tetramethyl-4H-1,3-dioxine (208) 
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imidazole, polymer-PPh3,
I2, THF, 0 to 18 
oC, 1 h
 
 
A solution of alcohol 224 (169 mg, 0.91 mmol) in THF (10 mL) was cooled to 0 ºC and treated 
with imidazole (154 mg 2.26 mmol), polymer bound triphenylphosphine (3 mmol/g, 603 mg, 
1.81 mmol) and iodine (460 mg, 1.81 mmol). The ensuing mixture was allowed to warm to  
18 ºC and stirred for a futher 1 h then poured into Na2S2O3 (10 mL of a 10% w/v aqueous 
solution). The resulting mixture was extracted with Et2O (3 x 30 mL) and the combined organic 
fractions were washed with brine (10 mL) then dried (Na2SO4), filtered and concentrated under 
reduced pressure (water bath kept at 5–10 ºC, protect from light) to give iodo-dioxin 208 (223 
mg, 83%) as an unstable colourless oil (Rf = 0.6, 3:7 v/v EtOAc/hexane). This material was used 
immediatly in the next step of the reaction sequence. 
 
1
H NMR (300 MHz) ( 4.75 (t, J = 0.7 Hz, 1H), 3.26 (t, J = 7.1 Hz, 2H), 2.55 (t, J = 7.1 Hz, 
2H), 1.48 (s, 6H), 1.30 (s, 6H). 
13
C NMR (75 MHz) ( 146.6 (C), 106.7 (CH), 99.2 (C), 71.0 (C), 38.2 (CH2), 30.2 (CH3), 27.0 
(CH3), 2.5 (CH2). 
IR &max 2971, 2928, 1705, 1618, 1463, 1436, 1368, 1378, 1347, 1314, 1260, 1241, 1217, 1200, 
1171, 1103, 1071, 1023, 976, 907, 868, 806 cm-1. 
Mass spectrum (EI, 70 eV) m/z 239 {[M + H – (CH3)2CO]
+, 74%}, 183 (95), 155 (100), 83 
(64), 71 (19), 59 (38), 55 (60), 43 (55). 
HREIMS Found: [M + H – (CH3)2CO]
+, 238.9937. C10H17O2
127I requires [M + H – 
(CH3)2CO]
+, 238.9933. 
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(3aR,7aS)-4-[2-(2,2-Dimethyl-4H-1,3-dioxin-6-yl)ethyl]-2,2-dimethyl-3a,7a-dihydro-1,3-
benzodioxole (225) 
 
+
1. t-BuLi, ZnCl2, THF,
    -78 to 18 oC, 45 min
2. Pd(PPh3)4,THF,
    18 oC, 2 hI
O
O
O
O
207 225
O
O
I
O
O
190  
 
A solution of iodo-dioxin 207 (255 mg, 0.95 mmol) in THF (5 mL) was treated with ZnCl2 
(1.05 mL of a 1.0 M solution of freshly fused ZnCl2 in THF, 1.05 mmol) then cooled to -78 ºC. 
t-BuLi (1.7 mL of a 1.7 M solution in pentane, 2.89 mmol) was added dropwise and the 
resulting solution allowed to stir at -78 ºC for 15 min then warmed to 18 ºC and stirred at this 
temperature for 30 min. This solution was then added, via cannula, to a solution of vinyl iodide 
190 (175 mg, 0.63 mmol) and Pd(PPh3)4 (58 mg, 0.05 mmol) in THF (5 mL) and the ensuing 
mixture stirred for a further 2 h at 18 ºC then quenched by addition of water (15 mL) and Et2O 
(30 mL). The separated aqueous phase was extracted with Et2O (2 x 30 mL) and the combined 
organic fractions were washed with water (20 mL) and brine (20 mL) then dried (Na2SO4), 
filtered and concentrated under reduced pressure. Purification by flash column chromatography 
(silica, 1:9 v/v EtOAc/hexane elution) and concentration of the appropriate fractions (Rf = 0.3, 
1:9 v/v EtOAc/hexane) gave the title compound 225 (53.3 mg, 29%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( 5.98 (dd, J = 9.6 and 5.5 Hz, 1H), 5.80 (dd, J = 9.6 and 3.7 Hz, 1H), 
5.73 (d, J = 5.5 Hz, 1H), 4.66 (dd, J = 8.6 and 3.7 Hz, 1H), 4.63 (t, J = 2.6 Hz, 1H), 4.55 (d, J = 
8.6 Hz, 1H), 4.18 (m, 2H), 2.41 (m, 2H), 2.26 (m, 2H), 1.44 (s, 6H), 1.41 (s, 3H), 1.39 (s, 3H). 
13
C NMR (75 MHz) ( 150.7 (C), 137.5 (C), 124.7 (CH), 122.8 (CH), 118.6 (CH), 105.3 (C), 
98.6 (C), 93.9 (CH), 73.4 (CH), 71.3 (CH), 59.2 (CH2), 31.6 (CH2), 30.6 (CH2), 26.9 (CH3), 
25.1 (CH3), 24.5 (CH3), 24.3 (CH3). 
IR &max 3043, 2990, 2933, 2840, 1683, 1455, 1370, 1333, 1229, 1204, 1139, 1092, 1024, 978, 
852, 709 cm-1. 
Mass spectrum (EI, 70 eV) m/z 292 (M+•, 12%), 219 (15), 176 (72), 159 (69), 147 (47), 133 
(31), 121 (80), 107 (107), 91 (45), 77(48), 55 (97), 43 (85). 
HREIMS Found: M+•, 292.1677. C17H24O4 requires M
+•, 292.1675. 
Optical Rotation [$]D = +93 (c 0.4, CHCl3). 
 
Chapter Five 186 
(1S,2R)-3-[2-(2,2-Dimethyl-4H-1,3-dioxin-6-yl)ethyl]cyclohexa-3,5-diene-1,2-diol (226) 
 
+
1. t-BuLi, ZnCl2, THF,
    -78 to 18 oC, 45 min
2. Pd(PPh3)4,THF,
    18 oC, 2 h
207 226
I
OH
OH
OH
OH
O
O
I
O
O
88  
 
A solution of iodo-dioxin 207 (281 mg, 1.05 mmol) in THF (5 mL) was treated with ZnCl2 
(1.15 mL of a 1.0 M solution of freshly fused ZnCl2 in THF, 1.15 mmol) then cooled to -78 ºC. 
t-BuLi (1.8 mL of a 1.7 M solution in pentane, 3.06 mmol) was added dropwise and the 
resultant solution was allowed to stir at -78 ºC for 15 min then warmed to 18 ºC and stirred at 
this temperature for 30 min. This solution was then added, via cannula, to a mixture of diol 88 
(166 mg, 0.697 mmol) and Pd(PPh3)4 (80 mg, 0.092 mmol). The ensuing mixture was stirred for 
2 h then quenched by addition of half brine (15 mL) and Et2O (30 mL). The separated aqueous 
phase was extracted with Et2O (4 x 30 mL) and the combined organic fractions were then 
washed with brine (20 mL) then dried (Na2SO4), filtered and concentrated under reduced 
pressure. Purification by flash column chromatography (silica deactivated with 10% w/w water, 
3:7 7 1:1 v/v EtOAc/hexane gradient elution) and concentration of the appropriate fractions  
(Rf = 0.1, 3:7 v/v EtOAc/hexane) gave the title compound 226 (42.2 mg, 24%) as an unstable 
colourless oil. This material was used immediately in the next step of the reaction sequence. 
 
1
H NMR (300 MHz) ( 5.92 (ddd, J = 9.7, 5.0 and 1.5 Hz, 1H), 5.79 (dd, J = 9.7 and 3.4 Hz, 
1H), 5.72 (d, J = 5.0 Hz, 1H), 4.63 (t, J = 2.6 Hz, 1H), 4.30 (br s, 1H), 4.17 (m, 2H), 4.05 (d, J = 
6.0 Hz, 1H), 2.42 (m, 2H), 2.24 (m, 2H), 1.44 (s, 3H), 1.42 (s, 3H) (OH proton resonances not 
observed). 
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(3aR,7aS)-2,2-Dimethyl-4-[2-(2,2,4,4-tetramethyl-4H-1,3-dioxin-6-yl)ethyl]-3a,7a -dihydro-
1,3-benzodioxole (227) 
 
+
1. t-BuLi, ZnCl2, THF,
    -78 to 18 oC, 45 min
2. Pd(PPh3)4,THF,
    18 oC, 2 hI
O
O
O
O
208 227
O
O
I
O
O
190  
 
A solution of iodo-dioxin 208 (223 mg, 0.75 mmol) in THF (4 mL) was cooled to -78 ºC then 
treated dropwise with t-BuLi (0.97 mL of a 1.7 M solution in pentane, 1.65 mmol). After 
stirring at this temperature for 20 min the reaction mixture was treated with ZnCl2 (830 µL of a 
1.0 M solution of freshly fused ZnCl2 in THF, 0.83 mmol) then warmed to 18 ºC and stirred at 
this temperature for 1 h to give a cloudy white solution. A solution of acetonide 190 (140 mg, 
0.50 mmol) and Pd(PPh3)4 (78 mg, 0.07 mmol) in THF (3.5 mL) was then added and the 
resulting mixture was stirred for a futher 2 h then quenched by addition of water (15 mL) and 
Et2O (30 mL). The separated aqueous phase was extracted with Et2O (2 x 30 mL) and combined 
organic fractions were washed with water (20 mL) and brine (20 mL) then dried (Na2SO4), 
filtered and concentrated under reduced pressure. Purification of the resulting yellow oil by 
flash column chromatography (silica, 1:9 v/v EtOAc/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3, 1:9 v/v EtOAc/hexane) gave title compound 227 (69.2 mg, 43%) 
as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( 5.96 (dd, J = 9.8 and 5.6 Hz, 1H), 5.78 (dd, J = 9.8 and 3.9 Hz, 1H), 
5.73 (d, J = 5.6 Hz, 1H), 4.66 (m, 2H), 4.53 (d, J = 8.9 Hz, 1H), 2.40 (m, 2H), 2.21 (m, 2H), 
1.45 (s, 6H), 1.41 (s, 3H), 1.39 (s, 3H), 1.26 (s, 6H). 
13
C NMR (75 MHz) ( 148.4 (C), 137.5 (C), 124.5 (CH), 122.9 (CH), 118.7 (CH), 105.3 (C), 
104.7 (CH), 98.9 (C), 73.4 (CH), 71.4 (CH), 70.9 (C), 31.6 (CH2), 30.6 (CH2), 30.4 (CH3), 26.9 
(CH3), 26.8 (CH3), 25.1 (CH3). 
IR &max 2989, 2934, 1683, 1442, 1378, 1368, 1347, 1242, 1203, 1156, 1105, 1019, 977, 871, 
816, 778, 720 cm-1. 
Mass spectrum (EI, 70 eV) m/z 262 {[M – (CH3)2CO]
+•, 5%}, 204 (41), 189 (15), 149 (47), 
121 (41), 104 (71), 91 (31), 83 (100), 77 (35), 55 (75), 43 (69). 
HREIMS Found: [M – (CH3)2CO]
+•, 262.1566. C19H28O4 requires [M – (CH3)2CO]
+•, 262.1569. 
Optical Rotation [$]D = +101 (c 1.3, CHCl3). 
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(3aS,4S,5aS,8aS,8bR)-2,2-Dimethylhexahydro-4,8a-ethenoindeno[4,5-d][1,3]dioxol-6(4H)-
one (230) and (3aS,4R,5aR,8aR,8bR)-2,2-dimethylhexahydro-4,8a-ethenoindeno[4,5-
d][1,3]dioxol-6(4H)-one (229) 
 
O
O
225
O
O O
O
O
O
O
O
+
229230
reflux, 16 h
BHT, toluene,
PhNEt2,
 
 
A mixture of dioxin 225 (6.3 mg, 0.02 mmol), BHT (1.9 mg, 0.01 mmol) and 
N,N-diethylaniline (50 µL, 0.31 mmol) in toluene (5 mL) was heated at reflux for 16 h then 
cooled and concentrated under reduced pressure. Purification of the ensuing light-yellow oil by 
flash column chromatography (silica, 1:4 7 2:3 v/v EtOAc/hexane gradient elution) afforded 
two fractions, A and B. 
 
Concentration of fraction A (Rf = 0.3, 3:7 v/v EtOAc/hexane) afforded the title syn-adduct 230 
(2.2 mg, 35%) as a white crystalline solid, m.p. = 93–96 ºC. 
 
1
H NMR (300 MHz) ( 6.35 (dd, J = 8.0 and 6.8 Hz, 1H), 5.81 (dd, J = 8.0 and 1.0 Hz, 1H), 
4.08 (ddd, J = 8.0, 4.2 and 0.7 Hz, 1H), 5.81 (dd, J = 8.0 Hz, 1H), 2.84 (m, 1H), 2.66 (ddd, J = 
10.0, 6.1 and 1.7 Hz, 1H), 2.49–2.36 (m, 1H), 2.23–1.95 (complex m, 4H), 1.49 (s, 3H), 1.40 
(ddd, J = 6.1, 2.4 and 1.0 Hz, 1H), 1.35 (s, 3H). 
13
C NMR (75 MHz) ( 217.8 (C), 137.0 (CH), 133.7 (CH), 112.3 (C), 77.1 (CH), 75.0 (CH), 
47.7 (C), 45.9 (CH), 36.2 (CH2), 35.0 (CH), 26.5 (CH3), 25.2 (CH2), 24.4 (CH3), 22.8 (CH2). 
IR &max 2993, 2965, 2932, 2861, 1739, 1450, 1376, 1268, 1209, 1144, 1110, 1069, 1058, 1016, 
872, 723 cm-1. 
Mass spectrum (EI, 70 eV) m/z 234 (M+•, 4%), 219 [(M – CH3•)
+, 50], 205 (37), 176 (85), 159 
(71), 147 (99), 133 (98), 120 (78), 105 (95), 100 (97), 91 (100), 77 (55), 65 (37), 55 (45), 43 
(79). 
HREIMS Found: (M – CH3•)
+, 219.1021. C14H18O3 requires (M – CH3•)
+, 219.1021. 
Elemental Analysis Found: C, 71.50; H, 7.75. C14H18O3 requires C, 71.77; H, 7.74%. 
Optical Rotation [$]D = +128 (c 1.04, CHCl3). 
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Concentration of fraction B (Rf = 0.2, 3:7 v/v EtOAc/hexane) afforded the title anti-adduct 229 
(2.9 mg, 46%) as a white crystalline solid, m.p. = 131–134 ºC. 
 
1
H NMR (300 MHz) ( 6.29 (t, J = 7.3 Hz, 1H), 5.74 (d, J = 8.3 Hz, 1H), 4.28 (ddd, J = 7.1, 2.7 
and 1.0 Hz, 1H), 4.23 (dd, J = 7.1 and 1.0 Hz, 1H), 2.88 (m, 1H), 2.51–2.18 (m, 3H), 1.99–1.88 
(m, 2H), 1.65–1.47 (m, 2H), 1.33 (s, 3H), 1.28 (s, 3H). 
13
C NMR (75 MHz) ( 215.2 (C), 135.7 (CH), 130.7 (CH), 109.1 (C), 83.3 (CH), 79.5 (CH), 
50.1 (CH), 47.5 (C), 36.9 (CH2), 35.7 (CH), 28.4 (CH2), 25.5 (CH3), 24.9 (CH3), 23.5 (CH2). 
IR &max 2986, 2934, 2886, 2865, 1742, 1455, 1378, 1368, 1207, 1142, 1068, 1058, 883, 745, 
717 cm-1. 
Mass spectrum (EI, 70 eV) m/z 234 (M+•, 12%), 219 (70), 176 (91), 147 (98), 133 (100), 120 
(74), 105 (88), 100 (77), 91 (99), 85 (52), 77 (45), 55 (36), 43 (75). 
HREIMS Found: M+•, 234.1256. C14H18O3 requires M
+•, 234.1256.  
Elemental Analysis Found: C, 71.58; H, 7.73. C14H18O3 requires C, 71.77; H, 7.74%.  
Optical Rotation [$]D = -102 (c 1.2, CHCl3). 
 
(3aS,4S,5aS,8aS,8bR)-2,2-Dimethylhexahydro-4,8a-ethenoindeno[4,5-d][1,3]dioxol-6(4H)-
one (230) [via (3aS,6S,7aS,8S,9R)-8,9-dihydroxy-2,3,7,7a-tetrahydro-3a,6-ethanoinden-
1(6H)-one (231) and (3aS,6S,7aR,8S,9R)-8,9-dihydroxy-2,3,7,7a-tetrahydro-3a,6-
ethanoinden-1(6H)-one (232)] 
 
HO
HO
226
O
O
+
232
HO
HO
O
231
O
HO
HO
3 : 1
BHT, toluene,
PhNEt2,
reflux 16 h
18 oC, 16 h
2,2-DMP, p-TsOH•H2O,
O
O
O
230  
 
A mixture of dioxin 226 (20.0 mg, 0.08 mmol), BHT (2.0 mg, 0.01 mmol) and 
N,N-diethylaniline (100 µL, 0.63 mmol) in toluene (10 mL) was heated at reflux for 16 h then 
cooled and concentrated under reduced pressure. Purification of the ensuing light-yellow oil by 
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flash column chromatography (silica, 1:1 v/v EtOAc/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.2, 3:7 v/v EtOAc/hexane) gave an inseparable (3:1) mixture of two 
Diels-Alder adducts tentatively assigned as title compounds 231 and 232 (12.1 mg, 78%). 
 
1
H NMR (300 MHz) ( (231, major isomer) 6.32 (dd, J = 8.2 and 6.6 Hz, 1H), 5.83 (d, J = 8.2 
Hz, 1H), 3.73 (m, 1H), 3.61 (m, 1H), 2.77–1.92 (complex m, 7H), 1.41 (m, 1H) (OH proton 
resonances not observed); (323, minor isomer) 6.23 (d, J = 8.2 Hz, 1H), 6.13 (dd, J = 8.2 and 
6.3 Hz, 1H), 3.65 (m, 1H), 3.58 (m, 1H), 2.77–1.92 (complex m, 7H), 1.41 (m, 1H) (OH proton 
resonances not observed). 
 
A solution of diols 231 and 232 (12.1 mg, 0.06 mmol) and 2,2-dimethoxypropane (115 µL, 0.93 
mmol) in CH2Cl2 (1 mL) was treated with p-TsOH•H2O (5 mg, 0.03 mmol) and the resulting 
solution stirred at 18 º C for 16 h before being quenched with NaHCO3 (5 mL of a saturated 
aqueous solution) and diluted with Et2O (10 mL). The separated aqueous phase was extracted 
with Et2O (2 x 10 mL) and the combined organic phases were washed with brine (10 mL) then 
dried (Na2SO4), filtered and concentrated under reduced pressure. The residue thus obtained was 
subjected to flash column chromatography (silica, 1:1 v/v EtOAc/hexane elution). Concentration 
of the appropriate fractions (Rf = 0.2, 3:7 v/v EtOAc/hexane) afforded syn-adduct 230 (10.4 mg, 
71%) as a white crystalline solid. This material was identical, in all respects, with authentic 
material. 
 
(3aS,4S,5aR,8aR,8bR)-2,2,5,5-Tetramethylhexahydro-4,8a-ethenoindeno[4,5-d][1,3]dioxol-
6(4H)-one (237) 
 
reflux, 4 days
BHT, mesitylene,
PhNEt2,
O
O
227
O
O O
O
O
237
 
 
A mixture of dioxin 227 (49.9 mg, 0.16 mmol), BHT (3.8 mg, 0.02 mmol) and 
N,N-diethylaniline (350 µL, 2.20 mmol) in mesitylene (35 mL) was heated at reflux for 4 days 
then cooled and concentrated under reduced pressure. Purification of the ensuing light-yellow 
oil by flash column chromatography (silica, 1:4 v/v EtOAc/hexane elution) and concentration of 
the appropriate fractions (Rf = 0.3, 3:7 v/v EtOAc/hexane) afforded compound 237 (13.1 mg, 
32%) as a white crystalline solid, m.p. = 101–104 ºC. 
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1
H NMR (300 MHz) ( 6.31 (t, J = 7.3 Hz, 1H), 5.81 (d, J = 8.0 Hz, 1H), 4.62 (ddd, J = 7.1, 2.9 
and 1.0 Hz, 1H), 4.18 (dd, J = 7.1 and 1.0 Hz, 1H), 2.47 (ddd, J = 6.6, 2.9 and 1.0 Hz, 1H), 
2.36–2.22 (m, 3H), 1.76 (m, 1H), 1.49 (s, 1H), 1.33 (s, 3H), 1.29 (s, 3H), 1.20 (s, 3H), 1.00 (s, 
3H). 
13
C NMR (75 MHz) ( 214.6 (C), 136.5 (CH), 129.5 (CH), 109.0 (C), 83.5 (CH), 77.1 (CH), 
59.8 (CH), 49.7 (C), 49.5 (CH), 38.6 (CH2), 37.4 (C), 29.9 (CH3), 28.5(CH2), 25.4 (CH3), 25.0 
(two signals overlapping, 2 x CH3). 
IR &max 2965, 2937, 2910, 2883, 1734, 1381, 1367, 1265, 1206, 1088, 1066, 879, 738 cm
-1. 
Mass spectrum (EI, 70 eV) m/z 262 (M+•, <1%), 247 [(M – CH3•)
+, 25], 204 (100), 175 (49), 
161 (30), 147 (46), 119 (49), 91 (46), 65 (13), 55 (41), 43 (54). 
HREIMS Found: (M – CH3•)
+, 247.1339. C16H22O3 requires (M – CH3•)
+, 247.1334. 
Optical Rotation [$]D = -107 (c 0.95, CHCl3). 
 
5-Methylhexa-1,4-dien-3-one (242) 
 
Method 1: 
 
243a 242
OH O
DDQ, Et2O,
18 oC, 24 hO
+
THF,
18 oC, 40 min
BrMg
243b 243  
 
Following a procedure established by Szymoniak et al.,196 a solution of 3-methyl-but-2-enal 
(243a) (770 µL, 7.98 mmol) in THF (2 mL) was added dropwise to a solution of vinyl 
magnesium bromide (243b) (10 mL of a 1.0 M solution in THF, 10.0 mmol) in THF (5 mL) at 
18 ºC. The ensuing mixture was stirred at this temperature for 40 min then water (5 mL) was 
added and the separated aqueous phase was extracted with Et2O (3 x 10 mL). The combined 
organic phases were then dried (MgSO4), filtered and concentrated under reduced pressure to 
give allylic alcohol 243 (800 mg, ca. 89%) as an orange oil. This material was sufficiently pure 
to be used in the next step of the reaction sequence without further purification. 
 
1
H NMR (300 MHz) ( 5.88 (ddd, J = 17.1, 10.3 and 5.8 Hz, 1H), 5.22 (dt, J = 17.1 and 1.5 Hz, 
1H), 5.18 (dt, J = 10.3 and 1.5 Hz, 1H), 5.07 (dt, J = 7.1 and 1.2 Hz, 1H), 4.84 (uneven t, J = 
7.1 and 5.8 Hz, 1H), 1.73 (d, J = 1.0 Hz, 3H), 1.70 (d, J = 1.0 Hz, 3H) 1.67 (br s, 1H). 
 
The data presented above as well as all the other data acquired on this compound matched those 
reported in the literature.123 
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DDQ (555 mg, 2.44 mmol) was added to a solution of alcohol 243 (252 mg, 2.25 mmol) in Et2O 
(1 mL) and the resulting slurry was stirred at 18 ºC for 24 h. The ensuing mixture was poured 
into pentane (10 mL) (to precipitate the DDQH2), the flask washed with additional pentane (2 x 
5 mL) and the resultant solid filtered off and washed with pentane (2 x 5 mL). The combined 
filtrates were carefully concentrated under reduced pressure (temp. = 40 ºC, pressure <750) to 
give (volatile) divinyl ketone 242 (101 mg, 41%) as a yellow liquid. This material was 
sufficiently pure to be used in the next step of the reaction sequence without further purification. 
 
1
H NMR (300 MHz) ( 6.39 (dd, J = 17.5 and 10.4 Hz, 1H), 6.27 (qu, J = 1.3 Hz, 1H), 6.19 (dd, 
J = 17.5 and 1.5 Hz, 1H), 5.73 (dd, J = 10.4 and 1.5 Hz, 1H), 2.17 (d, J = 1.3 Hz, 3H), 1.93 (d, J 
= 1.3 Hz, 3H). 
 
The data presented above as well as all the other data acquired on this compound matched those 
reported in the literature.139 
 
Method 2: 
 
218
O OH
242
O2. 150 - 200 ºC
1. Et2NH.HCl, CH2O,
    HCl, hydroquinone, 
    100 oC, 2 h
 
 
Following a procedure established by Mironov et al.,138 diethylamine hydrochloride (6.85 g, 
62.5 mmol), formaldehyde (5.1 mL of a 37% aqueous solution, 62.5 mmol), 4-hydroxy-4-
methylpentan-2-one (218) (7.75 mL, 62.5 mmol), HCl (250 µL of a 36% aqueous solution) and 
hydroquinone (125 mg, 1.14 mmol) were combined in a pyrex sealed reaction vessel and the 
contents was heated at 100 °C for 2 h. After cooling, the sealed tube was carefully opened and 
the reaction mixture transferred to a distillation apparatus (as the scale of the reaction was 
constrained by the size of the sealed tubes several batch runs were carried out simultaneously 
and combined at this point). After distilling off the water, the hydrochloride salt of the Mannich 
base was decomposed at 150–210 °C to give the title divinyl ketone 242 (2.4 g, 35%), which 
was obtained as a bright yellow liquid contaminated with mesityl oxide, &20 = 0.880 mg/mL. 
This material was used directly in the next step of the reaction sequence. 
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1,4-Pentadien-3-one (239) 
 
199 239
OH O
DDQ, Et2O,
18 oC, 24 h
 
 
DDQ (12.8 g, 56.6 mmol) was added to a solution of 1,4-pentadien-3-ol (199) (5.0 mL, 51.4 
mmol) in Et2O (20 mL, 2.5 M) and the resulting slurry was stirred at 18 ºC for 24 h. The 
ensuing mixture was then poured into pentane (100 mL) (to precipitate the DDQH2), the flask 
washed with additional pentane (2 x 20 mL) and the resultant solid filtered off and washed with 
pentane (2 x 20 mL). The combined filtrates were carefully concentrated under reduced pressure 
(temp. = 40 ºC, pressure <750) to give divinyl ketone 239 as a 60% solution in Et2O/pentane 
(ca. 6 mL, 72%). This material was used directly in the next step of the reaction sequence. For 
the purposes of characterization, a small sample of the solution was concentrated to afford title 
divinyl ketone 239 as a clear, bright-yellow liquid.  
 
1
H NMR (300 MHz) ( 6.64 (dd, J = 17.4 and 10.6 Hz, 2H), 6.32 (dd, J = 17.4 and 1.3 Hz, 2H), 
5.88 (dd, J = 10.6 and 1.3 Hz, 2H). 
 
The data presented above matched the equivalent spectral information reported in the 
literature.141 In addition, the following data were acquired on this compound, particularly 
because such spectral information is not available in the literature.  
 
13
C NMR (75 MHz) ( 190.1 (C), 134.2 (CH), 129.4 (CH2). 
IR &max 2926, 2857, 1698, 1679, 1613, 1403, 1090, 989, 928 cm
-1. 
 
General Procedure for the Michael addition of protected 3-iodocyclohexa-3,5-diene-1,2-
diols to enones 
 
A solution of iodo-diol (1.0 mole equiv.) in THF (0.2 M) was cooled to -30 °C then treated 
dropwise with i-PrMgCl (1.2–2.0 mole equiv. of a 2.0 M solution in THF). The ensuing mixture 
was warmed to 0 °C and stirred at this temperature until no starting material could be seen by 
1H NMR analysis (1–2 h). The reaction mixture was then cooled to -78 °C and treated with 
copper (I) bromide-dimethyl sulfide complex (0.1 mole equiv.) and HMPA (3.0 mole equiv.). A 
solution of enone (2.1 mole equiv.) and TMSCl (3.0 mole equiv.) in THF (ca. 2 mL) was then 
added dropwise, via syringe pump, over 1.5 h. The resulting mixture was allowed to warm to 18 
ºC over 16 h then treated with NH4Cl (ca. 20 mL of a saturated aqueous solution) and stirred at  
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18 ºC for 10 min. The biphasic system was separated and the aqueous layer was extracted with 
EtOAc (3 x ca. 30 ml). The combined organic fractions were washed with water (2 x ca. 10 
mL) and brine (ca. 20 mL) then dried (Na2SO4), filtered, concentrated under reduced pressure. 
The crude material thus obtained was subjected to flash column chromatography using the 
conditions defined below for each individual case. 
 
5-[(3aR,7aS)-2,2-Dimethyl-3a,7a-dihydro-1,3-benzodioxol-4-yl]pent-1-en-3-one (228) 
 
239190
O
I
O
O
+
1. i-PrMgCl, THF,
    -30 to 0 oC, 2 h
2. Cu(I)Br•Me2S, HMPA,
     TMSCl, THF,
     -78 to 18 oC, 16 h
O
O
O
228  
 
The Michael addition of iodo-diol 190 (503 mg, 1.81 mmol) to enone 239 (591 µL of a 60% 
solution in Et2O/pentane, ca. 3.80 mmol) was carried out as described in the general procedure 
and using 1.2 mole equiv. of i-PrMgCl (1.1 mL of a 2.0 M solution in THF, 2.2 mmol). The 
crude product thus obtained was subjected to flash column chromatography (1:9 v/v 
EtOAc/hexane elution). Concentration of the appropriate fractions (Rf = 0.4, 3:7 v/v 
EtOAc/hexane) gave the title enone 228 (274 mg, 65%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( 6.37 (dd, J = 17.7 and 10.3 Hz, 1H), 6.23 (dd, J = 17.7 and 1.5 Hz, 1H), 
5.96 (dd, J = 9.6 and 5.6 Hz, 1H), 5.84 (dd, J = 10.3 and 1.5 Hz, 1H), 5.79 (dd, J = 9.6 and 3.8 
Hz, 1H), 5.71 (d, J = 5.6 Hz, 1H), 4.66 (dd, J = 8.7 and 3.8 Hz, 1H), 4.53 (d, J = 8.7 Hz, 1H), 
2.83 (td, J = 7.5 and 3.0 Hz, 2H), 2.56 (t, J = 7.5 Hz, 2H), 1.39 (s, 3H), 1.38 (s, 3H). 
13
C NMR (75 MHz) ( 199.8 (C), 136.9 (C), 136.4 (CH), 128.2 (CH2), 124.4 (CH), 123.1 (CH), 
118.9 (CH), 105.3 (C), 73.4 (CH), 71.2 (CH), 37.4 (CH2), 27.9 (CH2), 26.8 (CH3), 25.0 (CH3). 
IR &max 3044, 2985, 2933, 2894, 1700, 1681, 1402, 1378, 1369, 1208, 1158, 1096, 1031, 962, 
838, 717 cm-1. 
Mass spectrum (EI, 70 eV) m/z 234 (M+•, <1%), 176 (48), 158 (75), 147 (40), 121 (75), 107 
(100), 91 (46), 77 (52), 55 (95), 43 (62). 
HREIMS Found: M+•, 234.1255. C14H18O3 requires M
+•, 234.1256. 
Optical Rotation [$]D = +89 (c 1.6, CHCl3). 
 
Experimental Procedures for Chapter Three 195 
(2S,3aS,7aS)-4-Iodo-2-phenyl-3a,7a-dihydro-1,3-benzodioxole (245) 
 
88
I
O
O
I
OH
OH
 -20 to -10 ºC, 2 h
BDMA, (+)-CSA, CH2Cl2,
245  
 
A suspension of (1S,2S)-3-iodocyclohexa-3,5-diene-1,2-diol (88) (1.00 g, 4.20 mmol) and 
(1S)-(+)-10-camphorsulfonic acid monohydrate (20.0 mg, 0.08 mmol) in CH2Cl2 (30 mL) was 
cooled to -20 ºC then benzaldehyde dimethylacetal (650 µL, 4.33 mmol) was added in a 
dropwise manner. The ensuing mixture was allowed to warm to -10 ºC over 2 h then NaOH (20 
mL of a 2.0 M aqueous solution) was added. The separated aqueous phase was extracted with 
CH2Cl2 (2 x 20 mL) and the combined organic fractions were washed with water (20 mL) and 
brine (20 mL) before being dried (Na2SO4), filtered and concentrated under reduced pressure to 
give the title acetal 245 (containing traces of benzaldehyde) (1.29 g, ca. 85%) as an unstable 
white solid (Rf = 0.6, 3:7 v/v EtOAc/hexane). This material was sufficiently pure to be used in 
the next step of the reaction sequence without further purification. 
 
1
H NMR (300 MHz) ( 7.50 (m, 2H), 7.37 (m, 3H), 6.70 (dt, J = 6.0 and 0.7 Hz, 1H), 6.09 (ddt, 
J = 9.5, 4.1 and 0.7 Hz, 1H), 5.81 (dd, J = 9.5 and 6.0 Hz, 1H), 5.77 (s, 1H), 4.83 (d, J = 9.2 Hz, 
1H), 4.70 (dd, J = 9.2 and 4.1 Hz, 1H). 
13
C NMR (75 MHz) ( 136.0 (C), 133.7 (CH), 129.6 (CH), 128.3 (CH), 127.2 (CH), 125.2 (CH), 
123.7 (CH), 99.1 (CH), 98.5 (C), 77.9 (CH), 72.8 (CH). 
IR &max 2880, 1458, 1395, 1364, 1333, 1312, 1284, 1216, 1087, 1059, 1009, 987, 948, 927, 
838, 762, 701 cm-1. 
Mass spectrum (EI, 70 eV) m/z 326 (M+•, 21%), 280 (76), 204 (65), 171 (50), 153 (82), 105 
(92), 93 (90), 77 (99), 65 (100), 51 (69), 39 (75). 
HREIMS Found: M+•, 325.9804. C13H11O2
127I requires M+•, 325.9804. 
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5-[(2S,3aR,7aS)-2-Phenyl-3a,7a-dihydro-1,3-benzodioxol-4-yl]pent-1-en-3-one (246) 
 
239245
O
I
O
O
+
1. i-PrMgCl, THF,
    -30 to 0 oC, 2 h
2. Cu(I)Br•Me2S, HMPA,
    TMSCl, THF,
     -78 to 18 oC, 16 h
O
O
O
246  
 
The Michael addition of iodo-diol 245 (690 mg, ca. 2.12 mmol) to enone 239 (691 µL of a 60% 
solution in Et2O/pentane, ca. 4.44 mmol) was carried out as described in the general procedure 
using 2.0 mole equiv. of i-PrMgCl (2.1 mL of a 2.0 M solution in THF, 4.2 mmol). The crude 
product was subjected to flash column chromatography (1:9 v/v EtOAc/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.3, 3:7 v/v EtOAc/hexane) gave the title enone 
246 (376 mg, 63%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( 7.45 (m, 2H), 7.35 (m, 3H), 6.34 (dd, J = 17.8 and 10.4 Hz, 1H), 6.19 
(dd, J = 17.8 and 1.3 Hz, 1H), 6.02 (dd, J = 9.5 and 5.6 Hz, 1H), 5.89 (dd, J = 9.5 and 3.7 Hz, 
1H), 5.80 (dd, J = 10.4 and 1.3 Hz, 1H), 5.80 (d, partially obscured, J = 5.6, 1H), 5.70 (s, 1H), 
4.73 (dd, J = 9.3 and 3.7 Hz, 1H), 4.60 (d, J = 9.3 Hz, 1H), 2.84 (m, 2H), 2.62 (m, 2H). 
13
C NMR (75 MHz) ( 199.8 (C), 136.8 (C), 136.3 (CH), 135.9 (C), 129.4 (CH), 128.3 (CH), 
128.2 (CH2), 127.0 (CH), 124.5 (CH), 122.2 (CH), 119.4 (CH), 99.1 (CH), 74.1 (CH), 72.3 
(CH), 37.5 (CH2), 28.1 (CH2). 
IR &max 3045, 2891, 1711, 1459, 1402, 1374, 1312, 1294, 1218, 1089, 1065, 1025, 1000, 919, 
761, 735, 699 cm-1. 
Mass spectrum (EI, 70 eV) m/z 282 (M+•, <1%), 175 (62), 158 (91), 147 (55), 133 (35), 121 
(72), 105 (90), 91 (52), 77 (85), 65 (28), 55 (100), 39 (31). 
HREIMS Found: M+•, 282.1254. C18H18O3 requires M
+•, 282.1256. 
Optical Rotation [$]D = +112 (c 1.5, CHCl3). 
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1-[(3aR,7aS)-2,2-Dimethyl-3a,7a-dihydro-1,3-benzodioxol-4-yl]-5-methylhex-4-en-3-one 
(236) 
 
242190
O
I
O
O
+
1. i-PrMgCl, THF,
    -30 to 0 oC, 2 h
2. Cu(I)Br•Me2S, HMPA,
    TMSCl, THF,
     -78 to 18 oC, 16 h
O
O
O
236
3. TBAF, THF,
    18 oC, 1 h
 
 
The Michael addition of iodo-diol 190 (1.00 g, 3.60 mmol) to enone 242 (945 µL, ca. 7.55 
mmol) was carried out as described in the general procedure using 1.5 mole equiv. of i-PrMgCl 
(2.7 mL of a 2.0 M solution in THF, 5.4 mmol). The initially formed product was a silyl enol 
ether so this was dissolved in THF (7 mL) then treated with tetra-n-butylammonium fluoride  
(7 mL of a 1.0 M solution in THF, 7.00 mmol) and stirred at 18 ºC for 1 h. The ensuing mixture 
was concentrated under reduced pressure onto silica (ca. 2 g, 230–400 mesh) and the resulting 
free-flowing solid subjected to flash column chromatography (silica, 1:9 v/v EtOAc/hexane 
elution). Concentration of the appropriate fractions (Rf = 0.4, 3:7 v/v EtOAc/hexane) gave the 
title enone 236 (700 mg, 74%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( 6.09 (qu, J = 1.2 Hz, 1H), 5.96 (dd, J = 9.7 and 5.6 Hz, 1H), 5.78 (dd, J 
= 9.7 and 3.7 Hz, 1H), 5.70 (d, J = 5.6 Hz, 1H), 4.66 (dd, J = 8.6 and 3.7 Hz, 1H), 4.53 (d, J = 
8.6 Hz, 1H), 2.65 (m, 2H), 2.53 (m, 2H), 2.34 (d, J = 1.1 Hz, 3H), 1.89 (d, J = 1.1 Hz, 3H), 1.40 
(s, 3H), 1.38 (s, 3H). 
13
C NMR (75 MHz) ( 199.9 (C) 155.4 (C), 137.3 (C), 124.5 (CH), 123.6 (CH), 122.9 (CH), 
118.6 (CH), 105.3 (C), 73.5 (CH), 71.3 (CH), 41.8 (CH2), 28.1 (CH2), 27.7 (CH3), 26.9 (CH3), 
25.0 (CH3), 20.8 (CH3). 
IR &max 3044, 2948, 2933, 2912, 1688, 1620, 1445, 1378, 1369, 1234, 1209, 1159, 1109, 1031, 
961, 888, 708 cm-1. 
Mass spectrum (EI, 70 eV) m/z 262 (M+•, 2%), 247 (2), 204 (33), 189 (10), 149 (34), 121 (33), 
104 (50), 91 (23), 83 (100), 77 (29), 65 (12), 55 (69), 43 (35), 39 (21). 
HREIMS Found: (M – CH3•)
+, 247.1334. C16H22O3 requires (M – CH3•)
+, 247.1334. 
Optical Rotation [$]D = +114 (c 0.3, CHCl3). 
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(3aS,7aS)-3a,7a-Dihydro-4-iodo-2,2,7-trimethylbenzo[d][1,3]dioxole (247) 
 
247a 247
I
O
O
I
OH
OH
18 oC, 30 min
2,2-DMP, p-TsOH•H2O,
 
 
A solution of (1S,2S)-3-iodo-6-methylcyclohexa-3,5-diene-1,2-diol (247a) (2.0 g, 7.93 mmol) 
in 2,2-dimethoxypropane (40 mL) was treated with p-TsOH•H2O (ca. 30 mg, 0.16 mmol) at  
18 ºC and stirred at this temperature for 30 min then quenched with triethylamine (1.0 mL) and 
concentrated under reduced pressure. The resulting brown residue was partitioned between 
water (40 mL) and Et2O (100 mL) and the separated aqueous phase was extracted with Et2O (2 
x 200 mL). The combined organic phases were washed with NaOH (100 mL of a 2.0 M 
solution) and brine (50 mL) then dried (Na2SO4), filtered and concentrated under reduced 
pressure (temp. = 30 ºC) to give title acetonide 247 (2.17 mg, 93%) as a pale-brown oil (Rf = 
0.6, 3:7 v/v EtOAc/hexane). This material was sufficiently pure to be used in the next step of the 
reaction sequence without further purification. 
 
1
H NMR (300 MHz) ( 6.54 (d, J = 6.2 Hz, 1H), 5.49 (dq, J = 6.2 and 1.6 Hz, 1H), 4.73 (d, J = 
8.4 Hz, 1H), 4.46 (dd, J = 8.4 and 0.7 Hz, 1H), 1.88 (d, J = 0.7 Hz, 3H), 1.43 (s, 3H), 1.42 (s, 
3H). 
Optical Rotation [$]D = +37 (c 1.0, CHCl3) [lit.
197 [$]D = +69 (c 0.77, CHCl3)]. 
 
The data presented above as well as all the other data acquired on this compound matched those 
reported in the literature.197 
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5-Methyl-1-[(3aR,7aS)-2,2,7-trimethyl-3a,7a-dihydro-1,3-benzodioxol-4-yl]hex-4-en-3-one 
(248) 
 
242247
O
I
O
O
+
1. i-PrMgCl, THF,
    -30 to 0 oC, 2 h
2. Cu(I)Br•Me2S, HMPA,
    TMSCl, THF,
     -78 to 18 oC, 16 h
O
O
O
248
3. TBAF, THF,
    18 oC, 1 h
 
 
The Michael addition of iodo-diol 247 (1.00 g, 3.42 mmol) to enone 242 (900 µL, ca. 7.20 
mmol) was carried out as described in the general procedure using 2.0 mole equiv. of i-PrMgCl 
(3.4 mL of a 2.0 M solution in THF, 6.8 mmol). The initially formed product was a silyl enol 
ether so this was dissolved in THF (7 mL) then treated with tetra-n-butylammonium fluoride  
(7 mL of a 1.0 M solution in THF, 7.00 mmol) and stirred at 18 ºC for 1 h. The ensuing mixture 
was concentrated under reduced pressure onto silica (ca. 2 g, 230–400 mesh) and the resulting 
free-flowing solid subjected to flash column chromatography (silica, 1:9 v/v EtOAc/hexane 
elution). Concentration of the appropriate fractions (Rf = 0.4, 3:7 v/v EtOAc/hexane) gave the 
title enone 248 (568 mg, 60%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( 6.09 (m, 1H), 5.65 (s, 2H), 4.50 (AB quartet, J = 8.4 Hz, 2H), 2.63 (m, 
2H), 2.51 (m, 2H), 2.13 (s, 3H), 1.88 (s, 3H), 1.86 (s, 3H), 1.40 (s, 3H), 1.35 (s, 3H). 
13
C NMR (75 MHz) ( 200.0 (C), 155.1 (C), 134.1 (C), 132.3 (C), 123.6 (CH), 119.7 (CH), 
119.6 (CH), 105.8 (C), 75.6 (CH), 74.3 (CH), 42.1 (CH2), 28.3 (CH2), 27.6 (CH3), 27.0 (CH3), 
25.3 (CH3), 20.7 (CH3), 19.8 (CH3). 
IR &max 2982, 2933, 2912, 1688, 1620, 1447, 1278, 1269, 1235, 1208, 1180, 1158, 1110, 1062, 
1039, 1013, 872 cm-1. 
Mass spectrum (EI, 70 eV) m/z 261 [(M – CH3•)
+, <1%], 218 (49), 199 (19), 191 (22), 185 
(18), 163 (39), 149 (58), 135 (55), 121 (90), 108 (26), 91 (39), 83 (100), 77 (35), 55 (81), 43 
(82). 
HREIMS Found: M+•, 276.1722. C17H24O3 requires M
+•, 276.1725. Found: (M – CH3•)
+, 
261.1491. C17H24O3 requires (M – CH3•)
+, 261.1491. 
Optical Rotation [$]D = +19 (c 0.9, CHCl3). 
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 [[(1S,2S)-3-Iodocyclohexa-3,5-diene-1,2-diyl]bis(oxy)]bis[tert-butyl(dimethyl)silane] (249) 
 
88 249
I
OTBS
OTBS
I
OH
OH
DMF, 18 oC, 3 h
TBSCl, imidazole,
 
 
A solution of t-butyldimethylsilyl chloride (2.45 g, 16.3 mmol) in dry DMF (5.3 mL) was added 
dropwise to a solution of diol 88 (1.0 g, 4.20 mmol) and imidazole (1.73 g, 25.4 mmol) in dry 
DMF (12.8 mmol) at 18 ºC. After stirring for 3 h at this temperature the reaction mixture was 
diluted with water (100 mL) and Et2O (150 mL). The separated aqueous phase was extracted 
with Et2O (3 x 100 mL) and the combined organic phases were washed with water (2 x 20 mL) 
and brine (20 mL) then dried (Na2SO4), filtered and concentrated under reduced pressure to give 
compound 249 (1.76 g, 90%) as an unstable brown oil, (Rf = 0.6, 1:9 v/v EtOAc/hexane). This 
material was sufficiently pure to be used in the next step of the reaction sequence without 
further purification. 
 
1
H NMR (300 MHz) ( 6.62 (d, J = 5.5 Hz, 1H), 5.89 (dd, J = 9.5 and 2.7 Hz, 1H), 5.65 (dd, J = 
9.5, 5.5 and 2.2 Hz, 1H), 4.43 (m, 1H), 4.08 (d, J = 4.9 Hz, 1H), 0.92 (s, 9H), 0.91 (s, 9H), 
0.17–0.10 (m, 12H). 
 
1-[(5S,6R)-5,6-Dihydroxycyclohexa-1,3-dien-1-yl]-5-methylhex-4-en-3-one (250) 
 
O
I
OTBS
OTBS
+
1. t-BuLi, Et2O, -78 
oC, 
    3 h
2. CuI, n-Bu3P, HMPA,
    TMSCl, THF,
    -78 to 18 oC, 16 h
249
242
O
OH
OH
250
O
OTBS
OTBS
250a
TBAF, THF,
0 to 18 ºC, 2 h
 
 
A solution of iodide 249 (127 mg, 0.27 mmol) in Et2O (2 mL) was cooled to -78 °C then 
treated, dropwise, with t-BuLi (320 µL of a 1.7 M solution in pentane, 0.54 mmol). The ensuing 
mixture was stirred at -78 °C for 3 h. In a separate flask, a slurry of anhydrous copper (I) iodide 
(52.0 mg, 0.27 mmol) in THF (2 mL) was treated with tri-n-butyl phosphine (170 µL, 0.68 
mmol) and the mixture was stirred until it became a colourless solution. This mixture was 
cooled to -78 °C then added, via cannula, to the organolithium derivative. The resulting orange 
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solution was stirred at -78 °C for 15 min then treated with HMPA (143 µL, 0.82 mmol). A 
solution of divinyl ketone 242 (73 µL, 0.58 mmol) and TMSCl (104 µL, 0.82 mmol) in THF (5 
mL) was then added dropwise over 3 h. After the addition was complete the reaction mixture 
was warmed to 18 ºC and allowed to stir at this temperature for 13 h. The reaction mixture was 
then poured into NH4Cl (10 mL of a saturated aqueous solution) and the separated aqueous 
phase was extracted with Et2O (3 x 30 mL). Combined organic phases were washed with brine 
(10 mL) then dried (Na2SO4), filtered and concentrated under reduced pressure to give 
compound 250a as a yellow oil. This material was dissolved in THF (2 mL) and the resultant 
solution was cooled to 0 ºC. tetra-n-Butylammonium fluoride (1.36 mL of a 1.0 M solution in 
THF, 1.37 mmol) was then added and the ensuing mixture was allowed to warm to 18 ºC and 
stirred at this temperature for 2 h. NaHCO3 (10 mL of a 50% w/v aqueous solution) were then 
added and the separated aqueous phase was extracted with CH2Cl2 (3 x 50 mL). The combined 
organic fractions were washed with brine (10 mL) then dried (Na2SO4), filtered and 
concentrated under reduced pressure. Purification of the ensuing residue by flash column 
chromatography (silica, 1:1 v/v EtOAc/hexane elution) and concentration of the appropriate 
fractions (Rf = 0.2, 3:7 v/v EtOAc/hexane) gave the title diol 250 (19.9 mg, 33%) as a clear, 
colourless oil. 
 
1
H NMR (300 MHz) ( 6.09 (s, 1H), 5.91 (ddd, J = 9.6, 5.4 and 1.0 Hz, 1H), 5.80 (dd, J = 9.6 
and 3.4 Hz, 1H), 5.68 (d, J = 5.4 Hz, 1H), 4.27 (br s, 1H), 4.07 (br t, J = 6.1 Hz, 1H), 2.93 (br d, 
J = 7.1 Hz, 1H), 2.67 (t, J = 7.1 Hz, 2H), 5.52 (t, J = 7.1 Hz, 2H), 2.45 (br d, J = 7.6 Hz, 1H), 
2.13 (s, 3H), 1.89 (s, 3H). 
13
C NMR (75 MHz) ( 200.5 (C), 156.4 (C), 140.9 (C), 127.8 (CH), 124.7 (CH), 123.5 (CH), 
119.9 (CH), 70.3 (CH), 68.7 (CH), 42.7 (CH2), 27.7(4) (CH2), 27.7(3) (CH3), 20.9 (CH3) 
IR &max 3372, 2921, 2853, 1684, 1618, 1444, 1380, 1231, 1142, 1109, 1075, 1032, 923, 809, 
681 cm-1 
Mass spectrum (EI, 70 eV) m/z 222 (M+•, <1%), [(M – H2O)
+•, 26], 148 (18), 121 (24), 107 
(41), 91 (17), 83 (100), 77 (27), 55 (54), 39 (25) 
HREIMS Found: M+•, 222.1256. C13H18O3 requires M
+•, 222.1256 
Optical Rotation [$]D = +5.8 (c 0.5, CHCl3) 
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(3aS,4S,5aS,8aS,8bR)-2,2-Dimethylhexahydro-4,8a-ethenoindeno[4,5-d][1,3]dioxol-6(4H)-
one (230) and (3aS,4R,5aR,8aR,8bR)-2,2-dimethylhexahydro-4,8a-ethenoindeno[4,5-
d][1,3]dioxol-6(4H)-one (229) 
 
BHT, toluene,
reflux, 16 h
O
O
O
228
O
O
O
O
O
O
+
229230
 
 
A solution of enone 228 (258 mg, 1.10 mmol) and BHT (24.7 mg, 0.11 mmol) in toluene (110 
mL) was heated at reflux for 16 h. The cooled reaction mixture was then concentrated under 
reduced pressure and the residue thus obtained was subjected to flash column chromatography 
(silica, 1:4 7 2:3 v/v EtOAc/hexane gradient elution) and so affording two fractions, A and B. 
 
Concentration of fraction A (Rf = 0.3, 3:7 v/v EtOAc/hexane) gave the title syn-adduct 230 (101 
mg, 39%) as a white crystalline solid, which was identical, in all respects, with authentic 
material. 
 
Concentration of fraction B (Rf = 0.2, 3:7 v/v EtOAc/hexane) gave the title anti-adduct 229 (113 
mg, 44%) as a white crystalline solid, which was identical, in all respects, with authentic 
material. 
 
(2S,3aS,4S,5aS,8aS,8bR)-2-Phenylhexahydro-4,8a-ethenoindeno[4,5-d][1,3]dioxol-6(4H)-
one  (252) and (2S,3aS,4R,5aR,8aR,8bR)-2-phenylhexahydro-4,8a-ethenoindeno[4,5-
d][1,3]dioxol-6(4H)-one (251) 
 
BHT, toluene,
reflux, 16 h
+
O
O
O
246
Ph
O
O
O
H
252
O
O H
O
251
 
 
A solution of enone 246 (129 mg, 0.46 mmol) and BHT (10 mg, 0.05 mmol) in toluene (45 mL) 
was heated at reflux for 24 h. The cooled reaction mixture was then concentrated under reduced 
pressure and the residue thus obtained was subjected to flash column chromatography (silica, 
1:9 7 3:7 v/v EtOAc/hexane gradient elution) and so affording two fractions, A and B. 
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Concentration of fraction A (Rf = 0.3, 3:7 v/v EtOAc/hexane) afforded the title syn-adduct 252 
(27 mg, 21%) as a clear, colourless oil. 
 
 1H NMR (300 MHz) ( 7.50 (m, 2H), 7.41 (m, 3H), 6.41 (dd, J = 8.1 and 6.8 Hz, 1H), 5.94 (s, 
1H), 5.89 (d, J = 8.1 Hz, 1H), 4.14 (dd, J = 8.4 and 3.9 Hz, 1H), 4.07 (d, J = 8.4 Hz, 1H), 3.02 
(m, 1H), 2.84 (ddd, J = 9.8, 6.1 and 1.5 Hz, 1H), 2.49–1.99 (complex m, 5H), 1.50 (ddd, J = 
12.7, 6.8 and 1.5 Hz, 1H). 
13
C NMR (75 MHz) ( 217.4 (C), 137.3 (CH), 136.4 (C), 134.1 (CH), 129.8 (CH), 128.6 (CH), 
126.8 (CH), 106.2 (CH), 77.8 (CH), 76.3 (CH), 47.8 (C), 46.1 (CH), 36.2 (CH2), 35.0 (CH), 
25.2 (CH2), 23.2 (CH2) . 
IR &max 3041, 2917, 2869, 1740, 1458, 1405, 1298, 1220, 1444, 1108, 1086, 1063, 1025, 991, 
884, 761, 743, 700, 643 cm-1. 
Mass spectrum (EI, 70 eV) m/z 282 (M+•, 5%), 253 (51), 176 (71), 159 (15), 147 (82), 133 
(82), 120 (40), 105 (96), 91 (100), 77 (61), 65 (21), 55 (32), 51 (20), 41 (24). 
HREIMS Found: M+•, 282.1255. C18H18O3 requires M
+•, 282.1256. 
Optical Rotation [$]D = +59 (c 0.3, CHCl3). 
 
Concentration of fraction B (Rf = 0.1, 3:7 v/v EtOAc/hexane) afforded the title anti-adduct 251 
(76 mg, 59%) as a white crystalline solid, m.p. = 174–179 ºC. 
 
1
H NMR (300 MHz) ( 7.47 (m, 2H), 7.35 (m, 3H), 6.44 (br t, J = 7.3 Hz, 1H), 5.89 (d, J = 8.3 
Hz, 1H), 5.63 (s, 1H), 4.34 (dd, J = 7.4 and 2.7 Hz, 1H), 4.28 (d, J = 7.4 Hz, 1H), 3.08 (m, 1H), 
2.49 (m, 2H), 2.29 (m, 1H), 2.01 (m, 2H), 1.65 (m, 2H). 
13
C NMR (75 MHz) ( 214.9 (C), 136.2 (CH), 136.1 (C), 131.1 (CH), 129.8 (CH), 128.3 (CH), 
127.5 (CH), 103.5 (CH), 83.8 (CH), 80.1 (CH), 50.3 (CH), 47.6 (C), 36.9 (CH2), 35.6 (CH), 
28.4 (CH2), 23.7 (CH2). 
IR &max 2922, 2873, 1732, 1462, 1404, 1358, 1313, 1218, 1150, 1112, 1084, 1062, 1028, 1019, 
1010, 994, 920, 853, 759, 698, 642 cm-1. 
Mass spectrum (EI, 70 eV) m/z 281 [(M – H•)+, 12%], 253 (9), 176 (69), 158 (18), 147 (68), 
133 (58), 120 (40), 105 (100), 91 (67), 77 (45), 65 (18), 55 (21), 51 (15), 39 (16). 
HREIMS Found: (M – H•)+, 281.1176. C18H18O3 requires (M – H•)
+, 281.1178. 
Optical Rotation [$]D = -75 (c 0.5, CHCl3). 
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(3aS,4S,5aR,8aR,8bR)-2,2,5,5-Tetramethylhexahydro-4,8a-ethenoindeno[4,5-d][1,3]dioxol-
6(4H)-one (237) 
 
236
O
O
237
O
O
reflux, 4 days
BHT, mesitylene,
O
O
 
 
A solution of enone 236 (129 mg, 0.46 mmol) and BHT (10 mg, 0.05 mmol) in mesitylene (45 
mL) was heated at reflux for 4 days. The cooled reaction mixture was then concentrated under 
reduced pressure and subjected to flash column chromatography (silica, 1:9 7 3:7 v/v 
EtOAc/hexane gradient elution) to afford compound 237 (58.1 mg, 45%) as a white crystalline 
solid. This material was identical, in all respects, with authentic material. 
 
1-[(3aR,7aS)-2,2-Dimethyl-3a,7a-dihydro-1,3-benzodioxol-4-yl]-5-methylhex-4-en-3-ol 
(253) 
 
O
O
O
236
HO
O
O
253
NaBH4, MeOH,
0 to 18 oC, 2 h
 
 
A solution of enone 236 (100 mg, 0.40 mmol) in MeOH (4 mL) was cooled to 0 ºC and treated 
with NaBH4 (29 mg, 0.77 mmol). The ensuing mixture was stirred at 0 ºC for 1 h then warmed 
to 18 ºC and stirred at this temperature for a further 1 h. Water (1 mL) was added then the 
solvents were removed under reduced pressure. The residue thus obtained was partitioned 
between half brine (10 mL) and CH2Cl2 (20 mL) then the separated aqueous phase was 
extracted with CH2Cl2 (2 x 20 mL). The combined organic fractions were washed with brine (10 
mL) before being dried (Na2SO4), filtered and concentrated under reduced pressure. Purification 
by flash column chromatography (silica, 1:9 7 3:7 v/v EtOAc/hexane gradient elution) and 
concentration of the appropriate fractions (Rf = 0.4, 1:1 v/v EtOAc/hexane) gave a ca. 1:1 
mixture of the epimeric forms of alcohol 253 (88 mg, 84%) as a clear, colourless oil. 
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1
H NMR (300 MHz) ( 5.96 (ddd, J = 9.6, 5.6 and 1.6 Hz 1H), 5.76 (m, 2H), 5.19 (m, 1H), 4.66 
(dd, J = 8.6 and 3.7 Hz, 1H), 5.12 (dd, J = 8.6 and 2.6 Hz, 1H), 4.37 (m, 1H), 2.26 (m, 2H), 
1.83–1.55 (m, 2H), 1.72 (s, 3H), 1.68 (s, 1.5H), 1.66 (1.5H), 1.40 (s, 3H), 1.38 (s, 1.5H), 1.37 
(s, 1.5H) (OH proton resonances not observed). 
13
C NMR (75 MHz) ( 138.0 (C), 137.8 (C), 135.6 (C), 135.2 (C), 127.9 (CH), 127.8 (CH), 
124.5 (two signals overlapping, 2 x CH), 122.8(4) (CH), 122.7(7) (CH), 118.6 (CH), 118.5 
(CH), 105.2(4) (C), 105.1(8) (C), 73.4(9) (CH), 73.4(7) (CH), 71.4(4) (CH), 71.4(0) (CH), 68.4 
(CH), 68.1 (CH), 35.2 (CH2), 35.0 (CH2), 29.7 (CH2), 29.5 (CH2), 26.9 (CH3), 26.8 (CH3), 
25.7(9) (CH3), 25.7(7) (CH3), 25.1 (CH3), 25.0 (CH3), 18.3(2) (CH3), 18.2(5) (CH3). 
IR &max 3435, 3044, 2984, 2931, 1448, 1402, 1377, 1235, 1209, 1158, 1046, 886, 716 cm
-1. 
Mass spectrum (EI, 70 eV) m/z 246 [(M – H2O)
+•, 1%), 231 [(M – H2O – CH3•)
+, 4], 206 (60), 
188 (42), 173 (51), 145 (35), 133 (41), 107 (100), 95 (52), 85 (54), 79 (59), 67 (31), 55 (36), 43 
(71). 
HREIMS Found: (M – H2O)
+•, 246.1614. C16H24O3 requires (M – H2O)
+•, 246.1620. 
 
5-Methyl-1-[(3aR,7aS)-2,2,7-trimethyl-3a,7a-dihydro-1,3-benzodioxol-4-yl]hex-4-en-3-ol 
(254) 
 
O
O
O
248
HO
O
O
254
NaBH4, MeOH,
0 to 18 oC, 2 h
 
 
Alcohol 254 was prepared in the same manner described immediately above for congener 253 
but now using enone 248 (107 mg, 0.39 mmol) as the starting material. In this manner a ca. 1:1 
mixture of the epimeric forms of the title alcohol 254 (89 mg, 83%) was obtained as a clear 
colourless oil, (Rf = 0.2, 3:7 v/v EtOAc/hexane). 
 
1
H NMR (300 MHz) ( 5.69 (m, 2H), 5.19 (m, 1H), 4.51 (s, 2H), 4.37 (m, 1H), 2.25 (m, 2H), 
1.87 (s, 3H), 1.84–1.57 (m, 2H), 1.72 (s, 3H), 1.68 (s, 1.5H), 1.66 (s, 1.5H), 1.42 (s, 3H), 1.37 
(s, 1.5H), 1.35 (s, 1.5H) (OH proton resonances not observed). 
13
C NMR (75 MHz) ( 135.5 (C), 135.2 (C), 134.8 (C), 134.6 (C), 132.2 (C), 132.1 (C), 128.0 
(CH), 127.9 (CH), 119.7 (CH), 119.6 (three signals overlapping, 3 x CH), 105.7(9) (C), 
105.7(6) (C), 75.8 (CH), 75.7 (CH), 74.4 (CH), 74.3 (CH), 68.4 (CH), 68.1 (CH), 35.4 (CH2), 
35.3 (CH2), 29.8 (CH2), 29.7 (CH2), 27.0(3) (CH3), 26.9(9) (CH3), 25.8 (two signals 
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overlapping, 2 x CH3), 25.4(3) (CH3), 25.3(6) (CH3), 19.8 (two signals overlapping, 2 x CH3), 
18.3(3) (CH3), 18.2(6) (CH3). 
IR &max 3434, 2983, 2932, 2914, 2879, 1448, 1377, 1235, 1209, 1159, 1064, 1045, 1021, 872, 
849 cm-1. 
Mass spectrum (EI, 70 eV) m/z 260 [(M – H2O)
+•, 6%), 245 [(M – H2O – CH3•)
+, 10], 220 (92), 
202 (52), 187 (67), 178 (25), 159 (40), 147 (48), 133 (27), 121 (100), 108 (59), 95 (69), 91 (53), 
85 (68), 77(51), 67 (30), 55 (40), 43 (65). 
HREIMS Found: (M – H2O)
+•, 260.1777. C17H26O3 requires (M – H2O)
+•, 260.1776. 
 
(3aS,4S,5aR,6R,8aR,8bR)-2,2,5,5-Tetramethyloctahydro-4,8a-ethenoindeno[4,5-
d][1,3]dioxol-6-ol (255) 
 
253
HO
O
O
255
O
O
HO
reflux, 4 days
BHT, mesitylene,
 
 
A solution of a ca. 1:1 mixture of the epimeric forms of alcohol 253 (43.3 mg, 0.16 mmol) and 
BHT (3.5 mg, 0.02 mmol) in mesitylene (35 mL) was heated at reflux for 4 days then cooled 
and concentrated under reduced pressure to give a yellow oil. Purification of this material by 
flash column chromatography (silica, 3:7 v/v EtOAc/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3, 1:1 v/v EtOAc/hexane) afforded the title compound 255 (19.1 
mg, 44%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( 6.11 (dd, J = 8.1 and 6.5 Hz, 1H), 5.70 (dd, J = 8.1 and 1.0 Hz, 1H), 
4.59 (ddd, J = 7.1, 3.0 and 1.0 Hz, 1H), 4.07 (dd, J = 7.1 and 1.0 Hz, 1H), 3.87 (tt, J = 8.5 and 
5.6 Hz, 1H), 2.42 (ddd, J = 6.5, 3.0 and 1.0 Hz, 1H), 2.21 (m, 1H), 1.90 (m, 2H), 1.60 (m, 1H), 
1.30 (s, 3H), 1.27 (s, 3H), 1.23 (d, J = 9.3 Hz, 1H), 1.14 (s, 3H), 1.00 (s, 3H) (OH proton 
resonance not observed). 
13
C NMR (75 MHz) ( 133.0 (CH), 132.3 (CH), 108.4 (C), 84.0 (CH), 77.2 (CH), 74.7 (CH), 
59.8 (CH), 50.6 (C), 49.0 (CH), 35.1 (C), 34.0 (CH2), 30.9 (CH3), 30.1 (CH2), 25.4(3) (CH3), 
25.3(6) (CH3), 25.0 (CH3). 
IR &max 3435, 3042, 2931, 2869, 1456, 1378, 1368, 1264, 1206, 1174, 1161, 1091, 1064, 1029, 
1006, 983, 967, 902, 884, 830, 816, 735, 702 cm-1. 
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Mass spectrum (EI, 70 eV) m/z 264 (M+•, <1%), 249 (55), 206 (52), 188 (95), 173 (89), 164 
(64), 159 (94), 145 (80), 133 (82), 120 (69), 105 (79), 100 (54), 91 (71), 85 (82), 77 (49), 69 
(50), 55 (60), 43 (100). 
HREIMS Found: M+•, 264.1726. C16H24O3 requires M
+•, 264.1725. 
 
(3aS,4S,5aR,6R,8aR,8bR)-2,2,4,5,5-Pentamethyloctahydro-4,8a-ethenoindeno[4,5-
d][1,3]dioxol-6-ol (256) 
 
254
HO
O
O
256
O
O
HO
reflux, 4 days
BHT, mesitylene,
 
 
A solution of ca. 1:1 mixture of the epimeric forms of alcohol 254 (53.1 mg, 0.19 mmol) and 
BHT (4.0 mg, 0.02 mmol) in mesitylene (40 mL) was heated at reflux for 4 days then cooled 
and concentrated under reduced pressure to give a yellow oil. Purification of this material by 
flash column chromatography (silica, 3:7 v/v EtOAc/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3, 1:1 v/v EtOAc/hexane) afforded the title compound 256 (24.3 
mg, 46%) as a colourless, semi–solid. 
 
1
H NMR (300 MHz) ( 5.68 (AB quartet, J = 8.3 Hz, 2H), 4.24 (d, J = 7.2 Hz, 1H), 4.08 (d, J = 
7.2 Hz, 1H), 3.90 (m, 1H), 2.20 (m, 1H), 1.87 (m, 2H), 1.60 (m, 1H), 1.30 (s, 3H), 1.27 (s, 3H), 
1.22 (d, J = 8.1 Hz, 1H), 1.19 (s, 3H), 1.02 (s, 3H), 0.94 (s, 3H) (OH proton resonance not 
observed). 
13
C NMR (75 MHz) ( 137.9 (CH), 132.2 (CH), 108.3 (C), 84.9 (CH), 81.4 (CH), 74.8 (CH), 
61.0 (CH), 49.4 (C), 46.3 (C), 37.4 (C), 34.0 (CH2), 30.0 (CH2), 27.0 (CH3), 25.6 (CH3), 25.0 
(CH3), 21.6 (CH3), 15.0 (CH3). 
IR &max 3429, 3036, 2967, 2872, 1455, 1370, 1282, 1255, 1207, 1167, 1085, 1056, 1017, 898, 
870, 733 cm-1. 
Mass spectrum (EI, 70 eV) m/z 263 [(M – CH3•)
+, 19%], 220 (73), 202 (28), 187 (31), 178 
(99), 173 (39), 163 (48), 147 (41), 134 (41), 119 (100), 105 (42), 95 (38), 91 (41), 77 (27), 69 
(18), 55 (35), 43 (64). 
HREIMS Found: (M – CH3•)
+, 263.1647. C17H26O3 requires (M – CH3•)
+, 263.1647. 
Optical Rotation [$]D = -5 (c 0.4, CHCl3). 
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(3aS,4S,5aR,6R,8aR,8bR)-2,2,4,5,5-Pentamethyloctahydro-4,8a-ethenoindeno[4,5-
d][1,3]dioxol-6-yl 3,5-dinitrobenzoate (256a) 
 
256
O
O
HO
CH2Cl2, 18 
oC, 16 h
3,5-dinitro-BzCl, Et3N, DMAP,
256a
O
O
O
O
O2N
NO2
 
 
A solution of alcohol 256 (9.8 mg, 0.04 mmol), triethylamine (20 µL, 0.14 mmol) and 4-(N,N-
dimethylamino)pyridine (17.3 mg, 0.14 mmol) in CH2Cl2 (1.0 mL) maintained at 18 ºC was 
treated with 3,5-dinitrobenzoyl chloride (24.2 mg, 0.105 mmol). The ensuing mixture was 
stirred at 18 ºC for 16 h then NaHCO3 (2 mL of a saturated aqueous solution) and CH2Cl2 (5 
mL) were added. The separated aqueous phase was extracted with CH2Cl2 (2 x 5 mL) and the 
combined organic fractions were washed with brine (2 mL) before being dried (Na2SO4), 
filtered and concentrated under reduced pressure. Purification of the resulting yellow oil by 
flash column chromatography (silica, 1:19 v/v EtOAc/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.6, 3:7 v/v EtOAc/hexane) afforded title ester 256a (10.1 mg, 61%) 
as a white crystalline solid, m.p. = 178–182 ºC 
 
1
H NMR (300 MHz) ( 9.24 (t, J = 2.2 Hz, 1H), 9.12 (d, J = 2.2 Hz, 2H), 5.78 (AB quartet, J = 
8.0 Hz, 2H), 5.09 (td, J = 9.0 and 5.6 Hz, 1H), 4.32 (d, J = 7.1 Hz, 1H), 4.19 (d, J = 7.1 Hz, 
1H), 2.54 (m, 1H), 2.08 (ddd, J = 13.0, 9.0 and 3.2 Hz, 1H), 1.93 (td, J = 13.0 and 8.5 Hz, 1H), 
1.80 (d, J = 9.0 Hz, 1H), 1.74 (m, 1H), 1.33 (s, 3H), 1.31 (s, 3H), 1.22 (s, 3H), 1.08 (s, 3H), 0.84 
(s, 3H). 
13
C NMR (75 MHz) ( 162.1 (C), 148.7 (C), 138.8 (CH), 134.0 (C), 131.1 (CH), 129.3 (CH), 
122.4 (CH), 108.7 (C), 84.5 (CH), 81.3 (CH), 80.2 (CH), 58.0 (CH), 49.2 (C), 46.3 (C), 37.6 
(C), 31.1 (CH2), 30.4 (CH2), 26.9 (CH3), 25.6 (CH3), 25.0 (CH3), 22.2 (CH3), 15.1 (CH3). 
IR &max 3103, 2922, 2851, 1729, 1628, 1547, 1461, 1370, 1344, 1276, 1208, 1168, 1075, 1018, 
920, 873, 804, 730, 721 cm-1. 
Mass spectrum (EI, 70 eV) m/z 457 [(M – CH3•)
+, 11%], 414 (22), 202 (100), 187 (39), 173 
(50), 160 (58), 145 (79), 121 (45), 85 (30), 69 (40), 57 (51), 43 (77). 
HREIMS Found: (M – CH3•)
+, 457.1609. C24H28N2O8 requires (M – CH3•)
+, 457.1611. 
Optical Rotation [$]D = -57 (c 0.15, CHCl3). 
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5.4 Experimental Procedures for Chapter Four 
 
1-[(3aR,7aS)-2,2-Dimethyl-3a,7a-dihydro-1,3-benzodioxol-4-yl]hex-5-en-3-ol (308) 
 
O
O
HO
308
+O
O
I
H
O
O
O
OTMSH
1.  HF-pyridine, 
     THF, -78 ºC, 2h,
2. MgBr
306
305190
1. i-PrMgCl, THF,
    -30 to 0 oC, 2 h
2. Cu(I)Br•Me2S, HMPA,
    TMSCl, THF,
     -78 to 18 oC, 20 h
,THF,
-78 to 0 ºC, 1.25 h
 
 
A solution of iodide 190 (910 mg, 3.27 mmol) in THF (16 mL, 0.2 M) was cooled to -30 °C 
then treated, dropwise, with i-PrMgCl (2.5 mL of a 2.0 M solution in THF, 5.0 mmol). The 
ensuing mixture was allowed to warm to 0 °C over 2 h after which time 1H NMR analysis of the 
reaction mixture revealed that no starting material remained. Accordingly, the mixture was 
cooled to -78 °C then treated with copper (I) bromide-dimethyl sulfide complex (67 mg, 0.33 
mmol) and HMPA (1.7 mL, 9.82 mmol). A solution of acrolein (305) (459 µL, 6.87 mmol) and 
TMSCl (1.25 mL, 9.82 mmol) in THF (2 mL) was then added, dropwise via syringe pump, over 
30 min. The reaction mixture was stirred at -78 °C for 4 h and then warmed up to 18 ºC and 
stirred at this temperature for a further 16 h. The reaction mixture was treated with triethylamine 
(5 mL) and water (20 mL) then extracted with EtOAc (3 x 50 mL). The combined organic 
fractions were washed with water (2 x 20 mL) and brine (20 mL) then concentrated under 
reduced pressure to give unstable silyl enol ether 306 as a clear, colourless oil. This material 
was used in the next step of the reaction sequence without purification. 
 
1
H NMR (300 MHz) ( 6.27 (dt, J = 11.9 and 1.2 Hz, 1H), 5.96 (dd, J = 9.8 and 5.8 Hz, 1H), 
5.75 (m, 2H), 5.00 (m, 1H), 4.65 (dd, J = 8.9 and 3.8 Hz, 1H), 4.50 (d, J = 8.7 Hz, 1H), 2.80 
(qd, J = 13.7 and 7.3 Hz, 1H), 1.39 (s, 3H), 1.38 (s, 3H), 0.18 (s, 9H) 
 
A solution of silyl enol ether 306 (129.1 mg, ca. 0.460 mmol) in THF (5 mL) was cooled to -78 
ºC and treated with a solution of HF-pyridine/pyridine/THF (2:1:1, 0.1 mL, 1.28 mmol). The 
reaction mixture was stirred at this temperature for 2 h then treated with a solution of allyl 
magnesium bromide in ether (1.15 mL of a 2 M solution prepared from allyl bromide and 
magnesium, 2.30 mmol). After stirring at -78 ºC for 15 min the reaction mixture was allowed to 
slowly warm to 0 ºC and stirred for a further 1 h then poured into water (20 mL). The ensuing 
mixture was extracted with Et2O (4 x 25 mL) and the combined organic fractions were washed 
with brine (25 mL) before being dried (Na2SO4), filtered and concentrated under reduced 
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pressure. Purification of the ensuing yellow oil by flash column chromatography (silica, 3:7 v/v 
EtOAc/hexane elution) afforded, after concentration of the appropriate fractions (Rf = 0.2, 3:7 
v/v EtOAc/hexane), a ca. 1:1 mixture of the epimeric forms of the title alcohol 308 (15 mg, 13% 
over 3 steps) as a clear, colourless oil.  
 
1
H NMR (300 MHz) ( 5.97 (dd, J = 9.5 and 5.6 Hz, 1H), 5.90–5.74 (m, 3H), 5.14 (m, 2H), 4.67 
(dt, J = 8.8 and 3.2 Hz, 1H), 4.54 (dd, J = 8.5 and 6.1 Hz, 1H), 3.69 (m, 1H), 2.48–2.13 (m, 4H), 
1.96 (br s, 1H), 1.82–1.57 (m, 2H), 1.40 (s, 3H), 1.39 (s, 1.5H), 1.38 (s, 1.5H). 
13
C NMR (75 MHz) ( 138.0 (C), 137.7 (C), 134.7 (CH), 134.6 (CH), 124.6 (CH), 124.5 (CH), 
122.8 (CH), 122.7 (CH), 118.8 (CH), 118.6 (CH), 118.2 (CH2), 118.0 (CH2), 105.2(5) (C), 
105.1(8) (C), 73.5 (CH), 73.4 (CH), 71.3(3) (CH), 71.3(0) (CH), 70.4 (CH), 69.9 (CH), 42.0 
(CH2), 41.9 (CH2), 34.3 (two overlapping signals, 2 x CH2), 30.0 (CH2), 29.6 (CH2), 26.9 (CH3), 
26.8 (CH3), 25.0 (CH3), 24.9 (CH3). 
IR &max 3434, 3074, 3045, 2984, 2932, 1640, 1439, 1402, 1379, 1370, 1235, 1210, 1158, 1046, 
916, 867, 717 cm-1. 
Mass spectrum (EI, 70 eV) m/z 235 [(M – CH3•)
+, 8%], 192 (87), 175 (30), 133 (72), 121 (21), 
107 (100), 95 (29), 91 (59), 77 (59), 65 (22), 55 (29), 43 (75). 
HREIMS Found: (M – CH3•)
+, 235.1330. C15H22O3 requires (M – CH3•)
+, 235.1334. 
 
Hepta-1,6-dien-4-ol (309) 
 
309309b309a
Br
O
OH
Mg, THF,
68 oC, 3 h
OH
+
 
 
Following a procedure established by Hutchison et al.,198 allyl bromide (309a) (ca. 20 drops) 
was added dropwise to a flask containing magnesium turnings (8.20 g, 0.34 mmol) and THF (20 
mL) until initiation of the reaction was observed. A mixture of allyl bromide (28.6 mL, 0.33 
mmol) and ethyl formate (309b) (13.0 mL, 0.16 mmol) in THF (145 mL) was then added via 
dropping funnel at a rate that maintained autoreflux of the reaction mixture. After the addition 
was completed the ensuing mixture was heated at reflux for 2 h then cooled to 0 °C and HCl (10 
% aqueous solution) was added until the aqueous phase was acidic to litmus paper. The ensuing 
biphasic system was separated and the aqueous layer was extracted with Et2O (2 x 20 mL). The 
combined organic phases were washed with NaHCO3 (20 mL of a saturated aqueous solution) 
and brine (20 mL) before being dried (MgSO4), filtered and concentrated under reduced 
pressure to give a yellow oil. Distillation of this material gave hepta-1,6-dien-4-ol (309) (15.5 g, 
85 %) as a clear, colourless liquid, b.p. = 150–151 °C. 
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1
H NMR (300 MHz) ( 5.83 (m, 2H), 5.14 (m, 4H), 3.70 (m, 1H), 2.24 (m, 4H), 1.83 (br d, J = 
3.6 Hz, 1H). 
 
The data presented above as well as all the other data acquired on this compound matched those 
reported in the literature.198 
 
tert-Butyl[(1-allylbut-3-en-1-yl)oxy]dimethylsilane (310)  
 
310309
CH2Cl2, 0 to 18 ºC, 2.5 h
OH OTBS
TBSOTf, 2,6-lutidine,
 
 
A solution of hepta-1,6-dien-4-ol (309) (10.0 mL, 0.08 mol) and 2,6-lutidine (16 mL, 0.14 mol) 
in CH2Cl2 (200 mL) was cooled to 0 °C then treated, dropwise, with TBSOTf (26.5 mL, 0.12 
mol) over 30 min. The ensuing mixture was then allowed to warm to 18 °C and after stirring at 
this temperature for 2 h it was diluted with Et2O (500 mL), washed with NaHSO4 (100 mL of a 
saturated aqueous solution) and brine (100 mL) before being dried (Na2SO4), filtered and 
concentrated under reduced pressure. The ensuing clear, yellow liquid was comprised of a ca. 
1:1.4 mixture of the desired silyl ether 310 and 2,6-lutidine. This mixture was used directly in 
the ozonolysis step with the lutidine serving to attenuate the reactivity of the ozone. For the 
purposes of characterization, a small sample of the mixture was subjected to flash column 
chromatography (silica, 1:9 v/v EtOAc/hexane elution) and thus affording, after concentration 
of the appropriate fractions (Rf = 0.8, 3:7 v/v EtOAc/hexane), the title silyl ether 310 as a clear, 
colourless liquid.  
 
1
H NMR (300 MHz) ( 5.84 (m, 2H), 5.13 (m, 2H), 5.02 (m, 2H), 3.75 (qu, J = 5.9 Hz, 1H), 
2.22 (m, 4H), 0.90 (s, 9H), 0.06 (s, 6H). 
 
The data presented above as well as all the other data acquired on this compound matched those 
reported in the literature.199 
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3-{[tert-Butyl(dimethyl)silyl]oxy}hex-5-en-1-ol (311) and 3-{[tert-butyl(dimethyl)silyl]oxy}-
pentane-1,5-diol (312) 
 
312
OH
OTBSOTBS
OHHO
OTBS
1. O3, CH2Cl2/MeOH,
    -78 oC, 1 h
2. NaBH4, 0 to 18 
oC, 
    3 h
+
311310  
 
A mixture of silyl ether 310 (6.0 g, 26.5 mmol) and 2,6-lutidine (3.98 g, 37.1 mmol) in 
CH2Cl2/MeOH (60 mL of a 1:1 v/v mixture) was cooled to –78 °C then sparged with ozone 
generated using a 500 Model Fischer portable ozone-generator. After 1 h the stream of ozone 
was replaced with nitrogen then the reaction mixture was diluted with MeOH (30 mL) and 
warmed to 0 °C. Granular NaBH4 (4.00 g, 0.12 mol) was then added in portions over 1 h 
(CAUTION - vigorous reaction). The resulting solution was carefully warmed to 18 °C and 
stirred at this temperature for a further 2 h. Water (30 mL) was then added to the reaction 
mixture and after 10 min the MeOH was removed under reduced pressure. The ensuing residue 
was extracted with CH2Cl2 (3 8 100 mL) and the combined organic fractions were washed with 
brine (50 mL) then dried (Na2SO4), filtered and concentrated under reduced pressure to give a 
colourless oil that was subjected to flash column chromatography (silica, 1:9 v/v EtOAc/hexane 
then 1:4 v/v MeOH/CH2Cl2 elution). In this manner three fractions, A, B and C, were obtained.  
 
Concentration of fraction A (Rf = 0.8, 3:7 v/v EtOAc/hexane) afforded the starting silyl ether 
310 (667 mg, 11% recovery) which was identical, in all respects, with authentic material.  
 
Concentration of fraction B (Rf = 0.5, 3:7 v/v EtOAc/hexane) afforded the title alcohol 311 
(2.62 g, 48% at 89% conversion) as a clear, colourless oil.  
 
1
H NMR (300 MHz) ( 5.78 (m, 1H), 5.08 (m, 1H), 5.03 (m, 1H), 3.97 (m, 1H), 3.80 (m, 1H), 
3.70 (m, 1H), 2.52 (broad s, 1H), 2.30 (t, J = 7.08, 2H), 1.80 (m, 1H), 1.65 (m, 1H), 0.90 (s, 
9H), 0.10 (s, 3H), 0.09 (s, 3H). 
13
C NMR (75 MHz) ( 134.5 (CH), 117.3 (CH2), 71.1 (CH), 60.0 (CH2), 41.7 (CH2), 37.7 (CH2), 
25.8 (CH3), 17.9 (C), –4.4 (CH3), –4.8 (CH3). 
IR &max 3350, 3077, 2954, 2930, 2887, 2857, 1641, 1472, 1463, 1434, 1413, 1361, 1255, 1071, 
1027, 1005, 969, 938, 912, 836, 775, 666 cm–1. 
Mass spectrum (EI, 70 eV) m/z 231 [(M + H)+, <1%], 189 [(M – CH2=CHCH2•)
+, 69], 185 
(10), 173 (38), 145 (100), 131 (58), 127 (10), 119 (10), 115 (15), 105 (25).  
HREIMS Found: (M + H)+, 231.1780. C12H26O2Si requires (M + H)
+, 231.1780. Found: (M –
 CH2=CHCH2•)
+, 189.1314. C12H26O2Si requires (M – CH2=CHCH2•)
+, 189.1311. 
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Concentration of fraction C (Rf = 0.2, EtOAc) afforded diol 312 (2.86 g, 46% at 89% 
conversion) as a clear, colourless oil.  
 
1
H NMR (300 MHz) ( 4.15 (qu, J = 5.9 Hz, 1H), 3.76 (m, 4H), 2.48 (broad s, 1H), 2.41 (broad 
s, 1H), 1.81 (m, 4H), 0.90 (s, 9H), 0.12 (s, 6H). 
13
C NMR (75 MHz) ( 69.4 (CH), 59.7 (CH2), 38.4 (CH2), 25.8 (CH3), 17.9 (CH), –4.7 (CH3). 
IR &max 3338, 2953, 2930, 2886, 2857, 1472, 1463, 1409, 1386, 1361, 1256, 1060, 1028, 1005, 
865, 836, 775, 721, 664 cm–1. 
Mass spectrum (EI, 70 eV) m/z 235 [(M + H)+, <1%], 189 (11), 159 (22), 147 (15), 131 (27), 
105 (95), 75 (100), 67 (16), 55 (20), 43 (16). 
HREIMS Found: (M + H)+, 235.1727. C11H26O3Si requires (M + H)
+, 235.1729.  
 
tert-Butyl{[1-(2-iodoethyl)but-3-en-1-yl]oxy}dimethylsilane (313) 
 
313311
OH
OTBS
I
OTBSimidazole, PPh3, I2,
benzene/Et2O, 18 
oC, 2 h
 
 
A vigorously stirred solution of alcohol 311 (2.32 g, 10.1 mmol), triphenylphosphine (4.21 g, 
16.1 mmol) and imidazole (1.10 g, 16.1 mmol) in benzene/Et2O (75 mL of a 1:2 v/v mixture) 
was treated with molecular iodine (4.08 g, 16.1 mmol). After 2 h at 18 °C the reaction mixture 
was diluted with Et2O (200 mL) then washed with Na2S2O3 (100 mL of a saturated aqueous 
solution) and brine (100 mL) before being dried (Na2SO4), filtered and concentrated under 
reduced pressure. The resulting light-yellow oil was redissolved in a minimal amount of hexane 
and left to stand at 18 °C overnight. The triphenylphosphine oxide thus formed was filtered off 
and washed with hexane (3 8 20 mL). The combined filtrates were concentrated under reduced 
pressure and the residual oil subjected to flash column chromatography (silica, hexane elution). 
Concentration of the appropriate fractions (Rf = 0.6, 1:9 v/v EtOAc/hexane) afforded the title 
iodide 313 (2.6 g, 75%) as a clear, pale-yellow oil. 
 
1
H NMR (300 MHz) ( 5.78 (m, 1H), 5.08 (m, 1H), 5.03 (m, 1H), 3.80 (qu, J = 5.9 Hz, 1H), 
3.21 (m, 2H), 2.24 (t, J = 6.5 Hz, 2H), 1.95 (m, 2H), 0.89 (s, 9H), 0.10 (s, 3H), 0.09 (s, 3H). 
13
C NMR (75 MHz) ( 134.2 (CH), 117.5 (CH2), 71.6 (CH), 41.6 (CH2), 40.5 (CH2), 25.8 (CH3), 
18.0 (C), 3.3 (CH2), –4.3 (CH3), –4.5 (CH3). 
IR &max 2955, 2929, 2894, 2857, 1641, 1471, 1462, 1434, 1361, 1256, 1218, 1170, 1141, 1064, 
1003, 943, 916, 835, 811, 775, 667 cm–1. 
Mass spectrum (EI, 70 eV) m/z 339 [(M – H•)+, <1%], 299 [(M – CH2=CHCH2•)
+, 78], 283 
(100), 255 (82), 215 (27), 185 (51), 155 (27), 127 (51), 115 (39), 99 (45), 81 (65), 73 (99).  
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HREIMS Found: (M – H•)+, 339.0627. C12H25O
127ISi requires (M – H•)+, 339.0641. Found: 
(M – CH2=CHCH2•)
+, 299.0339. C12H25O
127ISi requires (M – CH2=CHCH2•)
+, 299.0328. 
 
tert-Butyl[(1-{2-[(3aR,7aS)-2,2-dimethyl-3a,7a-dihydro-1,3-benzodioxol-4-yl]ethyl}but-3-
en-1-yl)oxy]dimethylsilane (318) 
 
O
O
I
I
OTBS 1. t-BuLi, ZnI2, Et2O,
    -78  to 18 oC, 1.25 h
2. Pd(PPh3)4, THF, 
    18 oC, 3 h
+
O
O
TBSO
318
313
190
 
 
A stirred solution of iodide 313 (1.89 g, 5.55 mmol) in Et2O (28 mL) was cooled to –78 °C and 
t-BuLi (7.18 mL of a 1.7 M solution in pentane, 12.2 mmol) was added dropwise over 4 min. 
After 3 min of further stirring a solution of anhydrous ZnI2 (1.95 g, 6.10 mmol) in THF (6.1 
mL) was added. The ensuing mixture was stirred at –78 °C for a further 15 min then allowed to 
warm to 18 °C over 1 h. A solution of vinyl iodide 190 (1.54 g, 5.55 mmol) and Pd(PPh3)4 (64 
mg, 0.56 mmol) in THF (5.6 mL) was then added dropwise to give an initially pale-yellow 
reaction mixture. After stirring for 3 h the by now bright-yellow coloured reaction mixture was 
quenched with NaHCO3 (20 mL of a saturated aqueous solution) and the separated aqueous 
phase was extracted with Et2O (3 8 100 mL). The combined organic phases were washed with 
brine (50 mL) before being dried (Na2SO4), filtered and concentrated under reduced pressure to 
a yellow oil. Subjection of this material to flash column chromatography (silica, 1:99 7 1:19 
v/v EtOAc/hexane gradient elution) and concentration of the appropriate fractions (Rf = 0.4, 1:9 
v/v EtOAc/hexane) afforded a ca. 1:1 mixture of the epimeric forms of the title compound 318 
(1.52 g, 75%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( 5.70 (dd, J = 9.5 and 5.6 Hz, 1H), 5.89–5.74 (complex m, 2H), 5.71 (d, J 
= 5.6 Hz, 1H), 5.06 (d, J = 6.3 Hz, 1H), 5.01 (s, 1H), 4.65 (dd, J = 8.8 and 3.9 Hz, 1H), 4.51 
(dd, J = 8.8 and, 4.2 Hz, 1H), 3.75 (m, 1H), 2.27 (m, 4H), 1.64 (m, 2H), 1.40 (s, 3H), 1.38 (s, 
3H), 0.89 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H). 
13
C NMR (75 MHz) ( 138.8 (C), 138.7 (C), 135.2 (two signals overlapping, 2 x CH), 124.7 
(two signals overlapping, 2 x CH), 122.7 (two signals overlapping, 2 x CH), 118.2 (CH), 118.1 
(CH), 116.8 (two signals overlapping, 2 x CH2), 105.3 (two signals overlapping, 2 x C), 73.6 
(CH), 73.5 (CH), 71.7 (CH), 71.6 (CH), 71.4 (two signals overlapping, 2 x CH), 41.9 (CH2), 
41.7 (CH2), 34.3 (two signals overlapping, 2 x CH2), 29.3 (CH2), 29.2 (CH2), 26.9 (two signals 
overlapping, 2 x CH3), 25.8 (two signals overlapping, 2 x CH3), 25.1 (two signals overlapping, 
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2 x CH3), 18.1 (two signals overlapping, 2 x C), –4.3 (two signals overlapping, 2 x CH3), –4.5 
(two signals overlapping, 2 x CH3). 
IR &max 2982, 2953, 2930, 2886, 2857, 1641, 1472, 1462, 1378, 1369, 1254, 1208, 1159, 1083, 
1067, 1005, 912, 869, 835, 774, 725, 666 cm–1. 
Mass spectrum (EI, 70 eV) m/z 364 (M+•, <1%), 349 (5), 307 (8), 306 (7), 249 (37), 231 (40), 
207 (31), 181 (100), 171 (31), 133 (84), 107 (41), 75 (71), 73 (72). 
HREIMS Found: M+•, 364.2443. C21H36O3Si requires M
+•, 364.2434. 
 
tert-Butyl{[(3aS,4R,5aS,7S,9aS,9bR)-2,2-dimethyloctahydro-4H-4,9a-ethenonaphtho[1,2-
d][1,3]dioxol-7-yl]oxy}dimethylsilane (319), tert-butyl{[(3aS,4R,5aS,7R,9aS,9bR)-2,2-
dimethyloctahydro-4H-4,9a-ethenonaphtho[1,2-d][1,3]dioxol-7-yl]oxy}dimethylsilane 
(320), tert-butyl{[(3aS,4S,5aR,7R,9aR,9bR)-2,2-dimethyloctahydro-4H-4,9a-
ethenonaphtho[1,2-d][1,3]dioxol-7-yl]oxy}dimethylsilane (321) and tert-
butyl{[(3aS,4S,5aR,7S,9aR,9bR)-2,2-dimethyloctahydro-4H-4,9a-ethenonaphtho[1,2-
d][1,3]dioxol-7-yl]oxy}dimethylsilane (322) 
 
 
 
A solution of diene 318 (3.30 g, 9.10 mmol) and BHT (75 mg, 0.34 mmol) in toluene (600 mL) 
was heated at reflux for 16 h. The cooled reaction mixture was concentrated under reduced 
pressure and the ensuing yellow oil subjected to flash column chromatography (silica, 1:99 7 
1:19 v/v EtOAc/hexane gradient elution) and thus affording three fractions, A, B and C.  
 
Concentration of fraction A (Rf = 0.4, 1:9 v/v EtOAc/hexane) afforded the title compound 319 
(128 mg, 4%) as a clear, colourless oil.  
 
1
H NMR (300 MHz) ( 6.21 (t, J = ~8.3 Hz, 1H), 5.91 (d, J = 8.3 Hz, 1H), 4.09 (ddd, J = 8.3, 
4.2 and 1.0 Hz, 1H), 3.91 (broad s, 1H), 3.63 (d, J = 8.3 Hz, 1H), 2.68 (m, 1H), 2.48 (m, 1H), 
2.28–2.06 (complex m, 3H), 1.68–1.25 (complex m, 3H), 1.49 (s, 3H), 1.33 (s, 3H), 1.00 (m, 
1H), 0.90 (s, 9H), 0.47 (m, 1H), 0.02(0) (s, 3H), 0.01(6) (s, 3H). 
BHT, toluene,
319 R = H, R' = OTBS
320 R = OTBS, R' = H
O
O
TBSO
O
O
O
O
+
reflux, 16 h
321 R = H, R' = OTBS
322 R = OTBS, R' = H
R
R
R'
R'
318
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13
C NMR (75 MHz) ( 135.2 (CH), 132.9 (CH), 111.6 (C), 80.2 (CH), 75.7 (CH), 66.4 (CH), 
42.2 (C), 40.1 (CH2), 34.8 (CH), 30.2 (CH2), 27.1 (CH2), 26.2 (CH3), 25.8 (CH3), 24.7 (CH3), 
24.6 (CH2), 23.5 (CH), 18.0 (C), –4.8 (CH3), –4.9 (CH3). 
IR &max 2951, 2928, 2858, 1472, 1462, 1446, 1379, 1371, 1259, 1207, 1165, 1143, 1119, 1100, 
1088, 1062, 978, 966, 884, 864, 836, 809, 772, 706, 688, 645 cm–1. 
Mass spectrum (EI, 70 eV) m/z 364 (M+•, <1%), 349 (7), 307 (9), 275 (11), 249 (61), 231 (47), 
205 (58), 174 (51), 157 (91), 145 (41), 131 (100), 117 (31), 101 (62), 91 (60), 75 (78), 57 (31). 
HREIMS Found: M+•, 364.2427. C21H36O3Si requires M
+•, 364.2434. 
Optical Rotation [$]D = +33 (c 0.2, CHCl3). 
 
Concentration of fraction B [Rf = 0.3(7), 1:9 v/v EtOAc/hexane] afforded a 5:1 and inseparable 
mixture of the title compounds 320 and 321 (1.58 g, 48%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( (320, major isomer) 6.11 (t, J = 8.0 and 6.6 Hz, 1H), 5.84 (dd, J = 8.3 
and 1.0 Hz, 1H), 4.18 (ddd, J = 7.3, 3.2 and 1.0 Hz, 1H), 3.93 (qu, J = 2.4 Hz, 1H), 3.80 (dd, J = 
7.3 and 1.2 Hz, 1H), 2.69 (m, 1H), 1.87–1.38 (complex m, 7H), 1.32 (s, 3H), 1.27 (s, 3H), 1.10–
0.82 (complex m, 1H), 0.89 (s, 9H), 0.69 (m, 1H), 0.03 (s, 3H), 0.02 (s, 3H); (321, minor 
isomer) 6.20 (dd, J = 8.0 and 6.6 Hz, 1H), 5.89 (d, J = 8.3 Hz, 1H), 4.07 (ddd, J = 8.3, 4.2 and 
1.2 Hz, 1H), 3.68 (d, J = 8.3 Hz, 1H), 3.52 (tt, J = 10.7 and 4.2 Hz, 1H), 2.69 (m, 1H), 2.23 
(ddd, J = 12.0, 9.3 and 2.4 Hz, 1H), 1.98 (m, 1H), 1.87–1.38 (complex m, 5H), 1.32 (s, 3H), 
1.27 (s, 3H), 1.10–0.82 (complex m, 1H), 0.87 (s, 9H), 0.58 (m, 1H), 0.05 (s, 3H), 0.04 (s, 3H). 
IR &max 2930, 2884, 2860, 1472, 1462, 1370, 1251, 1207, 1167, 1081, 1065, 1036, 1020, 976, 
869, 836, 774, 725, 699, 682 cm–1. 
Mass spectrum (EI, 70 eV) m/z 364 (M+•, 3%), 349 (45), 249 (58), 231 (31), 205 (21), 174 
(95), 173 (80), 157 (61), 145 (71), 132 (90), 131 (100), 117 (34), 101 (35), 91 (65), 75 (93), 73 
(50), 59 (21), 43 (28). 
HREIMS Found: M+•, 364.2437. C21H36O3Si requires M
+•, 364.2434. 
 
Concentration of fraction C (Rf = 0.3, 1:9 v/v EtOAc/hexane) afforded the title compound 322 
(1.47 g, 45%) as a white, crystalline solid, m.p. = 119–121 °C.  
 
1
H NMR (300 MHz) ( 6.09 (dd, J = 7.8 and 6.8 Hz, 1H), 5.80 (dd, J = 8.3 and 1.0 Hz, 1H), 
4.16 (ddd, J = 7.1, 3.2 and 0.7 Hz, 1H), 3.70 (dd, J = 7.3 and 1.2 Hz, 1H), 3.49 (m, 1H), 2.71 
(m, 1H), 2.11 (dt, J = 10.0 and 3.2 Hz, 1H), 1.81 (m, 1H), 1.64 (m, 2H), 1.49–1.17 (partially 
obscured m, 3H), 1.31 (s, 3H), 1.25 (s, 3H), 0.98 (partially obscured m, 1H), 0.87 (s, 9H), 0.79 
(m, 1H), 0.04(3) (s, 3H), 0.03(7) (s, 3H). 
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13
C NMR (75 MHz) ( 132.5 (CH), 130.3 (CH), 108.3 (C), 84.1 (CH), 79.4 (CH), 71.1 (CH), 
41.7 (CH2), 41.3 (C), 34.6 (CH), 34.0 (CH), 32.2 (CH2), 30.4 (CH2), 29.4 (CH2), 25.9 (CH3), 
25.5 (CH3), 24.9 (CH3), 18.2 (C), –4.5(8) (CH3), –4.6(1) (CH3). 
IR &max 2931, 2882, 2858, 1472, 1461, 1450, 1377, 1277, 1249, 1207, 1167, 1100, 1082, 1067, 
1042, 1005, 994, 887, 871, 836, 805, 774, 726, 699, 668 cm-1. 
Mass spectrum (EI, 70 eV) m/z 364 (M+•, <<1%), 363 [(M – H•)+, <1], 349 (27), 307 (35), 249 
(86), 174 (72), 157 (71), 145 (39), 132 (65), 131 (94), 117 (29), 105 (34), 91 (65), 75 (100).  
HRIEMS Found: M+•, 364.2437. C21H36O3Si requires M
+•, 364.2434. 
Elemental Analysis Found: C, 69.43; H, 10.06. C21H36O3Si requires C, 69.18; H, 9.95%.  
Optical Rotation [$]D = +15 (c 1.0, CHCl3). 
 
(3aS,4S,5aR,7R,9aR,9bR)-2,2-Dimethyloctahydro-4H-4,9a-ethenonaphtho[1,2-
d][1,3]dioxol-7-ol (324) and (3aS,4R,5aS,7R,9aS,9bR)-2,2-dimethyloctahydro-4H-4,9a-
ethenonaphtho[1,2-d][1,3]dioxol-7-ol (323) 
 
TBAF, THF,
18 oC, 72 h
O
O
O
O
TBSO
H
OTBS
H
+
O
O
O
O
HO
H
OH
H
+
324 323
321 320
:
1 5  
 
A solution of a 5:1 mixture of silyl ethers 320 and 321 (1.59 g, 4.37 mmol) in THF (15 mL) was 
treated with tetra-n-butylammonium fluoride (10 mL of a 1.0 M solution in THF, 10 mmol) and 
the ensuing mixture was stirred at 18 °C for 72 h. The reaction mixture was then concentrated 
under reduced pressure and the brown residue so obtained was subjected to flash column 
chromatography (silica, 1:99 7 1:19 v/v EtOAc/hexane gradient elution) thus giving two 
fractions, A and B.  
 
Concentration of fraction A (Rf = 0.3, 1:1 v/v EtOAc/hexane) afforded the alcohol derived from 
ether 324 (130 mg, 12%) as a white, crystalline solid, m.p. = 80–82 °C.  
 
1
H NMR (300 MHz) ( 6.21 (dd, J = 8.2 and 6.7 Hz, 1H), 5.87 (d, J = 8.1 Hz, 1H), 4.06 (ddd, J 
= 8.2, 4.1 and 1.1 Hz, 1H), 3.67 (d, J = 8.2 Hz, 1H), 3.53 (m, 1H), 2.67 (m, 1H), 2.22 (ddd, J = 
12.2, 9.3 and 2.6 Hz, 1H), 2.05–1.86 (complex m, 2H), 1.76 (broad s, 1H), 1.72–1.55 (complex 
m, 3H), 1.47 (s, 3H), 1.37 (m, 1H, partially obscured), 1.29 (s, 3H), 0.90 (q, J = 12.5 Hz, 1H), 
0.57 (dm, J = 11.0 Hz, 1H). 
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13
C NMR (75 MHz) ( 135.0 (CH), 132.7 (CH), 111.5 (C), 79.1 (CH), 75.5 (CH), 69.8 (CH), 
41.7 (CH2), 41.4 (C), 34.7 (CH), 32.0 (CH2), 29.1 (CH), 28.9 (CH2), 26.8 (CH2), 26.3 (CH3), 
24.4 (CH3). 
IR &max 3369, 2986, 2929, 2860, 1448, 1380, 1372, 1262, 1207, 1167, 1061, 1021, 992, 882, 
863, 708, 645, 524 cm–1. 
Mass spectrum (EI, 70 eV) m/z 250 (M+•, 6%), 235 [(M – CH3•)
+, 19], 192 (21), 174 (100), 157 
(46), 150 (68), 145 (91), 131 (78), 117 (48), 101 (78), 91 (99), 43 (48).  
HREIMS Found: M+•, 250.1573. C15H22O3 requires M
+•, 250.1569. 
Optical Rotation [$]D = +32 (c 1.4, CHCl3). 
 
Concentration of fraction B [Rf = 0.2(6), 1:1 v/v EtOAc/hexane] afforded the title compound 
323 (827 mg, 76%) as a white, crystalline solid, m.p. = 134–135 °C. 
 
1
H NMR (300 MHz) ( 6.12 (dd, J = 8.0 and 6.6 Hz, 1H), 5.83 (d, J = 8.0 Hz, 1H), 4.17 (ddd, J 
= 7.3, 3.3 and 1.0 Hz, 1H), 4.01 (broad t, J = 2.3 Hz, 1H), 3.81 (dd, J = 7.3 and 1.1 Hz, 1H), 
2.72 (m, 1H), 1.90 (m, 1H), 1.78–1.56 (complex m, 6H), 1.41 (s, 1H), 1.31 (s, 3H), 1.26 (s, 3H), 
1.70 (m, 1H), 0.72 (m, 1H). 
13
C NMR (75 MHz) ( 131.8 (CH), 131.0 (CH), 108.2 (C), 83.9 (CH), 79.3 (CH), 66.1 (CH), 
41.7 (C), 38.4 (CH2), 34.4 (CH), 29.1 (CH2), 28.9 (CH2), 27.8 (CH), 25.6 (CH2), 25.5 (CH3), 
24.9 (CH3). 
IR &max 3472, 2984, 2977, 2932, 2885, 2858, 1454, 1378, 1370, 1277, 1257, 1231, 1206, 1163, 
1076, 1054, 1013, 927, 881, 822, 725, 701, 601 cm–1. 
Mass spectrum (EI, 70 eV) m/z 250 (M+•, 5%), 235 [(M – CH3
•)+, 41], 192 (49), 174 (100), 157 
(22), 145 (72), 131 (79), 117 (40), 104 (51), 91 (90), 85 (27), 77 (26), 43 (48).  
HREIMS Found: M+•, 250.1562. C15H22O3 requires M
+•, 250.1569. 
Elemental Analysis Found: C, 71.83; H, 8.62. C15H22O3 requires C, 71.97; 8.86%.  
Optical Rotation [$]D = +29 (c 1.1, CHCl3). 
 
(3aS,4S,5aR,7S,9aR,9bR)-2,2-Dimethyloctahydro-4H-4,9a-ethenonaphtho[1,2d][1,3]dioxol-
7-ol (325) 
 
O
O
OTBS
H
O
O
OH
H
TBAF, THF,
50 oC, 36 h
322 325  
 
A solution of silyl ether 322 (99 mg, 0.27 mmol) in THF (2 mL) was treated with tetra-n-
butylammonium fluoride (1 mL of a 1.0 M solution in THF, 1 mmol) and the ensuing mixture 
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was warmed to 50 °C then stirred at this temperature for 24 h. After this time, an additional 
aliquot of tetra-n-butylammonium fluoride (1 mL of a 1.0 M solution in THF, 1 mmol) was 
added and the reaction mixture was stirred at 40 °C for a further 24 h then concentrated under 
reduced pressure. The brown residue thus obtained was subjected to flash column 
chromatography (silica, 3:7 v/v EtOAc/hexane elution) and concentration of the appropriate 
fractions (Rf = 0.3, 1:1 v/v EtOAc/hexane) afforded the title alcohol 325 (58.0 mg, 85%) as a 
white, crystalline solid, m.p. = 115–116 °C.  
 
1
H NMR (300 MHz) ( 6.23 (dd, J = 8.3 and 6.8 Hz, 1H), 5.92 (d, J = 8.3 Hz, 1H), 4.07 (dd, J = 
8.3 and 3.9 Hz, 1H), 3.96 (qu, J = 2.9 Hz, 1H), 3.66 (d, J = 8.3 Hz, 1H), 2.68 (m, 1H), 2.37 (m 
1H), 2.23 (ddd, J = 12.2, 9.5 and 2.7 Hz, 1H), 2.00 (td, J = 12.2 and 4.6 Hz, 1H), 1.81–1.53 
(complex m, 4H), 1.51 (s, 3H), 1.43 (dt, J = 13.7 and 3.7 Hz, 1H), 1.31 (s, 3H), 1.12 (td, J = 
13.7 and 2.7 Hz, 1H), 0.51 (dt, J = 12.5 and 2.9 Hz, 1H). 
13
C NMR (75 MHz) ( 134.5 (CH), 133.2 (CH), 111.6 (C), 79.8 (CH), 75.6 (CH), 66.3 (CH), 
42.0 (C), 38.9 (CH2), 34.8 (CH), 29.3 (CH2), 26.6 (CH2), 26.4 (CH3), 24.5(1) (CH2), 24.5(5) 
(CH3), 23.8 (CH). 
IR &max 3432, 3038, 2976, 2919, 2861, 1446, 1379, 1372, 1262, 1207, 1166, 1062, 1009, 972, 
884, 866, 705 cm–1. 
Mass spectrum (EI, 70 eV) m/z 250 (M+•, 3%), 235 [(M – CH3
•)+, 17], 192 (16), 174 (82), 157 
(38), 145 (90), 131 (79), 117 (41), 101 (100), 91 (90), 77 (25), 43 (39). 
HREIMS Found: M+•, 250.1570. C15H22O3 requires M
+•, 250.1569. 
Elemental Analysis Found: C, 71.80; H, 8.91. C15H22O3 requires C, 71.97; H, 8.86%.  
Optical Rotation [$]D = +29 (c 1.4, CHCl3). 
 
(3aS,4S,5aS,7S,9aS,9bR)-2,2-Dimethyloctahydro-4H-4,9a-ethanonaphtho[1,2-d][1,3]-
dioxol-7-ol (327) 
 
Method 1:  
 
H2, Pd/C, EtOH,
18 oC, 16 h
O
O
H
TBSO
O
O
H
HO
319 327  
 
A solution of alkene 319 (1.51 g, 4.14 mmol) in EtOH (80 mL) was treated with 10% palladium 
on carbon (1.20 g) and the resulting suspension was stirred at 18 °C under a hydrogen 
atmosphere (1 atm) for 16 h. The reaction mixture was then filtered through a ca. 5 cm deep pad 
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of CeliteTM and the solids thus retained were washed with EtOH (2 8 20 mL) and CH2Cl2 (2 8 
20 mL). The combined filtrates were concentrated under reduced pressure to give the title 
alcohol 327 (1.02 g, 98%) as a white, crystalline solid (Rf = 0.1, 3:7 v/v EtOAc/hexane), 
 m.p. = 120–121 °C.  
 
1
H NMR (300 MHz) ( 4.13 (m, J = 8.3 Hz, 1H), 3.60 (dd, J = 8.3 and 1.7 Hz, 1H), 3.50 (m, 
1H), 1.99–1.55 (complex m, 8H), 1.51 (s, 3H), 1.43–1.07 (complex m, 7H), 1.35 (s, 3H). 
13
C NMR (75 MHz) ( 108.1 (C), 82.3 (CH), 76.2 (CH), 70.5 (CH), 39.3 (CH2), 33.3(8) (C), 
33.3(6) (CH), 32.9 (CH2), 30.8 (CH2), 30.5 (CH2), 29.1 (CH), 25.8 (CH3), 24.1 (CH3), 18.8 
(CH2), 17.2 (CH2). 
IR &max 3413, 3366, 2986, 2928, 2863, 1470, 1447, 1379, 1371, 1260, 1207, 1164, 1064, 1023, 
963, 891, 877 cm–1. 
Mass spectrum (EI, 70 eV) m/z 251 [(M – H•)+, <1%], 237 [(M – CH3
•)+, 90], 219 (15), 177 
(45), 159 (100), 131 (89), 117 (43), 105 (31), 91 (69), 79 (49), 67 (32), 43 (54).  
HREIMS Found: (M – CH3•)
+, 237.1491. C15H24O3 requires (M – CH3•)
+, 237.1491.  
Elemental Analysis Found: C, 71.21; H, 9.43. C15H24O3 requires C, 71.39; H, 9.59%.  
Optical Rotation [$]D = –51 (c 1.4, CHCl3).  
 
 Method 2: [via (3aS,4R,5aS,7S,9aS,9bR)-2,2-dimethyloctahydro-4H-4,9a-
ethenonaphtho[1,2-d][1,3]d ioxol-7-ol (326)] 
 
319 326
O
O
H
TBSO TBAF, THF,
18 oC, 16 h
O
O
H
HO
 
 
A solution of silyl ether 319 (91 mg, 0.25 mmol) in THF (2 mL) was treated with tetra-n-
butylammonium fluoride (1 mL of a 1.0 M solution in THF, 1 mmol) and the ensuing mixture 
stirred at 18 °C for 16 h. The reaction mixture was then concentrated under reduced pressure 
and the brown residue thus obtained subjected to flash column chromatography (silica, 1:1 v/v 
EtOAc/hexane elution). Concentration of the appropriate fractions (Rf = 0.3, 1:1 v/v 
EtOAc/hexane) afforded the title alcohol 326 (65 mg, 97%) as a white, crystalline solid, m.p. = 
91–93 °C. 
 
1
H NMR (300 MHz) ( 6.12 (broadened dd, J = 8.3 and 6.8 Hz, 1H), 5.80 (dd, J = 8.3 and 1.0 
Hz, 1H), 4.17 (ddd, J = 7.1, 3.2 and 1.0 Hz, 1H), 3.71 (dd, J = 7.1 and 1.2 Hz, 1H), 3.53 (m, 
1H), 2.72 (m, 1H), 2.14 (m, 1H), 1.93 (m, 1H), 1.76 (m, 1H), 1.66 (ddd, J = 13.1, 9.3 and 2.4 
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Hz, 1H), 1.58 (broad s, 1H), 1.45–1.19 (complex m, 3H), 1.30 (s, 3H), 1.25 (s, 3H), 0.93 (q, J = 
12.5 Hz, 1H), 0.80 (ddd, J = 12.5, 4.6 and 3.2 Hz, 1H). 
13
C NMR (75 MHz) ( 132.3 (CH), 130.6 (CH), 108.3 (C), 83.9 (CH), 79.3 (CH), 70.3 (CH), 
41.3 (C), 41.2 (CH2), 34.6 (CH), 33.9 (CH), 31.9 (CH2), 30.3 (CH2), 29.2 (CH2), 25.5 (CH3), 
24.9 (CH3). 
IR &max 3408, 2981, 2930, 2863, 1451, 1372, 1245, 1205, 1166, 1062, 999, 885, 726, 699 cm
–1. 
Mass spectrum (EI, 70 eV) m/z 250 (M+•, 8%), 235 (50), 192 (45), 174 (93), 145 (79), 131 
(80), 117 (49), 100 (50), 91 (100), 77 (43), 43 (79). 
HRIEMS Found: M+•, 250.1562. C15H22O3 requires M
+•, 250.1569. 
Optical Rotation [$]D = +11 (c 1.05, CHCl3).  
 
326 327
O
O
H
HO
O
O
H
HO H2, Pd/C, EtOH,
18 oC, 16 h
 
 
A solution of alkene 326 (30 mg, 0.120 mmol) in EtOH (5 mL) was treated with 10% palladium 
on carbon (10 mg) and the resulting suspension stirred at 18 °C under a hydrogen atmosphere (1 
atm) for 16 h. The reaction mixture was then filtered through a ca. 1 cm deep pad of CeliteTM 
and the solids thus retained were washed with EtOH (2 8 5 mL) and CH2Cl2 (2 8 5 mL). The 
combined filtrates were concentrated under reduced pressure to give the title alcohol 327 (30.0 
mg, 99%) as a white, crystalline solid. This material was identical, in all respects, to that 
obtained via Method 1 detailed immediately above.  
 
(3aS,4S,5aS,7R,9aS,9bR)-2,2-Dimethyloctahydro-4H-4,9a-ethanonaphtho[1,2-
d][1,3]dioxol-7-ol (328) 
 
H2, Pd/C, EtOH,
18 oC, 16 h
O
O
HO
H
O
O
HO
H
323 328  
 
A solution of alkene 323 (0.87 g, 3.46 mmol) in EtOH (70 mL) was treated with 10% palladium 
on carbon (1.0 g) and the resulting suspension was stirred at 18 °C under a hydrogen 
atmosphere (1 atm) for 16 h. The reaction mixture was filtered through a pad of CeliteTM 
(approx 5 cm thick) and the retained solids were washed with EtOH (2 x 20 mL) and CH2Cl2 (2 
x 20 mL). The combined filtrates were concentrated under reduced pressure to give title alcohol 
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328 (0.87 g, 99%) as a white crystalline solid, (Rf = 0.1, 3:7 v/v EtOAc/hexane elution), m.p. = 
131–132 °C. 
  
1
H NMR (300 MHz) ( 4.13 (dd, J = 8.3 and 3.4 Hz, 1H), 4.05 (br s, 1H), 3.69 (d, J = 8.3 Hz, 
1H), 1.89–1.29 (complex m, 13H), 1.53 (s, 3H), 1.35 (s, 3H), 1.19 (m, 1H), 1.00 (m, 1H) 
13
C NMR (75 MHz) ( 108.1 (C), 82.2 (CH), 76.2 (CH), 66.2 (CH), 36.8 (CH2), 33.8 (C), 30.8 
(CH2), 29.0 (CH), 28.2 (CH2), 27.7 (CH2), 27.3 (CH), 25.8 (CH3), 24.1 (CH3), 19.0 (CH2), 16.5 
(CH2) 
IR &max 3476, 2986, 2978, 2948, 2922, 2885, 2865, 1468, 1455, 1379, 1373, 1262, 1207, 1160, 
1053, 1036, 997, 876 cm-1 
Mass spectrum (EI, 70 eV) 237 [(M – CH3
•)+, 100], 177 (15), 159 (88), 131 (51), 117 (19), 105 
(15), 91 (31), 79 (20), 67 (16), 55 (14), 43 (25) 
HREIMS Found: (M – CH3•)
+, 237.1492. C15H24O3 requires (M – CH3•)
+, 237.1491 
Elemental Analysis Found: C, 71.18; H, 9.34. C15H24O3 requires C, 71.39; H, 9.59% 
Optical Rotation [$]D  = -29 (c 0.7, CHCl3)   
 
(3aS,4S,5aS,9aS,9bR)-2,2-Dimethyloctahydro-4H-4,9a-ethanonaphtho[1,2-d][1,3]dioxol-7-
yl benzoate (239) 
 
O
O
BzCl, DMAP, Et3N,
CH2Cl2, 0 
oC, 1h
HO
O
O
BzO
327 + 328 329  
 
A solution of a ca. 1:1 mixture of alcohols 327 and 328 (1.50 g, 5.94 mmol), triethylamine (3.3 
mL, 23.7 mmol) and 4-(N,N-dimethylamino)pyridine (2.9 g, 23.7 mmol) in CH2Cl2 (60 mL) 
was cooled to 0 °C and treated with benzoyl chloride (2.0 mL, 17.2 mmol). The ensuing mixture 
was stirred at 0 °C for 1 h then NaHCO3 (20 mL of a saturated aqueous solution) was added and 
the biphasic system so-formed was warmed to 18 °C and stirred at this temperature for 30 min. 
CH2Cl2 (40 mL) was then added and the separated aqueous phase was extracted with CH2Cl2 (2 
8 20 mL). The combined organic fractions were washed with brine (20 mL) before being dried 
(Na2SO4), filtered and concentrated under reduced pressure onto silica (ca. 4 g, 230–400 mesh). 
The ensuing free-flowing solid was subjected to flash column chromatography (1:9 7 1:4 v/v 
EtOAc/hexane gradient elution) to afford, after concentration of the appropriate fractions, a ca. 
1:1 mixture of the epimeric forms of benzoate 329 (2.01 g, 95%) as a clear, colourless and 
viscous oil (Rf = 0.2, 1:9 v/v EtOAc/hexane).  
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1
H NMR (300 MHz) ( 8.04 (m, 2H), 7.55 (m, 1H), 7.43 (m, 2H), 5.27 (broad s, 0.5H), 4.85 (m, 
0.5H), 4.15 (m, 1H), 3.73 (dd, J = 8.2 and 1.4 Hz, 0.5H), 3.64 (d, J = 8.2 Hz, 0.5H), 2.15–1.02 
(complex m, 14H), 1.54 (s, 1.5H), 1.52 (s, 1.5H), 1.37 (s, 1.5H), 1.36 (s, 1.5H). 
13
C NMR (75 MHz) ( 166.0 (C), 165.7 (C), 132.7 (two signals overlapping, 2 x CH), 130.9 (C), 
130.7 (C), 129.4(9) (CH), 129.4(6) (CH), 128.3 (CH), 128.2 (CH), 108.1(9) (C), 108.1(6) (C), 
82.3 (CH), 82.1 (CH), 76.1 (two signals overlapping, 2 x CH), 73.4 (CH), 70.2 (CH), 35.3 
(CH2), 33.9 (CH2), 33.6 (C), 33.4 (C), 33.3 (CH), 32.7 (CH2), 30.7 (two signals overlapping, 2 x 
CH2), 29.3 (CH2), 29.0(0) (CH), 28.9(5) (CH), 28.6 (CH), 26.6 (CH2), 25.8(2) (CH3), 25.7(9) 
(CH3), 25.0 (CH2), 24.2 (CH3), 24.1 (CH3), 18.9(5) (CH2), 18.9(0) (CH2), 17.1 (CH2), 16.6 
(CH2).  
IR &max 2985, 2934, 2864, 1715, 1450, 1379, 1314, 1274, 1206, 1113, 1066, 1026, 877 cm
–1. 
Mass spectrum (EI, 70 eV) m/z 341 [(M – CH3•)
+, 100], 219 (28), 159 (82), 131 (36), 105 (65), 
91 (25), 77 (31), 43 (19). 
HREIMS Found: (M – CH3•)
+, 341.1756. C22H28O4 requires (M – CH3•)
+, 341.1753. 
 
(2S,3S,4R,4aS,8aS)-3,4-Dihydroxyoctahydro-2H-2,4a-ethanonaphthalen-7-yl benzoate 
(330) 
 
O
O
BzO
110 oC, 2 days
DOWEX-50, MeOH/H2O,
329
OH
OH
BzO
330  
 
A solution of a ca. 1:1 mixture of the epimeric forms of acetonide 329 (1.00 g, 2.81 mmol) in 
MeOH/water (24 mL of a 5:1 v/v mixture) was treated with DOWEX-50 resin [1.0 g, activated 
by sequential washing with NaHCO3 (saturated aqueous solution), water, 1 M aqueous HC1 
then water]. The ensuing mixture was heated at reflux for 72 h then cooled to 18 °C and the 
DOWEX-50 was removed by filtration and washed with MeOH (3 8 10 mL). The combined 
filtrates were concentrated under reduced pressure and the aqueous residue diluted with brine 
(20 mL) and extracted with CH2Cl2 (5 8 50 mL). The combined organic fractions were then 
dried (Na2SO4), filtered and concentrated under reduced pressure. The light-yellow oil thus 
obtained was subjected to flash column chromatography (silica, 3:7 v/v EtOAc/hexane elution) 
to afford two fractions, A and B.  
 
Concentration of fraction A (Rf = 0.2, 1:9 v/v EtOAc/hexane) afforded a ca. 1:1 mixture of the 
epimeric forms of the starting acetonide 329 (367 mg, 37% recovery). Thi material was 
identical, in all respects, with the authentic material.  
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Concentration of fraction B (Rf = 0.2, 1:1 v/v EtOAc/hexane) afforded a ca. 1:1 mixture of the 
epimeric forms of diol 330 (547 mg, 97% at 63% conversion) as a clear, colourless and viscous 
oil. 
 
1
H NMR (300 MHz) ( 8.03 (d, J = 11.7 Hz, 2H), 7.55 (m, 1H), 7.43 (m, 2H), 5.26 (s, 0.5H), 
4.83 (m, 0.5H), 3.91 (broad t, J = 4.0 Hz, 1H), 3.49 (d, J = 8.2 Hz, 0.5H), 3.40 (d, J = 8.4 Hz, 
0.5H), 2.81 (broad s, 2H), 2.09–1.19 (complex m, 13H), 1.03 (m, 1H). 
13
C NMR (75 MHz) ( 166.1 (C), 165.9 (C), 132.7(9) (CH), 132.7(5) (CH), 130.8 (CH), 130.6 
(CH), 129.4(5) (CH), 129.4(0) (CH), 128.3 (CH), 128.2 (CH), 74.8 (CH), 74.7 (CH), 73.5 (CH), 
70.2 (CH), 68.4 (CH), 68.3 (CH), 35.5 (CH2), 34.6 (C), 34.4 (C), 34.0 (CH2), 33.3 (CH), 32.9 
(CH2), 31.8(2) (CH2), 31.7(5) (CH), 31.7 (CH2), 29.2 (CH2), 28.8 (CH), 26.7 (CH2), 25.0 (CH2), 
18.8 (two signals overlapping, 2 x CH2), 17.4 (CH2), 16.9 (CH2) (signal due to one carbon 
obscured/overlapping). 
IR &max 3407, 2934, 2865, 1713, 1450, 1315, 1277, 1175, 1115, 1070, 1026, 985, 713 cm
–1. 
Mass spectrum (ES, +ve ion mode) m/z 339 [(M + Na)+, 100%], 195 (11), 177 (41), 159 (49), 
149 (18). 
HRESMS Found: (M + Na)+, 339.1583. C19H24O4 requires (M + Na)
+, 339.1572. 
 
(2S,4R,4aS,8aS)-4-Hydroxy-3-oxooctahydro-2H-2,4a-ethanonaphthalen-7-yl benzoate 
(331) 
 
0  oC, 4 h
4-AcNH-TEMPO,
p-TsOH•H2O, CH2Cl2,
OH
OH
BzO
330
OH
BzO
331
O
 
 
A solution of a ca. 1:1 mixture of the epimeric forms of diol 330 (1.20 g, 3.79 mmol) in CH2Cl2 
(75 mL) was cooled to 0 °C while a solution of p-TsOH•H2O (1.5 g, 7.96 mmol) and 
4-acetamido-TEMPO (1.8 g, 8.44 mmol) in CH2Cl2 (75 mL) was prepared and allowed to stir at 
18 °C for 30 min. The latter solution was then added to the first over 1.5 h and the ensuing 
mixture was stirred at 0 °C for a further 2.5 h, warmed to 18 °C then quenched with NaHCO3 
(50 mL of a saturated aqueous solution). The separated aqueous phase was extracted with 
CH2Cl2 (3 8 50 mL) and the combined organic fractions were washed with water (50 mL) and 
brine (50 mL) before being dried (Na2SO4), filtered and concentrated under reduced pressure. 
The resulting light-yellow oil was subjected to flash column chromatography (silica, 3:7 7 1:1 
v/v EtOAc/hexane gradient elution) to afford two fractions, A and B.  
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Concentration of fraction A (Rf = 0.2, 1:1 v/v EtOAc/hexane) afforded a ca. 1:1 mixture of the 
epimeric forms of the starting diol 331 (253 mg, 21% recovery). This material was identical, in 
all respects, with authentic material.  
 
Concentration of fraction B (Rf = 0.4, 1:1 v/v EtOAc/hexane) afforded a ca. 1:1 mixture of the 
epimeric forms of the title acyloin 331 (888 mg, 94% at 79% conversion) as a clear, colourless 
and viscous oil.  
 
1
H NMR (300 MHz) ( 8.03 (dm, J = 7.5 Hz, 2H), 7.54 (m, 1H), 7.43 (m, 2H), 5.33 (t, J = 2.7 
Hz, 0.5H), 4.94 (m, 0.5H), 3.56 (d, J = 1.2 Hz, 0.5H), 3.47 (d, J = 1.7 Hz, 0.5H), 3.17 (broad s, 
1H), 2.34 (broad t, J = 2.7 Hz, 1H), 2.18–1.51 (complex m, 11H), 1.39 (td, J = 13.7 and 3.9 Hz, 
0.5H) and 1.23 (m, 1.5H).  
13
C NMR (75 MHz) ( 218.5 (C), 218.3 (C), 165.9 (C), 165.6 (C), 132.8(2) (CH), 132.7(7) 
(CH), 130.6 (C), 130.4 (C), 129.4(2) (CH), 129.3(8) (CH), 128.3 (CH), 128.2 (CH), 80.7 (CH), 
80.6 (CH), 73.0 (CH), 69.8 (CH), 41.2 (two signals overlapping, 2 x CH), 39.7 (CH), 39.4 (C), 
35.4 (CH2), 35.1 (CH2), 34.1 (CH2), 30.7 (CH), 30.2 (CH2), 28.9 (two signals overlapping, 2 x 
CH2), 26.8 (CH2), 26.6 (CH2), 26.5 (CH2), 26.4 (CH2), 25.0 (CH2), 17.2 (CH2), 16.8 (CH2). 
IR &max 3464, 2943, 2867, 1714, 1601, 1583, 1471, 1450, 1314, 1276, 1175, 1116, 1099, 1069, 
1026, 984, 970, 912, 846, 834, 806, 714, 689 cm–1. 
Mass spectrum (EI, 70 eV) m/z 314 (M+•, 5%), 192 (93), 174 (20), 164 (30), 133 (38), 105 
(100), 91 (29), 77 (52), 67 (15), 55 (14), 41 (16). 
HREIMS Found: M+•, 314.1519. C19H22O4 requires M
+•, 314.1518. 
 
(2S,4R,4aS,8aS)-3-Oxooctahydro-2H-2,4a-ethanonaphthalene-4,7-diyl dibenzoate (332) 
 
OH
BzO
331
O BzCl, DMAP, CH2Cl2,
 0 oC, 12 h OBz
BzO
332
O
 
 
A solution of a ca. 1:1 mixture of the epimeric forms of acyloin 331 (911 mg, 2.93 mmol) and 
4-(N,N-dimethylamino)pyridine (1.43 g, 11.7 mmol) in CH2Cl2 (30 mL) was cooled to 0 °C and 
treated with benzoyl chloride (1.0 mL, 8.61 mmol). The ensuing mixture was stirred for 2 h at 
0 °C then NaHCO3 (15 mL of a saturated aqueous solution) was added. The resulting biphasic 
system was warmed to 18 °C then stirred for 30 min at this temperature before being treated 
with CH2Cl2 (20 mL). The separated aqueous phase was extracted with CH2Cl2 (2 8 20 mL) and 
the combined organic fractions were washed with brine (20 mL) then dried (Na2SO4), filtered 
and concentrated under reduced pressure onto silica (ca. 2 g, 230–400 mesh). The resulting 
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free-flowing solid was subjected to flash column chromatography (1:4 v/v EtOAc/hexane 
elution) to afford a ca. 1:1 mixture of the epimeric forms of the title bis-benzoate 332 (990 mg, 
82%) as a clear, colourless and viscous oil (Rf = 0.6, 1:1 v/v EtOAc/hexane). 
  
1
H NMR (300 MHz) ( 8.05 (m, 4H), 7.57 (m, 2H), 7.45 (m, 4H), 5.35 (t, J = 2.2 Hz, 0.5H), 
5.27 (s, 0.5H), 5.18 (s, 0.5H), 4.95 (m, 0.5H), 2.44 (t, J = 2.7 Hz, 1H), 2.29–1.25 (complex m, 
13H). 
13
C NMR (75 MHz) ( 211.4 (C), 211.2 (C), 165.9 (C), 165.8 (C), 165.7 (C), 133.3 (CH), 133.0 
(CH), 132.9 (CH), 130.4 (C), 129.9 (CH), 129.8 (CH), 129.5 (CH), 129.4 (C), 128.4(2) (CH), 
128.3(8) (CH), 128.3 (CH), 79.8 (CH), 79.7 (CH), 72.7 (CH), 69.4 (CH), 41.9(2) (CH), 41.8(9) 
(CH), 39.2 (C), 38.9 (C), 35.3 (CH2), 34.8 (CH), 34.0 (CH2), 30.4(0) (CH), 30.3(8) (CH2), 
29.5(1) (CH2), 29.4(8) (CH2), 27.1 (CH2), 26.3 (CH2), 25.4 (CH2), 25.3 (CH2), 24.8 (CH2), 18.4 
(CH2), 17.9 (CH2) (signals due to six carbons obscured/overlapping). 
IR &max 2941, 2869, 1718, 1601, 1450, 1314, 1274, 1176, 1111, 1069, 1026, 989, 910, 803, 710 
cm–1. 
Mass spectrum (EI, 70 eV) m/z 418 (M+•, 32%), 313 (15), 296 (25), 191 (29), 174 (15), 163 
(19), 146 (23), 135 (30), 105 (100), 91 (21), 77 (70), 67 (14), 51 (19). 
HREIMS Found: M+•, 418.1780. C26H26O5 requires M
+•, 418.1780. 
 
(2S,4aR,8aS)-3-Oxooctahydro-2H-2,4a-ethanonaphthalen-7-yl benzoate (333) 
 
BzO
333
O
-78 oC, ca. 30 min
SmI2, THF/MeOH,
OBz
BzO
332
O
 
 
A solution of a ca. 1:1 mixture of the epimeric forms of bis-benzoate 332 (900 mg, 2.15 mmol) 
in THF/MeOH (45 mL of a 2:1 v/v mixture) was cooled to –78 °C then SmI2 (0.1 M solution in 
THF) was added dropwise until the blue colour persisted (depending on the quality of the 
samarium reagent up to 5 equivalents were required). Once addition was complete, the reaction 
mixture was allowed to stir at –78 °C for a further 15 min then poured into K2CO3 (20 mL of a 
saturated aqueous solution) and diluted with Et2O (100 mL). The separated aqueous phase was 
extracted with Et2O (2 8 50 mL) and the combined organic fractions were washed with water 
(20 mL) and brine (20 mL) before being dried (Na2SO4), filtered and concentrated under 
reduced pressure to give a ca. 1:1 mixture of the epimeric forms of compound 333 (641 mg, 
quant.) as a clear, colourless oil (Rf = 0.3, 3:7 v/v EtOAc/hexane). 
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1
H NMR (300 MHz) ( 8.00 (m, 2H), 7.51 (m, 1H), 7.39 (m, 2H), 5.28 (broad t, J = 2.2 Hz, 
0.5H), 4.86 (tt, J = 11.2 and 4.6 Hz, 0.5H), 2.23–1.45 (complex m, 13H), 1.34 (m, 1H), 1.17 (m, 
2H). 
13
C NMR (75 MHz) ( 216.3 (C), 216.1 (C), 165.6 (C), 165.4 (C), 132.6(3) (CH), 132.5(8) 
(CH), 130.4 (C), 130.3 (C), 129.2(3) (CH), 129.1(8) (CH), 128.1 (CH), 128.0 (CH), 72.9 (CH), 
69.6 (CH), 52.4 (CH2), 51.7 (CH2), 42.4 (CH), 42.2 (CH), 35.7 (CH), 35.4 (CH2), 34.5 (CH2), 
34.3 (CH2), 34.2 (C), 34.0 (C), 31.6 (CH), 31.5 (CH2), 31.4 (CH2), 31.0 (CH2), 26.5 (CH2), 24.9 
(CH2), 23.4 (CH2), 23.0 (CH2), 22.6 (CH2) (signal due to one carbon obscured/overlapping). 
IR &max 2940, 2867, 1714, 1601, 1583, 1473, 1450, 1401, 1339, 1314, 1275, 1238, 1174, 1113, 
1097, 1069, 1025, 986, 967, 945, 714 cm–1. 
Mass spectrum (EI, 70 eV) m/z 298 (M+•, <1%), 176 (100), 148 (22), 133 (40), 122 (18), 105 
(80), 91 (18), 77 (36). 
HREIMS Found: M+•, 298.1567. C19H22O3 requires M
+•, 298.1569. 
 
(2S,4aR,8aS)-3-Methyleneoctahydro-2H-2,4a-ethanonaphthalen-7-yl benzoate (334) 
 
BzO
333
O
THF, -78 to 18 oC, 3.5 h
KHMDS, Ph3PCH3Br,
BzO
334  
 
A suspension of methyltriphenylphosphonium bromide (862 mg, 2.41 mmol) in THF (10 mL) 
was treated dropwise with KHMDS (4.6 mL of a 0.5 M solution in THF, 2.28 mmol). The 
resulting bright-yellow reaction mixture was stirred at 18 °C for 1.5 h then cooled to –78 °C and 
a solution of a ca. 1:1 mixture of the epimeric forms of ketone 333 (400 mg, 1.34 mmol) in THF 
(3 mL) was added dropwise. The ensuing mixture was stirred at –78 °C for 1 h then warmed to 
18 °C and stirred at this temperature for a further 2.5 h. After this time NH4Cl (20 mL of a 
saturated aqueous solution) and Et2O (100 mL) were added to the reaction mixture. The 
separated aqueous phase was extracted with Et2O (2 8 50 mL) then the combined organic 
phases were washed with brine (20 mL) before being dried (Na2SO4), filtered and concentrated, 
under reduced pressure, onto silica (ca. 500 mg, 230–400 mesh). The resulting free-flowing 
solid was subjected to flash column chromatography (silica, 1:9 v/v EtOAc/hexane elution) to 
afford a ca. 1:1 mixture of the epimeric forms of the title alkene 334 (335 mg, 84%) as a clear, 
colourless and viscous oil (Rf = 0.6, 3:7 v/v EtOAc/hexane). 
 
1
H NMR (300 MHz) ( 8.05 (dm, J = 7.1 Hz, 2H), 7.56 (m, 1H), 7.45 (m, 2H), 5.29 (broad qu, J 
= 2.7 Hz, 1H), 4.88 (m, 1H), 4.62 (broad q, J = 2.0 Hz, 1H), 2.15–1.00 (m, 16H). 
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13
C NMR (75 MHz) ( 166.0 (C), 165.9 (C), 152.3 (C), 151.9 (C), 132.7 (two signals 
overlapping, 2 x CH), 131.0 (C), 130.8 (C), 129.5 (two signals overlapping, 2 x CH), 128.3 
(CH), 128.2 (CH), 105.0 (CH2), 104.9 (CH2), 73.7 (CH), 70.5 (CH), 44.5 (CH2), 43.9 (CH2), 
36.5 (CH), 36.2 (CH2), 35.9 (CH), 35.8 (CH), 35.3 (CH2), 35.2 (CH2) 34.8 (CH2), 32.3 (C), 32.2 
(CH), 32.1 (C), 31.9 (CH2), 27.3 (CH2), 26.9 (CH2), 26.8 (CH2), 25.6 (CH2), 24.4 (CH2), 23.9 
(CH2) (signal due to one carbon obscured/overlapping). 
IR &max 2930, 2860, 1715, 1449, 1313, 1273, 1253, 1237, 1173, 1111, 1069, 1026, 987, 971, 
868, 711, 693 cm–1. 
Mass spectrum (EI, 70 eV) m/z 296 (M+•, 12%), 277 (8), 256 (4), 174 (100), 159 (29), 145 
(33), 131 (94), 105 (85), 91 (43), 77 (60), 41 (21).  
HREIMS Found: M+•, 296.1777. C20H24O2 requires M
+•, 296.1776. 
 
(2S,4aR,8aS)-3-Methyleneoctahydro-2H-2,4a-ethanonaphthalen-7-ol (335) 
 
BzO
334
K2CO3, MeOH,
18 oC, 3 days
HO
335  
 
A solution of a ca. 1:1 mixture of the epimeric forms of benzoate 334 (355 mg, 1.20 mmol) in 
MeOH (10 mL) was treated with anhydrous K2CO3 (350 mg, 2.53 mmol). The ensuing mixture 
was stirred at 18 °C for 72 h then the MeOH was removed under a stream of nitrogen. The 
residue thus obtained was partitioned between brine (10 mL) and CH2Cl2 (20 mL) then the 
separated aqueous phase was extracted with CH2Cl2 (4 8 20 mL). The combined organic 
fractions were dried (Na2SO4), filtered and concentrated under reduced pressure to give a light-
yellow oil. Subjection of this material to flash column chromatography (silica, 1:1 v/v diethyl 
ether/pentane elution) and concentration of the appropriate fractions (Rf = 0.2, 1:1 v/v 
EtOAc/hexane) afforded a ca. 1:1 mixture of the epimeric forms of the title alcohol 335 (219 
mg, 95%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( 4.72 (qu, J = 2.2 Hz, 1H), 4.58 (qu, J = 2.0 Hz, 1H), 4.05 (m, 0.5H), 
3.52 (m, 0.5H), 2.22–0.92 (complex m, 17H). 
13
C NMR (75 MHz) ( 152.5 (C), 152.3 (C), 104.8 (CH2), 104.7 (CH2), 70.7 (CH), 66.5 (CH), 
44.5 (CH2), 43.9 (CH2), 40.2 (CH2), 37.8 (CH2), 36.5 (CH), 36.0 (CH), 35.8 (CH), 35.5 (CH2), 
35.3 (two signals overlapping, 2 x CH2), 32.5 (C), 32.0 (C), 31.1 (CH2), 31.0 (CH), 30.8 (CH2), 
28.2 (CH2), 26.9 (CH2), 26.8 (CH2), 24.4 (CH2), 23.8 (CH2). 
IR &max 3338, 2928, 2859, 1647, 1444, 1365, 1234, 1180, 1062, 1049, 1009, 919, 870 cm
–1. 
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Mass spectrum (EI, 70 eV) m/z 192 (M+•, 31%), 174 (71), 159 (30), 146 (41), 131 (100), 117 
(20), 105 (35), 91 (51), 79 (31), 67 (16), 55 (15), 41 (29). 
HREIMS Found: M+•, 192.1515. C13H20O requires M
+•, 192.1514. 
 
(2S,4aR,8aS)-3-Methyleneoctahydro-7H-2,4a-ethanonaphthalen-7-one (336) 
 
IBX, DMSO,
18 oC, 16 h
HO
335
O
336  
 
IBX (215 mg, 0.77 mmol) was added to DMSO (5 mL) and the resulting suspension stirred until 
complete dissolution had occurred (ca. 15 min). The solution so-formed was added to a ca. 1:1 
mixture of the epimeric forms of alcohol 335 (98 mg, 0.51 mmol) and the ensuing mixture 
stirred for 16 h at 18 °C in the absence of light then diluted with water (10 mL) and extracted 
with CH2Cl2 (4 8 25 mL). The combined organic fractions were washed with brine (10 mL) 
before being dried (MgSO4), filtered and concentrated under reduced pressure to give a yellow 
oil. Subjection of this material to flash column chromatography (silica, 1:4 v/v diethyl 
ether/pentane elution) afforded, after concentration of the appropriate fractions (Rf = 0.5, 3:7 v/v 
EtOAc/hexane), the title ketone 336 (97 mg, quant.) as a white crystalline solid, m.p. = 57–
59 °C. 
 
1
H NMR (300 MHz) ( 4.77 (q, J = 2.2 Hz, 1H), 4.62 (q, J = 2.1 Hz, 1H), 2.51–2.09 (complex 
m, 7H), 2.02–1.63 (complex m, 6H), 1.53 (td, J = 13.7 and 4.9 Hz, 1H), 1.24 (m, 1H), 1.12 
(ddd, J = 12.4, 5.2 and 2.1 Hz, 1H). 
13
C NMR (75 MHz) ( 211.7 (C), 150.8 (C), 105.6 (CH2), 46.3 (CH2), 43.1 (CH2), 38.8 (CH), 
37.5 (CH2), 36.8 (CH2), 35.5(4) (CH2), 35.4(8) (CH), 32.3 (C), 26.6 (CH2), 24.0 (CH2). 
IR &max 2934, 2861, 1713, 1648, 1451, 1426, 1355, 1329, 1312, 1290, 1272, 1235, 1171, 1117, 
876, 518 cm–1. 
Mass spectrum (EI, 70 eV) m/z 190 (M+•, 100%), 175 (11), 161 (10), 147 (69), 133 (38), 119 
(50), 105 (54), 91 (91), 79 (57), 77 (36), 55 (33), 41 (50). 
HREIMS Found: M+•, 190.1356. C13H18O requires M
+•, 190.1358. 
Elemental Analysis Found: C, 82.14; H, 9.49. C13H18O requires C, 82.06; H, 9.49%. 
Optical Rotation [$]D = –28 (c 1.1, CHCl3). 
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(2S,4aR,8aS)-3-Methylene-1,2,3,4,8,8a-hexahydro-7H-2,4a-ethanonaphthalen-7-one (91) 
and (2S,4aR)-3-methylene-1,2,3,4,5,6-hexahydro-7H-2,4a-ethanonaphthalen-7-one (339) 
 
1. TMSOTf, Me3N, CH2Cl2, 
    0 to 18  oC, 2 h
2. IBX, MPO, DMSO,
    18 oC, 16 h
+
O
336
O
91
O
339
 
 
Following a protocol defined by Lalic and Corey,190 a solution of ketone 336 (55 mg, 0.29 
mmol) in CH2Cl2 (2.9 mL) was cooled to 0 °C then treated with Me3N (325 µL, 3.50 mmol) and 
TMSOTf (300 µL, 1.74 mmol). The ensuing mixture was stirred at 0 °C for 1.5 h, warmed to 
18 °C, stirred at this temperature for a further 30 min then diluted with pentane (50 mL). The 
resulting mixture was extracted with NaHCO3 (10 mL of a saturated aqueous solution) and 
washed with brine (10 mL) before being dried (Na2SO4), filtered and concentrated under 
reduced pressure to give a light-yellow oil. This crude mixture of silyl enol ethers was dissolved 
in DMSO (0.1 mL) then a solution of IBX and MPO (1.1 mL of a 0.4 M solution in DMSO, 
0.44 mmol) was added. The resulting mixture was protected from light and allowed to stir at 
18 °C for 16 h then poured into NaHCO3 (5 mL of a saturated aqueous solution) and extracted 
with EtOAc (5 8 10 mL). The combined organic fractions were washed with brine (10 mL) 
before being dried (Na2SO4), filtered and concentrated under reduced pressure to give a yellow 
oil. Subjection of this material to flash column chromatography (silica, 1:9 v/v EtOAc/hexane 
elution) afforded two fractions, A and B.  
 
Concentration of fraction A (Rf = 0.5, 3:7 v/v EtOAc/hexane) afforded the title enone 91 (35 
mg, 64%) as a clear, colourless oil.  
 
1
H NMR (300 MHz) ( 6.56 (d, J = 10.3 Hz, 1H), 5.87 (dd, J = 10.3 and 1.0 Hz, 1H), 4.83 (m, 
1H), 4.68 (m, 1H), 2.49–1.95 (complex m, 7H), 1.83–1.66 (complex m, 3H), 1.50 (m, 1H), 1.19 
(ddd, J = 12.5, 7.6 and 1.5 Hz, 1H). 
13
C NMR (75 MHz) ( 200.2 (C), 156.7 (CH), 148.9 (C), 127.7 (CH), 106.9 (CH2), 41.6 (CH2), 
40.8 (CH2), 36.0 (CH), 35.5(4) (C), 35.4(6) (CH), 34.9 (CH2), 26.4 (CH2), 24.5 (CH2). 
IR &max 2938, 2865, 1682, 1469, 1449, 1429, 1414, 1391, 1272, 1251, 1235, 1167, 877, 766, 
531 cm–1. 
Mass spectrum (EI, 70 eV) m/z 188 (M+•, 31%), 145 (19), 132 (29), 117 (16), 103 (23), 86 
(89), 84 (85), 75 (16), 51 (100), 49 (92), 47 (95), 41 (37), 35 (73). 
HRIEMS Found: M+•, 188.1201. C13H16O requires M
+•, 188.1201. 
Optical Rotation [$]D = +27 (c 0.9, CHCl3) [lit.
178 [$]D = +27.5 (c 0.83, CHCl3)]. 
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The data presented above matched the equivalent spectral information reported in the 
literature.48,178  
 
Concentration of fraction B (Rf = 0.3, 3:7 v/v EtOAc/hexane) afforded the title enone 339 (12 
mg, 21%) as a clear, colourless oil. 
 
1
H NMR (300 MHz) ( 5.84 (t, J = 1.8 Hz, 1H), 4.85 (m, 1H), 4.68 (m, 1H), 2.52–2.23 
(complex m, 7H), 1.84–1.65 (complex m, 5H), 1.51 (m, 1H). 
13
C NMR (75 MHz) ( 198.5 (C), 170.0 (C), 148.7 (CH2), 124.1 (CH), 106.8 (CH2), 39.8 (CH2), 
36.7 (CH), 36.4 (C), 36.3 (C), 33.9 (CH2), 32.1 (CH2), 30.3 (CH2), 26.4 (CH2). 
IR &max 2935, 2859, 1670, 1627, 1448, 1420, 1362, 1329, 1313, 1262, 1248, 1211, 1194, 1181, 
931, 913, 880, 847, 745, 611, 515 cm–1. 
Mass spectrum (EI, 70 eV) m/z 188 (M+•, 100%), 173 (11), 160 (29), 146 (60), 131 (51), 118 
(70), 117 (65), 104 (44), 91 (60), 77 (35), 65 (34), 51 (20), 39 (39). 
HRIEMS Found: M+•, 188.1203. C13H16O requires M
+•, 188.1201. 
Optical Rotation [$]D = +30 (c 0.7, CHCl3). 
 
({1-[2-((5S,6R)-5,6-bis{[tert-Butyl(dimethyl)silyl]oxy}cyclohexa-1,3-dien-1-yl)ethyl]but-3-
en-1-yl}oxy)(tert-butyl)dimethylsilane (340) 
 
340
249313
OTBS
OTBS
I
I
OTBS
OTBS
OTBS
TBSO
1. t-BuLi, ZnI2, Et2O,
    -78  to 18 oC, 1.25 h
2. Pd(PPh3)4, THF, 
    18 oC, 3 h
+
 
 
A solution of iodide 313 (211.3 mg, 0.621 mmol) in Et2O (3 mL) was cooled to -78 °C and 
t-BuLi (804 µL of a 1.7 M solution in pentane, 1.37 mmol) was added dropwise over 4 min. 
After 3 min a solution of anhydrous ZnI2 (683 µL of a freshly prepared 1.0 M solution in THF, 
0.683 mmol) was added. The ensuing mixture was stirred at -78 °C for a further 10 min then 
allowed to warm to 18 ºC over 1 h. A solution of acetonide 249 (290 mg, 0.622 mmol) and 
Pd(PPh3)4 (72 mg, 0.062 mmol) in THF (3 mL) was then added dropwise to the reaction mixture 
to give a pale-yellow solution. After stirring for 3 h the now bright-yellow reaction mixture was 
quenched by addition of NaHCO3 (10 mL of a saturated aqueous solution) and the separated 
aqueous phase was extracted with Et2O (3 x 20 mL). Combined organic phases were washed 
with brine (10 mL) then dried (Na2SO4), filtered and concentrated under reduced pressure to 
give the crude product as a yellow oil. Purification of this material by flash column 
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chromatography (silica, 1:99 v/v EtOAc/hexane elution) and concentration of the appropriate 
fractions (Rf = 0.6, 1:9 v/v EtOAc/hexane) afforded ca. 1:1 mixture of the epimeric forms of the 
title compound 340 (224 mg, 65%) as a colourless oil. This unstable material was used directly 
in the next step of the reaction sequence without further purification. 
 
1
H NMR (300 MHz) ( 5.89–5.76 (m, 2H), 5.73 (dd, J = 9.1 and 2.7 Hz, 1H), 5.63 (m, 1H), 5.04 
(m, 2H), 4.16 (m, 1H), 3.94 (d, J = 4.8 Hz, 1H), 3.74 (m, 1H), 2.35–2.02 (m, 4H), 1.72–1.46 (m, 
2H), 0.90 (s, 27H), 0.08 (s, 9H), 0.06 (s, 9H). 
HREIMS Found: M+•, 552.3854. C30H60O3Si3 requires M
+•, 552.3850. 
 
(1S,2R)-3-(3-Hydroxyhex-5-en-1-yl)cyclohexa-3,5-diene-1,2-diol (341) 
 
340
OTBS
OTBS
TBSO
TBAF, THF,
0 to 18 oC, 2 h
341
OH
OH
HO
 
 
A solution of tris-silyl ether 340 (119.0 mg, 0.215 mmol) in THF (2 mL) was cooled to 0 ºC 
then treated with tetra-n-butyl ammonium fluoride (2 mL of a 1 M solution in THF, 2 mmol) 
The ensuing mixture was allowed to warm to 18 ºC and stirred at this temperature for 2 h then 
concentrated under reduced pressure. The brown residue thus obtained was subjected to flash 
column chromatography (silica, EtOAc then 1:9 v/v MeOH/DCM elution). Concentration of the 
appropriate fractions (Rf = 0.2, EtOAc) afforded a ca. 1:1 mixture of the epimeric forms of the 
title triol 341 (35.0 mg, 78%) as a clear, colourless oil.  
 
1
H NMR (300 MHz) ( 5.97–5.73 (m, 4H), 5.13 (d, J = 12.2 Hz, 2H), 4.27 (br s, 1H), 4.09 (t, J 
= 6.8 Hz, 1H), 3.70 (m, 1H), 2.80 (br s, 1H), 2.52–2.14 (m, 5H), 1.80–1.56 (m, 3H). 
13
C NMR (75 MHz) ( 142.0 (C), 141.5 (C), 134.6 (two signals overlapping, 2 x CH), 127.6 
(CH), 127.3 (CH), 125.1 (CH), 124.9 (CH), 119.8 (CH), 119.5 (CH), 118.3 (two signals 
overlapping, 2 x CH2), 70.6 (CH), 70.5 (CH), 70.2 (two signals overlapping, 2 x CH), 69.0 
(CH), 68.7 (CH), 42.2 (CH2), 41.9 (CH2), 35.4 (CH2), 34.9 (CH2), 30.2 (CH2), 29.8 (CH2). 
IR &max 3360, 2923, 1429, 1401, 1259, 1148, 1066, 1023, 992, 917, 808 cm
-1. 
Mass spectrum (EI, 70 eV) m/z 192 [(M – H2O)
+•, 47], 133 (67), 107 (100), 95 (35), 77 (52), 
67 (25), 55 (25), 41 (46).  
HREIMS Found: M+•, 210.1248. C12H18O3 requires M
+•, 210.1256. 
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A.1 Appendix one 
 
 X-ray crystal structure report for compound 139 
 
A full X-ray crystallographic report for compound 139 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 139.pdf 
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A.2 Appendix two 
 
 X-ray crystal structure report for compound 141 
 
A full X-ray crystallographic report for compound 141 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 141.pdf 
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A.3 Appendix three 
 
 X-ray crystal structure report for compound 133 
 
A full X-ray crystallographic report for compound 133 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 133.pdf 
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A.4 Appendix four 
 
 X-ray crystal structure report for compound 144 
 
A full X-ray crystallographic report for compound 144 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 144.pdf 
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A.5 Appendix five 
 
 X-ray crystal structure report for compound 147 
 
A full X-ray crystallographic report for compound 147 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 147.pdf 
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A.6 Appendix six 
 
 X-ray crystal structure report for compound 150 
 
A full X-ray crystallographic report for compound 150 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 150.pdf 
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A.7 Appendix seven 
 
 X-ray crystal structure report for compound 157a 
 
A full X-ray crystallographic report for compound 157a (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 157a.pdf 
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A.8 Appendix eight 
 
 X-ray crystal structure report for compound 136 
 
A full X-ray crystallographic report for compound 136 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 136.pdf 
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A.9 Appendix nine 
 
 X-ray crystal structure report for compound 229 
 
A full X-ray crystallographic report for compound 229 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 229.pdf 
 
 
 
 

Appendices 259 
A.10 Appendix ten 
 
 X-ray crystal structure report for compound 230 
 
A full X-ray crystallographic report for compound 230 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 230.pdf 
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A.11 Appendix eleven 
 
 X-ray crystal structure report for compound 237 
 
A full X-ray crystallographic report for compound 237 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 237.pdf 
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A.12 Appendix twelve 
 
 X-ray crystal structure report for compound 256a 
 
A full X-ray crystallographic report for compound 256a (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 256a.pdf 
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A.13 Appendix thirteen 
 
 X-ray crystal structure report for compound 319 
 
A full X-ray crystallographic report for compound 319 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 319.pdf 
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A.14 Appendix fourteen 
 
 X-ray crystal structure report for compound 323 
 
A full X-ray crystallographic report for compound 323 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 323.pdf 
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A.15 Appendix fifteen 
 
 X-ray crystal structure report for compound 324 
 
A full X-ray crystallographic report for compound 324 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 324.pdf 
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A.16 Appendix sixteen 
 
 X-ray crystal structure report for compound 325 
 
A full X-ray crystallographic report for compound 325 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 325.pdf 
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A.17 Appendix seventeen 
 
 X-ray crystal structure report for compound 336 
 
A full X-ray crystallographic report for compound 336 (as complied by Anthony C. 
Willis of the Australian National University) is provided in PDF-format on the compact 
disc found on the inside back cover of this thesis. 
 
X-ray report 336.pdf 
 
 
 
 
 
 
